| DUMC136 | C. albicans | Clinical isolate | ERG11 | K128T, Y132H, F145L | Multiple substitution | P10613 | 528 | 5V5Z |  | Fluconazole (>61.254) | 1999 | 10223930 |
| B59626 | C. albicans | Clinical isolate | ERG11 | K128T, A149V | Double substitution | P10613 | 528 | 5V5Z |  | Fluconazole (>64), Itraconazole (1) | 1999 | 10537192 |
| B59630 | C. albicans | Clinical isolate | ERG11 | K128T, A149V | Double substitution | P10613 | 528 | 5V5Z |  | Fluconazole (64) | 1999 | 10537192 |
| C26 | C. albicans | Clinical isolate | ERG11 | Y132H, S405F | Double substitution | P10613 | 528 | 5V5Z |  | Fluconazole (>128), Itraconazole (>2) | 1999 | 10537192 |
| C40 | C. albicans | Clinical isolate | ERG11 | Y132H, G464S, R467K | Multiple substitution | P10613 | 528 | 5V5Z |  | Fluconazole (128), Itraconazole (1) | 1999 | 10537192 |
| J913004/1 | C. albicans | Clinical isolate | ERG11 | K128T, V452A, G464S | Multiple substitution | P10613 | 528 | 5V5Z |  | Fluconazole (64), Itraconazole (1) | 1999 | 10537192 |
| NCPF 3363 | C. albicans | Clinical isolate | ERG11 | Y132H, S279F, G465S | Multiple substitution | P10613 | 528 | 5V5Z |  | Fluconazole (32), Itraconazole (2) | 1999 | 10537192 |
| Darlington (ATCC64124) | C. albicans | Clinical isolate | ERG11 | F72L, Y132H | Double substitution | Q9P4W0 | 528 | AF-Q9P4W0-F1 | Structure not available | Fluconazole (>128), Ketoconazole (32), Itraconazole (>4) | 1999 | 10537193 |
| NFI 2007 | C. albicans | Clinical isolate | ERG11 | F126L, S405F, V437I | Multiple substitution | Q9P4W0 | 528 | AF-Q9P4W0-F1 | Structure not available | Fluconazole (32), Ketoconazole (1) | 1999 | 10537193 |
| NFI 2013 | C. albicans | Clinical isolate | ERG11 | Y132H, F449L | Double substitution | Q9P4W0 | 528 | AF-Q9P4W0-F1 | Structure not available | Fluconazole (>128), Ketoconazole (0.5), Itraconazole (>4) | 1999 | 10537193 |
| NFI 2021 | C. albicans | Clinical isolate | ERG11 | K143E, T229A | Double substitution | Q9P4W0 | 528 | AF-Q9P4W0-F1 |  | Fluconazole (>128), Ketoconazole (0.25), Itraconazole (>1) | 1999 | 10537193 |
| isolate 13 | C. albicans | Clinical isolate | ERG11 | R467K | Single substitution | Q9P4W0 | 528 | AF-Q9P4W0-F1 |  | Fluconazole (32) | 1999 | 10579098 |
| Darlington strain (pDarERG11(NCPF3310)) | C. albicans | Laboratory strain | ERG11 | Y132H, I471T | Double substitution | P10613 | 528 | 5V5Z |  | Fluconazole (128) | 2000 | 11036010 |
| 1619 | C. albicans | Clinical isolate | ERG11 | G307S | Single substitution | P10613 | 528 | 5V5Z |  | Fluconazole (64) | 2001 | 11557454 |
| 2257 | C. albicans | Clinical isolate | ERG11 | S405F | Single substitution | P10613 | 528 | 5V5Z |  | Fluconazole (64) | 2001 | 11557454 |
| 2307 | C. albicans | Clinical isolate | ERG11 | K128T | Single substitution | P10613 | 528 | 5V5Z |  | Fluconazole (>64) | 2001 | 11557454 |
| 2339 | C. albicans | Clinical isolate | ERG11 | S405F | Single substitution | P10613 | 528 | 5V5Z |  | Fluconazole (64) | 2001 | 11557454 |
| 2440 | C. albicans | Clinical isolate | ERG11 | V437I | Single substitution | P10613 | 528 | 5V5Z |  | Fluconazole (64) | 2001 | 11557454 |
| 2500 | C. albicans | Clinical isolate | ERG11 | V437I | Single substitution | P10613 | 528 | 5V5Z |  | Fluconazole (64) | 2001 | 11557454 |
| 3119 | C. albicans | Clinical isolate | ERG11 | Y132F | Single substitution | P10613 | 528 | 5V5Z |  | Fluconazole (>64) | 2001 | 11557454 |
| 3120 | C. albicans | Clinical isolate | ERG11 | Y132F | Single substitution | P10613 | 528 | 5V5Z |  | Fluconazole (>64) | 2001 | 11557454 |
| 3184 | C. albicans | Clinical isolate | ERG11 | Y132F | Single substitution | P10613 | 528 | 5V5Z |  | Fluconazole (64) | 2001 | 11557454 |
| 3281 | C. albicans | Clinical isolate | ERG11 | Y132F | Single substitution | P10613 | 528 | 5V5Z |  | Fluconazole (64) | 2001 | 11557454 |
| 3731 | C. albicans | Clinical isolate | ERG11 | F126L, K143R | Double substitution | P10613 | 528 | 5V5Z |  | Fluconazole (>64) | 2001 | 11557454 |
| 3733 | C. albicans | Clinical isolate | ERG11 | F126L, K143R | Double substitution | P10613 | 528 | 5V5Z |  | Fluconazole (64) | 2001 | 11557454 |
| 3795 | C. albicans | Clinical isolate | ERG11 | F126L, K143R | Double substitution | P10613 | 528 | 5V5Z |  | Fluconazole (>64) | 2001 | 11557454 |
| 4380 | C. albicans | Clinical isolate | ERG11 | V437I | Single substitution | P10613 | 528 | 5V5Z |  | Fluconazole (64) | 2001 | 11557454 |
| 4617 | C. albicans | Clinical isolate | ERG11 | T229A, F449S | Double substitution | P10613 | 528 | 5V5Z |  | Fluconazole (64) | 2001 | 11557454 |
| 4639 | C. albicans | Clinical isolate | ERG11 | T229A, F449S | Double substitution | P10613 | 528 | 5V5Z |  | Fluconazole (>64) | 2001 | 11557454 |
| 5052 | C. albicans | Clinical isolate | ERG11 | V437I, D446N | Double substitution | P10613 | 528 | 5V5Z |  | Fluconazole (64) | 2001 | 11557454 |
| 5108 | C. albicans | Clinical isolate | ERG11 | V437I, G464S | Double substitution | P10613 | 528 | 5V5Z | Structure not available | Fluconazole (64) | 2001 | 11557454 |
| R3.8 | C. albicans | Clinical isolate | ERG11 | G464S | Single substitution | Q9P4W0 | 528 | AF-Q9P4W0-F1 |  | Fluconazole (64) | 2002 | 11864952 |
| R5.1 | C. albicans | Clinical isolate | ERG11 | G464S | Single substitution | Q9P4W0 | 528 | AF-Q9P4W0-F1 |  | Fluconazole (64) | 2002 | 11864952 |
| S2.2 | C. albicans | Clinical isolate | ERG11 | G464S | Single substitution | Q9P4W0 | 528 | AF-Q9P4W0-F1 |  | Fluconazole (64) | 2002 | 11864952 |
| 3946(Patient1) | C. dubliniensis | Clinical isolate | ERG11 | F126L, T199A, R210G | Multiple substitution | B9WH07 | 528 | AF-B9WH07-F1 |  | Fluconazole (64) | 2002 | 12019078 |
| 4380(Patient1) | C. dubliniensis | Clinical isolate | ERG11 | G464S | Single substitution | B9WH07 | 528 | AF-B9WH07-F1 |  | Fluconazole (64) | 2002 | 12019078 |
| 4572(Patient 2) | C. dubliniensis | Clinical isolate | ERG11 | S113F, G289D | Double substitution | B9WH07 | 528 | AF-B9WH07-F1 |  | Fluconazole (64) | 2002 | 12019078 |
| 4713(Patient1) | C. dubliniensis | Clinical isolate | ERG11 | G464S | Single substitution | B9WH07 | 528 | AF-B9WH07-F1 |  | Fluconazole (64) | 2002 | 12019078 |
| 4806(Patient1) | C. dubliniensis | Clinical isolate | ERG11 | F148L, G307A, P515S | Multiple substitution | B9WH07 | 528 | AF-B9WH07-F1 |  | Fluconazole (64) | 2002 | 12019078 |
| 4807(Patient1) | C. dubliniensis | Clinical isolate | ERG11 | D288G, L300P, V437A | Multiple substitution | B9WH07 | 528 | AF-B9WH07-F1 |  | Fluconazole (32) | 2002 | 12019078 |
| 5143(Patient1) | C. dubliniensis | Clinical isolate | ERG11 | V125A, F126L, R398G, V437A | Multiple substitution | B9WH07 | 528 | AF-B9WH07-F1 |  | Fluconazole (32) | 2002 | 12019078 |
| CD36-C | C. dubliniensis | Laboratory strain | ERG3 | H318N, P272L | Double substitution | Q8NJ57 | 386 | AF-Q8NJ57-F1 |  | Fluconazole (256), Itraconazole (64), Ketoconazole (2) | 2003 | 12878500 |
| CD36-F | C. dubliniensis | Laboratory strain | ERG3 | Q160K | Single substitution | Q8NJ57 | 386 | AF-Q8NJ57-F1 |  | Fluconazole (256), Itraconazole (64), Ketoconazole (2) | 2003 | 12878500 |
| CD519-8A | C. dubliniensis | Laboratory strain | ERG11 | V402G, I188V, R499K | Multiple substitution | B9WH07 | 528 | AF-B9WH07-F1 |  | Fluconazole (128), Itraconazole (32), Ketoconazole (4) | 2003 | 12878500 |
| CD570-A | C. dubliniensis | Laboratory strain | ERG11ERG3 | R210I, D225YH269N | Double substitutionSingle substitution | B9WH07Q8NJ57 | 528386 | AF-B9WH07-F1AF-Q8NJ57-F1 |  | Fluconazole (256), Itraconazole (64), Ketoconazole (2) | 2003 | 12878500 |
| CD570-B | C. dubliniensis | Laboratory strain | ERG11 | R210I, D225Y | Double substitution | B9WH07 | 528 | AF-B9WH07-F1 |  | Fluconazole (256), Itraconazole (64), Ketoconazole (4) | 2003 | 12878500 |
| CD570-C | C. dubliniensis | Laboratory strain | ERG11ERG3 | R210I, D225YQ327K | Double substitutionSingle substitution | B9WH07Q8NJ57 | 528386 | AF-B9WH07-F1AF-Q8NJ57-F1 |  | Fluconazole (256), Itraconazole (64), Ketoconazole (2) | 2003 | 12878500 |
| CD570-D | C. dubliniensis | Laboratory strain | ERG11ERG3 | R210I, D225YQ327K | Double substitutionSingle substitution | B9WH07Q8NJ57 | 528386 | AF-B9WH07-F1AF-Q8NJ57-F1 |  | Fluconazole (256), Itraconazole (32), Ketoconazole (1) | 2003 | 12878500 |
| C369 | C. albicans | Clinical isolate | ERG11 | K128T, Y132H, D278N, G464S | Multiple substitution | P10613 | 528 | 5V5Z |  | Itraconazole (1), Voriconazole (2), Posaconazole (0.25) | 2004 | 14657086 |
| C371 | C. albicans | Clinical isolate | ERG11 | K128T, Y132H, D278N, G464S | Multiple substitution | P10613 | 528 | 5V5Z |  | Itraconazole (1), Voriconazole (4), Posaconazole (0.25), Fluconazole (>64) | 2004 | 14657086 |
| C372 | C. albicans | Clinical isolate | ERG11 | K128T, Y132H, D278N, G464S | Multiple substitution | P10613 | 528 | 5V5Z |  | Itraconazole (1), Voriconazole (2), Posaconazole (0.25), Fluconazole (>64) | 2004 | 14657086 |
| C373 | C. albicans | Clinical isolate | ERG11 | K128T, Y132H, D278N, G464S, P230L | Multiple substitution | P10613 | 528 | 5V5Z |  | Itraconazole (16), Voriconazole (4), Posaconazole (2), Fluconazole (>64) | 2004 | 14657086 |
| C375 | C. albicans | Clinical isolate | ERG11 | K128T, Y132H, D278N, G464S, P230L | Multiple substitution | P10613 | 528 | 5V5Z |  | Itraconazole (16), Voriconazole (2), Posaconazole (2) | 2004 | 14657086 |
| C376 | C. albicans | Clinical isolate | ERG11 | K128T, Y132H, D278N, G464S, P230L | Multiple substitution | P10613 | 528 | 5V5Z |  | Itraconazole (16), Voriconazole (2), Posaconazole (2) | 2004 | 14657086 |
| C378 | C. albicans | Clinical isolate | ERG11 | K128T, Y132H, D278N, G464S | Multiple substitution | P10613 | 528 | 5V5Z |  | Itraconazole (1), Voriconazole (2), Posaconazole (0.25) | 2004 | 14657086 |
| isolate 1 | C. albicans | Clinical isolate | ERG11 | K128T | Single substitution | P10613 | 528 | 5V5Z |  | Fluconazole (>64) | 2004 | 14688046 |
| isolate 10 | C. albicans | Clinical isolate | ERG11 | V509M | Single substitution | P10613 | 528 | 5V5Z |  | Fluconazole (64) | 2004 | 14688046 |
| isolate 11 | C. albicans | Clinical isolate | ERG11 | K143R | Single substitution | P10613 | 528 | 5V5Z |  | Fluconazole (>64) | 2004 | 14688046 |
| isolate 12 | C. albicans | Clinical isolate | ERG11 | R467K | Single substitution | P10613 | 528 | 5V5Z |  | Fluconazole (>64) | 2004 | 14688046 |
| isolate 5 | C. albicans | Clinical isolate | ERG11 | V437I | Single substitution | P10613 | 528 | 5V5Z |  | Fluconazole (>64) | 2004 | 14688046 |
| isolate 7 | C. albicans | Clinical isolate | ERG11 | K128T | Single substitution | P10613 | 528 | 5V5Z |  | Fluconazole (>64) | 2004 | 14688046 |
| C438 | C. albicans | Clinical isolate | ERG11 | Y257H, G464S | Double substitution | P10613 | 528 | 5V5Z |  | Fluconazole (128), Voriconazole (2) | 2004 | 15155210 |
| C439 | C. albicans | Clinical isolate | ERG11 | Y257H, G464S, G307S | Multiple substitution | P10613 | 528 | 5V5Z |  | Itraconazole (4), Fluconazole (>256), Voriconazole (16) | 2004 | 15155210 |
| C440 | C. albicans | Clinical isolate | ERG11 | Y257H, G464S, G307S, A61V | Multiple substitution | P10613 | 528 | 5V5Z |  | Posaconazole (4), Itraconazole (8), Fluconazole (>256), Voriconazole (>16) | 2004 | 15155210 |
| C444 | C. albicans | Clinical isolate | ERG11 | K143R | Single substitution | P10613 | 528 | 5V5Z |  | Fluconazole (256), Posaconazole (0.5), Itraconazole (0.5), Voriconazole (0.5) | 2004 | 15155210 |
| C477 | C. albicans | Clinical isolate | ERG11 | K128T, G464S, R467I | Multiple substitution | P10613 | 528 | 5V5Z |  | Fluconazole (256), Voriconazole (16) | 2004 | 15155210 |
| C478 | C. albicans | Clinical isolate | ERG11 | S405F | Single substitution | P10613 | 528 | 5V5Z |  | Fluconazole (64) | 2004 | 15155210 |
| C480 | C. albicans | Clinical isolate | ERG11 | K128T, G464S, R467I | Multiple substitution | P10613 | 528 | 5V5Z |  | Fluconazole (128), Voriconazole (8) | 2004 | 15155210 |
| C489 | C. albicans | Clinical isolate | ERG11 | Y132H, Y257H | Double substitution | P10613 | 528 | 5V5Z |  | Fluconazole (128) | 2004 | 15155210 |
| C497 | C. albicans | Clinical isolate | ERG11 | K128T, V452A | Double substitution | P10613 | 528 | 5V5Z |  | Itraconazole (2), Fluconazole (64), Posaconazole (0.5), Voriconazole (0.5) | 2004 | 15155210 |
| C507 | C. albicans | Clinical isolate | ERG11 | Y132H, H283R, G464S | Multiple substitution | P10613 | 528 | 5V5Z |  | Itraconazole (2), Fluconazole (64), Voriconazole (8) | 2004 | 15155210 |
| C527 | C. albicans | Clinical isolate | ERG11 | Y132H | Single substitution | P10613 | 528 | 5V5Z |  | Fluconazole (256), Voriconazole (4) | 2004 | 15155210 |
| C528 | C. albicans | Clinical isolate | ERG11 | Y132H | Single substitution | P10613 | 528 | 5V5Z |  | Fluconazole (256), Voriconazole (4) | 2004 | 15155210 |
| C530 | C. albicans | Clinical isolate | ERG11 | G464S | Single substitution | P10613 | 528 | 5V5Z |  | Fluconazole (256) | 2004 | 15155210 |
| C534 | C. albicans | Clinical isolate | ERG11 | Y132H | Single substitution | P10613 | 528 | 5V5Z |  | Fluconazole (256), Voriconazole (4) | 2004 | 15155210 |
| C535 | C. albicans | Clinical isolate | ERG11 | Y132H, G448V | Double substitution | P10613 | 528 | 5V5Z |  | Itraconazole (2), Fluconazole (256), Voriconazole (8) | 2004 | 15155210 |
| C536 | C. albicans | Clinical isolate | ERG11 | Y132H | Single substitution | P10613 | 528 | 5V5Z |  | Fluconazole (256), Voriconazole (4) | 2004 | 15155210 |
| C539 | C. albicans | Clinical isolate | ERG11 | Y132H, G448V | Double substitution | P10613 | 528 | 5V5Z |  | Itraconazole (2), Fluconazole (128), Voriconazole (8) | 2004 | 15155210 |
| C546 | C. albicans | Clinical isolate | ERG11 | Y132H | Single substitution | P10613 | 528 | 5V5Z |  | Fluconazole (128), Voriconazole (2) | 2004 | 15155210 |
| C572 | C. albicans | Clinical isolate | ERG11 | Y132H | Single substitution | P10613 | 528 | 5V5Z |  | Fluconazole (128), Voriconazole (2) | 2004 | 15155210 |
| C577 | C. albicans | Clinical isolate | ERG11 | G464S | Single substitution | P10613 | 528 | 5V5Z |  | Fluconazole (128) | 2004 | 15155210 |
| C583 | C. albicans | Clinical isolate | ERG11 | G464S | Single substitution | P10613 | 528 | 5V5Z |  | Fluconazole (256) | 2004 | 15155210 |
| C587 | C. albicans | Clinical isolate | ERG11 | G464S | Single substitution | P10613 | 528 | 5V5Z |  | Fluconazole (256), Voriconazole (4) | 2004 | 15155210 |
| C594 | C. albicans | Clinical isolate | ERG11 | Y132H, S405F | Double substitution | P10613 | 528 | 5V5Z |  | Itraconazole (2), Fluconazole (128), Voriconazole (16), Posaconazole (0.5) | 2004 | 15155210 |
| C600 | C. albicans | Clinical isolate | ERG11 | Y132H, S405F | Double substitution | P10613 | 528 | 5V5Z |  | Itraconazole (4), Fluconazole (>256), Voriconazole (16) | 2004 | 15155210 |
| 148032 | C. albicans | Clinical isolate | FCY1FUR1 | A31R, G107RC301Y | Double substitutionSingle substitution | P78594Q59QT3 | 150218 | AF-P78594-F17RH8 |  | 5-Flucytosine (128) | 2004 | 15155225 |
| 152050 | C. albicans | Clinical isolate | FUR1 | R101C | Single substitution | Q59QT3 | 218 | 7RH8 |  | 5-Flucytosine (128) | 2004 | 15155225 |
| 157023 | C. albicans | Clinical isolate | FCY1FUR1 | A31G, G107AR101C | Double substitutionSingle substitution | P78594Q59QT3 | 150218 | AF-P78594-F17RH8 |  | 5-Flucytosine (128) | 2004 | 15155225 |
| 175001 | C. albicans | Clinical isolate | FCY1FUR1 | A31G, G107AR101C | Double substitutionSingle substitution | P78594Q59QT3 | 150218 | AF-P78594-F17RH8 |  | 5-Flucytosine (128) | 2004 | 15155225 |
| 178010 | C. albicans | Clinical isolate | FCY1FUR1 | A31G, G107AR101C | Double substitutionSingle substitution | P78594Q59QT3 | 150218 | AF-P78594-F17RH8 |  | 5-Flucytosine (128) | 2004 | 15155225 |
| 14 | C. albicans | Clinical isolate | ERG11 | F380S | Single substitution | P10613 | 528 | 5V5Z |  | Fluconazole (>64) | 2004 | 15380275 |
| 21 | C. albicans | Clinical isolate | ERG11 | H283D | Single substitution | P10613 | 528 | 5V5Z |  | Ketoconazole (1) | 2004 | 15380275 |
| 23 | C. albicans | Clinical isolate | ERG11 | Y132F, F145L | Double substitution | P10613 | 528 | 5V5Z |  | Fluconazole (>64) | 2004 | 15380275 |
| 33 | C. albicans | Clinical isolate | ERG11 | K143E, P503L | Double substitution | P10613 | 528 | 5V5Z |  | Fluconazole (64) | 2004 | 15380275 |
| 36 | C. albicans | Clinical isolate | ERG11 | Y79C, T199I | Double substitution | P10613 | 528 | 5V5Z |  | Fluconazole (>64), Ketoconazole (2) | 2004 | 15380275 |
| 68 | C. albicans | Clinical isolate | ERG11 | I253V, V437I | Double substitution | P10613 | 528 | 5V5Z |  | Fluconazole (64) | 2004 | 15380275 |
| 8 | C. albicans | Clinical isolate | ERG11 | V130I | Single substitution | P10613 | 528 | 5V5Z |  | Fluconazole (64) | 2004 | 15380275 |
| C532 | C. albicans | Clinical isolate | ERG11 | Y132H | Single substitution | P10613 | 528 | 5V5Z |  | Fluconazole (256), Itraconazole (1), Voriconazole (8), Posaconazole (0.25) | 2004 | 15388421 |
| C600 | C. albicans | Clinical isolate | ERG11 | Y132H, S405F | Double substitution | P10613 | 528 | 5V5Z |  | Fluconazole (>256), Itraconazole (8), Voriconazole (8), Posaconazole (1) | 2004 | 15388421 |
| TIMM3209 | C. albicans | Clinical isolate | ERG11 | Y132H, G448V | Double substitution | P10613 | 528 | 5V5Z |  | Fluconazole (>128), Itraconazole (1) | 2004 | 15611610 |
| CLY16038 | C. krusei | Clinical isolate | FKS1 | R1361G | Single substitution | Q4U2W2 | 1885 | Model | Mismatch residue | Caspofungin (32) [RPMI 1640], Caspofungin (16) [AM3] | 2005 | 16048935 |
| CLY16996 | C. albicans | Clinical isolate | FKS1 | S645F | Single substitution | O13428 | 1897 | Model |  | Caspofungin (>8) [RPMI 1640], Caspofungin (2) [AM3] | 2005 | 16048935 |
| CLY16997 | C. albicans | Clinical isolate | FKS1 | S645P | Single substitution | O13428 | 1897 | Model |  | Caspofungin (>8) [RPMI 1640], Caspofungin (4) [AM3] | 2005 | 16048935 |
| CLY19230 | C. albicans | Clinical isolate | FKS1 | S645F | Single substitution | O13428 | 1897 | Model |  | Caspofungin (4) [RPMI 640], Caspofungin (2) [AM3] | 2005 | 16048935 |
| CLY19231 | C. albicans | Clinical isolate | FKS1 | S645F | Single substitution | O13428 | 1897 | Model |  | Caspofungin (4) [RPMI 1640], Caspofungin (2) [AM3] | 2005 | 16048935 |
| ISOLATE 29 | C. albicans | Clinical isolate | ERG11 | G464S | Single substitution | P10613 | 528 | 5V5Z |  | Fluconazole (>64) | 2005 | 16201925 |
| ISOLATE 34 | C. albicans | Clinical isolate | ERG11 | S405F | Single substitution | P10613 | 528 | 5V5Z |  | Fluconazole (>64) | 2005 | 16201925 |
| ISOLATE 35 | C. albicans | Clinical isolate | ERG11 | K128T | Single substitution | P10613 | 528 | 5V5Z |  | Fluconazole (>64) | 2005 | 16201925 |
| ISOLATE 36 | C. albicans | Clinical isolate | ERG11 | S405F | Single substitution | P10613 | 528 | 5V5Z |  | Fluconazole (>64) | 2005 | 16201925 |
| ISOLATE 37 | C. albicans | Clinical isolate | ERG11 | V437I | Single substitution | P10613 | 528 | 5V5Z |  | Fluconazole (>64) | 2005 | 16201925 |
| ISOLATE 38 | C. albicans | Clinical isolate | ERG11 | V437I | Single substitution | P10613 | 528 | 5V5Z |  | Fluconazole (>64) | 2005 | 16201925 |
| ISOLATE 41 | C. albicans | Clinical isolate | ERG11 | Y132F | Single substitution | P10613 | 528 | 5V5Z |  | Fluconazole (>64) | 2005 | 16201925 |
| ISOLATE 42 | C. albicans | Clinical isolate | ERG11 | Y132F | Single substitution | P10613 | 528 | 5V5Z |  | Fluconazole (>64) | 2005 | 16201925 |
| ISOLATE 43 | C. albicans | Clinical isolate | ERG11 | Y132F | Single substitution | P10613 | 528 | 5V5Z |  | Fluconazole (>64) | 2005 | 16201925 |
| ISOLATE 44 | C. albicans | Clinical isolate | ERG11 | Y132F | Single substitution | P10613 | 528 | 5V5Z |  | Fluconazole (>64) | 2005 | 16201925 |
| ISOLATE 45 | C. albicans | Clinical isolate | ERG11 | F126L, K143R | Double substitution | P10613 | 528 | 5V5Z |  | Fluconazole (>64) | 2005 | 16201925 |
| ISOLATE 46 | C. albicans | Clinical isolate | ERG11 | F126L, K143R | Double substitution | P10613 | 528 | 5V5Z |  | Fluconazole (>64) | 2005 | 16201925 |
| ISOLATE 47 | C. albicans | Clinical isolate | ERG11 | F126L, K143R | Double substitution | P10613 | 528 | 5V5Z |  | Fluconazole (>64) | 2005 | 16201925 |
| ISOLATE 48 | C. albicans | Clinical isolate | ERG11 | T229A | Single substitution | P10613 | 528 | 5V5Z |  | Fluconazole (>64) | 2005 | 16201925 |
| ISOLATE 49 | C. albicans | Clinical isolate | ERG11 | T229A | Single substitution | P10613 | 528 | 5V5Z |  | Fluconazole (>64) | 2005 | 16201925 |
| ISOLATE 50 | C. albicans | Clinical isolate | ERG11 | V437I, D446N | Double substitution | P10613 | 528 | 5V5Z |  | Fluconazole (>64) | 2005 | 16201925 |
| ISOLATE 51 | C. albicans | Clinical isolate | ERG11 | G464S | Single substitution | P10613 | 528 | 5V5Z |  | Fluconazole (>64) | 2005 | 16201925 |
| 21234 | C. tropicalis | Clinical isolate | ERG11 | Y132F | Single substitution | P14263 | 528 | AF-P14263-F1 |  | Clotrimazole (>250), Ketoconazole (1.5), Fluconazole (>256), Voriconazole (>32) | 2005 | 16251302 |
| Baseline | C. albicans | Clinical isolate | ERG11 | F145L | Single substitution | Q9P4W0 | 528 | AF-Q9P4W0-F1 |  | Fluconazole (32), Ravuconazole (4) | 2006 | 16464893 |
| week 36 no.1 | C. albicans | Clinical isolate | ERG11FKS1 | F145LS645F, R1361H | Single substitutionDouble substitution | Q9P4W0O13428 | 5281897 | AF-Q9P4W0-F1Model |  | Amphotericin B (2), Itraconazole (2), Fluconazole (256), Voriconazole (2), Ravuconazole (>=16), Posaconazole (1), Micafungin (2), Caspofungin (2), Anidulafungin (1) | 2006 | 16464893 |
| week 36 no.2 | C. albicans | Clinical isolate | ERG11FKS1 | F145LS645F, R1361H | Single substitutionDouble substitution | Q9P4W0O13428 | 5281897 | AF-Q9P4W0-F1Model |  | Itraconazole (>16), Fluconazole (>=512), Voriconazole (>=16), Ravuconazole (>=16), Posaconazole (2), Micafungin (2), Caspofungin (1) | 2006 | 16464893 |
| week 6 | C. albicans | Clinical isolate | ERG11FKS1 | F145LS645F, R1361H | Single substitutionDouble substitution | Q9P4W0O13428 | 5281897 | AF-Q9P4W0-F1Model |  | Amphotericin B (2), Fluconazole (64), Voriconazole (1), Ravuconazole (4), Micafungin (2), Caspofungin (2), Anidulafungin (1) | 2006 | 16464893 |
| cg13928 | C. glabrata | Clinical isolate | PDR1 | F575L | Single substitution | Q6FXU7 | 1107 | AF-Q6FXU7-F1 |  | Fluconazole (128) | 2006 | 16569856 |
| cg4672 | C. glabrata | Clinical isolate | PDR1 | W297S | Single substitution | Q6FXU7 | 1107 | AF-Q6FXU7-F1 |  | Fluconazole (256) | 2006 | 16569856 |
| Cg-ATCC2001-R | C. glabrata | Laboratory strain | FKS2 | F659V | Single substitution | Q6FMZ3 | 1897 | Model |  | Caspofungin (2) | 2006 | 16870797 |
| AL-10R | C. albicans | Clinical isolate | CDR1 | T950S | Single substitution | Q5ANA3 | 1501 | AF-Q5ANA3-F1 |  | Fluconazole (64) | 2007 | 17126815 |
| AL-1R | C. albicans | Clinical isolate | CDR1 | T950S | Single substitution | Q5ANA3 | 1501 | AF-Q5ANA3-F1 |  | Fluconazole (64), Ketoconazole (2), Itraconazole (8) | 2007 | 17126815 |
| AL-2R | C. albicans | Clinical isolate | CDR1 | T950S | Single substitution | Q5ANA3 | 1501 | AF-Q5ANA3-F1 |  | Fluconazole (64), Ketoconazole (1), Itraconazole (1) | 2007 | 17126815 |
| AL-3R | C. albicans | Clinical isolate | CDR1 | I916V, T950S, A1416E | Multiple substitution | Q5ANA3 | 1501 | AF-Q5ANA3-F1 | Mismatch residue | Fluconazole (64) | 2007 | 17126815 |
| AL-4R | C. albicans | Clinical isolate | CDR1 | T842S, I916V, T950S, F1399Y | Multiple substitution | Q5ANA3 | 1501 | AF-Q5ANA3-F1 |  | Fluconazole (64), Itraconazole (2) | 2007 | 17126815 |
| AL-5R | C. albicans | Clinical isolate | CDR1 | T950S | Single substitution | Q5ANA3 | 1501 | AF-Q5ANA3-F1 |  | Fluconazole (64), Ketoconazole (2), Itraconazole (1) | 2007 | 17126815 |
| AL-6R | C. albicans | Clinical isolate | CDR1 | I916V, T950S | Double substitution | Q5ANA3 | 1501 | AF-Q5ANA3-F1 |  | Fluconazole (64), Itraconazole (4) | 2007 | 17126815 |
| AL-7R | C. albicans | Clinical isolate | CDR1 | T842S, I916V, T950S | Multiple substitution | Q5ANA3 | 1501 | AF-Q5ANA3-F1 |  | Fluconazole (64) | 2007 | 17126815 |
| AL-8R | C. albicans | Clinical isolate | CDR1 | I916V, T950S, A1416E | Multiple substitution | Q5ANA3 | 1501 | AF-Q5ANA3-F1 | Mismatch residue | Fluconazole (64), Ketoconazole (4), Itraconazole (2) | 2007 | 17126815 |
| AL-9R | C. albicans | Clinical isolate | CDR1 | I916V, T950S | Double substitution | Q5ANA3 | 1501 | AF-Q5ANA3-F1 |  | Fluconazole (64), Ketoconazole (2), Itraconazole (8) | 2007 | 17126815 |
| 21229 | C. glabrata | Clinical isolate | ERG6 | C198F | Single substitution | Q6FRZ7 | 372 | AF-Q6FRZ7-F1 |  | Amphotericin B (1.3) | 2007 | 17158937 |
| Ck-100 | C. krusei | Clinical isolate | FKS1 | F655C | Single substitution | Q4U2W2 | 1885 | Model |  | Caspofungin (8), Micafungin (4), Anidulafungin (4) | 2007 | 17325225 |
| isolate 3 | C. albicans | Clinical isolate | FKS1 | F641S | Single substitution | A0A1D8PCT0 | 1897 | AF-A0A1D8PCT0-F1 |  | Caspofungin (2), Micafungin (0.5) | 2007 | 17468115 |
| isolate 4 | C. albicans | Clinical isolate | FKS1 | F641S | Single substitution | A0A1D8PCT0 | 1897 | AF-A0A1D8PCT0-F1 |  | Caspofungin (2), Micafungin (1) | 2007 | 17468115 |
| DSY2322 | C. albicans | Clinical isolate | ERG11TAC1 | S405FG980E | Single substitutionSingle substitution | Q9P4W0A0A1D8PN96 | 528981 | AF-Q9P4W0-F1AF-A0A1D8PN96-F1 |  | Fluconazole (16) | 2007 | 17693596 |
| DSY2323 | C. albicans | Clinical isolate | ERG11TAC1 | S405FG980E | Single substitutionSingle substitution | Q9P4W0A0A1D8PN96 | 528981 | AF-Q9P4W0-F1AF-A0A1D8PN96-F1 |  | Fluconazole (32) | 2007 | 17693596 |
| DSY289 (C26) | C. albicans | Clinical isolate | ERG11TAC1 | S405F, Y132HA736V | Double substitutionSingle substitution | Q9P4W0A0A1D8PN96 | 528981 | AF-Q9P4W0-F1AF-A0A1D8PN96-F1 |  | Fluconazole (>128) | 2007 | 17693596 |
| DSY348 (C82) | C. albicans | Clinical isolate | ERG11TAC1 | S405FA736V | Single substitutionSingle substitution | Q9P4W0A0A1D8PN96 | 528981 | AF-Q9P4W0-F1AF-A0A1D8PN96-F1 |  | Fluconazole (16) | 2007 | 17693596 |
| DSY3548 (isolate 16) | C. albicans | Clinical isolate | ERG11TAC1 | R467KA736V, L962-N969del | Single substitutionComplex | Q9P4W0A0A1D8PN96 | 528981 | AF-Q9P4W0-F1AF-A0A1D8PN96-F1 |  | Fluconazole (64) | 2007 | 17693596 |
| DSY3549 (isolate 17) | C. albicans | Clinical isolate | ERG11TAC1 | R467KA736V, L962-N969del | Single substitutionComplex | Q9P4W0A0A1D8PN96 | 528981 | AF-Q9P4W0-F1AF-A0A1D8PN96-F1 |  | Fluconazole (64) | 2007 | 17693596 |
| DSY3554 (D8-330) | C. albicans | Clinical isolate | TAC1 | T225A | Single substitution | A0A1D8PN96 | 981 | AF-A0A1D8PN96-F1 |  | Fluconazole (4) | 2007 | 17693596 |
| DSY3565 (D8-168) | C. albicans | Clinical isolate | TAC1 | T225A | Single substitution | A0A1D8PN96 | 981 | AF-A0A1D8PN96-F1 |  | Fluconazole (4) | 2007 | 17693596 |
| DSY732 | C. albicans | Clinical isolate | TAC1 | M677del | Deletion | A0A1D8PN96 | 981 | AF-A0A1D8PN96-F1 |  | Fluconazole (16) | 2007 | 17693596 |
| DSY735 | C. albicans | Clinical isolate | TAC1 | M677del | Deletion | A0A1D8PN96 | 981 | AF-A0A1D8PN96-F1 |  | Fluconazole (32) | 2007 | 17693596 |
| DSY296 | C. albicans | Clinical isolate | TAC1 | N977D | Single substitution | A0A1D8PN96 | 981 | AF-A0A1D8PN96-F1 |  | MIC90[Fluconazole (128)] | 2007 | 17905926 |
| ISOLATE 17 | C. albicans | Clinical isolate | TAC1 | A736C, L962-N969del | Complex | A0A1D8PN96 | 981 | AF-A0A1D8PN96-F1 | Structure not available | MIC80[Fluconazole (>64) | 2007 | 17905926 |
| ISOLATE 5674 | C. albicans | Clinical isolate | TAC1 | N972D | Single substitution | A0A1D8PN96 | 981 | AF-A0A1D8PN96-F1 |  | MIC50[Fluconazole (32)] | 2007 | 17905926 |
| 592, 4263, 4266, GZ03, GZ09, GZ15, GZ16, GZ17, GZ18, GZ23, GZ29, GZ34, GZ51 and GZ58 | C. albicans | Clinical isolate | ERG11 | A114S, Y257H | Double substitution | Q9P4W0 | 528 | AF-Q9P4W0-F1 |  | Fluconazole | 2008 | 18218640 |
| BPY55 | C. glabrata | Clinical isolate | PDR1 | P822L | Single substitution | Q6FXU7 | 1107 | AF-Q6FXU7-F1 |  | Fluconazole (64), Itraconazole (4), Ketoconazole (1), Voriconazole (2) | 2008 | 18312269 |
| Cgpgs1delta | C. glabrata | Laboratory strain | PGS1 | I215F, E458D, N484S | Multiple substitution | Q6FXL9 | 506 | AF-Q6FXL9-F1 |  | Voriconazole (2), Posaconazole (32) | 2008 | 18343926 |
| 06_3169 | C. glabrata | Clinical isolate | FKS1 | D632E | Single substitution | Q6FTN8 | 1863 | Model |  | Anidulafungin (2), Micafungin (2), Caspofungin (2) | 2008 | 18378714 |
| 06_3170 | C. glabrata | Clinical isolate | FKS1 | D632E | Single substitution | Q6FTN8 | 1863 | Model |  | Anidulafungin (2), Micafungin (2), Caspofungin (2) | 2008 | 18378714 |
| 960161 | C. metapsilosis | Clinical isolate | FKS1 | P660A | Single substitution | B0FTU4 | 887 | AF-B0FTU4-F1 | Mismatch residue | Anidulafungin (0.79), Caspofungin (1), Micafungin (1.59) | 2008 | 18443110 |
| 981224 | C. orthopsilosis | Clinical isolate | FKS1 | P660A | Single substitution | B0FTU3 | 822 | AF-B0FTU3-F1 | Mismatch residue | Anidulafungin (1.26), Caspofungin (0.79), Micafungin (1.26) | 2008 | 18443110 |
| am-2006-0113 | C. metapsilosis | Clinical isolate | FKS1 | P660A | Single substitution | B0FTU4 | 887 | AF-B0FTU4-F1 | Mismatch residue | Anidulafungin (0.63), Caspofungin (0.79), Micafungin (1.59) | 2008 | 18443110 |
| ATCC 22019 | C. parapsilosis | Laboratory strain | FKS1 | P660A | Single substitution | A9YLC3 | 1909 | Model | Mismatch residue | Anidulafungin (1.10), Caspofungin (1.40), Micafungin (1.60) | 2008 | 18443110 |
| H10 | C. orthopsilosis | Clinical isolate | FKS1 | P660A | Single substitution | B0FTU3 | 822 | AF-B0FTU3-F1 | Mismatch residue | Anidulafungin (0.79), Caspofungin (1), Micafungin (0.63) | 2008 | 18443110 |
| H4 | C. parapsilosis | Clinical isolate | FKS1 | P660A | Single substitution | A9YLC3 | 1909 | Model | Mismatch residue | Anidulafungin (2.24), Caspofungin (2.24), Micafungin (1.12) | 2008 | 18443110 |
| H5 | C. parapsilosis | Clinical isolate | FKS1 | P660A | Single substitution | A9YLC3 | 1909 | Model | Mismatch residue | Anidulafungin (1.59), Caspofungin (2.24), Micafungin (1.26) | 2008 | 18443110 |
| m122 | C. albicans | Clinical isolate | FKS1 | P649H | Single substitution | A0A1D8PCT0 | 1897 | AF-A0A1D8PCT0-F1 |  | Anidulafungin (0.15), Caspofungin (4), Micafungin (0.25) | 2008 | 18443110 |
| T51916 | C. glabrata | Clinical isolate | FKS2 | P633T | Single substitution | Q6FMZ3 | 1897 | Model | Mismatch residue | Anidulafungin (1.59), Caspofungin (2), Micafungin (0.40) | 2008 | 18443110 |
| ISOLATE S2 | C. albicans | Clinical isolate | ERG11UPC2 | G307S, G448EG648D | Double substitutionSingle substitution | P10613Q59QC7 | 528712 | 5V5ZAF-Q59QC7-F1 |  | Fluconazole (>64) | 2008 | 18487346 |
| 1587 | C. albicans | Clinical isolate | MRR1 | N803D | Single substitution | Q5A4G2 | 1108 | AF-Q5A4G2-F1 |  | Fluconazole | 2008 | 18577180 |
| 2271 | C. albicans | Clinical isolate | MRR1 | Q350L | Single substitution | Q5A4G2 | 1108 | AF-Q5A4G2-F1 |  | Fluconazole | 2008 | 18577180 |
| 5052 | C. albicans | Clinical isolate | MRR1 | P683H | Single substitution | Q5A4G2 | 1108 | AF-Q5A4G2-F1 |  | Fluconazole | 2008 | 18577180 |
| 6692 | C. albicans | Clinical isolate | MRR1 | T360I, K335N | Double substitution | Q5A4G2 | 1108 | AF-Q5A4G2-F1 |  | Fluconazole | 2008 | 18577180 |
| B4 | C. albicans | Clinical isolate | MRR1 | G878E | Single substitution | Q5A4G2 | 1108 | AF-Q5A4G2-F1 |  | Fluconazole | 2008 | 18577180 |
| CAPR510 | C. albicans | Laboratory strain | MRR1 | T381I | Single substitution | Q5A4G2 | 1108 | AF-Q5A4G2-F1 |  | Fluconazole | 2008 | 18577180 |
| CAPR513 | C. albicans | Laboratory strain | MRR1 | A880E | Single substitution | Q5A4G2 | 1108 | AF-Q5A4G2-F1 |  | Fluconazole | 2008 | 18577180 |
| CAPR514 | C. albicans | Laboratory strain | MRR1 | W893R | Single substitution | Q5A4G2 | 1108 | AF-Q5A4G2-F1 |  | Fluconazole | 2008 | 18577180 |
| CAPR515 | C. albicans | Laboratory strain | MRR1 | R873T | Single substitution | Q5A4G2 | 1108 | AF-Q5A4G2-F1 |  | Fluconazole | 2008 | 18577180 |
| CAPR517 | C. albicans | Laboratory strain | MRR1 | L998F | Single substitution | Q5A4G2 | 1108 | AF-Q5A4G2-F1 |  | Fluconazole | 2008 | 18577180 |
| DSY2286 | C. albicans | Clinical isolate | MRR1 | T896I | Single substitution | Q5A4G2 | 1108 | AF-Q5A4G2-F1 |  | Fluconazole | 2008 | 18577180 |
| DSY292 | C. albicans | Clinical isolate | MRR1 | P683H | Single substitution | Q5A4G2 | 1108 | AF-Q5A4G2-F1 |  | Fluconazole | 2008 | 18577180 |
| F5 | C. albicans | Clinical isolate | MRR1 | P683S | Single substitution | Q5A4G2 | 1108 | AF-Q5A4G2-F1 |  | Fluconazole | 2008 | 18577180 |
| G5 | C. albicans | Clinical isolate | MRR1 | G997V | Single substitution | Q5A4G2 | 1108 | AF-Q5A4G2-F1 |  | Fluconazole | 2008 | 18577180 |
| ISOLATE 1 | C. krusei | Clinical isolate | FKS1 | L658W, L701M | Double substitution | Q4U2W2 | 1885 | Model |  | Caspofungin (8) [RPMI], Caspofungin (4) [AM3] | 2008 | 18591282 |
| ISOLATE 19 | C. albicans | Clinical isolate | FKS1 | P649H, W1358R | Double substitution | O13428 | 1897 | Model |  | Caspofungin (1) [RPMI], Caspofungin (0.5) [AM3] | 2008 | 18591282 |
| ISOLATE 2 | C. tropicalis | Clinical isolate | FKS1 | L644W | Single substitution | C5M4K6 | 1640 | Model | Mismatch residue | Caspofungin (2) [RPMI], Caspofungin (1) [AM3] | 2008 | 18591282 |
| ISOLATE 20 | C. albicans | Clinical isolate | FKS1 | F641S, S645P | Double substitution | O13428 | 1897 | Model |  | Caspofungin (2) [RPMI], Caspofungin (2) [AM3] | 2008 | 18591282 |
| ISOLATE 21 | C. albicans | Clinical isolate | FKS1 | S645Y | Single substitution | O13428 | 1897 | Model |  | Caspofungin (2) [RPMI], Caspofungin (1) [AM3] | 2008 | 18591282 |
| ISOLATE 22 | C. albicans | Clinical isolate | FKS1 | F641S | Single substitution | O13428 | 1897 | Model |  | Caspofungin (2) [RPMI], Caspofungin (1) [AM3] | 2008 | 18591282 |
| ISOLATE 23 | C. albicans | Clinical isolate | FKS1 | W1358R | Single substitution | O13428 | 1897 | Model |  | Caspofungin (2) [RPMI], Caspofungin (0.5) [AM3] | 2008 | 18591282 |
| ISOLATE 24 | C. albicans | Clinical isolate | FKS1 | S645P | Single substitution | O13428 | 1897 | Model |  | Caspofungin (4) [RPMI], Caspofungin (16) [AM3] | 2008 | 18591282 |
| CD51II-A | C. dubliniensis | Laboratory strain | MRR1 | D987-I998del | Deletion | B9WEH2 | 1100 | AF-B9WEH2-F1 | Structure not available | Fluconazole | 2008 | 18809934 |
| CD51II-B | C. dubliniensis | Laboratory strain | MRR1 | T985del | Deletion | B9WEH2 | 1100 | AF-B9WEH2-F1 | Structure not available | Fluconazole | 2008 | 18809934 |
| CD57A | C. dubliniensis | Laboratory strain | MRR1 | S595Y | Single substitution | B9WEH2 | 1100 | AF-B9WEH2-F1 |  | Fluconazole | 2008 | 18809934 |
| CD57B | C. dubliniensis | Laboratory strain | MRR1 | T374I | Single substitution | B9WEH2 | 1100 | AF-B9WEH2-F1 |  | Fluconazole | 2008 | 18809934 |
| CM2 | C. dubliniensis | Clinical isolate | MRR1 | C866Y | Single substitution | B9WEH2 | 1100 | AF-B9WEH2-F1 |  | Fluconazole | 2008 | 18809934 |
| 119 | C. albicans | Clinical isolate | FKS1 | F641L | Single substitution | A0A1D8PCT0 | 1897 | AF-A0A1D8PCT0-F1 |  | Anidulafungin (0.16), Caspofungin (2.0), Micafungin (0.33) | 2009 | 18955538 |
| 121 | C. albicans | Clinical isolate | FKS1 | R1361H | Single substitution | A0A1D8PCT0 | 1897 | AF-A0A1D8PCT0-F1 |  | Anidulafungin (0.25), Caspofungin (2.0), Micafungin (0.25) | 2009 | 18955538 |
| 122 | C. albicans | Clinical isolate | FKS1 | P649H | Single substitution | A0A1D8PCT0 | 1897 | AF-A0A1D8PCT0-F1 |  | Anidulafungin (0.67), Caspofungin (4.0), Micafungin (0.83) | 2009 | 18955538 |
| 149 | C. albicans | Clinical isolate | FKS1 | D648Y | Single substitution | A0A1D8PCT0 | 1897 | AF-A0A1D8PCT0-F1 |  | Anidulafungin (0.83), Caspofungin (2.67), Micafungin (0.83) | 2009 | 18955538 |
| 177 | C. albicans | Clinical isolate | FKS1 | F641S | Single substitution | A0A1D8PCT0 | 1897 | AF-A0A1D8PCT0-F1 |  | Anidulafungin (0.83), Caspofungin (4.0), Micafungin (1.0) | 2009 | 18955538 |
| 194 | C. albicans | Clinical isolate | FKS1 | S645F, R1361H | Double substitution | A0A1D8PCT0 | 1897 | AF-A0A1D8PCT0-F1 |  | Anidulafungin (4), Caspofungin (4), Micafungin (2.67) | 2009 | 18955538 |
| 205 | C. albicans | Clinical isolate | FKS1 | S645P | Single substitution | A0A1D8PCT0 | 1897 | AF-A0A1D8PCT0-F1 |  | Anidulafungin (1.33), Caspofungin (8.0), Micafungin (4) | 2009 | 18955538 |
| 2762 | C. albicans | Clinical isolate | FKS1 | F641S | Single substitution | A0A1D8PCT0 | 1897 | AF-A0A1D8PCT0-F1 |  | Anidulafungin (1), Caspofungin (3.33), Micafungin (1) | 2009 | 18955538 |
| 5415 | C. albicans | Clinical isolate | FKS1 | S645P | Single substitution | A0A1D8PCT0 | 1897 | AF-A0A1D8PCT0-F1 |  | Anidulafungin (2), Caspofungin (8.0), Micafungin (4) | 2009 | 18955538 |
| 85 | C. albicans | Clinical isolate | FKS1 | S645F | Single substitution | A0A1D8PCT0 | 1897 | AF-A0A1D8PCT0-F1 |  | Anidulafungin (2), Caspofungin (4), Micafungin (2.67) | 2009 | 18955538 |
| 89 | C. albicans | Clinical isolate | FKS1 | S645Y | Single substitution | A0A1D8PCT0 | 1897 | AF-A0A1D8PCT0-F1 |  | Anidulafungin (2), Caspofungin (8.0), Micafungin (4) | 2009 | 18955538 |
| 90 | C. albicans | Clinical isolate | FKS1 | R1361H | Single substitution | A0A1D8PCT0 | 1897 | AF-A0A1D8PCT0-F1 |  | Anidulafungin (0.25), Caspofungin (1.0), Micafungin (0.50) | 2009 | 18955538 |
| A15 | C. albicans | Laboratory strain | FKS1 | S645P | Single substitution | A0A1D8PCT0 | 1897 | AF-A0A1D8PCT0-F1 |  | Anidulafungin (0.5), Caspofungin (4.0), Micafungin (0.5) | 2009 | 18955538 |
| A15-10 | C. albicans | Laboratory strain | FKS1 | S645P | Single substitution | A0A1D8PCT0 | 1897 | AF-A0A1D8PCT0-F1 |  | Anidulafungin (4), Caspofungin (8.0), Micafungin (4) | 2009 | 18955538 |
| y0109R | C. albicans | Laboratory strain | TAC1 | L47K, N977K | Double substitution | A0A1D8PN96 | 981 | AF-A0A1D8PN96-F1 | Mismatch residue | Fluconazole | 2008 | 19089303 |
| y0109R(ATCC76615) | C. albicans | Laboratory strain | ERG3 | D19E | Single substitution | Q59VG6 | 386 | AF-Q59VG6-F1 |  | Fluconazole | 2008 | 19089303 |
| C. albicans R | C. albicans | Clinical isolate | FKS1 | S645P | Single substitution | A0A1D8PCT0 | 1897 | AF-A0A1D8PCT0-F1 |  | ETEST[Caspofungin (>32), Anidulafungin (0.5)], EUCAST[Caspofungin (2), Anidulafungin (0.125)], CLSI[Caspofungin (1), Anidulafungin (0.5)] | 2009 | 19104024 |
| DSY2234 | C. glabrata | Clinical isolate | PDR1 | T588A | Single substitution | Q6FXU7 | 1107 | AF-Q6FXU7-F1 |  | Fluconazole (32), Itraconazole (1), Ketoconazole (1) | 2009 | 19148266 |
| DSY2254 | C. glabrata | Clinical isolate | PDR1 | D1082G | Single substitution | Q6FXU7 | 1107 | AF-Q6FXU7-F1 |  | Fluconazole (128), Itraconazole (2), Ketoconazole (2) | 2009 | 19148266 |
| DSY2257 | C. glabrata | Clinical isolate | PDR1 | N691D | Single substitution | Q6FXU7 | 1107 | AF-Q6FXU7-F1 |  | Fluconazole (32), Itraconazole (1), Ketoconazole (1) | 2009 | 19148266 |
| DSY2268 | C. glabrata | Clinical isolate | PDR1 | S316I | Single substitution | Q6FXU7 | 1107 | AF-Q6FXU7-F1 |  | Fluconazole (32), Itraconazole (1), Ketoconazole (1) | 2009 | 19148266 |
| DSY2271 | C. glabrata | Clinical isolate | PDR1 | D261G | Single substitution | Q6FXU7 | 1107 | AF-Q6FXU7-F1 |  | Fluconazole (128), Itraconazole (2), Ketoconazole (2) | 2009 | 19148266 |
| DSY2273 | C. glabrata | Clinical isolate | PDR1 | R293I | Single substitution | Q6FXU7 | 1107 | AF-Q6FXU7-F1 |  | Fluconazole (32), Itraconazole (2), Ketoconazole (1) | 2009 | 19148266 |
| DSY2277 | C. glabrata | Clinical isolate | PDR1 | R592S | Single substitution | Q6FXU7 | 1107 | AF-Q6FXU7-F1 |  | Fluconazole (32), Itraconazole (2), Ketoconazole (1) | 2009 | 19148266 |
| DSY2279 | C. glabrata | Clinical isolate | PDR1 | G583S | Single substitution | Q6FXU7 | 1107 | AF-Q6FXU7-F1 |  | Fluconazole (32) | 2009 | 19148266 |
| DSY2315 | C. glabrata | Clinical isolate | PDR1 | R376G | Single substitution | Q6FXU7 | 1107 | AF-Q6FXU7-F1 |  | Fluconazole (32) | 2009 | 19148266 |
| DSY489 | C. glabrata | Clinical isolate | PDR1 | L328F | Single substitution | Q6FXU7 | 1107 | AF-Q6FXU7-F1 |  | Fluconazole (128), Itraconazole (2), Ketoconazole (2) | 2009 | 19148266 |
| DSY530 | C. glabrata | Clinical isolate | PDR1 | E1083Q | Single substitution | Q6FXU7 | 1107 | AF-Q6FXU7-F1 |  | Fluconazole (64), Itraconazole (2), Ketoconazole (2) | 2009 | 19148266 |
| DSY565 | C. glabrata | Clinical isolate | PDR1 | I280F | Single substitution | Q6FXU7 | 1107 | AF-Q6FXU7-F1 | Mismatch residue | Fluconazole (128), Itraconazole (2), Ketoconazole (2) | 2009 | 19148266 |
| DSY704 | C. glabrata | Clinical isolate | PDR1 | T607S | Single substitution | Q6FXU7 | 1107 | AF-Q6FXU7-F1 |  | Fluconazole (32), Itraconazole (1), Ketoconazole (1) | 2009 | 19148266 |
| DSY727 | C. glabrata | Clinical isolate | PDR1 | D876Y | Single substitution | Q6FXU7 | 1107 | AF-Q6FXU7-F1 |  | Fluconazole (64), Itraconazole (2), Ketoconazole (2) | 2009 | 19148266 |
| DSY739 | C. glabrata | Clinical isolate | PDR1 | R376W | Single substitution | Q6FXU7 | 1107 | AF-Q6FXU7-F1 |  | Fluconazole (64), Itraconazole (2), Ketoconazole (2) | 2009 | 19148266 |
| DSY754 | C. glabrata | Clinical isolate | PDR1 | Y584C | Single substitution | Q6FXU7 | 1107 | AF-Q6FXU7-F1 |  | Fluconazole (32), Itraconazole (1), Ketoconazole (1) | 2009 | 19148266 |
| DSY756 | C. glabrata | Clinical isolate | PDR1 | S343F | Single substitution | Q6FXU7 | 1107 | AF-Q6FXU7-F1 |  | Fluconazole (128), Itraconazole (2), Ketoconazole (2) | 2009 | 19148266 |
| DSY774 | C. glabrata | Clinical isolate | PDR1 | R376G | Single substitution | Q6FXU7 | 1107 | AF-Q6FXU7-F1 |  | Fluconazole (128), Itraconazole (1) | 2009 | 19148266 |
| isolate 1 | C. glabrata | Clinical isolate | ERG11PDR1 | E502VH576Y | Single substitutionSingle substitution | P50859Q6FXU7 | 5331107 | 5JLCAF-Q6FXU7-F1 |  | Fluconazole (128), Itraconazole (8), Voriconazole (32) | 2009 | 19196495 |
| isolate 21 | C. glabrata | Clinical isolate | ERG11PDR1 | E502VH576Y | Single substitutionSingle substitution | P50859Q6FXU7 | 5331107 | 5JLCAF-Q6FXU7-F1 |  | Fluconazole (128), Itraconazole (>8), Voriconazole (>32) | 2009 | 19196495 |
| isolate 22 | C. glabrata | Clinical isolate | ERG11PDR1 | E502VH576Y | Single substitutionSingle substitution | P50859Q6FXU7 | 5331107 | 5JLCAF-Q6FXU7-F1 |  | Fluconazole (128), Itraconazole (>8), Voriconazole (>32) | 2009 | 19196495 |
| isolate 27 | C. glabrata | Clinical isolate | ERG11PDR1 | E502VH576Y | Single substitutionSingle substitution | P50859Q6FXU7 | 5331107 | 5JLCAF-Q6FXU7-F1 |  | Fluconazole (128), Itraconazole (>8), Voriconazole (>32) | 2009 | 19196495 |
| isolate 3 | C. glabrata | Clinical isolate | PDR1 | L347F | Single substitution | Q6FXU7 | 1107 | AF-Q6FXU7-F1 |  | Fluconazole (128), Itraconazole (2), Voriconazole (>32) | 2009 | 19196495 |
| isolate 7 | C. glabrata | Clinical isolate | ERG11PDR1 | E502VH576Y | Single substitutionSingle substitution | P50859Q6FXU7 | 5331107 | 5JLCAF-Q6FXU7-F1 |  | Fluconazole (128), Itraconazole (4), Voriconazole (32) | 2009 | 19196495 |
| 21900 | C. glabrata | Clinical isolate | FKS1 | D632G | Single substitution | Q6FTN8 | 1863 | Model |  | Anidulafungin (1), Caspofungin (4), Micafungin (0.5) | 2009 | 19546367 |
| 234 | C. glabrata | Clinical isolate | FKS2 | F659V | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (1), Caspofungin (4), Micafungin (1) | 2009 | 19546367 |
| 31498 | C. glabrata | Clinical isolate | FKS2 | F659del | Deletion | Q6FMZ3 | 1897 | Model |  | Anidulafungin (2), Caspofungin (2), Micafungin (4) | 2009 | 19546367 |
| 3169 | C. glabrata | Clinical isolate | FKS1 | D632E | Single substitution | Q6FTN8 | 1863 | Model |  | Anidulafungin (2), Caspofungin (2.52), Micafungin (2.52) | 2009 | 19546367 |
| 3830 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (1), Caspofungin (16), Micafungin (1) | 2009 | 19546367 |
| 41026 | C. glabrata | Clinical isolate | FKS2 | F659S | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (4), Caspofungin (16), Micafungin (4) | 2009 | 19546367 |
| 41400 | C. glabrata | Clinical isolate | FKS2 | D666G | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (2), Caspofungin (4), Micafungin (0.12) | 2009 | 19546367 |
| 42031 | C. glabrata | Clinical isolate | FKS2 | D666E | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (1), Caspofungin (4), Micafungin (0.25) | 2009 | 19546367 |
| 42971 | C. glabrata | Clinical isolate | FKS1FKS2 | D632YR1377stop | Single substitutionStop | Q6FTN8Q6FMZ3 | 18631897 | ModelModel |  | Anidulafungin (4), Caspofungin (8), Micafungin (1) | 2009 | 19546367 |
| 42997 | C. glabrata | Clinical isolate | FKS1 | F625S | Single substitution | Q6FTN8 | 1863 | Model |  | Anidulafungin (2), Caspofungin (8), Micafungin (0.5) | 2009 | 19546367 |
| 51916 | C. glabrata | Clinical isolate | FKS2 | P667T | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (1.59), Caspofungin (2), Micafungin (0.4) | 2009 | 19546367 |
| 5416 | C. glabrata | Clinical isolate | FKS2 | W1375L | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (0.25), Caspofungin (4), Micafungin (0.25) | 2009 | 19546367 |
| 5847 | C. glabrata | Clinical isolate | FKS1 | S629P | Single substitution | Q6FTN8 | 1863 | Model |  | Anidulafungin (4), Caspofungin (8), Micafungin (2) | 2009 | 19546367 |
| 10 | C. albicans | Clinical isolate | ERG11 | S405F, Y132H | Double substitution | Q9UVT4 | 528 | AF-Q9UVT4-F1 |  | Fluconazole (256) | 2009 | 19682357 |
| 11 | C. albicans | Clinical isolate | ERG11 | V437I | Single substitution | Q9UVT4 | 528 | AF-Q9UVT4-F1 |  | Fluconazole (256) | 2009 | 19682357 |
| 12-A | C. albicans | Clinical isolate | ERG11 | G464S | Single substitution | Q9UVT4 | 528 | AF-Q9UVT4-F1 |  | Fluconazole (256) | 2009 | 19682357 |
| 14 | C. albicans | Clinical isolate | ERG11 | K128T | Single substitution | Q9UVT4 | 528 | AF-Q9UVT4-F1 |  | Fluconazole (256), Voriconazole (>16) | 2009 | 19682357 |
| 15 | C. albicans | Clinical isolate | ERG11 | V437I | Single substitution | Q9UVT4 | 528 | AF-Q9UVT4-F1 |  | Fluconazole (256), Voriconazole (16) | 2009 | 19682357 |
| 16-B | C. albicans | Clinical isolate | ERG11 | G307S, G448E, K128T | Multiple substitution | Q9UVT4 | 528 | AF-Q9UVT4-F1 |  | Fluconazole (256), Voriconazole (2) | 2009 | 19682357 |
| 16-C | C. albicans | Clinical isolate | ERG11 | G307S, G448E, G464S, K128T | Multiple substitution | Q9UVT4 | 528 | AF-Q9UVT4-F1 |  | Fluconazole (256), Voriconazole (16) | 2009 | 19682357 |
| 17 | C. albicans | Clinical isolate | ERG11 | D278E | Single substitution | Q9UVT4 | 528 | AF-Q9UVT4-F1 |  | Fluconazole (64) | 2009 | 19682357 |
| 18 | C. albicans | Clinical isolate | ERG11 | K128T, R467K | Double substitution | Q9UVT4 | 528 | AF-Q9UVT4-F1 |  | Fluconazole (128) | 2009 | 19682357 |
| 19 | C. albicans | Clinical isolate | ERG11 | K128T, K143R | Double substitution | Q9UVT4 | 528 | AF-Q9UVT4-F1 |  | Fluconazole (256) | 2009 | 19682357 |
| 4 | C. albicans | Clinical isolate | ERG11 | K143R | Single substitution | Q9UVT4 | 528 | AF-Q9UVT4-F1 |  | Fluconazole (256) | 2009 | 19682357 |
| 5 | C. albicans | Clinical isolate | ERG11 | G307S | Single substitution | Q9UVT4 | 528 | AF-Q9UVT4-F1 |  | Fluconazole (256) | 2009 | 19682357 |
| 7 | C. albicans | Clinical isolate | ERG11 | G464S, K143R | Double substitution | Q9UVT4 | 528 | AF-Q9UVT4-F1 |  | Fluconazole (256), Voriconazole (>16) | 2009 | 19682357 |
| 8-A | C. albicans | Clinical isolate | ERG11 | F449S | Single substitution | Q9UVT4 | 528 | AF-Q9UVT4-F1 |  | Fluconazole (256) | 2009 | 19682357 |
| 8-B | C. albicans | Clinical isolate | ERG11 | F449S | Single substitution | Q9UVT4 | 528 | AF-Q9UVT4-F1 |  | Fluconazole (256), | 2009 | 19682357 |
| 9 | C. albicans | Clinical isolate | ERG11 | V437I | Single substitution | Q9UVT4 | 528 | AF-Q9UVT4-F1 |  | Fluconazole (256), Voriconazole (>16) | 2009 | 19682357 |
| C438 | C. albicans | Clinical isolate | ERG11 | Y257H, G464S | Double substitution | Q9UVT4 | 528 | AF-Q9UVT4-F1 |  | Fluconazole (128) | 2009 | 19682357 |
| C440 | C. albicans | Clinical isolate | ERG11 | A61V, Y257H, G307S, G464S | Multiple substitution | Q9UVT4 | 528 | AF-Q9UVT4-F1 |  | Fluconazole (>256), Voriconazole (>16) | 2009 | 19682357 |
| C480 | C. albicans | Clinical isolate | ERG11 | G464S, K128T, R467I | Multiple substitution | Q9UVT4 | 528 | AF-Q9UVT4-F1 |  | Fluconazole (128), Voriconazole (8) | 2009 | 19682357 |
| C507 | C. albicans | Clinical isolate | ERG11 | G464S, H283R, Y132H | Multiple substitution | Q9UVT4 | 528 | AF-Q9UVT4-F1 |  | Fluconazole (64), Voriconazole (8) | 2009 | 19682357 |
| C527 | C. albicans | Clinical isolate | ERG11 | Y132H | Single substitution | Q9UVT4 | 528 | AF-Q9UVT4-F1 |  | Fluconazole (256), Voriconazole (4) | 2009 | 19682357 |
| C577 | C. albicans | Clinical isolate | ERG11 | G464S | Single substitution | Q9UVT4 | 528 | AF-Q9UVT4-F1 |  | Fluconazole (128) | 2009 | 19682357 |
| C594 | C. albicans | Clinical isolate | ERG11 | S405F, Y132H | Double substitution | Q9UVT4 | 528 | AF-Q9UVT4-F1 |  | Fluconazole (128), Voriconazole (16) | 2009 | 19682357 |
| 348 | C. albicans | Clinical isolate | ERG11 | D153E | Single substitution | P10613 | 528 | 5V5Z |  | Fluconazole (>64), Itraconazole (2), Ketoconazole (2), Micafungin (>64) | 2011 | 19732347 |
| B | C. albicans | Clinical isolate | ERG11 | K143R | Single substitution | P10613 | 528 | 5V5Z |  | Itraconazole (1), Ketoconazole (2), Micafungin (>64) | 2011 | 19732347 |
| H1 | C. albicans | Clinical isolate | ERG11 | K143R, S412T, R469K | Multiple substitution | P10613 | 528 | 5V5Z |  | Fluconazole (>64), Itraconazole (4), Ketoconazole (4), Micafungin (>64), Clotrimazole (1) | 2011 | 19732347 |
| H2 | C. albicans | Clinical isolate | ERG11 | K143R, S412T, R469K | Multiple substitution | P10613 | 528 | 5V5Z |  | Itraconazole (2), Ketoconazole (2), Micafungin (64) | 2011 | 19732347 |
| H3 | C. albicans | Clinical isolate | ERG11 | G464S, G465S | Double substitution | P10613 | 528 | 5V5Z |  | Itraconazole (2), Ketoconazole (2), Micafungin (64) | 2011 | 19732347 |
| S2 (HIV patients) | C. albicans | Clinical isolate | UPC2 | G648D | Single substitution | Q59QC7 | 712 | AF-Q59QC7-F1 |  | Fluconazole (>64) | 2009 | 19750515 |
| isolate 2(03.01.2002) | C. glabrata | Clinical isolate | FUR1 | G190D | Single substitution | Q6FRF1 | 216 | AF-Q6FRF1-F1 |  | 5-Flucytosine (>32) | 2010 | 20038613 |
| isolate 3(07.01.2002) | C. glabrata | Clinical isolate | FUR1 | G190D | Single substitution | Q6FRF1 | 216 | AF-Q6FRF1-F1 |  | 5-Flucytosine (>32) | 2010 | 20038613 |
| isolate 4(14.03.2002) | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Fluconazole (>256), Voriconazole (12), Caspofungin (>32) | 2010 | 20038613 |
| isolate 5(16.03.2002) | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Fluconazole (>256), Voriconazole (16), Caspofungin (>32) | 2010 | 20038613 |
| 177 | C. albicans | Clinical isolate | FKS1 | F641S | Single substitution | A0A1D8PCT0 | 1897 | AF-A0A1D8PCT0-F1 |  | Anidulafungin (0.83), Caspofungin (4), Micafungin (1) | 2010 | 20145084 |
| 205 | C. albicans | Clinical isolate | FKS1 | S645P | Single substitution | A0A1D8PCT0 | 1897 | AF-A0A1D8PCT0-F1 |  | Anidulafungin (1.33), Caspofungin (8), Micafungin (4) | 2010 | 20145084 |
| CG-C2 | C. glabrata | Clinical isolate | FKS1 | S629P | Single substitution | Q6FTN8 | 1863 | Model |  | Anidulafungin (4), Caspofungin (8), Micafungin (2) | 2010 | 20145084 |
| CG-C3 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (8), Caspofungin (>16), Micafungin (>16) | 2010 | 20145084 |
| CT-C1 | C. tropicalis | Clinical isolate | FKS1 | F76S | Single substitution | C5M4K6 | 1640 | Model | Mismatch residue | Anidulafungin (1), Caspofungin (4), Micafungin (1) | 2010 | 20145084 |
| 2897 | C. albicans | Clinical isolate | ERG11 | G206D | Single substitution | P10613 | 528 | 5V5Z |  | Fluconazole (>64), Voriconazole (>16), Itraconazole (>16) | 2010 | 20367978 |
| 2972 | C. albicans | Clinical isolate | ERG11 | N349S, G227D | Double substitution | P10613 | 528 | 5V5Z |  | Fluconazole (>64), Voriconazole (0.06), Itraconazole (>16) | 2010 | 20367978 |
| 2989 | C. albicans | Clinical isolate | ERG11 | D153E, F72S, F416S | Multiple substitution | P10613 | 528 | 5V5Z |  | Fluconazole (>64), Voriconazole (>16), Itraconazole (>16) | 2010 | 20367978 |
| 2990 | C. albicans | Clinical isolate | ERG11 | V437I | Single substitution | P10613 | 528 | 5V5Z |  | Fluconazole (>64), Voriconazole (0.06), Itraconazole (0.5) | 2010 | 20367978 |
| 3997 | C. albicans | Clinical isolate | ERG11 | D153E, F145I | Double substitution | P10613 | 528 | 5V5Z |  | Fluconazole (>64), Voriconazole (>16), Itraconazole (0.5) | 2010 | 20367978 |
| 416 | C. albicans | Clinical isolate | ERG11 | R467K | Single substitution | P10613 | 528 | 5V5Z |  | Fluconazole (>64), Voriconazole (0.125), Itraconazole (0.5) | 2010 | 20367978 |
| 716 | C. albicans | Clinical isolate | ERG11 | Y132H, G448E, G464S, T482A | Multiple substitution | P10613 | 528 | 5V5Z |  | Fluconazole (>64), Voriconazole (>16), Itraconazole (2) | 2010 | 20367978 |
| 717 | C. albicans | Clinical isolate | ERG11 | Y132H, G448E, F103L, F198L, F422L | Multiple substitution | P10613 | 528 | 5V5Z |  | Fluconazole (>64), Voriconazole (2), Itraconazole (1) | 2010 | 20367978 |
| 4690 | C. glabrata | Clinical isolate | FKS2 | L644W | Single substitution | Q6FMZ3 | 1897 | Model | Mismatch residue | Caspofungin (0.25), Anidulafungin (0.12), Micafungin (0.06) | 2010 | 20368396 |
| 4700 | C. albicans | Clinical isolate | FKS1 | F641Y | Single substitution | A0A1D8PCT0 | 1897 | AF-A0A1D8PCT0-F1 |  | Caspofungin (1) | 2010 | 20368396 |
| 4707 | C. glabrata | Clinical isolate | FKS2 | S645P | Single substitution | Q6FMZ3 | 1897 | Model | Mismatch residue | Caspofungin (8), Anidulafungin (4), Micafungin (2) | 2010 | 20368396 |
| 4708 | C. glabrata | Clinical isolate | FKS1 | S645P | Single substitution | Q6FTN8 | 1863 | Model | Mismatch residue | Caspofungin (≥8), Anidulafungin (4), Micafungin (4) | 2010 | 20368396 |
| 4720 | C. glabrata | Clinical isolate | FKS2 | S645P | Single substitution | Q6FMZ3 | 1897 | Model | Mismatch residue | Caspofungin (≥8), Anidulafungin (4), Micafungin (4) | 2010 | 20368396 |
| 4748 | C. tropicalis | Clinical isolate | FKS1 | F641S | Single substitution | B6S6L8 | 1904 | Model | Mismatch residue | Caspofungin (4), Anidulafungin (1), Micafungin (0.5) | 2010 | 20368396 |
| 4780 | C. tropicalis | Clinical isolate | FKS1 | F641S | Single substitution | B6S6L8 | 1904 | Model | Mismatch residue | Caspofungin (4), Anidulafungin (1), Micafungin (0.5) | 2010 | 20368396 |
| Patient1 | C. krusei | Clinical isolate | FKS1 | H675Q | Single substitution | Q4U2W2 | 1885 | Model |  | Anidulafungin (0.25), Caspofungin (1), Micafungin (0.25) | 2010 | 20421445 |
| Patient11 | C. tropicalis | Clinical isolate | FKS1FKS1 | S80PS80P | Single substitutionSingle substitution | B6S6L8B6S6L8 | 19041904 | ModelModel |  | Anidulafungin (4), Caspofungin (8), Micafungin (2) Anidulafungin (2), Caspofungin (4), Micafungin (2) | 2010 | 20421445 |
| Patient3 | C. glabrata | Clinical isolate | FKS1 | S629P | Single substitution | Q6FTN8 | 1863 | Model |  | Anidulafungin (8), Caspofungin (>16), Micafungin (8) | 2010 | 20421445 |
| Patient5 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (4), Caspofungin (>16), Micafungin (4) | 2010 | 20421445 |
| Patient7 | C. glabrata | Clinical isolate | FKS2 | S663F | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (4), Caspofungin (4), Micafungin (4) | 2010 | 20421445 |
| Patient8 | C. glabrata | Clinical isolate | FKS2FKS2 | S663PS663P | Single substitutionSingle substitution | Q6FMZ3Q6FMZ3 | 18971897 | ModelModel |  | Anidulafungin (8), Caspofungin (>16), Micafungin (8) Anidulafungin (4), Caspofungin (>16), Micafungin (4) | 2010 | 20421445 |
| GZ03 | C. albicans | Clinical isolate | ERG11 | A114S, Y257H | Double substitution | P10613 | 528 | 5V5Z |  | Fluconazole (>64) | 2010 | 20515567 |
| GZ09 | C. albicans | Clinical isolate | ERG11 | A114S, Y257H | Double substitution | P10613 | 528 | 5V5Z |  | Fluconazole (>64) | 2010 | 20515567 |
| GZ15 | C. albicans | Clinical isolate | ERG11 | A114S, Y257H | Double substitution | P10613 | 528 | 5V5Z |  | Fluconazole (>64) | 2010 | 20515567 |
| GZ16 | C. albicans | Clinical isolate | ERG11 | A114S, Y257H | Double substitution | P10613 | 528 | 5V5Z |  | Fluconazole (>64) | 2010 | 20515567 |
| GZ17 | C. albicans | Clinical isolate | ERG11 | A114S, Y257H | Double substitution | P10613 | 528 | 5V5Z |  | Fluconazole (>64) | 2010 | 20515567 |
| GZ18 | C. albicans | Clinical isolate | ERG11 | A114S, Y257H | Double substitution | P10613 | 528 | 5V5Z |  | Fluconazole (>64) | 2010 | 20515567 |
| GZ23 | C. albicans | Clinical isolate | ERG11 | A114S, Y257H | Double substitution | P10613 | 528 | 5V5Z |  | Fluconazole (>64) | 2010 | 20515567 |
| GZ29 | C. albicans | Clinical isolate | ERG11 | A114S, Y257H | Double substitution | P10613 | 528 | 5V5Z |  | Fluconazole (>64) | 2010 | 20515567 |
| GZ34 | C. albicans | Clinical isolate | ERG11 | A114S, Y257H | Double substitution | P10613 | 528 | 5V5Z |  | Fluconazole (>64) | 2010 | 20515567 |
| GZ51 | C. albicans | Clinical isolate | ERG11 | A114S, Y257H | Double substitution | P10613 | 528 | 5V5Z |  | Fluconazole (>64) | 2010 | 20515567 |
| GZ58 | C. albicans | Clinical isolate | ERG11 | A114S, Y257H | Double substitution | P10613 | 528 | 5V5Z |  | Fluconazole (>64) | 2010 | 20515567 |
| J4263 | C. albicans | Clinical isolate | ERG11 | A114S, Y257H | Double substitution | P10613 | 528 | 5V5Z |  | Fluconazole (>64) | 2010 | 20515567 |
| J4266 | C. albicans | Clinical isolate | ERG11 | A114S, Y257H | Double substitution | P10613 | 528 | 5V5Z |  | Fluconazole (>64) | 2010 | 20515567 |
| J592 | C. albicans | Clinical isolate | ERG11 | A114S, Y257H | Double substitution | P10613 | 528 | 5V5Z |  | Fluconazole (>64) | 2010 | 20515567 |
| CA108 | C. albicans | Clinical isolate | ERG11ERG5 | A114S116RDLARKILSS125insertion | Single substitutionInsertion | P10613O94016 | 528517 | 5V5ZAF-O94016-F1 |  | Fluconazole (64), Voriconazole (8), Itraconazole (2), Ketoconazole (1), Clotrimazole (2), Amphotericin B (2) | 2010 | 20547793 |
| Cg12R | C. glabrata | Clinical isolate | PDR1 | G348A | Single substitution | Q6FXU7 | 1107 | AF-Q6FXU7-F1 |  | Fluconazole (256) | 2010 | 20547810 |
| Cg14R | C. glabrata | Clinical isolate | PDR1 | N764I | Single substitution | Q6FXU7 | 1107 | AF-Q6FXU7-F1 |  | Fluconazole (256) | 2010 | 20547810 |
| Cg16R | C. glabrata | Clinical isolate | PDR1 | R772I | Single substitution | Q6FXU7 | 1107 | AF-Q6FXU7-F1 |  | Fluconazole (256) | 2010 | 20547810 |
| Cg18R | C. glabrata | Clinical isolate | PDR1 | L344S | Single substitution | Q6FXU7 | 1107 | AF-Q6FXU7-F1 |  | Fluconazole (256) | 2010 | 20547810 |
| Cg22R | C. glabrata | Clinical isolate | PDR1 | L280F | Single substitution | Q6FXU7 | 1107 | AF-Q6FXU7-F1 |  | Fluconazole (256) | 2010 | 20547810 |
| Cg2R | C. glabrata | Clinical isolate | PDR1 | F575L | Single substitution | Q6FXU7 | 1107 | AF-Q6FXU7-F1 |  | Fluconazole (256) | 2010 | 20547810 |
| Cg4R | C. glabrata | Clinical isolate | PDR1 | S391L | Single substitution | Q6FXU7 | 1107 | AF-Q6FXU7-F1 |  | Fluconazole (256) | 2010 | 20547810 |
| Cg6R | C. glabrata | Clinical isolate | PDR1 | G943S | Single substitution | Q6FXU7 | 1107 | AF-Q6FXU7-F1 |  | Fluconazole (256) | 2010 | 20547810 |
| Cg8R | C. glabrata | Clinical isolate | PDR1 | W297S | Single substitution | Q6FXU7 | 1107 | AF-Q6FXU7-F1 |  | Fluconazole (256) | 2010 | 20547810 |
| CA1008 | C. albicans | Clinical isolate | ERG3 | K97E, L193P, V237A, A351V, A353T | Multiple substitution | O93875 | 386 | AF-O93875-F1 | Mismatch residue | Fluconazole (>256), Voriconazole (>16), Itraconazole (>16), Ketoconazole (>16), Clotrimazole (1), Fluconazole (>256), Voriconazole (>16) | 2010 | 20733039 |
| CA12 | C. albicans | Clinical isolate | ERG3 | W332R | Single substitution | O93875 | 386 | AF-O93875-F1 |  | Fluconazole (>256), Voriconazole (>16), Itraconazole (>16), Ketoconazole (>16), Clotrimazole (1), Fluconazole (>256), Voriconazole (>16) | 2010 | 20733039 |
| CA488 | C. albicans | Clinical isolate | ERG11ERG3 | D225G, E391GH243N, T330A, A351V | Double substitutionMultiple substitution | P10613O93875 | 528386 | 5V5ZAF-O93875-F1 |  | Fluconazole (>256), Voriconazole (>16), Itraconazole (>16), Ketoconazole (8), Clotrimazole (1) | 2010 | 20733039 |
| CA490 | C. albicans | Clinical isolate | ERG11ERG3 | F72S, T229A, N440S, R523GD147G, T330A, A351V | Multiple substitutionMultiple substitution | P10613O93875 | 528386 | 5V5ZAF-O93875-F1 |  | Fluconazole (>256), Voriconazole (>16), Itraconazole (>16), Ketoconazole (8), Clotrimazole (1) | 2010 | 20733039 |
| 20251.021 | C. glabrata | Clinical isolate | FCY1 | T84L | Single substitution | Q6FWB1 | 155 | AF-Q6FWB1-F1 |  | 5-Flucytosine (≥32)] | 2010 | 20823283 |
| 20408.055 | C. glabrata | Clinical isolate | FUR1 | G210D | Single substitution | Q6FRF1 | 216 | AF-Q6FRF1-F1 |  | 5-Flucytosine (≥32), 5-Flucytosine (≥4)] | 2010 | 20823283 |
| 66-FC1 | C. glabrata | Laboratory strain | FUR1 | I83K | Single substitution | Q6FRF1 | 216 | AF-Q6FRF1-F1 |  | 5-Flucytosine (≥32), 5-Flucytosine (≥4) | 2010 | 20823283 |
| 66-FC2 | C. glabrata | Laboratory strain | FUR1 | G73-V81del | Deletion | Q6FRF1 | 216 | AF-Q6FRF1-F1 |  | 5-Flucytosine (≥32), 5-Flucytosine (≥4) | 2010 | 20823283 |
| 66-FC3 | C. glabrata | Laboratory strain | FUR1 | G71V | Single substitution | Q6FRF1 | 216 | AF-Q6FRF1-F1 |  | 5-Flucytosine (≥32), 5-Flucytosine (≥4) | 2010 | 20823283 |
| 66-FC4 | C. glabrata | Laboratory strain | FCY1 | A15D | Single substitution | Q6FWB1 | 155 | AF-Q6FWB1-F1 |  | 5-Flucytosine (≥32) | 2010 | 20823283 |
| 66-FC5 | C. glabrata | Laboratory strain | FCY1 | A15D | Single substitution | Q6FWB1 | 155 | AF-Q6FWB1-F1 |  | 5-Flucytosine (≥32) | 2010 | 20823283 |
| 66-FC6 | C. glabrata | Laboratory strain | FCY1 | G11D | Single substitution | Q6FWB1 | 155 | AF-Q6FWB1-F1 |  | 5-Flucytosine (≥32) | 2010 | 20823283 |
| 66u-FC3 | C. glabrata | Laboratory strain | FCY1 | H59D | Single substitution | Q6FWB1 | 155 | AF-Q6FWB1-F1 |  | 5-Flucytosine (≥32) | 2010 | 20823283 |
| 66u-FC6 | C. glabrata | Laboratory strain | FCY1 | T92delstop | Stop | Q6FWB1 | 155 | AF-Q6FWB1-F1 | Structure not available | 5-Flucytosine (≥32) | 2010 | 20823283 |
| BG-FC4 | C. glabrata | Laboratory strain | FCY1 | E17stop | Stop | Q6FWB1 | 155 | AF-Q6FWB1-F1 |  | 5-Flucytosine (≥32)] | 2010 | 20823283 |
| TE34-78 | C. glabrata | Clinical isolate | FUR1 | L136R | Single substitution | Q6FRF1 | 216 | AF-Q6FRF1-F1 |  | 5-Flucytosine (≥32), 5-Flucytosine (≥4)] | 2010 | 20823283 |
| CAS08-0016 | C. glabrata | Clinical isolate | FKS1 | S629P | Single substitution | Q6FTN8 | 1863 | Model |  | Anidulafungin (1), Caspofungin (0.5), Micafungin (1) | 2010 | 20837754 |
| CAS08-0037 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (2), Caspofungin (4), Micafungin (2) | 2010 | 20837754 |
| CAS08-0094 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (4), Caspofungin (>16), Micafungin (4) | 2010 | 20837754 |
| CAS08-0209 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (2), Caspofungin (8), Micafungin (4) | 2010 | 20837754 |
| CAS08-0293 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (0.5), Caspofungin (>16), Micafungin (4) | 2010 | 20837754 |
| CAS08-0311 | C. glabrata | Clinical isolate | FKS2 | P667H | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (2), Caspofungin (2), Micafungin (0.25) | 2010 | 20837754 |
| CAS08-0425 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (2), Caspofungin (>16), Micafungin (4) | 2010 | 20837754 |
| CAS08-0725 | C. glabrata | Clinical isolate | FKS2 | F659Y | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (1), Caspofungin (0.5), Micafungin (0.25) | 2010 | 20837754 |
| CAS09-0901 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (2), Caspofungin (2), Micafungin (0.5) | 2010 | 20837754 |
| CAS09-1083 | C. glabrata | Clinical isolate | FKS2 | S663F | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (0.5), Caspofungin (0.25), Micafungin (0.125) | 2010 | 20837754 |
| CAS09-1204 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (0.5), Caspofungin (1), Micafungin (2) | 2010 | 20837754 |
| CAS09-1225 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (4), Caspofungin (>16), Micafungin (4) | 2010 | 20837754 |
| CAS09-1437 | C. glabrata | Clinical isolate | FKS1 | R631G | Single substitution | Q6FTN8 | 1863 | Model |  | Anidulafungin (0.25), Caspofungin (0.25), Micafungin (0.5) | 2010 | 20837754 |
| CAS09-1616 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (2), Caspofungin (1), Micafungin (2) | 2010 | 20837754 |
| CAS09-1648 | C. glabrata | Clinical isolate | FKS2 | R665G | Single substitution | Q6FMZ3 | 1897 | Model |  | Caspofungin (0.125), Micafungin (0.25) | 2010 | 20837754 |
| CAS09-1786 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (2), Caspofungin (>16), Micafungin (2) | 2010 | 20837754 |
| DST1151 | C. albicans | Clinical isolate | TAC1 | N740S | Single substitution | A0A1D8PN96 | 981 | AF-A0A1D8PN96-F1 |  | Fluconazole (48), Itraconazole (1) | 2010 | 20876623 |
| DST1152 | C. albicans | Clinical isolate | ERG11TAC1 | Y132FF973S, S290C | Single substitutionDouble substitution | Q9P4W0A0A1D8PN96 | 528981 | AF-Q9P4W0-F1AF-A0A1D8PN96-F1 |  | Fluconazole (24), Itraconazole (1) | 2010 | 20876623 |
| DST1154 | C. albicans | Clinical isolate | TAC1 | H741Y | Single substitution | A0A1D8PN96 | 981 | AF-A0A1D8PN96-F1 |  | Fluconazole (48), Itraconazole (0.75) | 2010 | 20876623 |
| DST1156 | C. albicans | Clinical isolate | ERG11TAC1 | Y132FF973S, S290C | Single substitutionDouble substitution | Q9P4W0A0A1D8PN96 | 528981 | AF-Q9P4W0-F1AF-A0A1D8PN96-F1 |  | Fluconazole (64), Itraconazole (0.5) | 2010 | 20876623 |
| DST1157 | C. albicans | Clinical isolate | TAC1 | N740S | Single substitution | A0A1D8PN96 | 981 | AF-A0A1D8PN96-F1 |  | Fluconazole (48), Itraconazole (1.5) | 2010 | 20876623 |
| DST1158 | C. albicans | Clinical isolate | ERG11TAC1 | H283RS108N | Single substitutionSingle substitution | Q9P4W0A0A1D8PN96 | 528981 | AF-Q9P4W0-F1AF-A0A1D8PN96-F1 |  | Fluconazole (48) | 2010 | 20876623 |
| DST1318 | C. albicans | Clinical isolate | ERG11TAC1 | D153EN972S | Single substitutionSingle substitution | Q9P4W0A0A1D8PN96 | 528981 | AF-Q9P4W0-F1AF-A0A1D8PN96-F1 |  | Fluconazole (32), Itraconazole (1.5) | 2010 | 20876623 |
| DST1489 | C. albicans | Clinical isolate | ERG11TAC1 | D153EN972S | Single substitutionSingle substitution | Q9P4W0A0A1D8PN96 | 528981 | AF-Q9P4W0-F1AF-A0A1D8PN96-F1 |  | Fluconazole (48), Itraconazole (12) | 2010 | 20876623 |
| DST1490 | C. albicans | Clinical isolate | TAC1TAC1 | R673QR673Q | Single substitutionSingle substitution | A0A1D8PN96A0A1D8PN96 | 981981 | AF-A0A1D8PN96-F1AF-A0A1D8PN96-F1 |  | Fluconazole (48), Itraconazole (2) Fluconazole (128), Itraconazole (2) | 2010 | 20876623 |
| DST1492 | C. albicans | Clinical isolate | TAC1 | H741Y | Single substitution | A0A1D8PN96 | 981 | AF-A0A1D8PN96-F1 |  | Fluconazole (24), Itraconazole (1.5) | 2010 | 20876623 |
| DST1493 | C. albicans | Clinical isolate | TAC1 | N977D, P276L | Double substitution | A0A1D8PN96 | 981 | AF-A0A1D8PN96-F1 |  | Fluconazole (6), Itraconazole (1.5) | 2010 | 20876623 |
| DST1494 | C. albicans | Clinical isolate | TAC1 | E461K | Single substitution | A0A1D8PN96 | 981 | AF-A0A1D8PN96-F1 |  | Fluconazole (128), Itraconazole (2) | 2010 | 20876623 |
| DST1495 | C. albicans | Clinical isolate | ERG11TAC1 | S405FE461K | Single substitutionSingle substitution | Q9P4W0A0A1D8PN96 | 528981 | AF-Q9P4W0-F1AF-A0A1D8PN96-F1 |  | Fluconazole (32), Itraconazole (1.5) | 2010 | 20876623 |
| DST203 | C. albicans | Clinical isolate | ERG11TAC1 | G464SN740D | Single substitutionSingle substitution | Q9P4W0A0A1D8PN96 | 528981 | AF-Q9P4W0-F1AF-A0A1D8PN96-F1 |  | Fluconazole (96), Itraconazole (2) | 2010 | 20876623 |
| DST360 | C. albicans | Clinical isolate | ERG11TAC1 | H283RA736T | Single substitutionSingle substitution | Q9P4W0A0A1D8PN96 | 528981 | AF-Q9P4W0-F1AF-A0A1D8PN96-F1 |  | Fluconazole (64), Itraconazole (12) | 2010 | 20876623 |
| 5674 | C. albicans | Clinical isolate | TAC1 | N972D | Single substitution | A0A1D8PN96 | 981 | AF-A0A1D8PN96-F1 |  | Fluconazole | 2009 | 21136999 |
| 6692 | C. albicans | Clinical isolate | MRR1 | T360I, K335N | Double substitution | Q5A4G2 | 1108 | AF-Q5A4G2-F1 |  | Fluconazole | 2009 | 21136999 |
| C56 | C. albicans | Clinical isolate | TAC1 | N977D | Single substitution | A0A1D8PN96 | 981 | AF-A0A1D8PN96-F1 |  | Fluconazole | 2009 | 21136999 |
| F5 | C. albicans | Clinical isolate | MRR1 | P683S | Single substitution | Q5A4G2 | 1108 | AF-Q5A4G2-F1 |  | Fluconazole | 2009 | 21136999 |
| G5 | C. albicans | Clinical isolate | MRR1 | G997V | Single substitution | Q5A4G2 | 1108 | AF-Q5A4G2-F1 |  | Fluconazole | 2009 | 21136999 |
| Gu5 | C. albicans | Clinical isolate | TAC1 | L979E | Single substitution | A0A1D8PN96 | 981 | AF-A0A1D8PN96-F1 |  | Fluconazole | 2009 | 21136999 |
| CT | C. tropicalis | Clinical isolate | FKS1 | S645P | Single substitution | C5MF18 | 1280 | AF-C5MF18-F1 | Mismatch residue | Anidulafungin (1), Caspofungin (0.5), Micafungin (0.5) | 2011 | 21146713 |
| Germany | C. albicans | Clinical isolate | FKS1 | F641I | Single substitution | A0A1D8PCT0 | 1897 | AF-A0A1D8PCT0-F1 |  | Caspofungin (1) | 2011 | 21146713 |
| West Roxbury, MA | C. glabrata | Clinical isolate | FKS1 | L641I | Single substitution | Q6FTN8 | 1863 | Model | Mismatch residue | Caspofungin (1) | 2011 | 21146713 |
| 30-2 | C. glabrata | Clinical isolate | FKS2 | S633P | Single substitution | Q6FMZ3 | 1897 | Model | Mismatch residue | Caspofungin (32), Anidulafungin (4), Micafungin (8) | 2011 | 21149621 |
| 44944 | C. glabrata | Clinical isolate | FKS2 | P659del | Deletion | Q6FMZ3 | 1897 | Model | Mismatch residue | Caspofungin (>32), Anidulafungin (4), Micafungin (4) | 2011 | 21149621 |
| ISOLATE 6955 | C. glabrata | Clinical isolate | PDR1 | K274N | Single substitution | Q6FXU7 | 1107 | AF-Q6FXU7-F1 |  | Fluconazole (16) | 2011 | 21193550 |
| SM3 | C. glabrata | Clinical isolate | PDR1 | L946S | Single substitution | Q6FXU7 | 1107 | AF-Q6FXU7-F1 |  | Fluconazole (64) | 2011 | 21193550 |
| 20S | C. albicans | Laboratory strain | FKS1 | S645F | Single substitution | A0A1D8PCT0 | 1897 | AF-A0A1D8PCT0-F1 |  | CLSI[Micafungin (1)], EUCAST[Micafungin (2)] | 2011 | 21502627 |
| 22S | C. albicans | Laboratory strain | FKS1 | S645Y | Single substitution | A0A1D8PCT0 | 1897 | AF-A0A1D8PCT0-F1 |  | CLSI[Micafungin (2)], EUCAST[Micafungin (2)] | 2011 | 21502627 |
| 36S | C. albicans | Laboratory strain | FKS1 | S645P | Single substitution | A0A1D8PCT0 | 1897 | AF-A0A1D8PCT0-F1 |  | CLSI[Micafungin (1)], EUCAST[Micafungin (2)] | 2011 | 21502627 |
| A15 | C. albicans | Laboratory strain | FKS1 | S645P | Single substitution | A0A1D8PCT0 | 1897 | AF-A0A1D8PCT0-F1 |  | CLSI[Micafungin (0.5)], EUCAST[Micafungin (1)] | 2011 | 21502627 |
| 43001 | C. albicans | Clinical isolate | FKS1 | F641S | Single substitution | A0A1D8PCT0 | 1897 | AF-A0A1D8PCT0-F1 |  | Caspofungin (4) | 2011 | 21502632 |
| 53264 | C. albicans | Clinical isolate | FKS1 | S645P | Single substitution | A0A1D8PCT0 | 1897 | AF-A0A1D8PCT0-F1 |  | Caspofungin (4) | 2011 | 21502632 |
| BC014R(FLC) | C. parapsilosis | Clinical isolate | MRR1 | G583R | Single substitution | G8BAV4 | 1128 | AF-G8BAV4-F1 |  | Fluconazole (128), Voriconazole (4) | 2011 | 21518843 |
| BC014R(VRC) | C. parapsilosis | Clinical isolate | MRR1 | K873N | Single substitution | G8BAV4 | 1128 | AF-G8BAV4-F1 |  | Fluconazole (128), Voriconazole (4) | 2011 | 21518843 |
| Ct-R | C. tropicalis | Clinical isolate | FKS1 | S80P | Single substitution | B6S6L8 | 1904 | Model | Mismatch residue | Anidulafungin (2), Caspofungin (8) | 2011 | 21543574 |
| CAAL37 | C. albicans | Clinical isolate | ERG11 | G464S, V456I | Double substitution | P10613 | 528 | 5V5Z |  | Fluconazole (>64) | 2011 | 21698128 |
| CAAL61 | C. albicans | Clinical isolate | ERG11 | G307S, Y447H | Double substitution | P10613 | 528 | 5V5Z |  | Fluconazole (>64) | 2011 | 21698128 |
| A152 | C. albicans | Laboratory strain | FKS1 | S645P | Single substitution | A0A1D8PCT0 | 1897 | AF-A0A1D8PCT0-F1 |  | Anidulafungin (0.5), Caspofungin (4), Micafungin (0.5) | 2011 | 21791665 |
| CLY16996 | C. albicans | Clinical isolate | FKS1 | S645F | Single substitution | A0A1D8PCT0 | 1897 | AF-A0A1D8PCT0-F1 |  | Anidulafungin (2), Caspofungin (4), Micafungin (2.67) | 2011 | 21791665 |
| CLY16997 | C. albicans | Clinical isolate | FKS1 | S645P | Single substitution | A0A1D8PCT0 | 1897 | AF-A0A1D8PCT0-F1 |  | Anidulafungin (4), Caspofungin (>8), Micafungin (4) | 2011 | 21791665 |
| CLY19230 | C. albicans | Clinical isolate | FKS1 | S645F | Single substitution | A0A1D8PCT0 | 1897 | AF-A0A1D8PCT0-F1 |  | Anidulafungin (2), Caspofungin (4), Micafungin (2) | 2011 | 21791665 |
| Cg30 | C. glabrata | Laboratory strain | FKS2 | P667T | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (0.5), Caspofungin (2.0), Micafungin (0.5), Amphotericin B (1) | 2012 | 22203604 |
| Cg51 | C. glabrata | Clinical isolate | FKS2 | D666G | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (1), Caspofungin (2), Micafungin (0.25), Amphotericin B (1) | 2012 | 22203604 |
| VSY2 | C. albicans | Clinical isolate | ERG3 | A351V | Single substitution | Q59VG6 | 386 | AF-Q59VG6-F1 |  | Fluconazole (>128), Itraconazole (>16), Voriconazole (>16), Posaconazole (>16), Amphotericin B (2) | 2012 | 22252807 |
| 05BL1-38 | C. albicans | Clinical isolate | FKS1 | F641S | Single substitution | A0A1D8PCT0 | 1897 | AF-A0A1D8PCT0-F1 |  | Caspofungin (2), Micafungin (1), Anidulafungin (0.125) | 2012 | 22257484 |
| 06BL1-33 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Caspofungin (8), Micafungin (8), Anidulafungin (2) | 2012 | 22257484 |
| 06BL1-34 | C. krusei | Clinical isolate | FKS1 | L648W | Single substitution | Q4U2W2 | 1885 | Model | Mismatch residue | Caspofungin (8), Micafungin (4), Anidulafungin (2) | 2012 | 22257484 |
| 06BL2-127 | C. albicans | Clinical isolate | FKS1 | F641S, S645P | Double substitution | A0A1D8PCT0 | 1897 | AF-A0A1D8PCT0-F1 |  | Caspofungin (2), Micafungin (0.5), Anidulafungin (0.125) | 2012 | 22257484 |
| 07BL2-157 | C. glabrata | Clinical isolate | FKS2 | F658del | Deletion | Q6FMZ3 | 1897 | Model |  | Caspofungin (1), Micafungin (0.5), Anidulafungin (0.5) | 2012 | 22257484 |
| 08BL1-94 | C. albicans | Clinical isolate | FKS1 | R1361G | Single substitution | A0A1D8PCT0 | 1897 | AF-A0A1D8PCT0-F1 |  | Caspofungin (4), Micafungin (1), Anidulafungin (0.5) | 2012 | 22257484 |
| 08BL2-142 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Caspofungin (4), Micafungin (2), Anidulafungin (2) | 2012 | 22257484 |
| 08BL2-143 | C. albicans | Clinical isolate | FKS1 | S645P | Single substitution | A0A1D8PCT0 | 1897 | AF-A0A1D8PCT0-F1 |  | Caspofungin (4), Micafungin (2), Anidulafungin (0.5) | 2012 | 22257484 |
| 09BL1-43 | C. albicans | Clinical isolate | FKS1 | F641S | Single substitution | A0A1D8PCT0 | 1897 | AF-A0A1D8PCT0-F1 |  | Caspofungin (2), Micafungin (1), Anidulafungin (0.25) | 2012 | 22257484 |
| 09BL1-55 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Caspofungin (4), Micafungin (4), Anidulafungin (0.5) | 2012 | 22257484 |
| 09BL1-77 | C. albicans | Clinical isolate | FKS1 | R647G | Single substitution | A0A1D8PCT0 | 1897 | AF-A0A1D8PCT0-F1 |  | Caspofungin (0.5), Micafungin (0.25), Anidulafungin (0.03) | 2012 | 22257484 |
| 10BL1-19 | C. glabrata | Clinical isolate | FKS2 | F659S, L664V | Double substitution | Q6FMZ3 | 1897 | Model |  | Caspofungin (4), Micafungin (0.5), Anidulafungin (1) | 2012 | 22257484 |
| 10BL1-50 | C. krusei | Clinical isolate | FKS1 | F645L | Single substitution | Q4U2W2 | 1885 | Model |  | Caspofungin (4), Micafungin (2), Anidulafungin (1) | 2012 | 22257484 |
| 10BL1-67 | C. glabrata | Clinical isolate | FKS2 | F658del | Deletion | Q6FMZ3 | 1897 | Model |  | Caspofungin (4), Micafungin (1), Anidulafungin (1) | 2012 | 22257484 |
| ODL13-1254 | C. albicans | Clinical isolate | FKS1 | S645Y | Single substitution | A0A1D8PCT0 | 1897 | AF-A0A1D8PCT0-F1 |  | Caspofungin (2), Micafungin (1), Micafungin (0.5) | 2012 | 22257484 |
| ODL19-1894 | C. albicans | Clinical isolate | FKS1 | S645P | Single substitution | A0A1D8PCT0 | 1897 | AF-A0A1D8PCT0-F1 |  | Caspofungin (2), Micafungin (20, Anidulafungin (0.25) | 2012 | 22257484 |
| ODL21-2028 | C. glabrata | Clinical isolate | FKS1 | S629P | Single substitution | Q6FTN8 | 1863 | Model |  | Caspofungin (1), Micafungin (0.25), Anidulafungin (0.25) | 2012 | 22257484 |
| ODL22-2183 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Caspofungin (2), Micafungin (0.25), Anidulafungin (1) | 2012 | 22257484 |
| ODL23-2221 | C. glabrata | Clinical isolate | FKS1FKS2 | F625IP667T | Single substitutionSingle substitution | Q6FTN8Q6FMZ3 | 18631897 | ModelModel |  | Caspofungin (4), Micafungin (2), Anidulafungin (0.25) | 2012 | 22257484 |
| ODL7-647 | C. glabrata | Clinical isolate | FKS2 | F658del | Deletion | Q6FMZ3 | 1897 | Model |  | Caspofungin (8), Micafungin (1), Anidulafungin (0.125) | 2012 | 22257484 |
| 10956A | C. glabrata | Clinical isolate | FKS2 | F659V | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (1), Caspofungin (2), Micafungin (0.12) | 2012 | 22278842 |
| 127F | C. glabrata | Clinical isolate | FKS1 | S629P | Single substitution | Q6FTN8 | 1863 | Model |  | Anidulafungin (2), Caspofungin (16), Micafungin (2) | 2012 | 22278842 |
| 30011F | C. glabrata | Clinical isolate | FKS1 | D648E | Single substitution | Q6FTN8 | 1863 | Model | Mismatch residue | Anidulafungin (0.25), Caspofungin (0.5), Micafungin (0.03) | 2012 | 22278842 |
| 748F | C. glabrata | Clinical isolate | FKS1 | D632Y | Single substitution | Q6FTN8 | 1863 | Model |  | Anidulafungin (0.25), Caspofungin (0.25), Micafungin (0.12) | 2012 | 22278842 |
| CAS08-0016 | C. glabrata | Clinical isolate | FKS1 | S629P | Single substitution | Q6FTN8 | 1863 | Model |  | Anidulafungin (1), Caspofungin (0.5), Micafungin (1) | 2012 | 22278842 |
| CAS08-0094 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (4), Caspofungin (>16), Micafungin (4) | 2012 | 22278842 |
| CAS08-0425 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (2), Caspofungin (16), Micafungin (4) | 2012 | 22278842 |
| CAS09-0869 | C. glabrata | Clinical isolate | FKS2 | F659Y | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (1), Caspofungin (2), Micafungin (0.25) | 2012 | 22278842 |
| CAS09-1083 | C. glabrata | Clinical isolate | FKS2 | S663F | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (0.5), Caspofungin (0.25), Micafungin (0.12) | 2012 | 22278842 |
| CAS09-1225 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (4), Caspofungin (>16), Micafungin (4) | 2012 | 22278842 |
| CAS09-1437 | C. glabrata | Clinical isolate | FKS1 | R631G | Single substitution | Q6FTN8 | 1863 | Model |  | Anidulafungin (0.25), Caspofungin (0.25), Micafungin (0.5) | 2012 | 22278842 |
| CAS09-1680 | C. glabrata | Clinical isolate | FKS1 | R631G | Single substitution | Q6FTN8 | 1863 | Model |  | Anidulafungin (0.25), Caspofungin (0.5), Micafungin (1) | 2012 | 22278842 |
| CAS09-1786 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (2), Caspofungin (>16), Micafungin (2) | 2012 | 22278842 |
| CAS11-2978 | C. glabrata | Clinical isolate | FKS1 | S629P | Single substitution | Q6FTN8 | 1863 | Model |  | Anidulafungin (0.5), Caspofungin (0.5), Micafungin (0.12) | 2012 | 22278842 |
| CAS11-3112 | C. glabrata | Clinical isolate | FKS1 | S629P | Single substitution | Q6FTN8 | 1863 | Model |  | Anidulafungin (0.5), Caspofungin (0.25), Micafungin (0.12) | 2012 | 22278842 |
| CAS11-3129 | C. glabrata | Clinical isolate | FKS1 | S629P | Single substitution | Q6FTN8 | 1863 | Model |  | Anidulafungin (4), Caspofungin (>16), Micafungin (2) | 2012 | 22278842 |
| CL7369 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (0.12), Caspofungin (1), Micafungin (0.06) | 2012 | 22391532 |
| CL7370 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (0.25), Caspofungin (1), Micafungin (0.12) | 2012 | 22391532 |
| 4872 | C. glabrata | Clinical isolate | FKS1FKS2 | S629P1547stop | Single substitutionStop | Q6FTN8Q6FMZ3 | 18631897 | ModelModel |  | Micafungin (2), Caspofungin (32) | 2012 | 22514266 |
| delFKS1 V1 | C. glabrata | Laboratory strain | FKS2 | F659del | Deletion | Q6FMZ3 | 1897 | Model |  | Micafungin (4) | 2012 | 22514266 |
| delFKS1 V2 | C. glabrata | Laboratory strain | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Micafungin (4) | 2012 | 22514266 |
| delFKS2 V1 | C. glabrata | Laboratory strain | FKS1 | S629P | Single substitution | Q6FTN8 | 1863 | Model |  | Micafungin (2) | 2012 | 22514266 |
| delFKS2 V2 | C. glabrata | Laboratory strain | FKS1 | R631G | Single substitution | Q6FTN8 | 1863 | Model |  | Micafungin (4) | 2012 | 22514266 |
| G17 V | C. glabrata | Laboratory strain | FKS1FKS2 | S629P1547stop | Single substitutionStop | Q6FTN8Q6FMZ3 | 18631897 | ModelModel |  | Micafungin (2) | 2012 | 22514266 |
| H10 | C. glabrata | Clinical isolate | FKS1 | S629P | Single substitution | Q6FTN8 | 1863 | Model |  | Micafungin (0.125), Caspofungin (2) | 2012 | 22514266 |
| H10 V1 | C. glabrata | Laboratory strain | FKS1FKS2 | S629P1547stop | Single substitutionStop | Q6FTN8Q6FMZ3 | 18631897 | ModelModel |  | Micafungin (2) | 2012 | 22514266 |
| H10 V2 | C. glabrata | Laboratory strain | FKS1FKS2 | S629PR1378G | Single substitutionSingle substitution | Q6FTN8Q6FMZ3 | 18631897 | ModelModel |  | Micafungin (4) | 2012 | 22514266 |
| H10 V3 | C. glabrata | Laboratory strain | FKS1FKS2 | S629P1547stop | Single substitutionStop | Q6FTN8Q6FMZ3 | 18631897 | ModelModel |  | Micafungin (2) | 2012 | 22514266 |
| H10 V4 | C. glabrata | Laboratory strain | FKS1FKS1 | A352DS629P | Single substitutionSingle substitution | Q6FTN8Q6FTN8 | 18631863 | ModelModel |  | Micafungin (2) | 2012 | 22514266 |
| H10 V5 | C. glabrata | Laboratory strain | FKS1FKS2 | S629PG1534S | Single substitutionSingle substitution | Q6FTN8Q6FMZ3 | 18631897 | ModelModel |  | Micafungin (2) | 2012 | 22514266 |
| H10 V6 | C. glabrata | Laboratory strain | FKS1FKS2 | S629PT458K | Single substitutionSingle substitution | Q6FTN8Q6FMZ3 | 18631897 | ModelModel |  | Micafungin (4) | 2012 | 22514266 |
| H10 V7 | C. glabrata | Laboratory strain | FKS1FKS2 | S629P1547stop | Single substitutionStop | Q6FTN8Q6FMZ3 | 18631897 | ModelModel |  | Micafungin (2) | 2012 | 22514266 |
| H10T13 | C. glabrata | Clinical isolate | FKS1FKS2 | S629P1547stop | Single substitutionStop | Q6FTN8Q6FMZ3 | 18631897 | ModelModel |  | Micafungin (2), Caspofungin (32) | 2012 | 22514266 |
| NAU3 V | C. glabrata | Laboratory strain | FKS1FKS2 | S629P1547stop | Single substitutionStop | Q6FTN8Q6FMZ3 | 18631897 | ModelModel |  | Micafungin (0.625) | 2012 | 22514266 |
| CG156 | C. glabrata | Clinical isolate | ERG11 | G315D | Single substitution | P50859 | 533 | 5JLC |  | Fluconazole (>256), Voriconazole (>256), Amphotericin B (32) | 2012 | 22615281 |
| patient isolate | C. albicans | Clinical isolate | FKS1 | S645P | Single substitution | A0A1D8PCT0 | 1897 | AF-A0A1D8PCT0-F1 |  | Caspofungin (>4), Anidulafungin (0.5), Micafungin (2) | 2012 | 22653922 |
| CAAL2 | C. albicans | Clinical isolate | ERG11ERG3 | D153EL193R, V351A | Single substitutionDouble substitution | P10613O93875 | 528386 | 5V5ZAF-O93875-F1 |  | Fluconazole (>64), Voriconazole (>8) [CLSI] Amphotericin B (0.75) [Etest] | 2012 | 22678731 |
| CAAL76 | C. albicans | Clinical isolate | ERG11ERG3 | K128TL122-I125del | Single substitutionDeletion | P10613O93875 | 528386 | 5V5ZAF-O93875-F1 |  | Fluconazole (>64), Voriconazole (>8) [CLSI] Amphotericin B (1) [Etest] | 2012 | 22678731 |
| isolate 13 | C. albicans | Clinical isolate | UPC2 | A643T | Single substitution | Q59QC7 | 712 | AF-Q59QC7-F1 |  | Fluconazole (16) | 2012 | 22923048 |
| isolate 15 | C. albicans | Clinical isolate | UPC2 | W478C | Single substitution | Q59QC7 | 712 | AF-Q59QC7-F1 |  | Fluconazole (16) | 2012 | 22923048 |
| isolate 18 | C. albicans | Clinical isolate | UPC2 | G304R | Single substitution | Q59QC7 | 712 | AF-Q59QC7-F1 |  | Fluconazole (32) | 2012 | 22923048 |
| isolate 19 | C. albicans | Clinical isolate | UPC2 | G304R | Single substitution | Q59QC7 | 712 | AF-Q59QC7-F1 |  | Fluconazole (32) | 2012 | 22923048 |
| isolate 21 | C. albicans | Clinical isolate | UPC2 | G648D | Single substitution | Q59QC7 | 712 | AF-Q59QC7-F1 |  | Fluconazole (32) | 2012 | 22923048 |
| isolate 25 | C. albicans | Clinical isolate | UPC2 | G648S | Single substitution | Q59QC7 | 712 | AF-Q59QC7-F1 |  | Fluconazole (64) | 2012 | 22923048 |
| isolate 27 | C. albicans | Clinical isolate | UPC2 | W478C | Single substitution | Q59QC7 | 712 | AF-Q59QC7-F1 |  | Fluconazole (64) | 2012 | 22923048 |
| isolate 28 | C. albicans | Clinical isolate | UPC2 | W478C | Single substitution | Q59QC7 | 712 | AF-Q59QC7-F1 |  | Fluconazole (64) | 2012 | 22923048 |
| isolate 30 | C. albicans | Clinical isolate | UPC2 | A643V | Single substitution | Q59QC7 | 712 | AF-Q59QC7-F1 |  | Fluconazole (64) | 2012 | 22923048 |
| isolate 33 | C. albicans | Clinical isolate | UPC2 | Y642F | Single substitution | Q59QC7 | 712 | AF-Q59QC7-F1 |  | Fluconazole (36) | 2012 | 22923048 |
| isolate 34 | C. albicans | Clinical isolate | UPC2 | Y642F | Single substitution | Q59QC7 | 712 | AF-Q59QC7-F1 |  | Fluconazole (37) | 2012 | 22923048 |
| isolate 35 | C. albicans | Clinical isolate | UPC2 | G648S | Single substitution | Q59QC7 | 712 | AF-Q59QC7-F1 |  | Fluconazole (>256) | 2012 | 22923048 |
| isolate 38 | C. albicans | Clinical isolate | UPC2 | G648D | Single substitution | Q59QC7 | 712 | AF-Q59QC7-F1 |  | Fluconazole (64) | 2012 | 22923048 |
| isolate 45 | C. albicans | Clinical isolate | UPC2 | A646V | Single substitution | Q59QC7 | 712 | AF-Q59QC7-F1 |  | Fluconazole (128) | 2012 | 22923048 |
| isolate 47 | C. albicans | Clinical isolate | UPC2 | G648D | Single substitution | Q59QC7 | 712 | AF-Q59QC7-F1 |  | Fluconazole (128) | 2012 | 22923048 |
| isolate 52 | C. albicans | Clinical isolate | UPC2 | G648D | Single substitution | Q59QC7 | 712 | AF-Q59QC7-F1 |  | Fluconazole (256) | 2012 | 22923048 |
| isolate 55 | C. albicans | Clinical isolate | UPC2 | G648S | Single substitution | Q59QC7 | 712 | AF-Q59QC7-F1 |  | Fluconazole (>256) | 2012 | 22923048 |
| isolate 56 | C. albicans | Clinical isolate | UPC2 | G648S | Single substitution | Q59QC7 | 712 | AF-Q59QC7-F1 |  | Fluconazole (>256) | 2012 | 22923048 |
| isolate 57 | C. albicans | Clinical isolate | UPC2 | G648S | Single substitution | Q59QC7 | 712 | AF-Q59QC7-F1 |  | Fluconazole (>256) | 2012 | 22923048 |
| isolate 58 | C. albicans | Clinical isolate | UPC2 | G648S | Single substitution | Q59QC7 | 712 | AF-Q59QC7-F1 |  | Fluconazole (>256) | 2012 | 22923048 |
| isolate 59 | C. albicans | Clinical isolate | UPC2 | G648D | Single substitution | Q59QC7 | 712 | AF-Q59QC7-F1 |  | Fluconazole (>256) | 2012 | 22923048 |
| isolate 65 | C. albicans | Clinical isolate | UPC2 | G648S | Single substitution | Q59QC7 | 712 | AF-Q59QC7-F1 |  | Fluconazole (>256) | 2012 | 22923048 |
| isolate 67 | C. albicans | Clinical isolate | UPC2UPC2 | A646VG648S, A646V | Single substitutionDouble substitution | Q59QC7Q59QC7 | 712712 | AF-Q59QC7-F1AF-Q59QC7-F1 |  | Fluconazole (>256) | 2012 | 22923048 |
| isolate 68 | C. albicans | Clinical isolate | UPC2 | A643V | Single substitution | Q59QC7 | 712 | AF-Q59QC7-F1 |  | Fluconazole (>256) | 2012 | 22923048 |
| isolate 69 | C. albicans | Clinical isolate | UPC2 | G648S | Single substitution | Q59QC7 | 712 | AF-Q59QC7-F1 |  | Fluconazole (>256) | 2012 | 22923048 |
| isolate 71 | C. albicans | Clinical isolate | UPC2 | G648D | Single substitution | Q59QC7 | 712 | AF-Q59QC7-F1 |  | Fluconazole (>256) | 2012 | 22923048 |
| CG 10956 | C. glabrata | Clinical isolate | FKS2 | F659V | Single substitution | E2GKZ6 | 1897 | Model |  | Anidulafungin (1), Caspofungin (2), Micafungin (0.25) | 2012 | 22948870 |
| CG 14378 | C. glabrata | Clinical isolate | FKS1 | S629P | Single substitution | E2GKZ4 | 1863 | Model |  | Anidulafungin (2), Caspofungin (4), Micafungin (2) | 2012 | 22948870 |
| CG 2092 | C. glabrata | Clinical isolate | FKS1 | L630I | Single substitution | E2GKZ4 | 1863 | Model |  | Anidulafungin (0.5), Caspofungin (1), Micafungin (0.13) | 2012 | 22948870 |
| CG 211 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | E2GKZ6 | 1897 | Model |  | Anidulafungin (1), Caspofungin (1), Micafungin (0.25) | 2012 | 22948870 |
| CG 4720 | C. glabrata | Clinical isolate | FKS2 | S645P | Single substitution | E2GKZ6 | 1897 | Model | Mismatch residue | Anidulafungin (4), Caspofungin (8), Micafungin (4) | 2012 | 22948870 |
| CG 4742 | C. glabrata | Clinical isolate | FKS2 | L632R | Single substitution | E2GKZ6 | 1897 | Model | Mismatch residue | Anidulafungin (0.25), Caspofungin (1), Micafungin (0.5) | 2012 | 22948870 |
| CG 4747 | C. glabrata | Clinical isolate | FKS2 | L646R | Single substitution | E2GKZ6 | 1897 | Model | Mismatch residue | Anidulafungin (0.06), Caspofungin (1), Micafungin (0.25) | 2012 | 22948870 |
| CG 729 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | E2GKZ6 | 1897 | Model |  | Anidulafungin (4), Caspofungin (16), Micafungin (8) | 2012 | 22948870 |
| CG 760 | C. glabrata | Clinical isolate | FKS2 | S663F | Single substitution | E2GKZ6 | 1897 | Model |  | Anidulafungin (1), Caspofungin (1), Micafungin (0.25) | 2012 | 22948870 |
| CG1012 | C. glabrata | Clinical isolate | ERG2 | I207V | Single substitution | Q6FKL1 | 224 | AF-Q6FKL1-F1 |  | Fluconazole (64), Voriconazole (2), Amphotericin B (2) | 2012 | 23027188 |
| CG388 | C. glabrata | Clinical isolate | ERG2 | I207V | Single substitution | Q6FKL1 | 224 | AF-Q6FKL1-F1 |  | Fluconazole (64), Voriconazole (2), Amphotericin B (2) | 2012 | 23027188 |
| CG44 | C. glabrata | Clinical isolate | ERG2 | I207V | Single substitution | Q6FKL1 | 224 | AF-Q6FKL1-F1 |  | Fluconazole (64), Voriconazole (2), Amphotericin B (2) | 2012 | 23027188 |
| CG852 | C. glabrata | Clinical isolate | ERG2 | I207V, L60F, T121V | Multiple substitution | Q6FKL1 | 224 | AF-Q6FKL1-F1 |  | Fluconazole (128), Voriconazole (2), Amphotericin B (8) | 2012 | 23027188 |
| CG872 | C. glabrata | Clinical isolate | ERG2 | I207V, T121I | Double substitution | Q6FKL1 | 224 | AF-Q6FKL1-F1 |  | Fluconazole (64), Voriconazole (1), Amphotericin B (8) | 2012 | 23027188 |
| Ca1 | C. albicans | Clinical isolate | FKS1 | D648Y | Single substitution | O13428 | 1897 | Model |  | Caspofungin (0.5) | 2013 | 23089746 |
| Ca2 | C. albicans | Clinical isolate | FKS1 | P649H | Single substitution | O13428 | 1897 | Model |  | Caspofungin (1) | 2013 | 23089746 |
| Cg | C. glabrata | Clinical isolate | FKS2 | S663F | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (0.25) [EUCAST], Caspofungin (4) [CLSI] | 2013 | 23089746 |
| Ct1 | C. tropicalis | Clinical isolate | FKS1 | F76S | Single substitution | B6S6L8 | 1904 | Model | Mismatch residue | Anidulafungin (0.125) [EUCAST], Caspofungin (0.25) [CLSI] | 2013 | 23089746 |
| Ct2 | C. tropicalis | Clinical isolate | FKS1 | S80P | Single substitution | B6S6L8 | 1904 | Model | Mismatch residue | Anidulafungin (0.25) | 2013 | 23089746 |
| Ct3 | C. tropicalis | Clinical isolate | FKS1 | S80P | Single substitution | B6S6L8 | 1904 | Model | Mismatch residue | Anidulafungin (0.25) | 2013 | 23089746 |
| ISOLATE 2( BC-CVC) | C. tropicalis | Clinical isolate | FKS1 | S80P | Single substitution | B6S6L8 | 1904 | Model | Mismatch residue | EUCAST[Anidulafungin (0.25), Micafungin (1)] Etest[Caspofungin (>32)] | 2013 | 23089761 |
| ISOLATE 3(Cavum oris) | C. tropicalis | Clinical isolate | FKS1 | S80P | Single substitution | B6S6L8 | 1904 | Model | Mismatch residue | EUCAST[Anidulafungin (0.5), Micafungin (>1)] Etest[Caspofungin (>32)] | 2013 | 23089761 |
| C. albicans CAI4-R | C. albicans | Laboratory strain | ERG11 | Y257H | Single substitution | Q9P4W0 | 528 | AF-Q9P4W0-F1 |  | Fluconazole (128) | 2013 | 23216650 |
| ISOLATE14 | C. tropicalis | Clinical isolate | ERG11 | S154F, Y132F | Double substitution | P14263 | 528 | AF-P14263-F1 |  | Itraconazole (2) | 2013 | 23221625 |
| ISOLATE17 | C. tropicalis | Clinical isolate | ERG11 | S154F, Y132F | Double substitution | P14263 | 528 | AF-P14263-F1 |  | Fluconazole (32) | 2013 | 23221625 |
| ISOLATE19 | C. tropicalis | Clinical isolate | ERG11 | S154F, Y132F | Double substitution | P14263 | 528 | AF-P14263-F1 |  | Itraconazole (1) | 2013 | 23221625 |
| ISOLATE1b | C. tropicalis | Clinical isolate | ERG11 | S154F, Y132F | Double substitution | P14263 | 528 | AF-P14263-F1 |  | Fluconazole (32) | 2013 | 23221625 |
| ISOLATE25 | C. tropicalis | Clinical isolate | ERG11 | S154F, Y132F | Double substitution | P14263 | 528 | AF-P14263-F1 |  | Itraconazole (2) | 2013 | 23221625 |
| ISOLATE28 | C. tropicalis | Clinical isolate | ERG11 | S154F, Y132F | Double substitution | P14263 | 528 | AF-P14263-F1 |  | Itraconazole (2) | 2013 | 23221625 |
| ISOLATE30 | C. tropicalis | Clinical isolate | ERG11 | S154F, Y132F | Double substitution | P14263 | 528 | AF-P14263-F1 |  | Fluconazole (32) | 2013 | 23221625 |
| ISOLATE31 | C. tropicalis | Clinical isolate | ERG11 | S154F, Y132F | Double substitution | P14263 | 528 | AF-P14263-F1 |  | Itraconazole (1) | 2013 | 23221625 |
| ISOLATE6 | C. tropicalis | Clinical isolate | ERG11 | S154F, Y132F | Double substitution | P14263 | 528 | AF-P14263-F1 |  | Fluconazole (32), Itraconazole (2), Voriconazole (2) | 2013 | 23221625 |
| ISOLATE7 | C. tropicalis | Clinical isolate | ERG11 | S154F, Y132F | Double substitution | P14263 | 528 | AF-P14263-F1 |  | Fluconazole (64), Itraconazole (2), Voriconazole (2) | 2013 | 23221625 |
| ISOLATE8 | C. tropicalis | Clinical isolate | ERG11 | S154F, Y132F | Double substitution | P14263 | 528 | AF-P14263-F1 |  | Fluconazole (32), Itraconazole (2), Voriconazole (2) | 2013 | 23221625 |
| ISOLATE9 | C. tropicalis | Clinical isolate | ERG11 | S154F, Y132F | Double substitution | P14263 | 528 | AF-P14263-F1 |  | Fluconazole (64), Itraconazole (1), Voriconazole (4) | 2013 | 23221625 |
| ISOLATE 02 | C. albicans | Clinical isolate | ERG11 | R467I | Single substitution | P10613 | 528 | 5V5Z |  | Fluconazole (64) | 2013 | 23402828 |
| ISOLATE 04 | C. albicans | Clinical isolate | ERG11 | K128T | Single substitution | P10613 | 528 | 5V5Z |  | Fluconazole (64) | 2013 | 23402828 |
| ISOLATE 07 | C. albicans | Clinical isolate | ERG11 | L321F | Single substitution | P10613 | 528 | 5V5Z |  | Fluconazole (64) | 2013 | 23402828 |
| isolate 89 | C. albicans | Clinical isolate | FKS1 | S645Y | Single substitution | A0A1D8PCT0 | 1897 | AF-A0A1D8PCT0-F1 |  | MIC50[Caspofungin (2), Posaconazole (0.25)], MIC100[Caspofungin (>16), Posaconazole (>16)] | 2013 | 23472097 |
| 13139 | C. albicans | Clinical isolate | ERG11 | Y132F, K143Q, Y257H | Multiple substitution | P10613 | 528 | 5V5Z |  | Fluconazole (>64), Itraconazole (>16), Voriconazole (8) | 2013 | 23480635 |
| 141 | C. albicans | Clinical isolate | ERG11 | A114S, Y257H, V437I | Multiple substitution | P10613 | 528 | 5V5Z |  | Itraconazole (>16) | 2013 | 23480635 |
| 201 | C. albicans | Clinical isolate | ERG11 | A114S, Y257H, V437I | Multiple substitution | P10613 | 528 | 5V5Z |  | Itraconazole (16) | 2013 | 23480635 |
| 206 | C. albicans | Clinical isolate | ERG11 | A114S, V437I | Double substitution | P10613 | 528 | 5V5Z |  | Itraconazole (16) | 2013 | 23480635 |
| 208 | C. albicans | Clinical isolate | ERG11 | Y132H, N435V, G448E, D502E | Multiple substitution | P10613 | 528 | 5V5Z | Structure not available | Itraconazole (16) | 2013 | 23480635 |
| 210 | C. albicans | Clinical isolate | ERG11 | Y132H, Y257H, V437I, G448E | Multiple substitution | P10613 | 528 | 5V5Z |  | Voriconazole (4) | 2013 | 23480635 |
| 21897 | C. albicans | Clinical isolate | ERG11 | Y132F, K143Q, V437I | Multiple substitution | P10613 | 528 | 5V5Z |  | Fluconazole (>64), Itraconazole (>16), Voriconazole (16) | 2013 | 23480635 |
| patient 10(ep 1) | C. glabrata | Clinical isolate | FKS1 | F625S | Single substitution | Q6FTN8 | 1863 | Model |  | Anidulafungin (2), Caspofungin (2), Micafungin (0.5), Fluconazole (128) | 2013 | 23487382 |
| patient 3(ep 1) | C. glabrata | Clinical isolate | FKS2 | R631G | Single substitution | Q6FMZ3 | 1897 | Model | Mismatch residue | Fluconazole (128) | 2013 | 23487382 |
| patient 4(ep 2) | C. glabrata | Clinical isolate | FKS2 | R665G | Single substitution | Q6FMZ3 | 1897 | Model |  | Caspofungin (0.5), Fluconazole (128) | 2013 | 23487382 |
| patient 5(ep 2) | C. glabrata | Clinical isolate | FKS2 | R665G | Single substitution | Q6FMZ3 | 1897 | Model |  | Caspofungin (0.5), Fluconazole (128) | 2013 | 23487382 |
| patient 6(ep 2) | C. glabrata | Clinical isolate | FKS2 | P667T | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (1), Caspofungin (1) | 2013 | 23487382 |
| patient 7(ep 1) | C. glabrata | Clinical isolate | FKS1 | D632E | Single substitution | Q6FTN8 | 1863 | Model |  | Anidulafungin (1), Caspofungin (0.5), Micafungin (0.25), Fluconazole (128) | 2013 | 23487382 |
| patient 7(ep 2) | C. glabrata | Clinical isolate | FKS1 | D632E | Single substitution | Q6FTN8 | 1863 | Model |  | Anidulafungin (1), Caspofungin (1), Micafungin (0.25), Fluconazole (128) | 2013 | 23487382 |
| patient 8(ep 1) | C. glabrata | Clinical isolate | FKS2 | F659V | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (1), Caspofungin (4), Micafungin (0.25), Fluconazole (64) | 2013 | 23487382 |
| patient 8(ep 2) | C. glabrata | Clinical isolate | FKS2 | F659V | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (1), Caspofungin (2), Micafungin (0.25) | 2013 | 23487382 |
| patient 9(ep 1) | C. glabrata | Clinical isolate | FKS1 | F625S | Single substitution | Q6FTN8 | 1863 | Model |  | Anidulafungin (2), Caspofungin (2), Micafungin (0.5) | 2013 | 23487382 |
| patient15(ep 2) | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (1), Caspofungin (2), Micafungin (0.5) | 2013 | 23487382 |
| patient16(ep 2) | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (4), Caspofungin (>8), Micafungin (>8), Fluconazole (128) | 2013 | 23487382 |
| patient17(ep 1) | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (2), Caspofungin (8), Micafungin (0.5) | 2013 | 23487382 |
| patient18(ep 1) | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Caspofungin (0.5) | 2013 | 23487382 |
| patient18(ep 2) | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (4), Caspofungin (>8), Micafungin (4), Fluconazole (128) | 2013 | 23487382 |
| patient19(ep 1) | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (1), Caspofungin (8), Micafungin (0.5) | 2013 | 23487382 |
| patient20(ep 1) | C. glabrata | Clinical isolate | FKS1 | S629P | Single substitution | Q6FTN8 | 1863 | Model |  | Anidulafungin (4), Caspofungin (>8), Micafungin (4), Fluconazole (128) | 2013 | 23487382 |
| patient21(ep 2) | C. glabrata | Clinical isolate | FKS2 | F658del | Deletion | Q6FMZ3 | 1897 | Model |  | Anidulafungin (1), Caspofungin (>8), Micafungin (2) | 2013 | 23487382 |
| ISOLATE 1 | C. glabrata | Clinical isolate | FKS1 | D632Y | Single substitution | Q6FTN8 | 1863 | Model |  | Caspofungin (2) | 2013 | 23669387 |
| ISOLATE 102 | C. glabrata | Clinical isolate | FKS2 | F659del | Deletion | Q6FMZ3 | 1897 | Model |  | Caspofungin (8) | 2013 | 23669387 |
| ISOLATE 129 | C. glabrata | Clinical isolate | FKS2 | F659L | Single substitution | Q6FMZ3 | 1897 | Model |  | Caspofungin (1) | 2013 | 23669387 |
| ISOLATE 187 | C. glabrata | Clinical isolate | FKS2 | F659L | Single substitution | Q6FMZ3 | 1897 | Model |  | Caspofungin (2) | 2013 | 23669387 |
| ISOLATE 190 | C. glabrata | Clinical isolate | FKS2 | F659del | Deletion | Q6FMZ3 | 1897 | Model |  | Caspofungin (8) | 2013 | 23669387 |
| ISOLATE 309 | C. glabrata | Clinical isolate | FKS1 | D632H | Single substitution | Q6FTN8 | 1863 | Model |  | Caspofungin (2) | 2013 | 23669387 |
| ISOLATE 35 | C. glabrata | Clinical isolate | FKS2 | F659L | Single substitution | Q6FMZ3 | 1897 | Model |  | Caspofungin (1) | 2013 | 23669387 |
| ISOLATE 755 | C. glabrata | Clinical isolate | FKS2 | F659S | Single substitution | Q6FMZ3 | 1897 | Model |  | Caspofungin (0.5) | 2013 | 23669387 |
| ISOLATE O-95 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Caspofungin (0.25) | 2013 | 23669387 |
| Ca1 | C. albicans | Clinical isolate | FKS1 | S654P | Single substitution | A0A1D8PCT0 | 1897 | AF-A0A1D8PCT0-F1 | Structure not available | Anidulafungin (0.5), Caspofungin (1), Micafungin (1) | 2013 | 23720791 |
| Ca2 | C. albicans | Clinical isolate | FKS1 | S629P | Single substitution | A0A1D8PCT0 | 1897 | AF-A0A1D8PCT0-F1 | Mismatch residue | Anidulafungin (0.5), Caspofungin (2), Micafungin (1) | 2013 | 23720791 |
| Ca3 | C. albicans | Clinical isolate | FKS1 | S645P | Single substitution | A0A1D8PCT0 | 1897 | AF-A0A1D8PCT0-F1 | Structure not available | Anidulafungin (0.25), Caspofungin (1), Micafungin (0.5) | 2013 | 23720791 |
| Cg1 | C. glabrata | Clinical isolate | FKS1FKS2 | F625SF641V | Single substitutionSingle substitution | Q6FTN8Q6FMZ3 | 18631897 | ModelModel |  | Anidulafungin (0.25), Caspofungin (0.25) Anidulafungin (1), Caspofungin (4) | 2013 | 23720791 |
| Cg2 | C. glabrata | Clinical isolate | FKS2FKS2 | D648ES659Y | Single substitutionSingle substitution | Q6FMZ3Q6FMZ3 | 18971897 | ModelModel |  | Anidulafungin (0.25), Caspofungin (0.5) Anidulafungin (1), Caspofungin (1), Micafungin (0.25) | 2013 | 23720791 |
| Cg3 | C. glabrata | Clinical isolate | FKS2FKS2 | F641YS663Y | Single substitutionSingle substitution | Q6FMZ3Q6FMZ3 | 18971897 | ModelModel |  | Anidulafungin (0.5), Caspofungin (0.25) Anidulafungin (1), Caspofungin (0.5), Micafungin (0.5) | 2013 | 23720791 |
| Cg4 | C. glabrata | Clinical isolate | FKS2FKS2 | L644WS663P | Single substitutionSingle substitution | Q6FMZ3Q6FMZ3 | 18971897 | ModelModel |  | Anidulafungin (1), Caspofungin (0.5), Micafungin (0.5) Anidulafungin (1), Caspofungin (1), Micafungin (0.5) | 2013 | 23720791 |
| Cg5 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (2), Caspofungin (1), Micafungin (1) | 2013 | 23720791 |
| Cg6 | C. glabrata | Clinical isolate | FKS1 | S629P | Single substitution | Q6FTN8 | 1863 | Model |  | Anidulafungin (4), Caspofungin (16), Micafungin (2) | 2013 | 23720791 |
| CG2 | C. glabrata | Clinical isolate | FKS2 | F659del | Deletion | Q6FMZ3 | 1897 | Model |  | Micafungin (0.5) | 2013 | 23817368 |
| CL-6835 | C. tropicalis | Clinical isolate | ERG11ERG3 | G464DS113G | Single substitutionSingle substitution | P14263C5MEI7 | 528392 | AF-P14263-F1AF-C5MEI7-F1 |  | Amphotericin B (2), Fluconazole (>64), Voriconazole (>8) | 2013 | 23877676 |
| TP-13650 | C. tropicalis | Clinical isolate | ERG11 | Y132F | Single substitution | P14263 | 528 | AF-P14263-F1 |  | Amphotericin B (0.25), Fluconazole (>64), Voriconazole (>8) | 2013 | 23877676 |
| CAAL28 | C. albicans | Clinical isolate | ERG11TAC1UPC2 | S405FS264P, N896SA451V | Single substitutionDouble substitutionSingle substitution | P10613Q1WCU6B4YK07 | 528981712 | 5V5ZAF-Q1WCU6-F1AF-B4YK07-F1 |  | Fluconazole (64) | 2013 | 24051054 |
| CAAL37 | C. albicans | Clinical isolate | ERG11MRR1TAC1 | G464SN937K, F1032LE841G, N896S | Single substitutionDouble substitutionDouble substitution | P10613Q5A4G2Q1WCU6 | 5281108981 | 5V5ZAF-Q5A4G2-F1AF-Q1WCU6-F1 |  | Fluconazole (>64) | 2013 | 24051054 |
| CAAL61 | C. albicans | Clinical isolate | ERG11MRR1TAC1UPC2 | G307S, Y447HK884EK87N, M170I, N174DG648S | Double substitutionSingle substitutionMultiple substitutionSingle substitution | P10613Q5A4G2Q1WCU6B4YK07 | 5281108981712 | 5V5ZAF-Q5A4G2-F1AF-Q1WCU6-F1AF-B4YK07-F1 |  | Fluconazole (>64) | 2013 | 24051054 |
| CAAL67 | C. albicans | Clinical isolate | MRR1TAC1 | N937K, F1032L, S1037LK87N, M170I, N174D, T225A, W442stop, N896S | Multiple substitutionComplex | Q5A4G2Q1WCU6 | 1108981 | AF-Q5A4G2-F1AF-Q1WCU6-F1 |  | Fluconazole (32) | 2013 | 24051054 |
| CAAL74 | C. albicans | Clinical isolate | ERG11MRR1TAC1UPC2 | Y132F, G448VR557KN896ST273A, G648S, K684E | Double substitutionSingle substitutionSingle substitutionMultiple substitution | P10613Q5A4G2Q1WCU6B4YK07 | 5281108981712 | 5V5ZAF-Q5A4G2-F1AF-Q1WCU6-F1AF-B4YK07-F1 |  | Fluconazole (>64) | 2013 | 24051054 |
| CAAL75 | C. albicans | Clinical isolate | ERG11TAC1UPC2 | Y132H, K143RW486C, N896S, G980WT273A | Double substitutionMultiple substitutionSingle substitution | P10613Q1WCU6B4YK07 | 528981712 | 5V5ZAF-Q1WCU6-F1AF-B4YK07-F1 |  | Fluconazole (>64), Voriconazole (4) | 2013 | 24051054 |
| C102 | C. albicans | Clinical isolate | ERG11 | S405F | Single substitution | P10613 | 528 | 5V5Z |  | Fluconazole (512), Itraconazole (2), Voriconazole (4) | 2013 | 24070847 |
| C112 | C. albicans | Clinical isolate | ERG11 | T123I, Y132H, L376F | Multiple substitution | P10613 | 528 | 5V5Z |  | Fluconazole (256), Itraconazole (2), Voriconazole (4) | 2013 | 24070847 |
| C125 | C. albicans | Clinical isolate | ERG11 | L480F | Single substitution | P10613 | 528 | 5V5Z |  | Fluconazole (128) | 2013 | 24070847 |
| C146 | C. albicans | Clinical isolate | ERG11 | G346A | Single substitution | P10613 | 528 | 5V5Z |  | Fluconazole (256), Itraconazole (1), Voriconazole (4) | 2013 | 24070847 |
| C159 | C. albicans | Clinical isolate | ERG11 | L480F | Single substitution | P10613 | 528 | 5V5Z |  | Fluconazole (128), Itraconazole (1) | 2013 | 24070847 |
| C16 | C. albicans | Clinical isolate | ERG11 | Y132H | Single substitution | P10613 | 528 | 5V5Z |  | Fluconazole (128), Itraconazole (1) | 2013 | 24070847 |
| C163 | C. albicans | Clinical isolate | ERG11 | A434V | Single substitution | P10613 | 528 | 5V5Z |  | Fluconazole (256) | 2013 | 24070847 |
| C194 | C. albicans | Clinical isolate | ERG11 | Y132H | Single substitution | P10613 | 528 | 5V5Z |  | Fluconazole (64) | 2013 | 24070847 |
| C211 | C. albicans | Clinical isolate | ERG11 | L480F | Single substitution | P10613 | 528 | 5V5Z |  | Fluconazole (256), Itraconazole (1) | 2013 | 24070847 |
| C239 | C. albicans | Clinical isolate | ERG11 | G346A | Single substitution | P10613 | 528 | 5V5Z |  | Fluconazole (256), Itraconazole (2), Voriconazole (8) | 2013 | 24070847 |
| C43 | C. albicans | Clinical isolate | ERG11 | Y132H | Single substitution | P10613 | 528 | 5V5Z |  | Fluconazole (256), Itraconazole (1) | 2013 | 24070847 |
| C47 | C. albicans | Clinical isolate | ERG11 | K128T, Y132H, G465S | Multiple substitution | P10613 | 528 | 5V5Z |  | Fluconazole (256), Voriconazole (4) | 2013 | 24070847 |
| C81 | C. albicans | Clinical isolate | ERG11 | Y132H | Single substitution | P10613 | 528 | 5V5Z |  | Fluconazole (128) | 2013 | 24070847 |
| C97 | C. albicans | Clinical isolate | ERG11 | T123I, Y132H | Double substitution | P10613 | 528 | 5V5Z |  | Fluconazole (128), Itraconazole (1) | 2013 | 24070847 |
| 10685J | C. glabrata | Clinical isolate | FKS2 | F384Y | Single substitution | Q6FMZ3 | 1897 | Model |  | Caspofungin (0.25) | 2014 | 24126582 |
| 10700J | C. glabrata | Clinical isolate | FKS2 | L662W, E78D, T926P | Multiple substitution | Q6FMZ3 | 1897 | Model |  | Micafungin (0.5), Anidulafungin (2), Caspofungin (1), Fluconazole (64) | 2014 | 24126582 |
| 10702J | C. glabrata | Clinical isolate | FKS1 | A995T | Single substitution | Q6FTN8 | 1863 | Model |  | Caspofungin (0.25) | 2014 | 24126582 |
| 10708J | C. glabrata | Clinical isolate | FKS1 | A1749V | Single substitution | Q6FTN8 | 1863 | Model |  | Micafungin (0.06), Anidulafungin (0.25), Caspofungin (0.25) | 2014 | 24126582 |
| 10728J | C. glabrata | Clinical isolate | FKS1 | D140Y, A1749V | Double substitution | Q6FTN8 | 1863 | Model |  | Caspofungin (0.25) | 2014 | 24126582 |
| 10729J | C. glabrata | Clinical isolate | FKS1 | L195F | Single substitution | Q6FTN8 | 1863 | Model |  | Caspofungin (0.25) | 2014 | 24126582 |
| 17823F | C. glabrata | Clinical isolate | FKS2 | A450T | Single substitution | Q6FMZ3 | 1897 | Model |  | Micafungin (0.06), Fluconazole (128) | 2014 | 24126582 |
| 2003 JAPAN | C. glabrata | Clinical isolate | FKS2 | F659V | Single substitution | Q6FMZ3 | 1897 | Model |  | Micafungin (0.25), Anidulafungin (1), Caspofungin (8) | 2014 | 24126582 |
| 2004 JAPAN | C. glabrata | Clinical isolate | FKS2 | L662W | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (0.5), Anidulafungin (2), Caspofungin (1), Fluconazole (64) | 2014 | 24126582 |
| 2004 SPAIN | C. glabrata | Clinical isolate | FKS2FKS2 | L664RL664R | Single substitutionSingle substitution | Q6FMZ3Q6FMZ3 | 18971897 | ModelModel |  | Micafungin (0.25), Anidulafungin (1), Caspofungin (0.25), Fluconazole (128) Micafungin (0.25), Anidulafungin (1), Caspofungin (0.5), Fluconazole (64) | 2014 | 24126582 |
| 2005 GERMANY | C. glabrata | Clinical isolate | FKS2 | D666Y | Single substitution | Q6FMZ3 | 1897 | Model |  | Micafungin (0.06), Caspofungin (0.25) | 2014 | 24126582 |
| 2005 OHIO | C. glabrata | Clinical isolate | FKS2 | F659Y | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (0.12), Anidulafungin (1), Caspofungin (1) | 2014 | 24126582 |
| 2006 GERMANY | C. glabrata | Clinical isolate | FKS2 | F659S | Single substitution | Q6FMZ3 | 1897 | Model |  | Micafungin (0.06), Anidulafungin (0.5), Caspofungin (0.5) | 2014 | 24126582 |
| 2006 VIRGINIA | C. glabrata | Clinical isolate | FKS2 | F659V | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (0.12), Anidulafungin (1), Caspofungin (2), Fluconazole (128) | 2014 | 24126582 |
| 2007 INDIANA | C. glabrata | Clinical isolate | FKS2 | F659S | Single substitution | Q6FMZ3 | 1897 | Model |  | Micafungin (0.06), Anidulafungin (0.25), Caspofungin (0.25) | 2014 | 24126582 |
| 2008 GERMANY | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (0.25), Anidulafungin (1), Caspofungin (1), Fluconazole (64) | 2014 | 24126582 |
| 2008 INDIANA | C. glabrata | Clinical isolate | FKS1FKS2 | S629P, R631SS663P | Double substitutionSingle substitution | Q6FTN8Q6FMZ3 | 18631897 | ModelModel |  | Micafungin (16), Anidulafungin (4), Caspofungin (2) Micafungin (4), Anidulafungin (4), Caspofungin (16) | 2014 | 24126582 |
| 2008 OHIO | C. glabrata | Clinical isolate | FKS1 | S629P | Single substitution | Q6FTN8 | 1863 | Model |  | Micafungin (1), Anidulafungin (2), Caspofungin (16), Fluconazole (128) | 2014 | 24126582 |
| 2008 WASHINGTON | C. glabrata | Clinical isolate | FKS1FKS1FKS2 | D632YS629PS663F | Single substitutionSingle substitutionSingle substitution | Q6FTN8Q6FTN8Q6FMZ3 | 186318631897 | ModelModelModel |  | Anidulafungin (0.25), Caspofungin (0.12), Fluconazole (128) Micafungin (0.5), Anidulafungin (2), Caspofungin (16) Micafungin (0.12), Anidulafungin (0.5), Caspofungin (0.25) | 2014 | 24126582 |
| 2009 GERMANY | C. glabrata | Clinical isolate | FKS2 | F659S | Single substitution | Q6FMZ3 | 1897 | Model |  | Micafungin (0.06), Anidulafungin (1), Caspofungin (0.5), Fluconazole (128) | 2014 | 24126582 |
| 2010 GERMANY | C. glabrata | Clinical isolate | FKS2 | L662W | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (0.25), Anidulafungin (1), Caspofungin (0.5) | 2014 | 24126582 |
| 2010 OHIO | C. glabrata | Clinical isolate | FKS2 | S663F | Single substitution | Q6FMZ3 | 1897 | Model |  | Micafungin (0.12), Anidulafungin (0.5), Caspofungin (0.25) | 2014 | 24126582 |
| 2010 TEXAS | C. glabrata | Clinical isolate | FKS1 | F625Y | Single substitution | Q6FTN8 | 1863 | Model |  | Micafungin (0.03), Anidulafungin (0.25), Caspofungin (0.12) | 2014 | 24126582 |
| 2011 AUSTRALIA | C. glabrata | Clinical isolate | FKS1FKS2 | F625SS663P | Single substitutionSingle substitution | Q6FTN8Q6FMZ3 | 18631897 | ModelModel |  | Micafungin (0.12), Anidulafungin (1), Caspofungin (0.5), Fluconazole (128) Micafungin (2), Anidulafungin (2), Caspofungin (2), Fluconazole (128) | 2014 | 24126582 |
| 2011 CANADA | C. glabrata | Clinical isolate | FKS2 | F659Y | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (0.25), Anidulafungin (1), Caspofungin (2) | 2014 | 24126582 |
| 2011 GREECE | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (2), Anidulafungin (4), Caspofungin (4) | 2014 | 24126582 |
| 2011 INDIANA | C. glabrata | Clinical isolate | FKS2 | S663Y | Single substitution | Q6FMZ3 | 1897 | Model |  | Micafungin (0.5), Anidulafungin (1), Caspofungin (0.5) | 2014 | 24126582 |
| 2011 LOUSIANA | C. glabrata | Clinical isolate | FKS1 | S629P | Single substitution | Q6FTN8 | 1863 | Model |  | Micafungin (4), Anidulafungin (2), Caspofungin (16), Fluconazole (128) | 2014 | 24126582 |
| 2011 NEWYORK | C. glabrata | Clinical isolate | FKS2 | P1371S | Single substitution | Q6FMZ3 | 1897 | Model |  | Micafungin (0.03), Caspofungin (0.25) | 2014 | 24126582 |
| 37706F | C. glabrata | Clinical isolate | FKS2 | S663Y, G680S | Double substitution | Q6FMZ3 | 1897 | Model |  | Micafungin (0.5), Anidulafungin (1), Caspofungin (0.5) | 2014 | 24126582 |
| 44075F | C. glabrata | Clinical isolate | FKS2 | T926P | Single substitution | Q6FMZ3 | 1897 | Model |  | Caspofungin (0.12), Micafungin (0.03) | 2014 | 24126582 |
| 46228A | C. glabrata | Clinical isolate | FKS1FKS2 | Y1279FT926P | Single substitutionSingle substitution | Q6FTN8Q6FMZ3 | 18631897 | ModelModel |  | Caspofungin (0.25), Fluconazole (128) | 2014 | 24126582 |
| 49079F | C. glabrata | Clinical isolate | FKS2 | S663P, T926P | Double substitution | Q6FMZ3 | 1897 | Model |  | Micafungin (2), Anidulafungin (2), Caspofungin (2), Fluconazole (>128) | 2014 | 24126582 |
| 49889F | C. glabrata | Clinical isolate | FKS2 | G680S | Single substitution | Q6FMZ3 | 1897 | Model |  | Caspofungin (0.25) | 2014 | 24126582 |
| 760F | C. glabrata | Clinical isolate | FKS2 | S663F, T926P | Double substitution | Q6FMZ3 | 1897 | Model |  | Micafungin (0.12), Anidulafungin (0.5), Caspofungin (0.25) | 2014 | 24126582 |
| CA1 | C. albicans | Clinical isolate | FKS1 | S629P | Single substitution | A0A1D8PCT0 | 1897 | AF-A0A1D8PCT0-F1 | Mismatch residue | Micafungin (1), Caspofungin (2) | 2014 | 24153129 |
| CA2 | C. albicans | Clinical isolate | FKS1 | S629P | Single substitution | A0A1D8PCT0 | 1897 | AF-A0A1D8PCT0-F1 | Mismatch residue | Micafungin (2), Caspofungin (2) | 2014 | 24153129 |
| CA3 | C. albicans | Clinical isolate | FKS1 | F641Y | Single substitution | A0A1D8PCT0 | 1897 | AF-A0A1D8PCT0-F1 |  | Caspofungin (1) | 2014 | 24153129 |
| CA4 | C. albicans | Clinical isolate | FKS1 | S645P | Single substitution | A0A1D8PCT0 | 1897 | AF-A0A1D8PCT0-F1 |  | Micafungin (1), Caspofungin (1) | 2014 | 24153129 |
| CA5 | C. albicans | Clinical isolate | FKS1 | S645P | Single substitution | A0A1D8PCT0 | 1897 | AF-A0A1D8PCT0-F1 |  | Caspofungin (1) | 2014 | 24153129 |
| CA6 | C. albicans | Clinical isolate | FKS1 | S645P | Single substitution | A0A1D8PCT0 | 1897 | AF-A0A1D8PCT0-F1 |  | Micafungin (2), Caspofungin (2) | 2014 | 24153129 |
| CA7 | C. albicans | Clinical isolate | FKS1 | S645Y | Single substitution | A0A1D8PCT0 | 1897 | AF-A0A1D8PCT0-F1 |  | Micafungin (2), Caspofungin (1) | 2014 | 24153129 |
| CG1 | C. glabrata | Clinical isolate | FKS1 | F625S | Single substitution | Q6FTN8 | 1863 | Model |  | Caspofungin (0.5) | 2014 | 24153129 |
| CG10 | C. glabrata | Clinical isolate | FKS2 | F659S | Single substitution | Q6FMZ3 | 1897 | Model |  | Caspofungin (0.5) | 2014 | 24153129 |
| CG11 | C. glabrata | Clinical isolate | FKS2 | F659S | Single substitution | Q6FMZ3 | 1897 | Model |  | Caspofungin (0.5) | 2014 | 24153129 |
| CG12 | C. glabrata | Clinical isolate | FKS2 | F659V | Single substitution | Q6FMZ3 | 1897 | Model |  | Micafungin (0.25), Caspofungin (8) | 2014 | 24153129 |
| CG13 | C. glabrata | Clinical isolate | FKS2 | F659V | Single substitution | Q6FMZ3 | 1897 | Model |  | Caspofungin (2) | 2014 | 24153129 |
| CG14 | C. glabrata | Clinical isolate | FKS2 | F659V | Single substitution | Q6FMZ3 | 1897 | Model |  | Micafungin (0.25), Caspofungin (4) | 2014 | 24153129 |
| CG15 | C. glabrata | Clinical isolate | FKS2 | F659V | Single substitution | Q6FMZ3 | 1897 | Model |  | Micafungin (0.25), Caspofungin (2) | 2014 | 24153129 |
| CG16 | C. glabrata | Clinical isolate | FKS2 | F659Y | Single substitution | Q6FMZ3 | 1897 | Model |  | Caspofungin (1) | 2014 | 24153129 |
| CG17 | C. glabrata | Clinical isolate | FKS2 | F659Y | Single substitution | Q6FMZ3 | 1897 | Model |  | Micafungin (0.25), Caspofungin (2) | 2014 | 24153129 |
| CG18 | C. glabrata | Clinical isolate | FKS2 | L662W | Single substitution | Q6FMZ3 | 1897 | Model |  | Micafungin (0.5), Caspofungin (1) | 2014 | 24153129 |
| CG19 | C. glabrata | Clinical isolate | FKS2 | L662W | Single substitution | Q6FMZ3 | 1897 | Model |  | Micafungin (0.25), Caspofungin (0.5) | 2014 | 24153129 |
| CG2 | C. glabrata | Clinical isolate | FKS1 | F625S | Single substitution | Q6FTN8 | 1863 | Model |  | Micafungin (0.5), Caspofungin (2) | 2014 | 24153129 |
| CG20 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Micafungin (0.25), Caspofungin (1) | 2014 | 24153129 |
| CG21 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Micafungin (4), Caspofungin (16) | 2014 | 24153129 |
| CG22 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Micafungin (2), Caspofungin (2) | 2014 | 24153129 |
| CG23 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Micafungin (2), Caspofungin (4) | 2014 | 24153129 |
| CG24 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Micafungin (0.5), Caspofungin (2) | 2014 | 24153129 |
| CG25 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Micafungin ()16), Caspofungin (16) | 2014 | 24153129 |
| CG26 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Micafungin (0.5), Caspofungin (8) | 2014 | 24153129 |
| CG27 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Caspofungin (0.5) | 2014 | 24153129 |
| CG28 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Micafungin (4), Caspofungin (16) | 2014 | 24153129 |
| CG29 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Micafungin (0.5), Caspofungin (8) | 2014 | 24153129 |
| CG3 | C. glabrata | Clinical isolate | FKS1 | F625S | Single substitution | Q6FTN8 | 1863 | Model |  | Micafungin (0.5), Caspofungin (2) | 2014 | 24153129 |
| CG30 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Caspofungin (0.5) | 2014 | 24153129 |
| CG31 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Micafungin (4), Caspofungin (16) | 2014 | 24153129 |
| CG32 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Micafungin (0.5), Caspofungin (8) | 2014 | 24153129 |
| CG33 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Micafungin (0.5), Caspofungin (1) | 2014 | 24153129 |
| CG34 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Micafungin (4), Caspofungin (16) | 2014 | 24153129 |
| CG35 | C. glabrata | Clinical isolate | FKS2 | S663Y | Single substitution | Q6FMZ3 | 1897 | Model |  | Micafungin (0.5), Caspofungin (0.5) | 2014 | 24153129 |
| CG36 | C. glabrata | Clinical isolate | FKS2 | L664R | Single substitution | Q6FMZ3 | 1897 | Model |  | Caspofungin (0.5) | 2014 | 24153129 |
| CG37 | C. glabrata | Clinical isolate | FKS2 | R665G | Single substitution | Q6FMZ3 | 1897 | Model |  | Caspofungin (0.5) | 2014 | 24153129 |
| CG38 | C. glabrata | Clinical isolate | FKS2 | R665S | Single substitution | Q6FMZ3 | 1897 | Model |  | Caspofungin (0.5) | 2014 | 24153129 |
| CG39 | C. glabrata | Clinical isolate | FKS2 | D666Y | Single substitution | Q6FMZ3 | 1897 | Model |  | Caspofungin (0.25) | 2014 | 24153129 |
| CG4 | C. glabrata | Clinical isolate | FKS1 | S629P | Single substitution | Q6FTN8 | 1863 | Model |  | Micafungin (1), Caspofungin (16) | 2014 | 24153129 |
| CG40 | C. glabrata | Clinical isolate | FKS2 | P667F | Single substitution | Q6FMZ3 | 1897 | Model |  | Caspofungin (1) | 2014 | 24153129 |
| CG41 | C. glabrata | Clinical isolate | FKS2 | F658del | Deletion | Q6FMZ3 | 1897 | Model |  | Micafungin (2), Caspofungin (16) | 2014 | 24153129 |
| CG42 | C. glabrata | Clinical isolate | FKS2 | P1371S | Single substitution | Q6FMZ3 | 1897 | Model |  | Caspofungin (0.25) | 2014 | 24153129 |
| CG5 | C. glabrata | Clinical isolate | FKS1 | S629P | Single substitution | Q6FTN8 | 1863 | Model |  | Micafungin (0.5), Caspofungin (16) | 2014 | 24153129 |
| CG6 | C. glabrata | Clinical isolate | FKS1 | S629P | Single substitution | Q6FTN8 | 1863 | Model |  | Micafungin (4), Caspofungin (16) | 2014 | 24153129 |
| CG7 | C. glabrata | Clinical isolate | FKS1 | S629P, R631S | Double substitution | Q6FTN8 | 1863 | Model |  | Micafungin (16), Caspofungin (2) | 2014 | 24153129 |
| CG8 | C. glabrata | Clinical isolate | FKS1 | D632E | Single substitution | Q6FTN8 | 1863 | Model |  | Micafungin (0.25), Caspofungin (0.5) | 2014 | 24153129 |
| CG9 | C. glabrata | Clinical isolate | FKS1 | D632E | Single substitution | Q6FTN8 | 1863 | Model |  | Micafungin (0.25), Caspofungin (1) | 2014 | 24153129 |
| CK1 | C. krusei | Clinical isolate | FKS1 | F655C | Single substitution | Q4U2W2 | 1885 | Model |  | Caspofungin (1) | 2014 | 24153129 |
| CK2 | C. krusei | Clinical isolate | FKS1 | R1361G | Single substitution | Q4U2W2 | 1885 | Model | Mismatch residue | Micafungin (2), Caspofungin (16) | 2014 | 24153129 |
| CT1 | C. tropicalis | Clinical isolate | FKS1 | F641S | Single substitution | B6S6L8 | 1904 | Model | Mismatch residue | Micafungin (1), Caspofungin (1) | 2014 | 24153129 |
| CT2 | C. tropicalis | Clinical isolate | FKS1 | S645P | Single substitution | B6S6L8 | 1904 | Model | Mismatch residue | Micafungin (1), Caspofungin (2) | 2014 | 24153129 |
| CT3 | C. tropicalis | Clinical isolate | FKS1 | S645P | Single substitution | B6S6L8 | 1904 | Model | Mismatch residue | Micafungin (1), Caspofungin (2) | 2014 | 24153129 |
| DPL1007 | C. albicans | Clinical isolate | FKS1 | F641S | Single substitution | A0A1D8PCT0 | 1897 | AF-A0A1D8PCT0-F1 |  | Caspofungin (1), Ibrexafungerp (MK-3118) (1) | 2014 | 24323472 |
| DPL1008 | C. albicans | Clinical isolate | FKS1 | S645P | Single substitution | A0A1D8PCT0 | 1897 | AF-A0A1D8PCT0-F1 |  | Caspofungin (4), Ibrexafungerp (MK-3118) (1) | 2014 | 24323472 |
| DPL1009 | C. albicans | Clinical isolate | FKS1 | S645Y | Single substitution | A0A1D8PCT0 | 1897 | AF-A0A1D8PCT0-F1 |  | Caspofungin (2), Ibrexafungerp (MK-3118) (0.12) | 2014 | 24323472 |
| DPL1010 | C. albicans | Clinical isolate | FKS1 | S645F | Single substitution | A0A1D8PCT0 | 1897 | AF-A0A1D8PCT0-F1 |  | Caspofungin (2), Ibrexafungerp (MK-3118) (0.12) | 2014 | 24323472 |
| DPL1011 | C. albicans | Clinical isolate | FKS1 | S645F, R1361H | Double substitution | A0A1D8PCT0 | 1897 | AF-A0A1D8PCT0-F1 |  | Caspofungin (2), Ibrexafungerp (MK-3118) (<0.03) | 2014 | 24323472 |
| DPL1013 | C. albicans | Clinical isolate | FKS1 | P649H | Single substitution | A0A1D8PCT0 | 1897 | AF-A0A1D8PCT0-F1 |  | Caspofungin (0.25), Ibrexafungerp (MK-3118) (0.25) | 2014 | 24323472 |
| DPL155 | C. glabrata | Clinical isolate | FKS2 | F659V | Single substitution | Q6FTN8 | 1863 | Model | Mismatch residue | Caspofungin (4), Ibrexafungerp (MK-3118) (2) | 2014 | 24323472 |
| DPL18 | C. albicans | Clinical isolate | FKS1 | F641S | Single substitution | A0A1D8PCT0 | 1897 | AF-A0A1D8PCT0-F1 |  | Caspofungin (0.5), Ibrexafungerp (MK-3118) (1) | 2014 | 24323472 |
| DPL20 | C. albicans | Clinical isolate | FKS1 | S645P | Single substitution | A0A1D8PCT0 | 1897 | AF-A0A1D8PCT0-F1 |  | Caspofungin (4), Ibrexafungerp (MK-3118) (0.5) | 2014 | 24323472 |
| DPL23 | C. glabrata | Clinical isolate | FKS2 | F659del | Deletion | Q6FTN8 | 1863 | Model | Mismatch residue | Caspofungin (>16), Ibrexafungerp (MK-3118) (4) | 2014 | 24323472 |
| DPL236 | C. glabrata | Clinical isolate | FKS1 | L664R | Single substitution | A0A1D8PCT0 | 1897 | AF-A0A1D8PCT0-F1 | Mismatch residue | Caspofungin (1), Ibrexafungerp (MK-3118) (0.5) | 2014 | 24323472 |
| DPL26 | C. glabrata | Clinical isolate | FKS2 | F659S | Single substitution | Q6FTN8 | 1863 | Model | Mismatch residue | Caspofungin (>16), Ibrexafungerp (MK-3118) (0.50) | 2014 | 24323472 |
| DPL30 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FTN8 | 1863 | Model | Mismatch residue | Caspofungin (>16), Ibrexafungerp (MK-3118) (0.50) | 2014 | 24323472 |
| DPL33 | C. glabrata | Clinical isolate | FKS2 | D666E | Single substitution | Q6FTN8 | 1863 | Model | Mismatch residue | Caspofungin (2), Ibrexafungerp (MK-3118) (0.25) | 2014 | 24323472 |
| DPL34 | C. glabrata | Clinical isolate | FKS2 | P667T | Single substitution | Q6FTN8 | 1863 | Model | Mismatch residue | Caspofungin (2), Ibrexafungerp (MK-3118) (0.5) | 2014 | 24323472 |
| DPL38 | C. glabrata | Clinical isolate | FKS1 | F625S | Single substitution | A0A1D8PCT0 | 1897 | AF-A0A1D8PCT0-F1 | Mismatch residue | Caspofungin (2), Ibrexafungerp (MK-3118) (4) | 2014 | 24323472 |
| DPL39 | C. glabrata | Clinical isolate | FKS1 | S629P | Single substitution | A0A1D8PCT0 | 1897 | AF-A0A1D8PCT0-F1 | Mismatch residue | Caspofungin (16), Ibrexafungerp (MK-3118) (0.5) | 2014 | 24323472 |
| DPL41 | C. glabrata | Clinical isolate | FKS1 | D632G | Single substitution | A0A1D8PCT0 | 1897 | AF-A0A1D8PCT0-F1 | Mismatch residue | Caspofungin (2), Ibrexafungerp (MK-3118) (0.5) | 2014 | 24323472 |
| DPL42 | C. glabrata | Clinical isolate | FKS1 | D632G | Single substitution | A0A1D8PCT0 | 1897 | AF-A0A1D8PCT0-F1 | Mismatch residue | Caspofungin (16), Ibrexafungerp (MK-3118) (8) | 2014 | 24323472 |
| 8622 A | C. glabrata | Clinical isolate | FKS2 | S663F | Single substitution | E2GKZ6 | 1897 | Model |  | Fluconazole (>64), Voriconazole (4), Anidulafungin (1), Caspofungin (1), Micafungin (0.5) | 2014 | 24468776 |
| 8622 B | C. glabrata | Clinical isolate | FKS2 | S663F | Single substitution | E2GKZ6 | 1897 | Model |  | Fluconazole (>64), Voriconazole (4), Anidulafungin (1), Caspofungin (1), Micafungin (0.5) | 2014 | 24468776 |
| 8622 C | C. glabrata | Clinical isolate | FKS2 | S663F | Single substitution | E2GKZ6 | 1897 | Model |  | Fluconazole (>64), Voriconazole (4), Anidulafungin (1), Caspofungin (1), Micafungin (0.5) | 2014 | 24468776 |
| 8622 D | C. glabrata | Clinical isolate | FKS2 | S663F | Single substitution | E2GKZ6 | 1897 | Model |  | Fluconazole (>64), Voriconazole (4), Anidulafungin (1), Caspofungin (1), Micafungin (0.5) | 2014 | 24468776 |
| 8622 E | C. glabrata | Clinical isolate | FKS2 | S663F | Single substitution | E2GKZ6 | 1897 | Model |  | Fluconazole (>64), Voriconazole (4), Anidulafungin (1), Caspofungin (1), Micafungin (0.5) | 2014 | 24468776 |
| ISOLATE 100 | C. glabrata | Clinical isolate | FKS2 | F708V | Single substitution | E2GKZ6 | 1897 | Model |  | Caspofungin (0.5) | 2014 | 24522619 |
| ISOLATE 120 | C. glabrata | Clinical isolate | FKS2 | F659del | Deletion | E2GKZ6 | 1897 | Model |  | Caspofungin (16) | 2014 | 24522619 |
| ISOLATE 177 | C. glabrata | Clinical isolate | FKS2 | F659Y | Single substitution | E2GKZ6 | 1897 | Model |  | Caspofungin (1) | 2014 | 24522619 |
| CaB | C. albicans | Clinical isolate | FKS1 | S645P | Single substitution | A0A1D8PCT0 | 1897 | AF-A0A1D8PCT0-F1 |  | Caspofungin (4), Micafungin (2), Anidulafungin (1) | 2014 | 24715154 |
| CaO | C. albicans | Clinical isolate | FKS1 | F641S | Single substitution | A0A1D8PCT0 | 1897 | AF-A0A1D8PCT0-F1 |  | Caspofungin (4), Micafungin (1) | 2014 | 24715154 |
| CaS | C. albicans | Clinical isolate | FKS1 | S645P | Single substitution | A0A1D8PCT0 | 1897 | AF-A0A1D8PCT0-F1 |  | Caspofungin (4), Micafungin (2) | 2014 | 24715154 |
| CgO | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Caspofungin (1), Micafungin (0.5), Anidulafungin (2) | 2014 | 24715154 |
| CgU | C. glabrata | Clinical isolate | FKS2 | S663F | Single substitution | Q6FMZ3 | 1897 | Model |  | Caspofungin (1), Micafungin (0.25), Anidulafungin (1) | 2014 | 24715154 |
| CkB | C. kefyr | Clinical isolate | FKS1 | F641P | Single substitution | W0TDH9 | 1892 | Model |  | Caspofungin (2), Micafungin (4), Anidulafungin (2) | 2014 | 24715154 |
| CkO | C. krusei | Clinical isolate | FKS1 | L701M | Single substitution | Q4U2W2 | 1885 | Model |  | Caspofungin (1) | 2014 | 24715154 |
| 111.12 | C. albicans | Clinical isolate | FKS1 | R647G, P649L | Double substitution | A0A1D8PCT0 | 1897 | AF-A0A1D8PCT0-F1 |  | EUCAST[Micafungin (1), Voriconazole (4), Fluconazole (>16)], Etest[Caspofungin (2)] | 2014 | 24733467 |
| RRCL 110.12 | C. albicans | Clinical isolate | FKS1 | R647G, P649L | Double substitution | A0A1D8PCT0 | 1897 | AF-A0A1D8PCT0-F1 |  | EUCAST[Micafungin (1), Voriconazole (4), Fluconazole (>16)], Etest[Caspofungin (2)] | 2014 | 24733467 |
| FMR 8489 | C. glabrata | Clinical isolate | FKS2 | L707S | Single substitution | Q6FMZ3 | 1897 | Model |  | Caspofungin (0.12) | 2014 | 24733474 |
| FMR 8498 | C. glabrata | Clinical isolate | FKS2 | L707S | Single substitution | Q6FMZ3 | 1897 | Model |  | Caspofungin (0.12) | 2014 | 24733474 |
| JMI-10956 | C. glabrata | Clinical isolate | FKS2 | F659V, L707S | Double substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (1) [EUCAST] Caspofungin (2) [CLSI] | 2014 | 24733474 |
| JMI-127 | C. glabrata | Clinical isolate | FKS1 | S629P | Single substitution | Q6FTN8 | 1863 | Model |  | Anidulafungin (2) [EUCAST] Caspofungin (16) [CLSI] | 2014 | 24733474 |
| JMI-14378 | C. glabrata | Clinical isolate | FKS1 | S629P | Single substitution | Q6FTN8 | 1863 | Model |  | Anidulafungin (2) [EUCAST] Caspofungin (4) [CLSI] | 2014 | 24733474 |
| JMI-206 | C. glabrata | Clinical isolate | FKS2 | F659S | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (1) [EUCAST] Caspofungin (1) [CLSI] | 2014 | 24733474 |
| JMI-2092 | C. glabrata | Clinical isolate | FKS2 | L707S | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (0.5) [EUCAST Caspofungin (1) [CLSI] | 2014 | 24733474 |
| JMI-211 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (1) [EUCAST] Caspofungin (1) [CLSI] | 2014 | 24733474 |
| JMI-297 | C. glabrata | Clinical isolate | FKS1 | S629P, R631S, A1037T | Multiple substitution | Q6FTN8 | 1863 | Model |  | Anidulafungin (1) [EUCAST] Caspofungin (1) [CLSI] | 2014 | 24733474 |
| JMI-729 | C. glabrata | Clinical isolate | FKS2 | F663P | Single substitution | Q6FMZ3 | 1897 | Model | Mismatch residue | Anidulafungin (4) [EUCAST] Caspofungin (>16) [CLSI] | 2014 | 24733474 |
| JMI-760 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (1) [EUCAST] Caspofungin (1) [CLSI] | 2014 | 24733474 |
| UTHSC 10461 | C. glabrata | Clinical isolate | FKS2 | L707S | Single substitution | Q6FMZ3 | 1897 | Model |  | Caspofungin (0.5) | 2014 | 24733474 |
| 20.551.099 | C. glabrata | Clinical isolate | FKS2 | F659Y | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (1), Caspofungin (2) | 2014 | 24829248 |
| 20.593.033 | C. glabrata | Clinical isolate | FKS1FKS2 | W645stopS663P | StopSingle substitution | Q6FTN8Q6FMZ3 | 18631897 | ModelModel |  | Anidulafungin (4), Caspofungin (>8), Micafungin (4) | 2014 | 24829248 |
| 21900 | C. glabrata | Clinical isolate | FKS1 | D632G | Single substitution | Q6FTN8 | 1863 | Model |  | Anidulafungin (1), Caspofungin (4) | 2014 | 24829248 |
| 3.83 0 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (2), Caspofungin (>8), Micafungin (1) | 2014 | 24829248 |
| 31498 | C. glabrata | Clinical isolate | FKS2 | F659del | Deletion | Q6FMZ3 | 1897 | Model |  | Anidulafungin (2), Caspofungin (8), Micafungin (4) | 2014 | 24829248 |
| 3169 | C. glabrata | Clinical isolate | FKS1 | D632E | Single substitution | Q6FTN8 | 1863 | Model |  | Anidulafungin (2), Caspofungin (2), Micafungin (2) | 2014 | 24829248 |
| 37178 | C. glabrata | Clinical isolate | FKS1FKS2 | W645stopS663P | StopSingle substitution | Q6FTN8Q6FMZ3 | 18631897 | ModelModel |  | Anidulafungin (4), Caspofungin (>8), Micafungin (8) | 2014 | 24829248 |
| 42971 | C. glabrata | Clinical isolate | FKS1 | D632Y | Single substitution | Q6FTN8 | 1863 | Model |  | Anidulafungin (4), Caspofungin (4), Micafungin (1) | 2014 | 24829248 |
| 42997 | C. glabrata | Clinical isolate | FKS1 | F625S | Single substitution | Q6FTN8 | 1863 | Model |  | Anidulafungin (2), Caspofungin (2), Micafungin (0.5) | 2014 | 24829248 |
| 5847 | C. glabrata | Clinical isolate | FKS1 | S629P | Single substitution | Q6FTN8 | 1863 | Model |  | Anidulafungin (4), Caspofungin (>8), Micafungin (2) | 2014 | 24829248 |
| 6183 | C. glabrata | Clinical isolate | FKS2 | F659S | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (4), Caspofungin (>8), Micafungin (4) | 2014 | 24829248 |
| LMDM 34 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (2), Caspofungin (>8), Micafungin (2) | 2014 | 24829248 |
| LMDM 37 | C. glabrata | Clinical isolate | FKS1 | D632E | Single substitution | Q6FTN8 | 1863 | Model |  | Anidulafungin (2), Caspofungin (4), Micafungin (4) | 2014 | 24829248 |
| M234 | C. glabrata | Clinical isolate | FKS2 | F659V | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (1), Caspofungin (4), Micafungin (1) | 2014 | 24829248 |
| M2791 | C. glabrata | Clinical isolate | FKS2 | S663F | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (4), Caspofungin (4), Micafungin (4) | 2014 | 24829248 |
| M2798 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (8), Caspofungin (>8), Micafungin (8) | 2014 | 24829248 |
| IUM 09-0233 | C. krusei | Clinical isolate | FKS1 | A647T, L701M | Double substitution | Q4U2W2 | 1885 | Model |  | Anidulafungin (0.25), Caspofungin (4), Micafungin (4), Fluconazole (16) | 2014 | 24858652 |
| RclinD35 | C. krusei | Clinical isolate | ERG11 | Y132H | Single substitution | A9YUC7 | 528 | AF-A9YUC7-F1 | Mismatch residue | Voriconazole (4) | 2014 | 24867987 |
| RclinD84 | C. krusei | Clinical isolate | ERG11 | Y132H | Single substitution | A9YUC7 | 528 | AF-A9YUC7-F1 | Mismatch residue | Voriconazole (4) | 2014 | 24867987 |
| patient 10 | C. glabrata | Clinical isolate | FKS1 | S629P | Single substitution | Q6FTN8 | 1863 | Model |  | Caspofungin (8) | 2014 | 24879785 |
| patient 6 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Caspofungin (0.5) | 2014 | 24879785 |
| patient 7 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Caspofungin (8) | 2014 | 24879785 |
| patient 8 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Caspofungin (8) | 2014 | 24879785 |
| patient 9 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Caspofungin (8) | 2014 | 24879785 |
| Cg1 | C. glabrata | Clinical isolate | FKS1 | D632Y | Single substitution | Q6FTN8 | 1863 | Model |  | Anidulafungin (0.25), Caspofungin (0.125) | 2014 | 24890592 |
| Cg10 | C. glabrata | Clinical isolate | FKS2 | F659S | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (1), Caspofungin (1), Micafungin (0.25) | 2014 | 24890592 |
| Cg11 | C. glabrata | Clinical isolate | FKS1 | R631G | Single substitution | Q6FTN8 | 1863 | Model |  | Micafungin (0.25) | 2014 | 24890592 |
| Cg12 | C. glabrata | Clinical isolate | FKS1 | D632V | Single substitution | Q6FTN8 | 1863 | Model |  | Anidulafungin (1), Caspofungin (1), Micafungin (0.25) | 2014 | 24890592 |
| Cg13 | C. glabrata | Clinical isolate | FKS2 | F659Y | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (1), Caspofungin (1), Micafungin (0.25) | 2014 | 24890592 |
| Cg14 | C. glabrata | Clinical isolate | FKS1 | I634V | Single substitution | Q6FTN8 | 1863 | Model |  | Micafungin (0.25) | 2014 | 24890592 |
| Cg15 | C. glabrata | Clinical isolate | FKS2 | F659Y | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (1), Caspofungin (2), Micafungin (0.25) | 2014 | 24890592 |
| Cg16 | C. glabrata | Clinical isolate | FKS2 | F659Y | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (0.5), Caspofungin (1), Micafungin (0.25) | 2014 | 24890592 |
| Cg17 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (2), Caspofungin (2) | 2014 | 24890592 |
| Cg18 | C. glabrata | Clinical isolate | FKS1FKS2 | R631GD666V | Single substitutionSingle substitution | Q6FTN8Q6FMZ3 | 18631897 | ModelModel |  | Anidulafungin (0.5), Micafungin (0.5) | 2014 | 24890592 |
| Cg19 | C. glabrata | Clinical isolate | FKS1 | R631G | Single substitution | Q6FTN8 | 1863 | Model |  | Micafungin (0.5), Fluconazole (128) | 2014 | 24890592 |
| Cg2 | C. glabrata | Clinical isolate | FKS2 | S663F | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (0.5), Caspofungin (0.25) | 2014 | 24890592 |
| Cg20 | C. glabrata | Clinical isolate | FKS2 | F658del | Deletion | Q6FMZ3 | 1897 | Model |  | Anidulafungin (1), Caspofungin (1), Micafungin (0.5), Fluconazole (128) | 2014 | 24890592 |
| Cg21 | C. glabrata | Clinical isolate | FKS1FKS2 | S629PD666V | Single substitutionSingle substitution | Q6FTN8Q6FMZ3 | 18631897 | ModelModel |  | Micafungin (0.5) | 2014 | 24890592 |
| Cg22 | C. glabrata | Clinical isolate | FKS1 | S629P | Single substitution | Q6FTN8 | 1863 | Model |  | Anidulafungin (1), Caspofungin (0.5), Micafungin (1) | 2014 | 24890592 |
| Cg23 | C. glabrata | Clinical isolate | FKS1 | R631G | Single substitution | Q6FTN8 | 1863 | Model |  | Caspofungin (0.5), Micafungin (1) | 2014 | 24890592 |
| Cg24 | C. glabrata | Clinical isolate | FKS1 | S629P | Single substitution | Q6FTN8 | 1863 | Model |  | Anidulafungin (2), Caspofungin (8), Micafungin (1), Fluconazole (256) | 2014 | 24890592 |
| Cg25 | C. glabrata | Clinical isolate | FKS1FKS2 | S629PD666V | Single substitutionSingle substitution | Q6FTN8Q6FMZ3 | 18631897 | ModelModel |  | Anidulafungin (2), Caspofungin (4), Micafungin (1), Fluconazole (64) | 2014 | 24890592 |
| Cg26 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (2), Caspofungin (16), Micafungin (1), Fluconazole (64) | 2014 | 24890592 |
| Cg27 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (1), Caspofungin (4), Micafungin (1), Fluconazole (64) | 2014 | 24890592 |
| Cg28 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (2), Caspofungin (4), Micafungin (2) | 2014 | 24890592 |
| Cg29 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (0.5), Caspofungin (1), Micafungin (2) | 2014 | 24890592 |
| Cg3 | C. glabrata | Clinical isolate | FKS1 | S629P | Single substitution | Q6FTN8 | 1863 | Model |  | Anidulafungin (0.5), Caspofungin (0.5), Fluconazole (64) | 2014 | 24890592 |
| Cg30 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (4), Caspofungin (8), Micafungin (2), Fluconazole (128) | 2014 | 24890592 |
| Cg31 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (2), Caspofungin (1), Micafungin (2), Fluconazole (128) | 2014 | 24890592 |
| Cg32 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (2), Caspofungin (>16), Micafungin (2), Fluconazole (128) | 2014 | 24890592 |
| Cg33 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (2), Caspofungin (>16), Micafungin (2), Fluconazole (64) | 2014 | 24890592 |
| Cg34 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (4), Caspofungin (>16), Micafungin (2) | 2014 | 24890592 |
| Cg35 | C. glabrata | Clinical isolate | FKS1 | S629P | Single substitution | Q6FTN8 | 1863 | Model |  | Anidulafungin (4), Caspofungin (>16), Micafungin (2) | 2014 | 24890592 |
| Cg36 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (4), Caspofungin (16), Micafungin (2) | 2014 | 24890592 |
| Cg37 | C. glabrata | Clinical isolate | FKS2 | F658del | Deletion | Q6FMZ3 | 1897 | Model |  | Anidulafungin (4), Caspofungin (>16), Micafungin (2) | 2014 | 24890592 |
| Cg38 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (1), Caspofungin (16), Micafungin (2) | 2014 | 24890592 |
| Cg39 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (4), Caspofungin (>16), Micafungin (2) | 2014 | 24890592 |
| Cg4 | C. glabrata | Clinical isolate | FKS1 | S629P | Single substitution | Q6FTN8 | 1863 | Model |  | Anidulafungin (0.5), Fluconazole (64) | 2014 | 24890592 |
| Cg40 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (2), Caspofungin (16), Micafungin (2) | 2014 | 24890592 |
| Cg41 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (4), Caspofungin (>16), Micafungin (4) | 2014 | 24890592 |
| Cg42 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (2), Caspofungin (8), Micafungin (4) | 2014 | 24890592 |
| Cg43 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (0.5), Caspofungin (16), Micafungin (4), Fluconazole (256) | 2014 | 24890592 |
| Cg44 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (0.5), Caspofungin (16), Micafungin (4), Fluconazole (256) | 2014 | 24890592 |
| Cg45 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (2), Caspofungin (16), Micafungin (4), Fluconazole (128) | 2014 | 24890592 |
| Cg46 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (4), Caspofungin (>16), Micafungin (4), Fluconazole (64) | 2014 | 24890592 |
| Cg47 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (2), Caspofungin (16), Micafungin (4) | 2014 | 24890592 |
| Cg48 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (4), Caspofungin (16), Micafungin (4) | 2014 | 24890592 |
| Cg5 | C. glabrata | Clinical isolate | FKS2 | P667H | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (2), Caspofungin (2), Micafungin (0.25) | 2014 | 24890592 |
| Cg6 | C. glabrata | Clinical isolate | FKS2 | F659Y | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (1), Caspofungin (0.5), Micafungin (0.25), Fluconazole (256) | 2014 | 24890592 |
| Cg7 | C. glabrata | Clinical isolate | FKS2 | F659Y | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (1), Caspofungin (2), Micafungin (0.25), Fluconazole (256) | 2014 | 24890592 |
| Cg8 | C. glabrata | Clinical isolate | FKS1 | R631G | Single substitution | Q6FTN8 | 1863 | Model |  | Micafungin (0.25), Fluconazole (64) | 2014 | 24890592 |
| Cg9 | C. glabrata | Clinical isolate | FKS2 | R663F | Single substitution | Q6FMZ3 | 1897 | Model | Mismatch residue | Anidulafungin (2), Caspofungin (2), Micafungin (0.25), Fluconazole (64) | 2014 | 24890592 |
| ISOLATE NO 02 | C. albicans | Clinical isolate | ERG11 | R467I | Single substitution | P10613 | 528 | 5V5Z |  | Fluconazole (64) | 2014 | 24930991 |
| ISOLATE NO 11 | C. albicans | Clinical isolate | ERG11 | K128T | Single substitution | P10613 | 528 | 5V5Z |  | Fluconazole (64) | 2014 | 24930991 |
| ISOLATE NO 25 | C. albicans | Clinical isolate | ERG11 | L321F | Single substitution | P10613 | 528 | 5V5Z |  | Fluconazole (64) | 2014 | 24930991 |
| C. kefyr PAZ | C. kefyr | Clinical isolate | ERG11 | E123Q, K151E | Double substitution | W8NYE2 | 526 | AF-W8NYE2-F1 |  | Fluconazole (>256), Voriconazole (>32) | 2014 | 24936404 |
| Ca1 | C. albicans | Clinical isolate | FKS1 | S629P | Single substitution | A0A1D8PCT0 | 1897 | AF-A0A1D8PCT0-F1 | Mismatch residue | Anidulafungin (1), Caspofungin (2) | 2014 | 24951808 |
| Ca2 | C. albicans | Clinical isolate | FKS1 | F641Y | Single substitution | A0A1D8PCT0 | 1897 | AF-A0A1D8PCT0-F1 |  | Caspofungin (1) | 2014 | 24951808 |
| Ca3 | C. albicans | Clinical isolate | FKS1 | S645P | Single substitution | A0A1D8PCT0 | 1897 | AF-A0A1D8PCT0-F1 |  | Anidulafungin (1), Caspofungin (2) | 2014 | 24951808 |
| Ca4 | C. albicans | Clinical isolate | FKS1 | S645Y | Single substitution | A0A1D8PCT0 | 1897 | AF-A0A1D8PCT0-F1 |  | Anidulafungin (1), Caspofungin (1) | 2014 | 24951808 |
| Cg1 | C. glabrata | Clinical isolate | FKS1 | F625S | Single substitution | Q6FTN8 | 1863 | Model |  | Anidulafungin (1), Caspofungin (0.5) | 2014 | 24951808 |
| Cg10 | C. glabrata | Clinical isolate | FKS2 | F659S | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (0.5), Caspofungin (0.5) | 2014 | 24951808 |
| Cg11 | C. glabrata | Clinical isolate | FKS2 | F659S | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (1), Caspofungin (0.5) | 2014 | 24951808 |
| Cg12 | C. glabrata | Clinical isolate | FKS2 | F659V | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (1), Caspofungin (8) | 2014 | 24951808 |
| Cg13 | C. glabrata | Clinical isolate | FKS2 | F659V | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (1), Caspofungin (2) | 2014 | 24951808 |
| Cg14 | C. glabrata | Clinical isolate | FKS2 | F659V | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (1), Caspofungin (4) | 2014 | 24951808 |
| Cg15 | C. glabrata | Clinical isolate | FKS2 | F659V | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (1), Caspofungin (2) | 2014 | 24951808 |
| Cg16 | C. glabrata | Clinical isolate | FKS2 | F659Y | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (1), Caspofungin (1) | 2014 | 24951808 |
| Cg17 | C. glabrata | Clinical isolate | FKS2 | F659Y | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (1), Caspofungin (2) | 2014 | 24951808 |
| Cg18 | C. glabrata | Clinical isolate | FKS2 | L662W | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (2), Caspofungin (1) | 2014 | 24951808 |
| Cg19 | C. glabrata | Clinical isolate | FKS2 | L662W | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (1), Caspofungin (0.5) | 2014 | 24951808 |
| Cg2 | C. glabrata | Clinical isolate | FKS1 | F625S | Single substitution | Q6FTN8 | 1863 | Model |  | Anidulafungin (2), Caspofungin (2) | 2014 | 24951808 |
| Cg20 | C. glabrata | Clinical isolate | FKS2 | S663F | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (0.5) | 2014 | 24951808 |
| Cg21 | C. glabrata | Clinical isolate | FKS2 | S663F | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (0.5) | 2014 | 24951808 |
| Cg22 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (1), Caspofungin (1) | 2014 | 24951808 |
| Cg23 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (4), Caspofungin (16) | 2014 | 24951808 |
| Cg24 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (2), Caspofungin (2) | 2014 | 24951808 |
| Cg25 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (4), Caspofungin (4) | 2014 | 24951808 |
| Cg26 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (1), Caspofungin (2) | 2014 | 24951808 |
| Cg27 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (4), Caspofungin (16) | 2014 | 24951808 |
| Cg28 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (2), Caspofungin (8) | 2014 | 24951808 |
| Cg29 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Caspofungin (0.5) | 2014 | 24951808 |
| Cg3 | C. glabrata | Clinical isolate | FKS1 | F625S | Single substitution | Q6FTN8 | 1863 | Model |  | Anidulafungin (2), Caspofungin (2) | 2014 | 24951808 |
| Cg30 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (4), Caspofungin (16) | 2014 | 24951808 |
| Cg31 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (1), Caspofungin (8) | 2014 | 24951808 |
| Cg32 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Caspofungin (0.5) | 2014 | 24951808 |
| Cg33 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (4), Caspofungin (16) | 2014 | 24951808 |
| Cg34 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (1), Caspofungin (8) | 2014 | 24951808 |
| Cg35 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (1), Caspofungin (1) | 2014 | 24951808 |
| Cg36 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (4), Caspofungin (16) | 2014 | 24951808 |
| Cg37 | C. glabrata | Clinical isolate | FKS2 | S663Y | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (1), Caspofungin (0.5) | 2014 | 24951808 |
| Cg38 | C. glabrata | Clinical isolate | FKS2 | L664R | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (1), Caspofungin (0.5) | 2014 | 24951808 |
| Cg39 | C. glabrata | Clinical isolate | FKS2 | R665G | Single substitution | Q6FMZ3 | 1897 | Model |  | Caspofungin (0.5) | 2014 | 24951808 |
| Cg4 | C. glabrata | Clinical isolate | FKS1 | S629P | Single substitution | Q6FTN8 | 1863 | Model |  | Anidulafungin (2), Caspofungin (16) | 2014 | 24951808 |
| Cg40 | C. glabrata | Clinical isolate | FKS2 | R665S | Single substitution | Q6FMZ3 | 1897 | Model |  | Caspofungin (0.5) | 2014 | 24951808 |
| Cg41 | C. glabrata | Clinical isolate | FKS2 | P667T | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (1), Caspofungin (1) | 2014 | 24951808 |
| Cg42 | C. glabrata | Clinical isolate | FKS2 | F658del | Deletion | Q6FMZ3 | 1897 | Model |  | Anidulafungin (1), Caspofungin (16) | 2014 | 24951808 |
| Cg5 | C. glabrata | Clinical isolate | FKS1 | S629P | Single substitution | Q6FTN8 | 1863 | Model |  | Anidulafungin (2), Caspofungin (16) | 2014 | 24951808 |
| Cg6 | C. glabrata | Clinical isolate | FKS1 | S629P | Single substitution | Q6FTN8 | 1863 | Model |  | Anidulafungin (2), Caspofungin (16) | 2014 | 24951808 |
| Cg7 | C. glabrata | Clinical isolate | FKS1 | S629P, R631S | Double substitution | Q6FTN8 | 1863 | Model |  | Anidulafungin (4), Caspofungin (2) | 2014 | 24951808 |
| Cg8 | C. glabrata | Clinical isolate | FKS1 | D632E | Single substitution | Q6FTN8 | 1863 | Model |  | Anidulafungin (1), Caspofungin (0.5) | 2014 | 24951808 |
| Cg9 | C. glabrata | Clinical isolate | FKS1 | D632E | Single substitution | Q6FTN8 | 1863 | Model |  | Anidulafungin (1), Caspofungin (1) | 2014 | 24951808 |
| Ckru1 | C. krusei | Clinical isolate | FKS1 | F655C | Single substitution | Q4U2W2 | 1885 | Model |  | Caspofungin (1) | 2014 | 24951808 |
| Ckru2 | C. krusei | Clinical isolate | FKS1 | R1361G | Single substitution | Q4U2W2 | 1885 | Model | Mismatch residue | Anidulafungin (1), Caspofungin (16) | 2014 | 24951808 |
| Ct1 | C. tropicalis | Clinical isolate | FKS1 | F641S | Single substitution | C5MFG3 | 1570 | Model | Mismatch residue | Anidulafungin (1), Caspofungin (1) | 2014 | 24951808 |
| Ct2 | C. tropicalis | Clinical isolate | FKS1 | S645P | Single substitution | C5MFG3 | 1570 | Model | Structure not available | Anidulafungin (1), Caspofungin (2) | 2014 | 24951808 |
| Ct3 | C. tropicalis | Clinical isolate | FKS1 | S645P | Single substitution | C5MFG3 | 1570 | Model | Structure not available | Caspofungin (2) | 2014 | 24951808 |
| C113 | C. kefyr | Clinical isolate | FKS1 | R647G | Single substitution | Not available | Not available | Not available | Structure not available | Anidulafungin (0.25), Caspofungin (0.125), Micafungin (4) | 2014 | 24982083 |
| C116 | C. kefyr | Clinical isolate | FKS1 | F641del | Deletion | Not available | Not available | Not available | Structure not available | Anidulafungin (>8.0), Caspofungin (4), Micafungin (>8) | 2014 | 24982083 |
| C132 | C. kefyr | Clinical isolate | FKS1 | S645P | Single substitution | Not available | Not available | Not available | Structure not available | Anidulafungin (>8), Caspofungin (2), Micafungin (>8) | 2014 | 24982083 |
| C133 | C. kefyr | Clinical isolate | FKS1 | S645P | Single substitution | Not available | Not available | Not available | Structure not available | Anidulafungin (>8), Caspofungin (2), Micafungin (>8) | 2014 | 24982083 |
| C134 | C. kefyr | Clinical isolate | FKS1 | S645P | Single substitution | Not available | Not available | Not available | Structure not available | Anidulafungin (>8), Caspofungin (2), Micafungin (>8) | 2014 | 24982083 |
| C135 | C. kefyr | Clinical isolate | FKS1 | S645P | Single substitution | Not available | Not available | Not available | Structure not available | Anidulafungin (>8), Caspofungin (2), Micafungin (>8) | 2014 | 24982083 |
| C136 | C. kefyr | Clinical isolate | FKS1 | S645P | Single substitution | Not available | Not available | Not available | Structure not available | Anidulafungin (>8), Caspofungin (2), Micafungin (>8) | 2014 | 24982083 |
| Ca | C. albicans | Clinical isolate | FKS1 | S645P | Single substitution | A0A1D8PCT0 | 1897 | AF-A0A1D8PCT0-F1 |  | Caspofungin (>32), Micafungin (>1), Anidulafungin (1.5) | 2014 | 25025677 |
| PATIENT 11 | C. orthopsilosis | Clinical isolate | FKS1 | P660A | Single substitution | H8X1R5 | 1902 | Model | Mismatch residue | Caspofungin (1), Anidulafungin (0.5), Micafungin (0.5) | 2014 | 25108876 |
| PATIENT 12 | C. orthopsilosis | Clinical isolate | FKS1 | P660A | Single substitution | H8X1R5 | 1902 | Model | Mismatch residue | Caspofungin (2), Micafungin (2), Anidulafungin (2) | 2014 | 25108876 |
| PATIENT 15 | C. orthopsilosis | Clinical isolate | FKS1 | P660A | Single substitution | H8X1R5 | 1902 | Model | Mismatch residue | Caspofungin (8), Micafungin (2), Anidulafungin (2) | 2014 | 25108876 |
| PATIENT 4 | C. parapsilosis | Clinical isolate | FKS1 | P660A | Single substitution | A9YLC3 | 1909 | Model | Mismatch residue | Caspofungin (1), Micafungin (2), Anidulafungin (2) | 2014 | 25108876 |
| PATIENT 5 | C. parapsilosis | Clinical isolate | FKS1 | P660A | Single substitution | A9YLC3 | 1909 | Model | Mismatch residue | Caspofungin (0.5), Anidulafungin (1), Micafungin (1) | 2014 | 25108876 |
| PATIENT 9 | C. parapsilosis | Clinical isolate | FKS1 | P660A | Single substitution | A9YLC3 | 1909 | Model | Mismatch residue | Caspofungin (0.5), Anidulafungin (0.5), Micafungin (0.5) | 2014 | 25108876 |
| Cd | C. dubliniensis | Clinical isolate | FKS1 | S645P | Single substitution | D3IZZ7 | 1897 | Model | Structure not available | Anidulafungin (2), Caspofungin (2), Micafungin (1) | 2014 | 25129315 |
| Cg1 | C. glabrata | Clinical isolate | FKS2 | F659Y | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (0.25), Caspofungin (0.5) | 2014 | 25129315 |
| Cg2 | C. glabrata | Clinical isolate | FKS2 | F659del | Deletion | Q6FMZ3 | 1897 | Model |  | Anidulafungin (2), Caspofungin (1), Micafungin (1) | 2014 | 25129315 |
| Cg3 | C. glabrata | Clinical isolate | FKS2 | S663F | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (2), Caspofungin (2), Micafungin (1) | 2014 | 25129315 |
| Cg4 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (2), Caspofungin (0.5), Micafungin (1) | 2014 | 25129315 |
| Ckef | C. kefyr | Clinical isolate | FKS1 | R1344S | Single substitution | W0TDH9 | 1892 | Model | Mismatch residue | Anidulafungin (2), Caspofungin (0.5), Micafungin (1) | 2014 | 25129315 |
| Ckru | C. krusei | Clinical isolate | FKS1 | L701M | Single substitution | Q4U2W2 | 1885 | Model |  | Anidulafungin (1), Caspofungin (1) | 2014 | 25129315 |
| Cg | C. glabrata | Clinical isolate | PDR1 | D243N | Single substitution | Q6FXU7 | 1107 | AF-Q6FXU7-F1 |  | Fluconazole (64), Voriconazole (1), Posaconazole (16), Prochloraz (64) | 2014 | 25132632 |
| SH131/128-2 | C. albicans | Clinical isolate | ERG11 | K128T, Y132H, G465S | Multiple substitution | P10613 | 528 | 5V5Z |  | Fluconazole (128), Itraconazole (4) | 2015 | 25351710 |
| SH149 | C. albicans | Clinical isolate | ERG11 | Y132H, G448E | Double substitution | P10613 | 528 | 5V5Z |  | Voriconazole (8), Fluconazole (128), Itraconazole (4) | 2015 | 25351710 |
| SH174 | C. albicans | Clinical isolate | ERG11 | K128T | Single substitution | P10613 | 528 | 5V5Z |  | Voriconazole (8), Fluconazole (128), Itraconazole (4) | 2015 | 25351710 |
| SH22 | C. albicans | Clinical isolate | ERG11 | Y132H, G448R | Double substitution | P10613 | 528 | 5V5Z |  | Voriconazole (8), Fluconazole (128), Itraconazole (4) | 2015 | 25351710 |
| SH37 | C. albicans | Clinical isolate | ERG11 | V332L | Single substitution | P10613 | 528 | 5V5Z |  | Voriconazole (8), Fluconazole (128), Itraconazole (4) | 2015 | 25351710 |
| SH42 | C. albicans | Clinical isolate | ERG11 | A114S, Y257H | Double substitution | P10613 | 528 | 5V5Z |  | Voriconazole (8), Fluconazole (128), Itraconazole (4) | 2015 | 25351710 |
| SH50 | C. albicans | Clinical isolate | ERG11 | A114S, Y257H | Double substitution | P10613 | 528 | 5V5Z |  | Voriconazole (8), Fluconazole (128), Itraconazole (4) | 2015 | 25351710 |
| SH52/43-2 | C. albicans | Clinical isolate | ERG11 | V332L | Single substitution | P10613 | 528 | 5V5Z |  | Voriconazole (8), Fluconazole (128), Itraconazole (4) | 2015 | 25351710 |
| SH54 | C. albicans | Clinical isolate | ERG11 | K128T, Y132H, G465S | Multiple substitution | P10613 | 528 | 5V5Z |  | Fluconazole (128), Itraconazole (4) | 2015 | 25351710 |
| SH58 | C. albicans | Clinical isolate | ERG11 | G465S | Single substitution | P10613 | 528 | 5V5Z |  | Itraconazole (4) | 2015 | 25351710 |
| SH59 | C. albicans | Clinical isolate | ERG11 | V332L | Single substitution | P10613 | 528 | 5V5Z |  | Voriconazole (8), Fluconazole (128), Itraconazole (4) | 2015 | 25351710 |
| SH70 | C. albicans | Clinical isolate | ERG11 | A114S, Y257H | Double substitution | P10613 | 528 | 5V5Z |  | Voriconazole (8), Fluconazole (128), Itraconazole (4) | 2015 | 25351710 |
| 10 | C. albicans | Clinical isolate | ERG11 | K143R | Single substitution | P10613 | 528 | 5V5Z |  | Fluconazole (16) | 2014 | 25385095 |
| 13 | C. albicans | Clinical isolate | ERG11UPC2 | K143RA643T | Single substitutionSingle substitution | P10613Q59QC7 | 528712 | 5V5ZAF-Q59QC7-F1 |  | Fluconazole (16) | 2014 | 25385095 |
| 15 | C. albicans | Clinical isolate | UPC2 | W478C | Single substitution | Q59QC7 | 712 | AF-Q59QC7-F1 |  | Fluconazole (16) | 2014 | 25385095 |
| 16 | C. albicans | Clinical isolate | ERG11 | Q21R | Single substitution | P10613 | 528 | 5V5Z |  | Fluconazole (16) | 2014 | 25385095 |
| 17 | C. albicans | Clinical isolate | ERG11 | A114S, Y257H | Double substitution | P10613 | 528 | 5V5Z |  | Fluconazole (32) | 2014 | 25385095 |
| 18 | C. albicans | Clinical isolate | ERG11 | S405F | Single substitution | P10613 | 528 | 5V5Z |  | Fluconazole (32) | 2014 | 25385095 |
| 21 | C. albicans | Clinical isolate | ERG11UPC2 | A114V, H283RG648D | Double substitutionSingle substitution | P10613Q59QC7 | 528712 | 5V5ZAF-Q59QC7-F1 |  | Fluconazole (32) | 2014 | 25385095 |
| 22 | C. albicans | Clinical isolate | ERG11 | F145L | Single substitution | P10613 | 528 | 5V5Z |  | Fluconazole (32) | 2014 | 25385095 |
| 23 | C. albicans | Clinical isolate | ERG11 | I483V | Single substitution | P10613 | 528 | 5V5Z |  | Fluconazole (32) | 2014 | 25385095 |
| 25 | C. albicans | Clinical isolate | ERG11UPC2 | D446EG648S | Single substitutionSingle substitution | P10613Q59QC7 | 528712 | 5V5ZAF-Q59QC7-F1 |  | Fluconazole (32) | 2014 | 25385095 |
| 26 | C. albicans | Clinical isolate | ERG11 | G307S | Single substitution | P10613 | 528 | 5V5Z |  | Fluconazole (32) | 2014 | 25385095 |
| 27 | C. albicans | Clinical isolate | UPC2 | W478C | Single substitution | Q59QC7 | 712 | AF-Q59QC7-F1 |  | Fluconazole (64) | 2014 | 25385095 |
| 28 | C. albicans | Clinical isolate | UPC2 | W478C | Single substitution | Q59QC7 | 712 | AF-Q59QC7-F1 |  | Fluconazole (64) | 2014 | 25385095 |
| 29 | C. albicans | Clinical isolate | ERG11 | Y132F, F145L | Double substitution | P10613 | 528 | 5V5Z |  | Fluconazole (64) | 2014 | 25385095 |
| 30 | C. albicans | Clinical isolate | ERG11UPC2 | F126L, Y132FA643V | Double substitutionSingle substitution | P10613Q59QC7 | 528712 | 5V5ZAF-Q59QC7-F1 |  | Fluconazole (64) | 2014 | 25385095 |
| 31 | C. albicans | Clinical isolate | ERG11 | G448E | Single substitution | P10613 | 528 | 5V5Z |  | Fluconazole (64) | 2014 | 25385095 |
| 32 | C. albicans | Clinical isolate | ERG11 | G464S | Single substitution | P10613 | 528 | 5V5Z |  | Fluconazole (64) | 2014 | 25385095 |
| 33 | C. albicans | Clinical isolate | ERG11UPC2 | F145LY642F | Single substitutionSingle substitution | P10613Q59QC7 | 528712 | 5V5ZAF-Q59QC7-F1 |  | Fluconazole (64) | 2014 | 25385095 |
| 34 | C. albicans | Clinical isolate | UPC2 | Y642F | Single substitution | Q59QC7 | 712 | AF-Q59QC7-F1 |  | Fluconazole (64) | 2014 | 25385095 |
| 35 | C. albicans | Clinical isolate | UPC2 | G648S | Single substitution | Q59QC7 | 712 | AF-Q59QC7-F1 |  | Fluconazole (64) | 2014 | 25385095 |
| 38 | C. albicans | Clinical isolate | UPC2 | G648D | Single substitution | Q59QC7 | 712 | AF-Q59QC7-F1 |  | Fluconazole (64) | 2014 | 25385095 |
| 40 | C. albicans | Clinical isolate | ERG11 | F449V | Single substitution | P10613 | 528 | 5V5Z |  | Fluconazole (128) | 2014 | 25385095 |
| 43 | C. albicans | Clinical isolate | ERG11 | D278N, G464S | Double substitution | P10613 | 528 | 5V5Z |  | Fluconazole (128) | 2014 | 25385095 |
| 45 | C. albicans | Clinical isolate | ERG11UPC2 | G464SA646V | Single substitutionSingle substitution | P10613Q59QC7 | 528712 | 5V5ZAF-Q59QC7-F1 |  | Fluconazole (128) | 2014 | 25385095 |
| 46 | C. albicans | Clinical isolate | ERG11 | G307S, L403F, G448R | Multiple substitution | P10613 | 528 | 5V5Z |  | Fluconazole (128) | 2014 | 25385095 |
| 47 | C. albicans | Clinical isolate | ERG11UPC2 | A114V, Y132F, V437IG648D | Multiple substitutionSingle substitution | P10613Q59QC7 | 528712 | 5V5ZAF-Q59QC7-F1 |  | Fluconazole (128) | 2014 | 25385095 |
| 48 | C. albicans | Clinical isolate | ERG11 | Y132F | Single substitution | P10613 | 528 | 5V5Z |  | Fluconazole (256) | 2014 | 25385095 |
| 49 | C. albicans | Clinical isolate | ERG11 | G307S, V437I, Y447S | Multiple substitution | P10613 | 528 | 5V5Z |  | Fluconazole (256) | 2014 | 25385095 |
| 50 | C. albicans | Clinical isolate | ERG11 | Y132F, K143R | Double substitution | P10613 | 528 | 5V5Z |  | Fluconazole (256) | 2014 | 25385095 |
| 52 | C. albicans | Clinical isolate | UPC2 | G648D | Single substitution | Q59QC7 | 712 | AF-Q59QC7-F1 |  | Fluconazole (256) | 2014 | 25385095 |
| 55 | C. albicans | Clinical isolate | UPC2 | G648S | Single substitution | Q59QC7 | 712 | AF-Q59QC7-F1 |  | Fluconazole (>256) | 2014 | 25385095 |
| 56 | C. albicans | Clinical isolate | UPC2 | G648S | Single substitution | Q59QC7 | 712 | AF-Q59QC7-F1 |  | Fluconazole (>256) | 2014 | 25385095 |
| 57 | C. albicans | Clinical isolate | UPC2 | G648S | Single substitution | Q59QC7 | 712 | AF-Q59QC7-F1 |  | Fluconazole (>256) | 2014 | 25385095 |
| 58 | C. albicans | Clinical isolate | UPC2 | G648S | Single substitution | Q59QC7 | 712 | AF-Q59QC7-F1 |  | Fluconazole (>256) | 2014 | 25385095 |
| 59 | C. albicans | Clinical isolate | ERG11UPC2 | Y132F, T229A, F449LG648D | Multiple substitutionSingle substitution | P10613Q59QC7 | 528712 | 5V5ZAF-Q59QC7-F1 |  | Fluconazole (>256) | 2014 | 25385095 |
| 65 | C. albicans | Clinical isolate | UPC2 | G648S | Single substitution | Q59QC7 | 712 | AF-Q59QC7-F1 |  | Fluconazole (>256) | 2014 | 25385095 |
| 67 | C. albicans | Clinical isolate | UPC2 | G648S | Single substitution | Q59QC7 | 712 | AF-Q59QC7-F1 |  | Fluconazole (>256) | 2014 | 25385095 |
| 68 | C. albicans | Clinical isolate | ERG11UPC2 | Y132F, I471M, I483VT273A, A643V | Multiple substitutionDouble substitution | P10613Q59QC7 | 528712 | 5V5ZAF-Q59QC7-F1 |  | Fluconazole (>256) | 2014 | 25385095 |
| 69 | C. albicans | Clinical isolate | UPC2 | G648S | Single substitution | Q59QC7 | 712 | AF-Q59QC7-F1 |  | Fluconazole (>256) | 2014 | 25385095 |
| 70 | C. albicans | Clinical isolate | ERG11UPC2 | M258L, G464SA646V | Double substitutionSingle substitution | P10613Q59QC7 | 528712 | 5V5ZAF-Q59QC7-F1 |  | Fluconazole (>256) | 2014 | 25385095 |
| 71 | C. albicans | Clinical isolate | ERG11UPC2 | Y132F, V437I, F449LG648D | Multiple substitutionSingle substitution | P10613Q59QC7 | 528712 | 5V5ZAF-Q59QC7-F1 |  | Fluconazole (>256) | 2014 | 25385095 |
| 72 | C. albicans | Clinical isolate | ERG11 | A114V, D153E | Double substitution | P10613 | 528 | 5V5Z |  | Fluconazole (>256) | 2014 | 25385095 |
| BMU05457 | C. tropicalis | Clinical isolate | ERG11 | Y132F | Single substitution | C5MGS9 | 528 | AF-C5MGS9-F1 |  | Fluconazole (>64) | 2015 | 25398256 |
| C26 | C. albicans | Clinical isolate | ERG11 | Y132H, S405F | Double substitution | P10613 | 528 | 5V5Z |  | Fluconazole (>128), Itraconazole (>2) | 2015 | 25398256 |
| CAS08-0060 | C. parapsilosis | Clinical isolate | MRR1 | G53A | Single substitution | G8BAV4 | 1128 | AF-G8BAV4-F1 | Mismatch residue | Fluconazole (16) | 2015 | 25451046 |
| CAS08-0339 | C. parapsilosis | Clinical isolate | MRR1 | A859T | Single substitution | G8BAV4 | 1128 | AF-G8BAV4-F1 |  | Fluconazole (8) | 2015 | 25451046 |
| CAS08-0490 | C. parapsilosis | Clinical isolate | ERG11 | Y132F | Single substitution | G8B9T3 | 522 | AF-G8B9T3-F1 | Mismatch residue | Fluconazole (16), Voriconazole (1) | 2015 | 25451046 |
| CAS08-0796 | C. parapsilosis | Clinical isolate | ERG11 | Y132F | Single substitution | G8B9T3 | 522 | AF-G8B9T3-F1 | Mismatch residue | Fluconazole (8) | 2015 | 25451046 |
| CAS09-0912 | C. parapsilosis | Clinical isolate | ERG11 | Y132F | Single substitution | G8B9T3 | 522 | AF-G8B9T3-F1 | Mismatch residue | Fluconazole (8) | 2015 | 25451046 |
| CAS09-0959 | C. parapsilosis | Clinical isolate | ERG11 | Y132F | Single substitution | G8B9T3 | 522 | AF-G8B9T3-F1 | Mismatch residue | Fluconazole (32), Voriconazole (1) | 2015 | 25451046 |
| CAS09-1107 | C. parapsilosis | Clinical isolate | ERG11 | Y132F | Single substitution | G8B9T3 | 522 | AF-G8B9T3-F1 | Mismatch residue | Fluconazole (8) | 2015 | 25451046 |
| CAS09-1291 | C. parapsilosis | Clinical isolate | ERG11 | Y132F | Single substitution | G8B9T3 | 522 | AF-G8B9T3-F1 | Mismatch residue | Fluconazole (16), Voriconazole (1) | 2015 | 25451046 |
| CAS09-1299 | C. parapsilosis | Clinical isolate | MRR1 | A619V | Single substitution | G8BAV4 | 1128 | AF-G8BAV4-F1 |  | Fluconazole (8) | 2015 | 25451046 |
| CAS09-1321 | C. parapsilosis | Clinical isolate | ERG11 | Y132F | Single substitution | G8B9T3 | 522 | AF-G8B9T3-F1 | Mismatch residue | Fluconazole (64), Voriconazole (1) | 2015 | 25451046 |
| CAS09-1504 | C. parapsilosis | Clinical isolate | ERG11 | Y132F | Single substitution | G8B9T3 | 522 | AF-G8B9T3-F1 | Mismatch residue | Fluconazole (32), Voriconazole (2) | 2015 | 25451046 |
| CAS09-1783 | C. parapsilosis | Clinical isolate | ERG11 | Y132F | Single substitution | G8B9T3 | 522 | AF-G8B9T3-F1 | Mismatch residue | Fluconazole (16) | 2015 | 25451046 |
| CAS10-1830 | C. parapsilosis | Clinical isolate | MRR1MRR1 | K177NQ1053X | Single substitutionSingle substitution | G8BAV4G8BAV4 | 11281128 | AF-G8BAV4-F1AF-G8BAV4-F1 |  | Fluconazole (8) | 2015 | 25451046 |
| CAS10-1852 | C. parapsilosis | Clinical isolate | MRR1 | R405K | Single substitution | G8BAV4 | 1128 | AF-G8BAV4-F1 |  | Fluconazole (8) | 2015 | 25451046 |
| CAS10-1966 | C. parapsilosis | Clinical isolate | ERG11 | Y132F | Single substitution | G8B9T3 | 522 | AF-G8B9T3-F1 | Mismatch residue | Fluconazole (8) | 2015 | 25451046 |
| CAS10-2364 | C. parapsilosis | Clinical isolate | ERG11 | Y132F | Single substitution | G8B9T3 | 522 | AF-G8B9T3-F1 | Mismatch residue | Fluconazole (16) | 2015 | 25451046 |
| CAS10-2602 | C. parapsilosis | Clinical isolate | ERG11 | Y132F | Single substitution | G8B9T3 | 522 | AF-G8B9T3-F1 | Mismatch residue | Fluconazole (8) | 2015 | 25451046 |
| CAS11-3037 | C. parapsilosis | Clinical isolate | ERG11 | Y132F | Single substitution | G8B9T3 | 522 | AF-G8B9T3-F1 | Mismatch residue | Fluconazole (16) | 2015 | 25451046 |
| CAS11-3108 | C. parapsilosis | Clinical isolate | MRR1 | D615G | Single substitution | G8BAV4 | 1128 | AF-G8BAV4-F1 |  | Fluconazole (8) | 2015 | 25451046 |
| CAS11-3324 | C. parapsilosis | Clinical isolate | ERG11 | Y132F | Single substitution | G8B9T3 | 522 | AF-G8B9T3-F1 | Mismatch residue | Fluconazole (16), Voriconazole (1) | 2015 | 25451046 |
| CAS11-3362 | C. parapsilosis | Clinical isolate | ERG11 | Y132F | Single substitution | G8B9T3 | 522 | AF-G8B9T3-F1 | Mismatch residue | Fluconazole (8) | 2015 | 25451046 |
| CAS12-3954 | C. parapsilosis | Clinical isolate | ERG11 | Y132F | Single substitution | G8B9T3 | 522 | AF-G8B9T3-F1 | Mismatch residue | Fluconazole (16) | 2015 | 25451046 |
| CAS12-3992 | C. parapsilosis | Clinical isolate | ERG11 | Y132F | Single substitution | G8B9T3 | 522 | AF-G8B9T3-F1 | Mismatch residue | Fluconazole (8) | 2015 | 25451046 |
| CAS12-4342 | C. parapsilosis | Clinical isolate | MRR1 | L779F | Single substitution | G8BAV4 | 1128 | AF-G8BAV4-F1 |  | Fluconazole (32) | 2015 | 25451046 |
| CAS12-4406 | C. parapsilosis | Clinical isolate | MRR1 | K177N | Single substitution | G8BAV4 | 1128 | AF-G8BAV4-F1 |  | Fluconazole (8) | 2015 | 25451046 |
| H13139 | C. albicans | Clinical isolate | ERG11 | Y132F, K143Q, Y257H | Multiple substitution | Q5I4C6 | 528 | AF-Q5I4C6-F1 |  | Fluconazole (>64), Itraconazole (>16), Voriconazole (8) | 2015 | 25748216 |
| H21897 | C. albicans | Clinical isolate | ERG11 | Y132F, K143Q | Double substitution | Q5I4C6 | 528 | AF-Q5I4C6-F1 |  | Fluconazole (>64), Itraconazole (>16), Voriconazole (16) | 2015 | 25748216 |
| H64110 | C. albicans | Clinical isolate | ERG11 | Y132F, K143Q, Y257H | Multiple substitution | Q5I4C6 | 528 | AF-Q5I4C6-F1 |  | Fluconazole (>64), Itraconazole (16), Voriconazole (4) | 2015 | 25748216 |
| Y141 | C. albicans | Clinical isolate | ERG11TAC1 | A114S, Y257HA736V | Double substitutionSingle substitution | Q5I4C6Q1WCU6 | 528981 | AF-Q5I4C6-F1AF-Q1WCU6-F1 |  | Itraconazole (>16) | 2015 | 25748216 |
| Y201 | C. albicans | Clinical isolate | ERG11TAC1 | A114S, Y257HA736V | Double substitutionSingle substitution | Q5I4C6Q1WCU6 | 528981 | AF-Q5I4C6-F1AF-Q1WCU6-F1 |  | Itraconazole (16) | 2015 | 25748216 |
| Y206 | C. albicans | Clinical isolate | ERG11 | Y132H | Single substitution | Q5I4C6 | 528 | AF-Q5I4C6-F1 |  | Itraconazole (16) | 2015 | 25748216 |
| Y208 | C. albicans | Clinical isolate | ERG11 | Y132H, G448E | Double substitution | Q5I4C6 | 528 | AF-Q5I4C6-F1 |  | Itraconazole (16) | 2015 | 25748216 |
| Y210 | C. albicans | Clinical isolate | ERG11 | Y132F, Y257H, G448E | Multiple substitution | Q5I4C6 | 528 | AF-Q5I4C6-F1 |  | Voriconazole (4) | 2015 | 25748216 |
| 1031LL | C. parapsilosis | Clinical isolate | FKS1 | S745L | Single substitution | A9YLC3 | 1909 | Model |  | Anidulafungin (2), Micafungin (1), Caspofungin (1) | 2015 | 25779577 |
| 1064LL | C. parapsilosis | Clinical isolate | FKS1 | M1328I | Single substitution | A9YLC3 | 1909 | Model |  | Anidulafungin (1), Micafungin (1), Caspofungin (2) | 2015 | 25779577 |
| 462LL | C. parapsilosis | Clinical isolate | FKS1 | S745L | Single substitution | A9YLC3 | 1909 | Model |  | Anidulafungin (1), Micafungin (1), Caspofungin (1) | 2015 | 25779577 |
| 474LL | C. parapsilosis | Clinical isolate | FKS1 | M1328I | Single substitution | A9YLC3 | 1909 | Model |  | Anidulafungin (1), Micafungin (1), Caspofungin (1) | 2015 | 25779577 |
| 544LL | C. parapsilosis | Clinical isolate | FKS1 | S745L | Single substitution | A9YLC3 | 1909 | Model |  | Anidulafungin (1), Micafungin (1), Caspofungin (1) | 2015 | 25779577 |
| 681LL | C. parapsilosis | Clinical isolate | FKS1 | A1422G | Single substitution | A9YLC3 | 1909 | Model |  | Anidulafungin (2), Micafungin (1), Caspofungin (1) | 2015 | 25779577 |
| 713LL | C. parapsilosis | Clinical isolate | FKS1 | S745L | Single substitution | A9YLC3 | 1909 | Model |  | Anidulafungin (1), Micafungin (1), Caspofungin (1) | 2015 | 25779577 |
| 831LL | C. parapsilosis | Clinical isolate | FKS1 | S745L | Single substitution | A9YLC3 | 1909 | Model |  | Anidulafungin (2), Micafungin (1), Caspofungin (1) | 2015 | 25779577 |
| 928LL | C. parapsilosis | Clinical isolate | FKS1 | V595I | Single substitution | A9YLC3 | 1909 | Model |  | Anidulafungin (1), Micafungin (1), Caspofungin (1) | 2015 | 25779577 |
| AX-32 | C. parapsilosis | Clinical isolate | FKS1 | S745L | Single substitution | A9YLC3 | 1909 | Model |  | Anidulafungin (1), Micafungin (1), Caspofungin (1) | 2015 | 25779577 |
| ST-14 | C. parapsilosis | Clinical isolate | FKS1 | F1386S | Single substitution | A9YLC3 | 1909 | Model |  | Anidulafungin (1), Micafungin (1), Caspofungin (1) | 2015 | 25779577 |
| 2762 | C. glabrata | Clinical isolate | FKS1 | F641S | Single substitution | Q6FTN8 | 1863 | Model | Mismatch residue | Caspofungin (4), Micafungin (1) | 2015 | 25878347 |
| A15 | C. glabrata | Clinical isolate | FKS1 | S645P | Single substitution | Q6FTN8 | 1863 | Model | Mismatch residue | Anidulafungin (0.5), Caspofungin (4), Micafungin (0.5) | 2015 | 25878347 |
| A15-10 | C. glabrata | Clinical isolate | FKS1 | S645P | Single substitution | Q6FTN8 | 1863 | Model | Mismatch residue | Anidulafungin (2), Caspofungin (8), Micafungin (4) | 2015 | 25878347 |
| M119 | C. glabrata | Clinical isolate | FKS1 | F641L | Single substitution | Q6FTN8 | 1863 | Model | Mismatch residue | Caspofungin (2) | 2015 | 25878347 |
| M121 | C. glabrata | Clinical isolate | FKS1 | R1361H | Single substitution | Q6FTN8 | 1863 | Model | Mismatch residue | Caspofungin (2) | 2015 | 25878347 |
| M122 | C. glabrata | Clinical isolate | FKS1 | P649H | Single substitution | Q6FTN8 | 1863 | Model | Mismatch residue | Caspofungin (2.52) | 2015 | 25878347 |
| M149 | C. glabrata | Clinical isolate | FKS1 | D648Y | Single substitution | Q6FTN8 | 1863 | Model | Mismatch residue | Anidulafungin (4), Caspofungin (4), Micafungin (2.52) | 2015 | 25878347 |
| M177 | C. glabrata | Clinical isolate | FKS1 | F641S | Single substitution | Q6FTN8 | 1863 | Model | Mismatch residue | Caspofungin (4), Micafungin (1) | 2015 | 25878347 |
| M194 | C. glabrata | Clinical isolate | FKS1 | S645F, R1361H | Double substitution | Q6FTN8 | 1863 | Model | Mismatch residue | Anidulafungin (4), Caspofungin (4), Micafungin (2.67) | 2015 | 25878347 |
| M205 | C. glabrata | Clinical isolate | FKS1 | S645P | Single substitution | Q6FTN8 | 1863 | Model | Mismatch residue | Anidulafungin (1.26), Caspofungin (8), Micafungin (4) | 2015 | 25878347 |
| M85 | C. glabrata | Clinical isolate | FKS1 | S645F | Single substitution | Q6FTN8 | 1863 | Model | Mismatch residue | Anidulafungin (1.5), Caspofungin (2), Micafungin (2.52) | 2015 | 25878347 |
| M89 | C. glabrata | Clinical isolate | FKS1 | S645Y | Single substitution | Q6FTN8 | 1863 | Model | Mismatch residue | Anidulafungin (2), Caspofungin (4), Micafungin (4) | 2015 | 25878347 |
| M90 | C. glabrata | Clinical isolate | FKS1 | R1361H | Single substitution | Q6FTN8 | 1863 | Model | Mismatch residue | Caspofungin (1), Micafungin (0.5) | 2015 | 25878347 |
| CG-Australia1 | C. glabrata | Clinical isolate | FKS2 | S663F | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (≥0.5), Caspofungin (≥0.5), Micafungin (≥0.5) | 2015 | 25899126 |
| CG-Australia2 | C. glabrata | Clinical isolate | FKS1 | F625S | Single substitution | Q6FTN8 | 1863 | Model |  | Anidulafungin (0.5) | 2015 | 25899126 |
| P4 | C. albicans | Clinical isolate | ERG11TAC1 | G307SR688Q | Single substitutionSingle substitution | P10613A0A1D8PN96 | 528981 | 5V5ZAF-A0A1D8PN96-F1 |  | Fluconazole (8) | 2015 | 26017038 |
| P5 | C. albicans | Clinical isolate | ERG11TAC1 | A61E, G307SR673L | Double substitutionSingle substitution | P10613A0A1D8PN96 | 528981 | 5V5ZAF-A0A1D8PN96-F1 |  | Fluconazole (>16), Itraconazole (16), Voriconazole (1), Posaconazole (>4) | 2015 | 26017038 |
| P7 | C. albicans | Clinical isolate | ERG11FKS1TAC1 | A61E, G307SS645PR673L | Double substitutionSingle substitutionSingle substitution | P10613A0A1D8PCT0A0A1D8PN96 | 5281897981 | 5V5ZAF-A0A1D8PCT0-F1AF-A0A1D8PN96-F1 |  | Fluconazole (>16), Itraconazole (16), Voriconazole (0.25), Posaconazole (4), Anidulafungin (1) [EUCAST] Caspofungin (>32) [Etest] | 2015 | 26017038 |
| P8 | C. albicans | Clinical isolate | ERG11ERG2FKS1TAC1 | A61E, G307SF105fsS645PR673L | Double substitutionFrameshiftSingle substitutionSingle substitution | P10613A0A1D8PCB9A0A1D8PCT0A0A1D8PN96 | 5282171897981 | 5V5ZAF-A0A1D8PCB9-F1AF-A0A1D8PCT0-F1AF-A0A1D8PN96-F1 |  | Fluconazole (>16), Itraconazole (16), Voriconazole (0.125), Posaconazole (4), Anidulafungin (1) [EUCAST] Caspofungin (>32), Amphotericin B (>32) [Etest] | 2015 | 26017038 |
| P9 | C. albicans | Clinical isolate | ERG11ERG2FKS1TAC1 | A61E, G307SF105fsS645PR673L | Double substitutionFrameshiftSingle substitutionSingle substitution | P10613A0A1D8PCB9A0A1D8PCT0A0A1D8PN96 | 5282171897981 | 5V5ZAF-A0A1D8PCB9-F1AF-A0A1D8PCT0-F1AF-A0A1D8PN96-F1 |  | Fluconazole (>16), Itraconazole (16), Voriconazole (0.125), Posaconazole (0.5-4), Anidulafungin (1) [EUCAST] Caspofungin (>32), Amphotericin B (>32) [Etest] | 2015 | 26017038 |
| CA-GRE-TOP | C. albicans | Clinical isolate | ERG3ERG3 | D103ND103N | Single substitutionSingle substitution | Q59VG6Q59VG6 | 386386 | AF-Q59VG6-F1AF-Q59VG6-F1 |  | Antifungal Echinocandin | 2015 | 26017039 |
| CA-HM-MAC1 | C. albicans | Clinical isolate | ERG3 | W228Stop | Stop | Q59VG6 | 386 | AF-Q59VG6-F1 |  | Azole | 2015 | 26017039 |
| CA-HM-MAC2 | C. albicans | Clinical isolate | ERG3 | W228Stop | Stop | Q59VG6 | 386 | AF-Q59VG6-F1 |  | Azole | 2015 | 26017039 |
| CG-GRE-CAP | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Echinocandin | 2015 | 26017039 |
| CG-GRE-DUC | C. glabrata | Clinical isolate | FKS1 | F625S | Single substitution | Q6FTN8 | 1863 | Model |  | Echinocandin | 2015 | 26017039 |
| CG-HM-HAB1 | C. glabrata | Clinical isolate | PDR1 | T370I | Single substitution | Q6FXU7 | 1107 | AF-Q6FXU7-F1 | Structure not available | Fluconazole (>64), Voriconazole (4) | 2015 | 26017039 |
| CG-HM-HAB2a | C. glabrata | Clinical isolate | FKS2 | F659S, S663A | Double substitution | Q6FMZ3 | 1897 | Model |  | Caspofungin (2), Anidulafungin (2), Micafungin (1) | 2015 | 26017039 |
| CG-HM-HAB2b | C. glabrata | Clinical isolate | PDR1 | T370I | Single substitution | Q6FXU7 | 1107 | AF-Q6FXU7-F1 | Structure not available | Fluconazole (>64), Voriconazole (8) | 2015 | 26017039 |
| ABR-1 | C. albicans | Clinical isolate | orf19.7235 | D216Y | Single substitution | A0A1D8PFX9 | 892 | AF-A0A1D8PFX9-F1 |  | Amphotericin B (0.462) | 2015 | 26030729 |
| ABR-10 | C. albicans | Clinical isolate | ERG2 | S97P | Single substitution | A0A1D8PCB9 | 217 | AF-A0A1D8PCB9-F1 |  | Amphotericin B (1.848) | 2015 | 26030729 |
| ABR-2 | C. albicans | Clinical isolate | ERG2 | W79X | Single substitution | A0A1D8PCB9 | 217 | AF-A0A1D8PCB9-F1 | Structure not available | Amphotericin B (1.848) | 2015 | 26030729 |
| ABR-3 | C. albicans | Clinical isolate | ERG2 | G129D | Single substitution | A0A1D8PCB9 | 217 | AF-A0A1D8PCB9-F1 |  | Amphotericin B (0.924) | 2015 | 26030729 |
| ABR-4 | C. albicans | Clinical isolate | orf19.7235 | D216Y | Single substitution | A0A1D8PFX9 | 892 | AF-A0A1D8PFX9-F1 |  | Amphotericin B (0.462) | 2015 | 26030729 |
| ABR-o1 | C. albicans | Clinical isolate | ERG6 | D60N | Single substitution | O74198 | 376 | AF-O74198-F1 |  | Amphotericin B (1.848) | 2015 | 26030729 |
| ABR-o13 | C. albicans | Clinical isolate | ERG2 | I16N | Single substitution | A0A1D8PCB9 | 217 | AF-A0A1D8PCB9-F1 |  | Amphotericin B (1.848) | 2015 | 26030729 |
| AUR-1 | C. albicans | Clinical isolate | ERG2 | G183V | Single substitution | A0A1D8PCB9 | 217 | AF-A0A1D8PCB9-F1 |  | Amphotericin B (0.924) | 2015 | 26030729 |
| AUR-10 | C. albicans | Clinical isolate | ERG2 | L185X | Single substitution | A0A1D8PCB9 | 217 | AF-A0A1D8PCB9-F1 | Structure not available | Amphotericin B (1.848) | 2015 | 26030729 |
| AUR-3 | C. albicans | Clinical isolate | ERG2 | L58X | Single substitution | A0A1D8PCB9 | 217 | AF-A0A1D8PCB9-F1 | Mismatch residue | Amphotericin B (0.924) | 2015 | 26030729 |
| AUR-5 | C. albicans | Clinical isolate | ERG2 | G129D | Single substitution | A0A1D8PCB9 | 217 | AF-A0A1D8PCB9-F1 |  | Amphotericin B (0.924) | 2015 | 26030729 |
| AUR-7 | C. albicans | Clinical isolate | ERG2 | G129D | Single substitution | A0A1D8PCB9 | 217 | AF-A0A1D8PCB9-F1 |  | Amphotericin B (1.848) | 2015 | 26030729 |
| MUR-6 | C. albicans | Clinical isolate | orf19.7235 | D216Y | Single substitution | A0A1D8PFX9 | 892 | AF-A0A1D8PFX9-F1 |  | Amphotericin B (0.462) | 2015 | 26030729 |
| MUR-7 | C. albicans | Clinical isolate | ERG2 | H95P | Single substitution | A0A1D8PCB9 | 217 | AF-A0A1D8PCB9-F1 |  | Amphotericin B (0.924) | 2015 | 26030729 |
| MUR-9 | C. albicans | Clinical isolate | RPP1A | D106E, D97E | Double substitution | Q9HFQ7 | 106 | AF-Q9HFQ7-F1 |  | Amphotericin B (0.924) | 2015 | 26030729 |
| MUR-N2 | C. albicans | Clinical isolate | ERG6 | I222V, Y366X | Double substitution | O74198 | 376 | AF-O74198-F1 | Mismatch residue | Amphotericin B (1.848) | 2015 | 26030729 |
| MUR-o3 | C. albicans | Clinical isolate | ERG6 | Y194F | Single substitution | O74198 | 376 | AF-O74198-F1 | Mismatch residue | Amphotericin B (0.924) | 2015 | 26030729 |
| Cp29 | C. parapsilosis | Clinical isolate | MRR1 | A854V | Single substitution | G8BAV4 | 1128 | AF-G8BAV4-F1 |  | Fluconazole (64), Voriconazole (1) | 2015 | 26169412 |
| Cp30 | C. parapsilosis | Clinical isolate | MRR1 | R479K | Single substitution | G8BAV4 | 1128 | AF-G8BAV4-F1 |  | Fluconazole (128), Voriconazole (2), Itraconazole (1) | 2015 | 26169412 |
| Cp35 | C. parapsilosis | Clinical isolate | TAC1 | G650E | Single substitution | G8B9R1 | 980 | AF-G8B9R1-F1 |  | Fluconazole (128), Voriconazole (4) | 2015 | 26169412 |
| Cp36 | C. parapsilosis | Clinical isolate | MRR1 | I283R | Single substitution | G8BAV4 | 1128 | AF-G8BAV4-F1 |  | Fluconazole (64) | 2015 | 26169412 |
| Cp38 | C. parapsilosis | Clinical isolate | TAC1 | G650E | Single substitution | G8B9R1 | 980 | AF-G8B9R1-F1 |  | Fluconazole (256), Voriconazole (4) | 2015 | 26169412 |
| Cp40 | C. parapsilosis | Clinical isolate | TAC1 | L978W | Single substitution | G8B9R1 | 980 | AF-G8B9R1-F1 |  | Fluconazole (128), Voriconazole (8) | 2015 | 26169412 |
| JB12 | C. parapsilosis | Laboratory strain | MRR1 | K873N | Single substitution | A0A0K0NQY2 | 1128 | AF-A0A0K0NQY2-F1 |  | Fluconazole (64), Voriconazole (2) | 2015 | 26248365 |
| JB14 | C. parapsilosis | Laboratory strain | MRR1 | G583R | Single substitution | A0A0K0NQY2 | 1128 | AF-A0A0K0NQY2-F1 |  | Fluconazole (64), Voriconazole (2) | 2015 | 26248365 |
| JB4 | C. parapsilosis | Laboratory strain | MRR1 | K873N, Q1064P | Double substitution | A0A0K0NQY2 | 1128 | AF-A0A0K0NQY2-F1 |  | Fluconazole (64), Voriconazole (2) | 2015 | 26248365 |
| LEMI8379 | C. parapsilosis | Clinical isolate | ERG11 | A395T | Single substitution | G8B9T3 | 522 | AF-G8B9T3-F1 | Mismatch residue | Fluconazole (8) | 2015 | 26259795 |
| LEMI8382 | C. parapsilosis | Clinical isolate | ERG11 | A395T | Single substitution | G8B9T3 | 522 | AF-G8B9T3-F1 | Mismatch residue | Fluconazole (8) | 2015 | 26259795 |
| LEMI8383 | C. parapsilosis | Clinical isolate | ERG11 | A395T | Single substitution | G8B9T3 | 522 | AF-G8B9T3-F1 | Mismatch residue | Fluconazole (8) | 2015 | 26259795 |
| LEMI8646 | C. parapsilosis | Clinical isolate | ERG11 | A395T | Single substitution | G8B9T3 | 522 | AF-G8B9T3-F1 | Mismatch residue | Fluconazole (8), Voriconazole (1) | 2015 | 26259795 |
| LEMI8650 | C. parapsilosis | Clinical isolate | ERG11 | A395T | Single substitution | G8B9T3 | 522 | AF-G8B9T3-F1 | Mismatch residue | Fluconazole (8) | 2015 | 26259795 |
| LEMI8653 | C. parapsilosis | Clinical isolate | ERG11 | A395T | Single substitution | G8B9T3 | 522 | AF-G8B9T3-F1 | Mismatch residue | Fluconazole (16) | 2015 | 26259795 |
| LEMI8655 | C. parapsilosis | Clinical isolate | ERG11 | A395T | Single substitution | G8B9T3 | 522 | AF-G8B9T3-F1 | Mismatch residue | Fluconazole (16) | 2015 | 26259795 |
| LEMI8657 | C. parapsilosis | Clinical isolate | ERG11 | A395T | Single substitution | G8B9T3 | 522 | AF-G8B9T3-F1 | Mismatch residue | Fluconazole (16) | 2015 | 26259795 |
| LEMI8662 | C. parapsilosis | Clinical isolate | ERG11 | A395T | Single substitution | G8B9T3 | 522 | AF-G8B9T3-F1 | Mismatch residue | Fluconazole (16) | 2015 | 26259795 |
| PU123 | C. parapsilosis | Clinical isolate | MRR1 | L986P | Single substitution | G8BAV4 | 1128 | AF-G8BAV4-F1 |  | Fluconazole (32) | 2015 | 26282840 |
| PU127 | C. parapsilosis | Clinical isolate | MRR1 | L986P | Single substitution | G8BAV4 | 1128 | AF-G8BAV4-F1 |  | Fluconazole (32) | 2015 | 26282840 |
| BC2_11/06/13 | C. krusei | Clinical isolate | FKS1 | P663Q | Single substitution | Q4U2W2 | 1885 | Model |  | Caspofungin (4), Micafungin (0.5), Anidulafungin (0.125) | 2015 | 26324281 |
| BC3_14/06/13 | C. krusei | Clinical isolate | FKS1 | F655L | Single substitution | Q4U2W2 | 1885 | Model |  | Caspofungin (4), Micafungin (0.1), Anidulafungin (0.5) | 2015 | 26324281 |
| BC4_16/06/13 | C. krusei | Clinical isolate | FKS1 | S659P | Single substitution | Q4U2W2 | 1885 | Model |  | Caspofungin (2), Micafungin (0.5), Anidulafungin (0.06) | 2015 | 26324281 |
| BC5_19/06/13 | C. krusei | Clinical isolate | FKS1 | P663Q | Single substitution | Q4U2W2 | 1885 | Model |  | Caspofungin (4), Micafungin (1), Anidulafungin (0.125) | 2015 | 26324281 |
| BC6_23/06/13 | C. krusei | Clinical isolate | FKS1 | F655L | Single substitution | Q4U2W2 | 1885 | Model |  | Caspofungin (4), Micafungin (1), Anidulafungin (1) | 2015 | 26324281 |
| BC7_26/06/13 | C. krusei | Clinical isolate | FKS1 | P663Q | Single substitution | Q4U2W2 | 1885 | Model |  | Caspofungin (2), Micafungin (1), Anidulafungin (0.125) | 2015 | 26324281 |
| BC8_29/06/13 | C. krusei | Clinical isolate | FKS1 | P663Q | Single substitution | Q4U2W2 | 1885 | Model |  | Caspofungin (4), Micafungin (1), Anidulafungin (0.25) | 2015 | 26324281 |
| CC1_11/06/13 | C. krusei | Clinical isolate | FKS1 | P663Q | Single substitution | Q4U2W2 | 1885 | Model |  | Caspofungin (4), Micafungin (0.5), Anidulafungin (0.125) | 2015 | 26324281 |
| CC2_14/06/13 | C. krusei | Clinical isolate | FKS1 | P663Q | Single substitution | Q4U2W2 | 1885 | Model |  | Caspofungin (4), Micafungin (1), Anidulafungin (0.125) | 2015 | 26324281 |
| CC3_26/06/13 | C. krusei | Clinical isolate | FKS1 | P663Q | Single substitution | Q4U2W2 | 1885 | Model |  | Caspofungin (4), Micafungin (1), Anidulafungin (0.125) | 2015 | 26324281 |
| CTC1_16/06/13 | C. krusei | Clinical isolate | FKS1 | P663Q | Single substitution | Q4U2W2 | 1885 | Model |  | Caspofungin (1), Micafungin (1), Anidulafungin (0.125) | 2015 | 26324281 |
| CTC2_23/06/13 | C. krusei | Clinical isolate | FKS1 | S659P | Single substitution | Q4U2W2 | 1885 | Model |  | Caspofungin (2), Micafungin (0.5), Anidulafungin (0.06) | 2015 | 26324281 |
| STC_15/06/13 | C. krusei | Clinical isolate | FKS1 | P663Q | Single substitution | Q4U2W2 | 1885 | Model |  | Caspofungin (4), Micafungin (1), Anidulafungin (0.125) | 2015 | 26324281 |
| UC_15/06/13 | C. krusei | Clinical isolate | FKS1 | F655L | Single substitution | Q4U2W2 | 1885 | Model |  | Caspofungin (2), Micafungin (1), Anidulafungin (0.5) | 2015 | 26324281 |
| 4263 | C. albicans | Clinical isolate | ERG11 | A114S, Y257H | Double substitution | P10613 | 528 | 5V5Z |  | Fluconazole (>64) | 2015 | 26349561 |
| 4266 | C. albicans | Clinical isolate | ERG11 | A114S, Y257H | Double substitution | P10613 | 528 | 5V5Z |  | Fluconazole (>64) | 2015 | 26349561 |
| 592 | C. albicans | Clinical isolate | ERG11 | A114S, Y257H | Double substitution | P10613 | 528 | 5V5Z |  | Fluconazole (>64) | 2015 | 26349561 |
| GZ03 | C. albicans | Clinical isolate | ERG11 | A114S, Y257H | Double substitution | P10613 | 528 | 5V5Z |  | Fluconazole (>64) | 2015 | 26349561 |
| GZ09 | C. albicans | Clinical isolate | ERG11 | A114S, Y257H | Double substitution | P10613 | 528 | 5V5Z |  | Fluconazole (>64) | 2015 | 26349561 |
| GZ15 | C. albicans | Clinical isolate | ERG11 | A114S, Y257H | Double substitution | P10613 | 528 | 5V5Z |  | Fluconazole (>64) | 2015 | 26349561 |
| GZ16 | C. albicans | Clinical isolate | ERG11 | A114S, Y257H | Double substitution | P10613 | 528 | 5V5Z |  | Fluconazole (>64) | 2015 | 26349561 |
| GZ17 | C. albicans | Clinical isolate | ERG11 | A114S, Y257H | Double substitution | P10613 | 528 | 5V5Z |  | Fluconazole (>64) | 2015 | 26349561 |
| GZ18 | C. albicans | Clinical isolate | ERG11 | A114S, Y257H | Double substitution | P10613 | 528 | 5V5Z |  | Fluconazole (>64) | 2015 | 26349561 |
| GZ23 | C. albicans | Clinical isolate | ERG11 | A114S, Y257H | Double substitution | P10613 | 528 | 5V5Z |  | Fluconazole (>64) | 2015 | 26349561 |
| GZ29 | C. albicans | Clinical isolate | ERG11 | A114S, Y257H | Double substitution | P10613 | 528 | 5V5Z |  | Fluconazole (>64) | 2015 | 26349561 |
| GZ34 | C. albicans | Clinical isolate | ERG11 | A114S, Y257H | Double substitution | P10613 | 528 | 5V5Z |  | Fluconazole (>64) | 2015 | 26349561 |
| GZ51 | C. albicans | Clinical isolate | ERG11 | A114S, Y257H | Double substitution | P10613 | 528 | 5V5Z |  | Fluconazole (>64) | 2015 | 26349561 |
| GZ58 | C. albicans | Clinical isolate | ERG11 | A114S, Y257H | Double substitution | P10613 | 528 | 5V5Z |  | Fluconazole (>64) | 2015 | 26349561 |
| CA | C. albicans | Clinical isolate | FKS1 | S645P | Single substitution | A0A1D8PCT0 | 1897 | AF-A0A1D8PCT0-F1 |  | Caspofungin (>8), Micafungin (>2), Fluconazole (>256) | 2015 | 26392494 |
| CG1 | C. glabrata | Clinical isolate | FKS1 | D632Y | Single substitution | Q6FTN8 | 1863 | Model |  | Caspofungin (2), Micafungin (0.25), Anidulafungin (0.5) | 2015 | 26392494 |
| CG2 | C. glabrata | Clinical isolate | FKS2 | F659del | Deletion | Q6FMZ3 | 1897 | Model |  | Anidulafungin (2), Caspofungin (>8), Micafungin (4), Fluconazole (128) | 2015 | 26392494 |
| CG3 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (2), Caspofungin (>8), Micafungin (8), Fluconazole (256) | 2015 | 26392494 |
| CG4 | C. glabrata | Clinical isolate | FKS2 | F659S | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (0.5), Caspofungin (1), Fluconazole (>128) | 2015 | 26392494 |
| CG5 | C. glabrata | Clinical isolate | FKS2 | F659L | Single substitution | Q6FMZ3 | 1897 | Model |  | Caspofungin (1) | 2015 | 26392494 |
| CG6 | C. glabrata | Clinical isolate | FKS1 | R636S | Single substitution | Q6FTN8 | 1863 | Model | Mismatch residue | Anidulafungin (0.5), Caspofungin (4) | 2015 | 26392494 |
| C15 | C. albicans | Clinical isolate | MRR2 | H358N, E439K, S466L, A468G, S469T, T470N | Multiple substitution | Q59MJ1 | 710 | AF-Q59MJ1-F1 |  | Fluconazole (32) | 2015 | 26404130 |
| C7 | C. albicans | Clinical isolate | MRR2 | H358N, E439K, S466L, A468G, S469T, T470N | Multiple substitution | Q59MJ1 | 710 | AF-Q59MJ1-F1 |  | Fluconazole (64) | 2015 | 26404130 |
| C9 | C. albicans | Clinical isolate | MRR2 | H358N, E439K, S466L, A468G, S469T, T470N | Multiple substitution | Q59MJ1 | 710 | AF-Q59MJ1-F1 |  | Fluconazole (128) | 2015 | 26404130 |
| 20/10/2013 | C. lusitaniae | Clinical isolate | FKS1 | S638P | Single substitution | A0A202G441 | 1886 | Model |  | Caspofungin (8), Micafungin (16), Anidulafungin (4) | 2015 | 26438490 |
| 23/08/2013 | C. lusitaniae | Clinical isolate | FKS1 | S631Y | Single substitution | A0A202G441 | 1886 | Model |  | Caspofungin (8), Micafungin (16), Anidulafungin (4) | 2015 | 26438490 |
| 41275 | C. lusitaniae | Clinical isolate | FKS1 | S638Y | Single substitution | A0A202G441 | 1886 | Model |  | Caspofungin (4), Micafungin (16), Anidulafungin (2), Amphotericin B (2) | 2015 | 26438490 |
| 41315 | C. lusitaniae | Clinical isolate | FKS1 | S631Y | Single substitution | A0A202G441 | 1886 | Model |  | Caspofungin (4), Micafungin (8), Anidulafungin (4), Fluconazole (32) | 2015 | 26438490 |
| n=13 isolates | C. albicans | Clinical isolate | ERG11 | E116D | Single substitution | C7DRL6 | 528 | AF-C7DRL6-F1 | Structure not available | Fluconazole (>64), Itraconazole (>1) | 2016 | 26648048 |
| CgGermany | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (2), Caspofungin (16), Micafungin (1), Fluconazole (128), Voriconazole (16) | 2016 | 26806376 |
| isolate 6 | C. tropicalis | Clinical isolate | ERG3 | 378fs | Frameshift | C5MEI7 | 392 | AF-C5MEI7-F1 |  | Fluconazole (>64), Itraconazole (>16), Ketoconazole (16), Posaconazole (>16), Voriconazole (>16) | 2016 | 26949597 |
| isolate 7 | C. tropicalis | Clinical isolate | ERG3 | 378fs | Frameshift | C5MEI7 | 392 | AF-C5MEI7-F1 |  | Fluconazole (>64), Itraconazole (>16), Ketoconazole (>16), Posaconazole (>16), Voriconazole (>16) | 2016 | 26949597 |
| isolate 8 | C. tropicalis | Clinical isolate | ERG3 | 378fs | Frameshift | C5MEI7 | 392 | AF-C5MEI7-F1 |  | Fluconazole (>64), Itraconazole (>16), Ketoconazole (>16), Posaconazole (>16), Voriconazole (>16) | 2016 | 26949597 |
| Duke 246 | C. glabrata | Clinical isolate | MSH2PDR1 | P208S, N890IG1079R | Double substitutionSingle substitution | Q6FQA9Q6FXU7 | 9571107 | AF-Q6FQA9-F1AF-Q6FXU7-F1 |  | Fluconazole | 2016 | 27020939 |
| Duke 249 | C. glabrata | Clinical isolate | FKS2MSH2PDR1 | S663PP208S, N890IG1079R | Single substitutionDouble substitutionSingle substitution | Q6FMZ3Q6FQA9Q6FXU7 | 18979571107 | ModelAF-Q6FQA9-F1AF-Q6FXU7-F1 |  | Multidrug | 2016 | 27020939 |
| Duke 307 | C. glabrata | Clinical isolate | FKS2MSH2 | S663PE231G, L269F | Single substitutionDouble substitution | Q6FMZ3Q6FQA9 | 1897957 | ModelAF-Q6FQA9-F1 |  | Echinocandin | 2016 | 27020939 |
| SK 1 | C. glabrata | Clinical isolate | MSH2PDR1 | V239LL825P | Single substitutionSingle substitution | Q6FQA9Q6FXU7 | 9571107 | AF-Q6FQA9-F1AF-Q6FXU7-F1 |  | Fluconazole | 2016 | 27020939 |
| SK 2 | C. glabrata | Clinical isolate | FKS2MSH2PDR1 | I660_L661insFV239LL825P | InsertionSingle substitutionSingle substitution | Q6FMZ3Q6FQA9Q6FXU7 | 18979571107 | ModelAF-Q6FQA9-F1AF-Q6FXU7-F1 |  | Multidrug | 2016 | 27020939 |
| UHL 2248 | C. glabrata | Clinical isolate | MSH2PDR1 | V239L, A942TE1083Q | Double substitutionSingle substitution | Q6FQA9Q6FXU7 | 9571107 | AF-Q6FQA9-F1AF-Q6FXU7-F1 |  | Fluconazole | 2016 | 27020939 |
| UHL 2257 | C. glabrata | Clinical isolate | MSH2PDR1 | V239LN691D | Single substitutionSingle substitution | Q6FQA9Q6FXU7 | 9571107 | AF-Q6FQA9-F1AF-Q6FXU7-F1 |  | Fluconazole | 2016 | 27020939 |
| UHL 2268 | C. glabrata | Clinical isolate | MSH2PDR1 | V239S, A942TS316I | Double substitutionSingle substitution | Q6FQA9Q6FXU7 | 9571107 | AF-Q6FQA9-F1AF-Q6FXU7-F1 |  | Fluconazole | 2016 | 27020939 |
| UHL 2271 | C. glabrata | Clinical isolate | MSH2PDR1 | V239LD261G | Single substitutionSingle substitution | Q6FQA9Q6FXU7 | 9571107 | AF-Q6FQA9-F1AF-Q6FXU7-F1 |  | Fluconazole | 2016 | 27020939 |
| UHL 2273 | C. glabrata | Clinical isolate | MSH2PDR1 | V239L, A942TR293I | Double substitutionSingle substitution | Q6FQA9Q6FXU7 | 9571107 | AF-Q6FQA9-F1AF-Q6FXU7-F1 |  | Fluconazole | 2016 | 27020939 |
| UHL 2277 | C. glabrata | Clinical isolate | MSH2PDR1 | V239L, A942TR592S | Double substitutionSingle substitution | Q6FQA9Q6FXU7 | 9571107 | AF-Q6FQA9-F1AF-Q6FXU7-F1 |  | Fluconazole | 2016 | 27020939 |
| UHL 2279 | C. glabrata | Clinical isolate | MSH2PDR1 | V239L, A942TG583S | Double substitutionSingle substitution | Q6FQA9Q6FXU7 | 9571107 | AF-Q6FQA9-F1AF-Q6FXU7-F1 |  | Fluconazole | 2016 | 27020939 |
| UHL 2282 | C. glabrata | Clinical isolate | MSH2 | V239L, A942T | Double substitution | Q6FQA9 | 957 | AF-Q6FQA9-F1 |  | Fluconazole | 2016 | 27020939 |
| UHL 2312 | C. glabrata | Clinical isolate | MSH2PDR1 | V239L, A942TY584C | Double substitutionSingle substitution | Q6FQA9Q6FXU7 | 9571107 | AF-Q6FQA9-F1AF-Q6FXU7-F1 |  | Fluconazole | 2016 | 27020939 |
| UHL 530 | C. glabrata | Clinical isolate | MSH2PDR1 | V239L, A942TE1083Q | Double substitutionSingle substitution | Q6FQA9Q6FXU7 | 9571107 | AF-Q6FQA9-F1AF-Q6FXU7-F1 |  | Fluconazole | 2016 | 27020939 |
| WSU 057-02 | C. glabrata | Clinical isolate | MSH2PDR1 | V239L, A942TR792stop | Double substitutionStop | Q6FQA9Q6FXU7 | 9571107 | AF-Q6FQA9-F1AF-Q6FXU7-F1 |  | Fluconazole | 2016 | 27020939 |
| WSU 162-11 | C. glabrata | Clinical isolate | MSH2PDR1 | E231G, L269FR295G | Double substitutionSingle substitution | Q6FQA9Q6FXU7 | 9571107 | AF-Q6FQA9-F1AF-Q6FXU7-F1 |  | Fluconazole | 2016 | 27020939 |
| WSU 659-11 | C. glabrata | Clinical isolate | MSH2PDR1 | E231G, L269FR265G | Double substitutionSingle substitution | Q6FQA9Q6FXU7 | 9571107 | AF-Q6FQA9-F1AF-Q6FXU7-F1 |  | Fluconazole | 2016 | 27020939 |
| WSU 86-14 | C. glabrata | Clinical isolate | MSH2PDR1 | E231G, L269FE340G | Double substitutionSingle substitution | Q6FQA9Q6FXU7 | 9571107 | AF-Q6FQA9-F1AF-Q6FXU7-F1 |  | Fluconazole | 2016 | 27020939 |
| WSU 906-05 | C. glabrata | Clinical isolate | MSH2PDR1 | V239LD1082G | Single substitutionSingle substitution | Q6FQA9Q6FXU7 | 9571107 | AF-Q6FQA9-F1AF-Q6FXU7-F1 |  | Fluconazole | 2016 | 27020939 |
| WSU 961-00 | C. glabrata | Clinical isolate | MSH2PDR1 | V239L, A942TR792stop | Double substitutionStop | Q6FQA9Q6FXU7 | 9571107 | AF-Q6FQA9-F1AF-Q6FXU7-F1 |  | Fluconazole | 2016 | 27020939 |
| patient 1 | C. tropicalis | Clinical isolate | UPC2 | A251T, Q289L | Double substitution | C5MAR7 | 782 | AF-C5MAR7-F1 |  | Fluconazole (32), Itraconazole (1) | 2016 | 27044550 |
| patient 2 | C. tropicalis | Clinical isolate | UPC2 | A297S, T393I, 301-304del, Q320insertPP | Complex | C5MAR7 | 782 | AF-C5MAR7-F1 |  | Fluconazole (16), Voriconazole (1), Itraconazole (2) | 2016 | 27044550 |
| patient 4 | C. tropicalis | Clinical isolate | UPC2 | A251T, G392E | Double substitution | C5MAR7 | 782 | AF-C5MAR7-F1 |  | Fluconazole (8), Itraconazole (1), Posaconazole (0.25) | 2016 | 27044550 |
| patient 5 | C. tropicalis | Clinical isolate | ERG11UPC2 | L333IG392E | Single substitutionSingle substitution | P14263C5MAR7 | 528782 | AF-P14263-F1AF-C5MAR7-F1 |  | Fluconazole (4), Itraconazole (1), Posaconazole (0.25) | 2016 | 27044550 |
| patient 6 | C. tropicalis | Clinical isolate | UPC2 | A251T, Q289L, G392E | Multiple substitution | C5MAR7 | 782 | AF-C5MAR7-F1 |  | Fluconazole (4), Itraconazole (1), Posaconazole (0.5) | 2016 | 27044550 |
| patient 7 | C. tropicalis | Clinical isolate | ERG11UPC2 | G464SA251T, Q289L | Single substitutionDouble substitution | P14263C5MAR7 | 528782 | AF-P14263-F1AF-C5MAR7-F1 |  | Fluconazole (64), Voriconazole (2), Itraconazole (2), Posaconazole (1) | 2016 | 27044550 |
| patient 8 | C. tropicalis | Clinical isolate | UPC2 | A251T, Q289L, L343F | Multiple substitution | C5MAR7 | 782 | AF-C5MAR7-F1 |  | Fluconazole (16), Voriconazole (2), Itraconazole (1), Posaconazole (0.25) | 2016 | 27044550 |
| patient 9 | C. tropicalis | Clinical isolate | UPC2 | A251T, Q289L, G392E | Multiple substitution | C5MAR7 | 782 | AF-C5MAR7-F1 |  | Fluconazole (4), Posaconazole (0.25) | 2016 | 27044550 |
| Cg1 | C. glabrata | Clinical isolate | FKS2 | F659del | Deletion | Q6FMZ3 | 1897 | Model |  | Anidulafungin (1), Micafungin (0.5) | 2016 | 27061369 |
| Cg2 | C. glabrata | Clinical isolate | FKS2 | D666E, K753Q | Double substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (0.5) | 2016 | 27061369 |
| Cg3 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (2), Caspofungin (1), Micafungin (0.5) | 2016 | 27061369 |
| Ct1 | C. tropicalis | Clinical isolate | FKS1 | F641L | Single substitution | B6S6L8 | 1904 | Model | Mismatch residue | Anidulafungin (1) | 2016 | 27061369 |
| Ct2 | C. tropicalis | Clinical isolate | FKS1 | F641S | Single substitution | B6S6L8 | 1904 | Model | Mismatch residue | Anidulafungin (2), Caspofungin (2), Micafungin (1) | 2016 | 27061369 |
| patient 1 | C. glabrata | Clinical isolate | FKS2 | S663F | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (0.5-1), Micafungin (0.25), Caspofungin (0.5-1) | 2016 | 27069849 |
| patient 2 | C. glabrata | Clinical isolate | FKS2 | R1377K | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (2), Micafungin (2) | 2016 | 27069849 |
| CA1 | C. albicans | Clinical isolate | FKS1 | F641I | Single substitution | A0A1D8PCT0 | 1897 | AF-A0A1D8PCT0-F1 |  | Rezafungin (CD101) (0.12), Anidulafungin (0.12), Caspofungin (0.5) | 2016 | 27287236 |
| CA2 | C. albicans | Clinical isolate | FKS1 | F641S | Single substitution | A0A1D8PCT0 | 1897 | AF-A0A1D8PCT0-F1 |  | Rezafungin (CD101) (0.25), Anidulafungin (0.12), Caspofungin (0.5) | 2016 | 27287236 |
| CA3 | C. albicans | Clinical isolate | FKS1 | S645P | Single substitution | A0A1D8PCT0 | 1897 | AF-A0A1D8PCT0-F1 |  | Rezafungin (CD101) (0.5), Anidulafungin (0.5), Caspofungin (2) | 2016 | 27287236 |
| CA4 | C. albicans | Clinical isolate | FKS1 | F641S | Single substitution | A0A1D8PCT0 | 1897 | AF-A0A1D8PCT0-F1 |  | Rezafungin (CD101) (0.25), Anidulafungin (0.25), Caspofungin (1) | 2016 | 27287236 |
| CA5 | C. albicans | Clinical isolate | FKS1 | S645Y | Single substitution | A0A1D8PCT0 | 1897 | AF-A0A1D8PCT0-F1 |  | Rezafungin (CD101) (1), Anidulafungin (2), Caspofungin (1) | 2016 | 27287236 |
| CA6 | C. albicans | Clinical isolate | FKS1 | S645F | Single substitution | A0A1D8PCT0 | 1897 | AF-A0A1D8PCT0-F1 |  | Rezafungin (CD101) (0.5), Anidulafungin (1), Caspofungin (1) | 2016 | 27287236 |
| CA7 | C. albicans | Clinical isolate | FKS1 | D698Y | Single substitution | A0A1D8PCT0 | 1897 | AF-A0A1D8PCT0-F1 | Mismatch residue | Rezafungin (CD101) (0.25), Anidulafungin (0.25), Caspofungin (0.5) | 2016 | 27287236 |
| CA8 | C. albicans | Clinical isolate | FKS1 | P649H | Single substitution | A0A1D8PCT0 | 1897 | AF-A0A1D8PCT0-F1 |  | Rezafungin (CD101) (0.25), Anidulafungin (0.25), Caspofungin (0.5) | 2016 | 27287236 |
| CA9 | C. albicans | Clinical isolate | FKS1 | S645P | Single substitution | A0A1D8PCT0 | 1897 | AF-A0A1D8PCT0-F1 |  | Rezafungin (CD101) (1), Anidulafungin (1), Caspofungin (1) | 2016 | 27287236 |
| CG1 | C. glabrata | Clinical isolate | FKS2 | F659V | Single substitution | Q6FMZ3 | 1897 | Model |  | Rezafungin (CD101) (1), Anidulafungin (1), Caspofungin (0.5) | 2016 | 27287236 |
| CG2 | C. glabrata | Clinical isolate | FKS1 | S629P | Single substitution | Q6FTN8 | 1863 | Model |  | Rezafungin (CD101) (2), Anidulafungin (4), Caspofungin (≥8) | 2016 | 27287236 |
| CG3 | C. glabrata | Clinical isolate | FKS1 | D632Y | Single substitution | Q6FTN8 | 1863 | Model |  | Rezafungin (CD101) (0.12), Anidulafungin (0.25), Caspofungin (0.25) | 2016 | 27287236 |
| CG4 | C. glabrata | Clinical isolate | FKS1 | L630I | Single substitution | Q6FTN8 | 1863 | Model |  | Rezafungin (CD101) (0.06), Anidulafungin (0.06), Caspofungin (0.25) | 2016 | 27287236 |
| CG5 | C. glabrata | Clinical isolate | FKS2 | D648E | Single substitution | Q6FMZ3 | 1897 | Model | Mismatch residue | Rezafungin (CD101) (0.25), Anidulafungin (0.25), Caspofungin (0.25) | 2016 | 27287236 |
| CG6 | C. glabrata | Clinical isolate | FKS1 | F625Y | Single substitution | Q6FTN8 | 1863 | Model |  | Rezafungin (CD101) (0.06), Anidulafungin (0.12), Caspofungin (0.12) | 2016 | 27287236 |
| CG7 | C. glabrata | Clinical isolate | FKS1 | F625S | Single substitution | Q6FTN8 | 1863 | Model |  | Rezafungin (CD101) (0.5), Anidulafungin (1), Caspofungin (2) | 2016 | 27287236 |
| CG8 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Rezafungin (CD101) (1), Anidulafungin (2), Caspofungin (1) | 2016 | 27287236 |
| CG9 | C. glabrata | Clinical isolate | FKS2 | P667T | Single substitution | Q6FMZ3 | 1897 | Model |  | Rezafungin (CD101) (0.25), Anidulafungin (0.25), Caspofungin (0.5) | 2016 | 27287236 |
| Ck1 | C. krusei | Clinical isolate | FKS1 | R1361G | Single substitution | Q4U2W2 | 1885 | Model | Mismatch residue | Rezafungin (CD101) (1), Anidulafungin (2), Caspofungin (8) | 2016 | 27287236 |
| Ck2 | C. krusei | Clinical isolate | FKS1 | F655C | Single substitution | Q4U2W2 | 1885 | Model |  | Rezafungin (CD101) (0.25), Anidulafungin (0.5), Caspofungin (1) | 2016 | 27287236 |
| CT1 | C. tropicalis | Clinical isolate | FKS1 | S645P | Single substitution | C5MF18 | 1280 | AF-C5MF18-F1 | Mismatch residue | Rezafungin (CD101) (0.5), Anidulafungin (1), Caspofungin (2) | 2016 | 27287236 |
| CT2 | C. tropicalis | Clinical isolate | FKS1 | F641S | Single substitution | C5MF18 | 1280 | AF-C5MF18-F1 | Structure not available | Rezafungin (CD101) (0.25), Anidulafungin (0.25), Caspofungin (0.25) | 2016 | 27287236 |
| DPL18 | C. albicans | Clinical isolate | FKS1 | F641S | Single substitution | A0A1D8PCT0 | 1897 | AF-A0A1D8PCT0-F1 |  | Micafungin | 2016 | 27354115 |
| DPL20 | C. albicans | Clinical isolate | FKS1 | S645P | Single substitution | A0A1D8PCT0 | 1897 | AF-A0A1D8PCT0-F1 |  | Micafungin | 2016 | 27354115 |
| DPL22 | C. albicans | Clinical isolate | FKS1 | S645P | Single substitution | A0A1D8PCT0 | 1897 | AF-A0A1D8PCT0-F1 |  | Micafungin | 2016 | 27354115 |
| DPL23 | C. glabrata | Clinical isolate | FKS2 | F659del | Deletion | Q6FMZ3 | 1897 | Model |  | Micafungin | 2016 | 27354115 |
| DPL30 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Micafungin | 2016 | 27354115 |
| LIF-E10 | C. albicans | Clinical isolate | ERG11 | G448V, G464S | Double substitution | Q9P4W0 | 528 | AF-Q9P4W0-F1 |  | Fluconazole (64), Voriconazole (1) | 2016 | 27414653 |
| LIF12560 | C. albicans | Clinical isolate | ERG11 | E116D, T128K, A298V | Multiple substitution | Q9P4W0 | 528 | AF-Q9P4W0-F1 | Structure not available | Fluconazole (8) | 2016 | 27414653 |
| R1 | C. glabrata | Clinical isolate | ERG11 | H146Q, V168F, M218K, D234E, G236V, M389V, R403G, V409L | Multiple substitution | P50859 | 533 | 5JLC |  | Fluconazole (>64), Voriconazole (8), Itraconazole (1) | 2016 | 27436465 |
| R2 | C. glabrata | Clinical isolate | ERG11 | I240F, K276N, K354R, M364L, V409L, E418K | Multiple substitution | P50859 | 533 | 5JLC |  | Fluconazole (>64), Voriconazole (8), Itraconazole (4) | 2016 | 27436465 |
| R3 | C. glabrata | Clinical isolate | ERG11 | Y252S, M267L, V407F | Multiple substitution | P50859 | 533 | 5JLC |  | Fluconazole (64), Voriconazole (0.5), Itraconazole (4) | 2016 | 27436465 |
| R4 | C. glabrata | Clinical isolate | ERG11 | I240F, E287D, Y405H | Multiple substitution | P50859 | 533 | 5JLC |  | Fluconazole (64), Voriconazole (0.5), Itraconazole (1) | 2016 | 27436465 |
| ISOLATE 3 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Amphotericin B (1), Fluconazole (>64), Itraconazole (>16), Voriconazole (4), Posaconazole (>8), Caspofungin (>16), Micafungin (2) | 2016 | 27484020 |
| ISOLATE 4 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Amphotericin B (1), Fluconazole (>64), Itraconazole (>16), Voriconazole (4), Posaconazole (>8), Caspofungin (>16), Micafungin (2) | 2016 | 27484020 |
| ISOLATE 5 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Amphotericin B (1), Fluconazole (>64), Itraconazole (>16), Voriconazole (4), Posaconazole (>8), Caspofungin (>16), Micafungin (1) | 2016 | 27484020 |
| n=1 isolate | C. glabrata | Clinical isolate | FKS1FKS2 | D632YF659L | Single substitutionSingle substitution | Q6FTN8Q6FMZ3 | 18631897 | ModelModel |  | Anidulafungin (4), Caspofungin (4), Micafungin (1) Anidulafungin (1), Caspofungin (2), Micafungin (0.12) | 2016 | 27550360 |
| n=2 isolates | C. glabrata | Clinical isolate | FKS1FKS1 | D632ED632E | Single substitutionSingle substitution | Q6FTN8Q6FTN8 | 18631863 | ModelModel |  | Anidulafungin (2), Caspofungin (2), Micafungin (2) Anidulafungin (1), Caspofungin (0.5-1), Micafungin (0.25) | 2016 | 27550360 |
| n=3 isolates | C. glabrata | Clinical isolate | FKS1FKS2FKS2FKS2 | F625SF659delF659SS663F | Single substitutionDeletionSingle substitutionSingle substitution | Q6FTN8Q6FMZ3Q6FMZ3Q6FMZ3 | 1863189718971897 | ModelModelModelModel |  | Anidulafungin (2), Caspofungin (2), Micafungin (0.5) Anidulafungin (2), Caspofungin (8), Micafungin (4) Anidulafungin (1-4), Caspofungin (1-32), Micafungin (0.12-4) Anidulafungin (4), Caspofungin (4), Micafungin (4) | 2016 | 27550360 |
| n=4 isolates | C. glabrata | Clinical isolate | FKS1FKS2 | S629PF659V | Single substitutionSingle substitution | Q6FTN8Q6FMZ3 | 18631897 | ModelModel |  | Anidulafungin (4-8), Caspofungin (8-32), Micafungin (2-8) Anidulafungin (1), Caspofungin (4), Micafungin (0.25-1) | 2016 | 27550360 |
| n=6 isolates | C. glabrata | Clinical isolate | FKS1 | F625S | Single substitution | Q6FTN8 | 1863 | Model |  | Anidulafungin (0.06-0.12), Caspofungin (0.06-0.25), Micafungin (0.03) | 2016 | 27550360 |
| n=8 isolates | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (1-8), Caspofungin (4-32), Micafungin (0.5-32) | 2016 | 27550360 |
| R1 | C. glabrata | Clinical isolate | PDR1 | D243N, P915R | Double substitution | Q66WF3 | 1107 | AF-Q5S636-F1 |  | Fluconazole (>64), Voriconazole (8), Itraconazole (1) | 2017 | 27744635 |
| R2 | C. glabrata | Clinical isolate | PDR1 | W297R, P915R | Double substitution | Q66WF3 | 1107 | AF-Q5S636-F1 |  | Fluconazole (>64), Voriconazole (8), Itraconazole (4) | 2017 | 27744635 |
| R4 | C. glabrata | Clinical isolate | PDR1 | T588A, P915R | Double substitution | Q66WF3 | 1107 | AF-Q5S636-F1 |  | Fluconazole (>64), Itraconazole (2) | 2017 | 27744635 |
| R5 | C. glabrata | Clinical isolate | PDR1 | F575L, P915R | Double substitution | Q66WF3 | 1107 | AF-Q5S636-F1 |  | Fluconazole (>64), Itraconazole (1) | 2017 | 27744635 |
| R7 | C. glabrata | Clinical isolate | PDR1 | H576Y, P915R | Double substitution | Q66WF3 | 1107 | AF-Q5S636-F1 |  | Fluconazole (>64), Itraconazole (1) | 2017 | 27744635 |
| D113/drainage fluid | C. dubliniensis | Clinical isolate | FKS1 | S645P | Single substitution | B9W729 | 1897 | Model |  | Anidulafungin (0.5), Micafungin (0.5) [EUCAST] Caspofungin (1.5) [Etest] | 2017 | 27855078 |
| D113/mouth | C. dubliniensis | Clinical isolate | FKS1 | S645P | Single substitution | B9W729 | 1897 | Model |  | Anidulafungin (0.5), Micafungin (0.5) [EUCAST] Caspofungin (1) [Etest] | 2017 | 27855078 |
| D12/urine | C. glabrata | Clinical isolate | FKS2 | F659S | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (0.125), Micafungin (0.062) | 2017 | 27855078 |
| D120/abdominal collection | C. dubliniensis | Clinical isolate | FKS1 | S645P | Single substitution | B9W729 | 1897 | Model |  | Anidulafungin (0.5), Micafungin (0.5) [EUCAST] Caspofungin (1) [Etest] | 2017 | 27855078 |
| D120/abscess | C. dubliniensis | Clinical isolate | FKS1 | S645P | Single substitution | B9W729 | 1897 | Model |  | Anidulafungin (0.125), Micafungin (0.5) [EUCAST] Caspofungin (3) [Etest] | 2017 | 27855078 |
| D127/peritoneal fluid | C. dubliniensis | Clinical isolate | FKS1 | S645P | Single substitution | B9W729 | 1897 | Model |  | Anidulafungin (0.125), Micafungin (0.5) [EUCAST] Caspofungin (1.5) [Etest] | 2017 | 27855078 |
| D19/ urine | C. glabrata | Clinical isolate | FKS2 | F659S | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (0.125), Micafungin (0.062) | 2017 | 27855078 |
| D26/anus | C. glabrata | Clinical isolate | FKS2 | F659S | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (0.125) | 2017 | 27855078 |
| D26/inguinal | C. glabrata | Clinical isolate | FKS2 | F659S | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (0.125), Micafungin (0.062) | 2017 | 27855078 |
| D26/urine | C. glabrata | Clinical isolate | FKS2 | F659S | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (0.125), Micafungin (0.062) | 2017 | 27855078 |
| D32/anus | C. albicans | Clinical isolate | FKS1 | S645P | Single substitution | A0A1D8PCT0 | 1897 | AF-A0A1D8PCT0-F1 |  | Anidulafungin (0.125), Micafungin (1) | 2017 | 27855078 |
| D33/urine | C. glabrata | Clinical isolate | FKS2 | F659S | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (0.125), Micafungin (0.062) | 2017 | 27855078 |
| D40/anus | C. glabrata | Clinical isolate | FKS2 | F659S | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (0.125), Micafungin (0.062) | 2017 | 27855078 |
| D40/inguinal | C. glabrata | Clinical isolate | FKS2 | F659S | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (0.125), Micafungin (0.062) | 2017 | 27855078 |
| D40/urine | C. glabrata | Clinical isolate | FKS2 | F659S | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (0.125), Micafungin (0.062) | 2017 | 27855078 |
| D47/urine | C. glabrata | Clinical isolate | FKS2 | F659S | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (0.25), Micafungin (0.062) | 2017 | 27855078 |
| D54/inguinal | C. glabrata | Clinical isolate | FKS2 | F659S | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (0.125) | 2017 | 27855078 |
| D54/urine | C. glabrata | Clinical isolate | FKS2 | F659S | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (0.25), Micafungin (0.062) | 2017 | 27855078 |
| D61/anus | C. glabrata | Clinical isolate | FKS2 | F659S | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (0.25), Micafungin (0.125) [EUCAST] Micafungin (0.25) [Etest] | 2017 | 27855078 |
| D61/urine | C. glabrata | Clinical isolate | FKS2 | F659S, S663A | Double substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (0.5), Micafungin (0.25) [EUCAST] Micafungin (0.25), Caspofungin (0.75) [Etest] | 2017 | 27855078 |
| D68/urine | C. glabrata | Clinical isolate | FKS2 | F659S, S663A | Double substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (1), Micafungin (0.25) [EUCAST] Micafungin (0.38), Caspofungin (0.75) [Etest] | 2017 | 27855078 |
| D75/anus | C. glabrata | Clinical isolate | FKS2 | F659S, S663A | Double substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (0.5), Micafungin (0.5) [EUCAST] Micafungin (0.25), Caspofungin (0.5) [Etest] | 2017 | 27855078 |
| D75/inguinal | C. glabrata | Clinical isolate | FKS2 | F659S, S663A | Double substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (2), Micafungin (0.5) [EUCAST] Micafungin (0.25), [Etest] | 2017 | 27855078 |
| D75/urine | C. glabrata | Clinical isolate | FKS2 | F659S, S663A | Double substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (0.5), Micafungin (0.25) [EUCAST] Micafungin (0.25), Caspofungin (0.5) [Etest] | 2017 | 27855078 |
| D82/urine | C. glabrata | Clinical isolate | FKS2 | F659S, S663A | Double substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (1), Micafungin (0.5) [EUCAST] Caspofungin (0.5) [Etest] | 2017 | 27855078 |
| D89/anus | C. glabrata | Clinical isolate | FKS2 | F659S, S663A, D666E | Multiple substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (1), Micafungin (8) [EUCAST] Micafungin (0.25), Caspofungin (4) [Etest] | 2017 | 27855078 |
| D89/inguinal | C. glabrata | Clinical isolate | FKS2 | F659S, S663A | Double substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (1), Micafungin (0.5) [EUCAST] Micafungin (0.25) [Etest] | 2017 | 27855078 |
| CG1(Initial Micafungin conc:0.062) | C. glabrata | Clinical isolate | FKS2 | S663P, D666Y | Double substitution | Q6FMZ3 | 1897 | Model |  | Micafungin (0.5), Anidulafungin (2) | 2017 | 27872063 |
| CG1(Initial Micafungin conc:0.125) | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Micafungin (1), Anidulafungin (2) | 2017 | 27872063 |
| CG1(Initial Micafungin conc:0.25) | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Micafungin (1), Anidulafungin (2) | 2017 | 27872063 |
| CG1(Initial Micafungin conc:0.5) | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Micafungin (2), Anidulafungin (2) | 2017 | 27872063 |
| CG1(Initial Micafungin conc:1) | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Micafungin (2), Anidulafungin (4) | 2017 | 27872063 |
| CG1(Initial Micafungin conc:2) | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Micafungin (4), Anidulafungin (4) | 2017 | 27872063 |
| CG2(Initial Micafungin conc:0.125) | C. glabrata | Clinical isolate | FKS2 | S663Y | Single substitution | Q6FMZ3 | 1897 | Model |  | Micafungin (0.125), Anidulafungin (0.5) | 2017 | 27872063 |
| CG2(Initial Micafungin conc:0.25) | C. glabrata | Clinical isolate | FKS2 | S663Y | Single substitution | Q6FMZ3 | 1897 | Model |  | Micafungin (0.125), Anidulafungin (1) | 2017 | 27872063 |
| CG2(Initial Micafungin conc:0.5) | C. glabrata | Clinical isolate | FKS2 | S663Y | Single substitution | Q6FMZ3 | 1897 | Model |  | Micafungin (0.25), Anidulafungin (2) | 2017 | 27872063 |
| CG2(Initial Micafungin conc:1) | C. glabrata | Clinical isolate | FKS2 | S663Y | Single substitution | Q6FMZ3 | 1897 | Model |  | Micafungin (0.5), Anidulafungin (2) | 2017 | 27872063 |
| CG2(Initial Micafungin conc:2) | C. glabrata | Clinical isolate | FKS2 | S663Y | Single substitution | Q6FMZ3 | 1897 | Model |  | Micafungin (1), Anidulafungin (2) | 2017 | 27872063 |
| CG3(Initial Micafungin conc:0.25) | C. glabrata | Clinical isolate | FKS2 | F658del | Deletion | Q6FMZ3 | 1897 | Model |  | Anidulafungin (0.5) | 2017 | 27872063 |
| CG3(Initial Micafungin conc:0.5) | C. glabrata | Clinical isolate | FKS2 | F658del | Deletion | Q6FMZ3 | 1897 | Model |  | Anidulafungin (1) | 2017 | 27872063 |
| CG3(Initial Micafungin conc:1) | C. glabrata | Clinical isolate | FKS2 | F658del | Deletion | Q6FMZ3 | 1897 | Model |  | Anidulafungin (1) | 2017 | 27872063 |
| CG3(Initial Micafungin conc:2) | C. glabrata | Clinical isolate | FKS2 | F658del | Deletion | Q6FMZ3 | 1897 | Model |  | Micafungin (0.062), Anidulafungin (1) | 2017 | 27872063 |
| CG4(initial Micafungin conc. 0.125,0.25,0.5,1,2 | C. glabrata | Clinical isolate | FKS2 | F658del | Deletion | Q6FMZ3 | 1897 | Model |  | Micafungin (2), Anidulafungin (2) | 2017 | 27872063 |
| CG5(Initial Micafungin conc:0.125) | C. glabrata | Clinical isolate | FKS2 | F658del | Deletion | Q6FMZ3 | 1897 | Model |  | Micafungin (2), Anidulafungin (2) | 2017 | 27872063 |
| CG5(Initial Micafungin conc:0.25) | C. glabrata | Clinical isolate | FKS2 | F658del | Deletion | Q6FMZ3 | 1897 | Model |  | Micafungin (2), Anidulafungin (2) | 2017 | 27872063 |
| CG5(Initial Micafungin conc:0.5) | C. glabrata | Clinical isolate | FKS2 | F658del | Deletion | Q6FMZ3 | 1897 | Model |  | Micafungin (2), Anidulafungin (2) | 2017 | 27872063 |
| CG5(Initial Micafungin conc:1) | C. glabrata | Clinical isolate | FKS2 | F658del | Deletion | Q6FMZ3 | 1897 | Model |  | Micafungin (2), Anidulafungin (4) | 2017 | 27872063 |
| CG5(Initial Micafungin conc:2) | C. glabrata | Clinical isolate | FKS2 | F658del | Deletion | Q6FMZ3 | 1897 | Model |  | Micafungin (4), Anidulafungin (4) | 2017 | 27872063 |
| CA17 | C. albicans | Clinical isolate | ERG11 | T123I, Y132H | Double substitution | Q5I4C6 | 528 | AF-Q5I4C6-F1 |  | 5-Flucytosine (>32), Fluconazole (>64), Itraconazole (>1), Voriconazole (>4) | 2017 | 27976986 |
| CA22 | C. albicans | Clinical isolate | ERG11 | K128T | Single substitution | Q5I4C6 | 528 | AF-Q5I4C6-F1 |  | 5-Flucytosine (>32), Fluconazole (>64), Itraconazole (>1), Voriconazole (>4) | 2017 | 27976986 |
| CA312 | C. albicans | Clinical isolate | ERG11 | T123I, Y132H | Double substitution | Q5I4C6 | 528 | AF-Q5I4C6-F1 |  | 5-Flucytosine (>32), Fluconazole (>64), Itraconazole (>1), Voriconazole (>4) | 2017 | 27976986 |
| CA36 | C. albicans | Clinical isolate | ERG11 | V234F | Single substitution | Q5I4C6 | 528 | AF-Q5I4C6-F1 |  | 5-Flucytosine (>32), Fluconazole (>64), Itraconazole (>1), Voriconazole (>4) | 2017 | 27976986 |
| CA37 | C. albicans | Clinical isolate | ERG11 | K128T | Single substitution | Q5I4C6 | 528 | AF-Q5I4C6-F1 |  | 5-Flucytosine (>32), Fluconazole (>64), Itraconazole (>1), Voriconazole (>4) | 2017 | 27976986 |
| CA39 | C. albicans | Clinical isolate | ERG11 | D117E | Single substitution | Q5I4C6 | 528 | AF-Q5I4C6-F1 | Mismatch residue | 5-Flucytosine (>32), Fluconazole (>64), Itraconazole (>1), Voriconazole (>4) | 2017 | 27976986 |
| CA42 | C. albicans | Clinical isolate | ERG11 | E174A | Single substitution | Q5I4C6 | 528 | AF-Q5I4C6-F1 |  | 5-Flucytosine (>32), Fluconazole (>64), Itraconazole (>1), Voriconazole (>4) | 2017 | 27976986 |
| CA43 | C. albicans | Clinical isolate | ERG11 | E165K | Single substitution | Q5I4C6 | 528 | AF-Q5I4C6-F1 | Mismatch residue | 5-Flucytosine (>32), Fluconazole (>64), Itraconazole (>1), Voriconazole (>4) | 2017 | 27976986 |
| CNRMA13.694 | C. tropicalis | Clinical isolate | FKS1 | S645P | Single substitution | B6S6L8 | 1904 | Model | Mismatch residue | Caspofungin (4), Micafungin (0.5), Anidulafungin (0.5) | 2016 | 27995055 |
| CNRMA13.695 | C. albicans | Clinical isolate | FKS1 | S645P | Single substitution | A0A1D8PCT0 | 1897 | AF-A0A1D8PCT0-F1 |  | Caspofungin (4), Micafungin (2), Anidulafungin (0.25) | 2016 | 27995055 |
| CNRMA13.778 | C. tropicalis | Clinical isolate | FKS1 | S645P | Single substitution | B6S6L8 | 1904 | Model | Mismatch residue | Caspofungin (4), Micafungin (0.5), Anidulafungin (0.5) | 2016 | 27995055 |
| CNRMA13.779 | C. albicans | Clinical isolate | FKS1 | S645P | Single substitution | A0A1D8PCT0 | 1897 | AF-A0A1D8PCT0-F1 |  | Caspofungin (4), Micafungin (1), Anidulafungin (0.25) | 2016 | 27995055 |
| Cg1A | C. glabrata | Clinical isolate | MSH2PDR1 | P208S, N890IG1079R | Double substitutionSingle substitution | Q6FQA9Q6FXU7 | 9571107 | AF-Q6FQA9-F1AF-Q6FXU7-F1 |  | Fluconazole (128.1) | 2016 | 28018323 |
| Cg1B | C. glabrata | Clinical isolate | FKS2MSH2PDR1 | S663PP208S, N890IG1079R | Single substitutionDouble substitutionSingle substitution | Q6FMZ3Q6FQA9Q6FXU7 | 18979571107 | ModelAF-Q6FQA9-F1AF-Q6FXU7-F1 |  | Fluconazole (128.1), Anidulafungin (4), Micafungin (8.1), Caspofungin (8.1) | 2016 | 28018323 |
| Cg2A | C. glabrata | Clinical isolate | MSH2 | E231G, L269F | Double substitution | Q6FQA9 | 957 | AF-Q6FQA9-F1 |  | Fluconazole (16) | 2016 | 28018323 |
| Cg2B | C. glabrata | Clinical isolate | FKS2MSH2 | S663PE231G, L269F | Single substitutionDouble substitution | Q6FMZ3Q6FQA9 | 1897957 | ModelAF-Q6FQA9-F1 |  | Anidulafungin (1), Caspofungin (2), Micafungin (0.5) | 2016 | 28018323 |
| Cg3B | C. glabrata | Clinical isolate | FKS2 | P667T | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (1), Caspofungin (1) | 2016 | 28018323 |
| 124i | C. krusei | Clinical isolate | FKS1 | L701M | Single substitution | Q4U2W2 | 1885 | Model |  | Anidulafungin (0.125), Caspofungin (1) | 2017 | 28065893 |
| 217i | C. albicans | Clinical isolate | ERG11 | K128T, T220L | Double substitution | P10613 | 528 | 5V5Z | Mismatch residue | Itraconazole (0.125) | 2017 | 28065893 |
| 24i | C. tropicalis | Clinical isolate | ERG11 | K143X | Single substitution | C5MGS9 | 528 | AF-C5MGS9-F1 | Structure not available | Itraconazole (>8), Voriconazole (4), Posaconazole (4), Fluconazole (64) | 2017 | 28065893 |
| 403i | C. tropicalis | Clinical isolate | ERG11 | K143R | Single substitution | C5MGS9 | 528 | AF-C5MGS9-F1 |  | Itraconazole (1), Voriconazole (8), Posaconazole (1), Fluconazole (>64) | 2017 | 28065893 |
| 541i | C. albicans | Clinical isolate | ERG11 | T220L | Single substitution | P10613 | 528 | 5V5Z | Mismatch residue | Voriconazole (1) | 2017 | 28065893 |
| ISOLATE 230 | C. glabrata | Clinical isolate | FKS2 | F658del | Deletion | Q6FMZ3 | 1897 | Model |  | Micafungin (0.25) | 2016 | 28066361 |
| ISOLATE 96 | C. glabrata | Clinical isolate | FKS1MSH2 | K1323TP208S, N890I | Single substitutionDouble substitution | Q6FTN8Q6FQA9 | 1863957 | ModelAF-Q6FQA9-F1 |  | Fluconazole (64), Micafungin (0.03) | 2016 | 28066361 |
| BC014Rpsc | C. parapsilosis | Clinical isolate | ERG3 | R135I | Single substitution | G8B7T4 | 405 | AF-G8B7T4-F1 |  | Fluconazole (>64), Voriconazole (>8), Posaconazole (>16) | 2017 | 28196695 |
| Ca | C. albicans | Clinical isolate | FKS1 | S645P | Single substitution | A0A1D8PCT0 | 1897 | AF-A0A1D8PCT0-F1 |  | Caspofungin (4), Anidulafungin (0.25), Micafungin (2) | 2017 | 28293420 |
| Ct | C. tropicalis | Clinical isolate | FKS1 | S80P | Single substitution | C5MF18 | 1280 | AF-C5MF18-F1 | Mismatch residue | Caspofungin (2), Anidulafungin (0.5), Micafungin (1) | 2017 | 28293420 |
| CMRL-10 | C. glabrata | Clinical isolate | CDR1ERG9SNQ2 | H58YC128FY777C | Single substitutionSingle substitutionSingle substitution | Q6FK23Q9HGZ6Q6FQN3 | 14994431507 | AF-Q6FK23-F1AF-Q9HGZ6-F1AF-Q6FQN3-F1 |  | Voriconazole (0.5) | 2017 | 28344162 |
| CMRL-12 | C. glabrata | Clinical isolate | CDR1FLR1PDR1 | H58YV254IN768D | Single substitutionSingle substitutionSingle substitution | Q6FK23Q6FRT6Q6FXU7 | 14995571107 | AF-Q6FK23-F1AF-Q6FRT6-F1AF-Q6FXU7-F1 |  | Posaconazole (>8), Voriconazole (2), Itraconazole (8), Fluconazole (128) | 2017 | 28344162 |
| CMRL-2 | C. glabrata | Clinical isolate | FKS1FLR1SNQ2 | S629PI116VG1421S | Single substitutionSingle substitutionSingle substitution | Q6FTN8Q6FRT6Q6FQN3 | 18635571507 | ModelAF-Q6FRT6-F1AF-Q6FQN3-F1 |  | Anidulafungin (1), Micafungin (1), Caspofungin (8), | 2017 | 28344162 |
| CMRL-4 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Amphotericin B (2), Anidulafungin (1), Micafungin (1), Caspofungin (>8) | 2017 | 28344162 |
| CMRL-5 | C. glabrata | Clinical isolate | CDR1ERG9 | H58YC128F | Single substitutionSingle substitution | Q6FK23Q9HGZ6 | 1499443 | AF-Q6FK23-F1AF-Q9HGZ6-F1 |  | Voriconazole (0.5) | 2017 | 28344162 |
| CMRL-6 | C. glabrata | Clinical isolate | CDR1ERG9FCY2PDR1 | H58YC128FA237TR376Q | Single substitutionSingle substitutionSingle substitutionSingle substitution | Q6FK23Q9HGZ6Q6FLU1Q6FXU7 | 14994435431107 | AF-Q6FK23-F1AF-Q9HGZ6-F1AF-Q6FLU1-F1AF-Q6FXU7-F1 |  | 5-Flucytosine (>64), Posaconazole (>8), Voriconazole (8), Itraconazole (>16), Fluconazole (256) | 2017 | 28344162 |
| CMRL-7 | C. glabrata | Clinical isolate | CDR1FLR1PDR1 | M638I, N1108SI116V, M103IR250K, G943D | Double substitutionDouble substitutionDouble substitution | Q6FK23Q6FRT6Q6FXU7 | 14995571107 | AF-Q6FK23-F1AF-Q6FRT6-F1AF-Q6FXU7-F1 |  | Voriconazole (8), Fluconazole (256), Caspofungin (0.25) | 2017 | 28344162 |
| CMRL-9 | C. glabrata | Clinical isolate | ERG9FLR1PDR1 | C344YI116V, M103ID243N | Single substitutionDouble substitutionSingle substitution | Q9HGZ6Q6FRT6Q6FXU7 | 4435571107 | AF-Q9HGZ6-F1AF-Q6FRT6-F1AF-Q6FXU7-F1 |  | Voriconazole (0.5) | 2017 | 28344162 |
| Kw2006-15 | C. parapsilosis | Clinical isolate | ERG11 | Y132F, R398I | Multiple substitution | C7EXA5 | 522 | AF-C7EXA5-F1 | Structure not available | Etest[Fluconazole (>256), Voriconazole (>32)], Vitek II[Fluconazole (32), Voriconazole (2)] | 2017 | 28353392 |
| Kw2097-14 | C. parapsilosis | Clinical isolate | ERG11 | Y132F, R398I | Multiple substitution | C7EXA5 | 522 | AF-C7EXA5-F1 | Structure not available | Etest[Fluconazole (24)], Vitek II[Fluconazole (64), Voriconazole (1)] | 2017 | 28353392 |
| Kw210-12 | C. parapsilosis | Clinical isolate | ERG11 | Y132F, R398I | Multiple substitution | C7EXA5 | 522 | AF-C7EXA5-F1 | Structure not available | Etest[Fluconazole (16), Voriconazole (2)], Vitek II[Fluconazole (16), Voriconazole (1)] | 2017 | 28353392 |
| Kw3816-15 | C. parapsilosis | Clinical isolate | ERG11 | Y132F, R398I | Multiple substitution | C7EXA5 | 522 | AF-C7EXA5-F1 | Structure not available | Etest[Fluconazole (>256), Voriconazole (2)]Vitek II[Fluconazole (32), Voriconazole (1)] | 2017 | 28353392 |
| Kw576-15 | C. parapsilosis | Clinical isolate | ERG11 | Y132F, R398I | Multiple substitution | C7EXA5 | 522 | AF-C7EXA5-F1 | Structure not available | Etest[Fluconazole (12), Voriconazole (1)], Vitek II[Fluconazole (16), Voriconazole (1), Caspofungin (1)] | 2017 | 28353392 |
| 1587 | C. albicans | Clinical isolate | MRR1 | N803D | Single substitution | Q5A4G2 | 1108 | AF-Q5A4G2-F1 |  | Fluconazole (4) | 2017 | 28461316 |
| 2271 | C. albicans | Clinical isolate | MRR1 | Q350L | Single substitution | Q5A4G2 | 1108 | AF-Q5A4G2-F1 |  | Fluconazole (16) | 2017 | 28461316 |
| 6692 | C. albicans | Clinical isolate | MRR1 | K335N, T360I | Double substitution | Q5A4G2 | 1108 | AF-Q5A4G2-F1 |  | Fluconazole (64) | 2017 | 28461316 |
| B4 | C. albicans | Clinical isolate | MRR1 | G878E | Single substitution | Q5A4G2 | 1108 | AF-Q5A4G2-F1 |  | Fluconazole (32) | 2017 | 28461316 |
| DSY2286 | C. albicans | Clinical isolate | MRR1 | T896I | Single substitution | Q5A4G2 | 1108 | AF-Q5A4G2-F1 |  | Fluconazole (16) | 2017 | 28461316 |
| DSY296 | C. albicans | Clinical isolate | TAC1 | N977D | Single substitution | A0A1D8PN96 | 981 | AF-A0A1D8PN96-F1 |  | Fluconazole (128) | 2017 | 28461316 |
| F5 | C. albicans | Clinical isolate | MRR1UPC2 | P683SG648S | Single substitutionSingle substitution | Q5A4G2Q59QC7 | 1108712 | AF-Q5A4G2-F1AF-Q59QC7-F1 |  | Fluconazole (128) | 2017 | 28461316 |
| G5 | C. albicans | Clinical isolate | MRR1 | G997V | Single substitution | Q5A4G2 | 1108 | AF-Q5A4G2-F1 |  | Fluconazole (128) | 2017 | 28461316 |
| Gu5 | C. albicans | Clinical isolate | TAC1 | G980E | Single substitution | A0A1D8PN96 | 981 | AF-A0A1D8PN96-F1 |  | Fluconazole (>256) | 2017 | 28461316 |
| TW17 | C. albicans | Clinical isolate | MRR1TAC1UPC2 | G947SA736V, 962-969DelA643V | Single substitutionComplexSingle substitution | Q5A4G2A0A1D8PN96Q59QC7 | 1108981712 | AF-Q5A4G2-F1AF-A0A1D8PN96-F1AF-Q59QC7-F1 |  | Fluconazole (>256) | 2017 | 28461316 |
| CG 849W | C. glabrata | Clinical isolate | FKS2 | F659S | Single substitution | Q6FMZ3 | 1897 | Model |  | Caspofungin (0.38) | 2017 | 28491490 |
| CG 864P | C. glabrata | Clinical isolate | FKS2 | F659del | Deletion | Q6FMZ3 | 1897 | Model |  | Caspofungin (>32), Micafungin (1.5), Anidulafungin (1) | 2017 | 28491490 |
| Ct | C. tropicalis | Clinical isolate | ERG11 | Y132C, S154C | Double substitution | C5MGS9 | 528 | AF-C5MGS9-F1 |  | Fluconazole (256), Itraconazole (4), Voriconazole (16), Posaconazole (2) | 2017 | 28507109 |
| CA1 | C. albicans | Clinical isolate | FKS1 | F641I | Single substitution | A0A1D8PCT0 | 1897 | AF-A0A1D8PCT0-F1 |  | Ibrexafungerp (SCY-078) (2) | 2017 | 28533234 |
| CA2 | C. albicans | Clinical isolate | FKS1 | F641S | Single substitution | A0A1D8PCT0 | 1897 | AF-A0A1D8PCT0-F1 | Structure not available | Ibrexafungerp (SCY-078) (2), Caspofungin (1) | 2017 | 28533234 |
| CA3 | C. albicans | Clinical isolate | FKS1 | S629P | Single substitution | A0A1D8PCT0 | 1897 | AF-A0A1D8PCT0-F1 | Mismatch residue | Ibrexafungerp (SCY-078) (0.5), Anidulafungin (1), Caspofungin (2), Micafungin (2) | 2017 | 28533234 |
| CA4 | C. albicans | Clinical isolate | FKS1 | L701M | Single substitution | A0A1D8PCT0 | 1897 | AF-A0A1D8PCT0-F1 | Mismatch residue | Anidulafungin (1), Caspofungin (2), Micafungin (2) | 2017 | 28533234 |
| CA5 | C. albicans | Clinical isolate | FKS1 | S645P | Single substitution | A0A1D8PCT0 | 1897 | AF-A0A1D8PCT0-F1 |  | Caspofungin (2) | 2017 | 28533234 |
| CD | C. dubliniensis | Clinical isolate | FKS1 | S645P | Single substitution | D3IZZ7 | 1897 | Model | Structure not available | Anidulafungin (0.5), Caspofungin (2), Micafungin (1) | 2017 | 28533234 |
| CG1 | C. glabrata | Clinical isolate | FKS2 | F659del | Deletion | Q6FMZ3 | 1897 | Model |  | Ibrexafungerp (SCY-078) (16), Anidulafungin (4), Caspofungin (16), Micafungin (2) | 2017 | 28533234 |
| CG10 | C. glabrata | Clinical isolate | FKS2 | D648E | Single substitution | Q6FMZ3 | 1897 | Model | Mismatch residue | Anidulafungin (0.5) | 2017 | 28533234 |
| CG11 | C. glabrata | Clinical isolate | FKS1 | S645P | Single substitution | Q6FTN8 | 1863 | Model | Mismatch residue | Anidulafungin (2), Caspofungin (2), Micafungin (1) | 2017 | 28533234 |
| CG12 | C. glabrata | Clinical isolate | FKS2 | F659Y | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (2), Caspofungin (2), Micafungin (0.25) | 2017 | 28533234 |
| CG13 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (1), Caspofungin (0.5), Micafungin (0.25) | 2017 | 28533234 |
| CG14 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (1), Caspofungin (0.5), Micafungin (0.5) | 2017 | 28533234 |
| CG15 | C. glabrata | Clinical isolate | FKS1 | S629P | Single substitution | Q6FTN8 | 1863 | Model |  | Anidulafungin (2), Caspofungin (8), Micafungin (2) | 2017 | 28533234 |
| CG16 | C. glabrata | Clinical isolate | FKS1 | S629P | Single substitution | Q6FTN8 | 1863 | Model |  | Anidulafungin (4), Caspofungin (8), Micafungin (2) | 2017 | 28533234 |
| CG17 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (4), Caspofungin (16), Micafungin (4) | 2017 | 28533234 |
| CG18 | C. glabrata | Clinical isolate | FKS2 | S663F | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (1), Caspofungin (0.5) | 2017 | 28533234 |
| CG19 | C. glabrata | Clinical isolate | FKS2 | D666E, K753Q | Double substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (0.5), Caspofungin (0.5) | 2017 | 28533234 |
| CG2 | C. glabrata | Clinical isolate | FKS1 | D632Y | Single substitution | Q6FTN8 | 1863 | Model |  | Ibrexafungerp (SCY-078) (4), Anidulafungin (2), Caspofungin (1) | 2017 | 28533234 |
| CG20 | C. glabrata | Clinical isolate | FKS2 | S663F | Single substitution | Q6FMZ3 | 1897 | Model |  | Caspofungin (0.25) | 2017 | 28533234 |
| CG3 | C. glabrata | Clinical isolate | FKS2 | F659S | Single substitution | Q6FMZ3 | 1897 | Model |  | Ibrexafungerp (SCY-078) (4), Anidulafungin (2), Caspofungin (2), Micafungin (0.25) | 2017 | 28533234 |
| CG4 | C. glabrata | Clinical isolate | FKS2 | L662W | Single substitution | Q6FMZ3 | 1897 | Model |  | Ibrexafungerp (SCY-078) (4), Anidulafungin (4), Caspofungin (2), Micafungin (1) | 2017 | 28533234 |
| CG5 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Ibrexafungerp (SCY-078) (4), Anidulafungin (4), Caspofungin (2), Micafungin (1) | 2017 | 28533234 |
| CG6 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Ibrexafungerp (SCY-078) (4), Anidulafungin (4), Caspofungin (4), Micafungin (2) | 2017 | 28533234 |
| CG7 | C. glabrata | Clinical isolate | FKS2 | F659V | Single substitution | Q6FMZ3 | 1897 | Model |  | Ibrexafungerp (SCY-078) (2), Anidulafungin (1), Caspofungin (0.5) | 2017 | 28533234 |
| CG8 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Ibrexafungerp (SCY-078) (2), Anidulafungin (1), Caspofungin (0.5), Micafungin (1) | 2017 | 28533234 |
| CG9 | C. glabrata | Clinical isolate | FKS1 | R631S, S629P | Double substitution | Q6FTN8 | 1863 | Model |  | Anidulafungin (0.5), Caspofungin (0.5) | 2017 | 28533234 |
| CKF | C. kefyr | Clinical isolate | FKS1 | R1344S | Single substitution | W0TDH9 | 1892 | Model | Mismatch residue | Anidulafungin (0.5), Caspofungin (0.06), Micafungin (0.25) | 2017 | 28533234 |
| CKU | C. krusei | Clinical isolate | FKS1 | L701M | Single substitution | Q4U2W2 | 1885 | Model |  | Caspofungin (1) | 2017 | 28533234 |
| CT | C. tropicalis | Clinical isolate | FKS1 | F641S | Single substitution | B6S6L8 | 1904 | Model | Mismatch residue | Ibrexafungerp (SCY-078) (2), Anidulafungin (2), Caspofungin (2), Micafungin (2) | 2017 | 28533234 |
| BAD144-27 | C. glabrata | Clinical isolate | FKS2 | F659del | Deletion | Q6FMZ3 | 1897 | Model |  | Ibrexafungerp (SCY-078) (2.52), Micafungin (1.26) | 2017 | 28630180 |
| BAD144-4 | C. glabrata | Clinical isolate | FKS1 | F625L | Single substitution | Q6FTN8 | 1863 | Model |  | Ibrexafungerp (SCY-078) (0.79), Micafungin (0.08) | 2017 | 28630180 |
| BAD144-9 | C. glabrata | Clinical isolate | FKS2 | F659L, I661F | Double substitution | Q6FMZ3 | 1897 | Model |  | Ibrexafungerp (SCY-078) (1.59), Micafungin (0.4) | 2017 | 28630180 |
| BAD40-15 | C. glabrata | Clinical isolate | FKS1 | F625del | Deletion | Q6FTN8 | 1863 | Model |  | Ibrexafungerp (SCY-078) (1.26), Micafungin (0.06) | 2017 | 28630180 |
| BAD40-18 | C. glabrata | Clinical isolate | FKS2 | E655A | Single substitution | Q6FMZ3 | 1897 | Model |  | Ibrexafungerp (SCY-078) (2.52), Micafungin (0.2) | 2017 | 28630180 |
| BAD40-2 | C. glabrata | Clinical isolate | FKS2 | F659del | Deletion | Q6FMZ3 | 1897 | Model |  | Ibrexafungerp (SCY-078) (2.52), Micafungin (2.52) | 2017 | 28630180 |
| BAD40-20 | C. glabrata | Clinical isolate | FKS2 | F659L | Single substitution | Q6FMZ3 | 1897 | Model |  | Ibrexafungerp (SCY-078) (3.17), Micafungin (0.08) | 2017 | 28630180 |
| BAD40-31 | C. glabrata | Clinical isolate | FKS2 | F659del | Deletion | Q6FMZ3 | 1897 | Model |  | Ibrexafungerp (SCY-078) (2), Micafungin (0.79) | 2017 | 28630180 |
| BAD40-36 | C. glabrata | Clinical isolate | FKS2 | W715L | Single substitution | Q6FMZ3 | 1897 | Model |  | Ibrexafungerp (SCY-078) (4), Micafungin (0.31) | 2017 | 28630180 |
| BAD40-9 | C. glabrata | Clinical isolate | FKS2 | A1390D | Single substitution | Q6FMZ3 | 1897 | Model |  | Ibrexafungerp (SCY-078) (8), Micafungin (0.12) | 2017 | 28630180 |
| BAD47-14 | C. glabrata | Clinical isolate | FKS2 | F659del | Deletion | Q6FMZ3 | 1897 | Model |  | Ibrexafungerp (SCY-078) (2), Micafungin (0.5) | 2017 | 28630180 |
| BAD47-3 | C. glabrata | Clinical isolate | FKS2 | F659S | Single substitution | Q6FMZ3 | 1897 | Model |  | Ibrexafungerp (SCY-078) (3.17), Micafungin (0.25) | 2017 | 28630180 |
| BAD47-5 | C. glabrata | Clinical isolate | FKS2 | F659del | Deletion | Q6FMZ3 | 1897 | Model |  | Ibrexafungerp (SCY-078) (2), Micafungin (0.79) | 2017 | 28630180 |
| BAD47-6 | C. glabrata | Clinical isolate | FKS2 | F659del | Deletion | Q6FMZ3 | 1897 | Model |  | Ibrexafungerp (SCY-078) (2), Micafungin (0.79) | 2017 | 28630180 |
| BAD47-9 | C. glabrata | Clinical isolate | FKS2 | F659del | Deletion | Q6FMZ3 | 1897 | Model |  | Ibrexafungerp (SCY-078) (2), Micafungin (1) | 2017 | 28630180 |
| 35176 (isolate 2) | C. parapsilosis | Clinical isolate | ERG3 | G111R | Single substitution | A0A1L2BH72 | 405 | AF-A0A1L2BH72-F1 | Mismatch residue | Fluconazole (>64), Voriconazole (>160, Itraconazole (>16), Posaconazole (>16), Anidulafungin (4), Caspofungin (>16), Micafungin (>16) | 2017 | 28630186 |
| DSY565 | C. glabrata | Clinical isolate | PDR1 | L280F | Single substitution | Q66WF3 | 1107 | AF-Q66WF3-F1 |  | Fluconazole (64), Voriconazole (1) | 2017 | 28663342 |
| California 1 | C. glabrata | Clinical isolate | FKS1 | S629P | Single substitution | Q6FTN8 | 1863 | Model |  | Anidulafungin (2), Caspofungin (8), Micafungin (2) | 2017 | 28784671 |
| California 2 | C. glabrata | Clinical isolate | FKS2 | F659S | Single substitution | Q6FMZ3 | 1897 | Model |  | Micafungin (0.25), Caspofungin (0.5) | 2017 | 28784671 |
| California 3 | C. glabrata | Clinical isolate | FKS1 | F625S | Single substitution | Q6FTN8 | 1863 | Model |  | Anidulafungin (1), Caspofungin (1), Micafungin (0.25) | 2017 | 28784671 |
| Canada | C. glabrata | Clinical isolate | FKS1FKS2 | S629PS663P | Single substitutionSingle substitution | Q6FTN8Q6FMZ3 | 18631897 | ModelModel |  | Anidulafungin (4), Caspofungin (>8), Micafungin (4) | 2017 | 28784671 |
| Georgia | C. glabrata | Clinical isolate | FKS1 | F625S | Single substitution | Q6FTN8 | 1863 | Model |  | Anidulafungin (2), Caspofungin (2), Micafungin (0.5) | 2017 | 28784671 |
| Indiana 1 | C. albicans | Clinical isolate | FKS1 | S645P | Single substitution | A0A1D8PCT0 | 1897 | AF-A0A1D8PCT0-F1 |  | Caspofungin (1), Micafungin (1) | 2017 | 28784671 |
| Indiana 2 | C. glabrata | Clinical isolate | FKS1FKS2 | F625SF659Y | Single substitutionSingle substitution | Q6FTN8Q6FMZ3 | 18631897 | ModelModel |  | Anidulafungin (2), Caspofungin (2), Micafungin (0.5) | 2017 | 28784671 |
| Israel | C. glabrata | Clinical isolate | FKS2 | F659S | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (2), Caspofungin (2), Micafungin (2) | 2017 | 28784671 |
| New York 1 | C. albicans | Clinical isolate | FKS1 | S645P | Single substitution | A0A1D8PCT0 | 1897 | AF-A0A1D8PCT0-F1 |  | Caspofungin (1), Micafungin (1) | 2017 | 28784671 |
| New York 2 | C. glabrata | Clinical isolate | FKS2 | P667T | Single substitution | Q6FMZ3 | 1897 | Model |  | Caspofungin (0.5) | 2017 | 28784671 |
| New York 3 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (0.5), Micafungin (0.25) | 2017 | 28784671 |
| New York 4 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (2), Caspofungin (2), Micafungin (2) | 2017 | 28784671 |
| ATCC 90028mtS645Y | C. albicans | Laboratory strain | FKS1 | S645Y | Single substitution | A0A1D8PCT0 | 1897 | AF-A0A1D8PCT0-F1 |  | Anidulafungin (1), Micafungin (1) | 2017 | 28827418 |
| CA 46503mtS645P | C. albicans | Laboratory strain | FKS1 | S645P | Single substitution | A0A1D8PCT0 | 1897 | AF-A0A1D8PCT0-F1 |  | Anidulafungin (1), Micafungin (1) | 2017 | 28827418 |
| n=1 ISOLATES | C. glabrata | Clinical isolate | FKS2 | D666G | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (2) | 2017 | 28831086 |
| n=2 ISOLATES | C. glabrata | Clinical isolate | FKS1FKS1FKS1 | D632EF625SS629P | Single substitutionSingle substitutionSingle substitution | Q6FTN8Q6FTN8Q6FTN8 | 186318631863 | ModelModelModel |  | Anidulafungin (1) Anidulafungin (1-2) Anidulafungin (2-4) | 2017 | 28831086 |
| n=3 ISOLATES | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (1-4) | 2017 | 28831086 |
| Ca | C. albicans | Clinical isolate | FKS1 | S645P | Single substitution | A0A1D8PCT0 | 1897 | AF-A0A1D8PCT0-F1 |  | Fluconazole (16), Voriconazole (1), Micafungin (2), Caspofungin (≥4) | 2017 | 28841000 |
| Ca-SC5314-R | C. lusitaniae | Laboratory strain | ERG11 | K143E | Single substitution | C4Y9P2 | 525 | AF-C4Y9P2-F1 |  | Fluconazole (8) | 2018 | 29038279 |
| Cl-6936/01 | C. lusitaniae | Laboratory strain | ERG11 | K143E | Single substitution | C4Y9P2 | 525 | AF-C4Y9P2-F1 |  | Fluconazole (8) | 2018 | 29038279 |
| Cl-6936/02 | C. lusitaniae | Laboratory strain | ERG11 | E115Q, K143E | Double substitution | C4Y9P2 | 525 | AF-C4Y9P2-F1 |  | Fluconazole (16) | 2018 | 29038279 |
| FFUL887 | C. glabrata | Clinical isolate | CAGL0L04400gCAGL0L09383gGAL11AGAL11BHST1PDH1PDR1SIN3UPC2A | C24G, A58V, I137L, D229E, I346V, E574K, I593L, E710D, A933VS116N, I185V, M202VS134N, S965G, S1084NQ203P, H322N, P372S, I615N, 839GinsertionM70KK438Q, E839DL98S, D243N, K274QN50K, K288TR92K, N304S, E822V | Multiple substitutionMultiple substitutionMultiple substitutionComplexSingle substitutionDouble substitutionMultiple substitutionDouble substitutionMultiple substitution | Q6FLC8Q6FKR1Q6FRS9Q6FUT5Q6FWI7O74208Q6FXU7Q6FVE7Q6FX18 | 9873661095838509154211071493922 | AF-Q6FLC8-F1AF-Q6FKR1-F1AF-Q6FRS9-F1AF-Q6FUT5-F1AF-Q6FWI7-F1AF-O74208-F1AF-Q6FXU7-F1ModelAF-Q6FX18-F1 |  | Fluconazole, Voriconazole | 2018 | 29087506 |
| C1 | C. albicans | Clinical isolate | ERG11 | T123I, Y132H | Double substitution | P10613 | 528 | 5V5Z |  | Itraconazole (16), Voriconazole (16), Fluconazole (128) | 2018 | 29136186 |
| C108 | C. albicans | Clinical isolate | ERG11 | T123I, Y132H | Double substitution | P10613 | 528 | 5V5Z |  | Itraconazole (16), Voriconazole (8), Fluconazole (64) | 2018 | 29136186 |
| C121 | C. albicans | Clinical isolate | ERG11 | A114S, Y257H | Double substitution | P10613 | 528 | 5V5Z |  | Itraconazole (16), Voriconazole (32), Fluconazole (128) | 2018 | 29136186 |
| C14 | C. albicans | Clinical isolate | ERG11 | T123I, Y132H | Double substitution | P10613 | 528 | 5V5Z |  | Itraconazole (16), Voriconazole (8), Fluconazole (128) | 2018 | 29136186 |
| C17 | C. albicans | Clinical isolate | ERG11 | A114S, G465S | Double substitution | P10613 | 528 | 5V5Z |  | Itraconazole (16), Voriconazole (2), Fluconazole (64) | 2018 | 29136186 |
| C2 | C. albicans | Clinical isolate | ERG11 | T123I, Y132H | Double substitution | P10613 | 528 | 5V5Z |  | Itraconazole (16), Voriconazole (16), Fluconazole (128) | 2018 | 29136186 |
| C20 | C. albicans | Clinical isolate | ERG11 | Y132H, G448E | Double substitution | P10613 | 528 | 5V5Z |  | Itraconazole (16), Voriconazole (16), Fluconazole (128) | 2018 | 29136186 |
| C21 | C. albicans | Clinical isolate | ERG11 | Y132H, G448E | Double substitution | P10613 | 528 | 5V5Z |  | Itraconazole (16), Voriconazole (2), Fluconazole (64) | 2018 | 29136186 |
| C22 | C. albicans | Clinical isolate | ERG11 | K128T, Y132H, G465S | Multiple substitution | P10613 | 528 | 5V5Z |  | Itraconazole (16), Voriconazole (2), Fluconazole (64) | 2018 | 29136186 |
| C23 | C. albicans | Clinical isolate | ERG11 | T123I, Y132H | Double substitution | P10613 | 528 | 5V5Z |  | Itraconazole (16), Voriconazole (2), Fluconazole (128) | 2018 | 29136186 |
| C25 | C. albicans | Clinical isolate | ERG11 | A114S | Single substitution | P10613 | 528 | 5V5Z |  | Itraconazole (16), Voriconazole (2), Fluconazole (128) | 2018 | 29136186 |
| C26 | C. albicans | Clinical isolate | ERG11 | K128T, Y132H | Double substitution | P10613 | 528 | 5V5Z |  | Itraconazole (16), Voriconazole (16), Fluconazole (128) | 2018 | 29136186 |
| C3 | C. albicans | Clinical isolate | ERG11 | T123I, Y132H | Double substitution | P10613 | 528 | 5V5Z |  | Itraconazole (16), Voriconazole (16), Fluconazole (128) | 2018 | 29136186 |
| C6 | C. albicans | Clinical isolate | ERG11 | T123I, Y132H | Double substitution | P10613 | 528 | 5V5Z |  | Itraconazole (16), Voriconazole (8), Fluconazole (128) | 2018 | 29136186 |
| C7 | C. albicans | Clinical isolate | ERG11 | A114S | Single substitution | P10613 | 528 | 5V5Z |  | Itraconazole (16), Voriconazole (16), Fluconazole (128) | 2018 | 29136186 |
| C9 | C. albicans | Clinical isolate | ERG11 | T123I, Y132H | Double substitution | P10613 | 528 | 5V5Z |  | Itraconazole (16), Voriconazole (8), Fluconazole (64) | 2018 | 29136186 |
| R183 | C. albicans | Clinical isolate | ERG11 | T123I, Y132H | Double substitution | P10613 | 528 | 5V5Z |  | Itraconazole (16), Voriconazole (16), Fluconazole (128) | 2018 | 29136186 |
| R21 | C. albicans | Clinical isolate | ERG11 | T123I, Y132H | Double substitution | P10613 | 528 | 5V5Z |  | Itraconazole (8), Voriconazole (16), Fluconazole (128) | 2018 | 29136186 |
| R255 | C. albicans | Clinical isolate | ERG11ERG3 | T123I, Y132HA18P | Double substitutionSingle substitution | P10613Q59VG6 | 528386 | 5V5ZAF-Q59VG6-F1 |  | Itraconazole (16), Voriconazole (16), Fluconazole (128) | 2018 | 29136186 |
| R410 | C. albicans | Clinical isolate | ERG11 | K128T | Single substitution | P10613 | 528 | 5V5Z |  | Itraconazole (16), Voriconazole (4), Fluconazole (64) | 2018 | 29136186 |
| R415 | C. albicans | Clinical isolate | ERG11 | T123I, Y132H | Double substitution | P10613 | 528 | 5V5Z |  | Itraconazole (16), Voriconazole (16), Fluconazole (128) | 2018 | 29136186 |
| R44 | C. albicans | Clinical isolate | ERG11 | T123I, Y132H | Double substitution | P10613 | 528 | 5V5Z |  | Itraconazole (8), Voriconazole (2), Fluconazole (64) | 2018 | 29136186 |
| R517 | C. albicans | Clinical isolate | ERG11 | T123I, Y132H | Double substitution | P10613 | 528 | 5V5Z |  | Itraconazole (16), Voriconazole (16), Fluconazole (64) | 2018 | 29136186 |
| R654 | C. albicans | Clinical isolate | ERG11 | T123I, Y132H | Double substitution | P10613 | 528 | 5V5Z |  | Itraconazole (16), Voriconazole (8), Fluconazole (128) | 2018 | 29136186 |
| R901 | C. albicans | Clinical isolate | ERG11 | P98S, T123I, Y132H | Multiple substitution | P10613 | 528 | 5V5Z |  | Itraconazole (8), Voriconazole (8), Fluconazole (64) | 2018 | 29136186 |
| S1007 | C. albicans | Clinical isolate | ERG11ERG3 | Y132H, Y286D, G448ER365G | Multiple substitutionSingle substitution | P10613Q59VG6 | 528386 | 5V5ZAF-Q59VG6-F1 |  | Itraconazole (16), Voriconazole (8), Fluconazole (128) | 2018 | 29136186 |
| S20 | C. albicans | Clinical isolate | ERG11 | T123I, Y132H | Double substitution | P10613 | 528 | 5V5Z |  | Itraconazole (8), Voriconazole (8), Fluconazole (64) | 2018 | 29136186 |
| S201 | C. albicans | Clinical isolate | ERG11 | Y132H, G448E | Double substitution | P10613 | 528 | 5V5Z |  | Itraconazole (4), Voriconazole (2), Fluconazole (64) | 2018 | 29136186 |
| S202 | C. albicans | Clinical isolate | ERG11 | Y132H, G448E | Double substitution | P10613 | 528 | 5V5Z |  | Itraconazole (16), Voriconazole (8), Fluconazole (128) | 2018 | 29136186 |
| S27 | C. albicans | Clinical isolate | ERG11 | T123I, Y132H | Double substitution | P10613 | 528 | 5V5Z |  | Itraconazole (16), Voriconazole (16), Fluconazole (128) | 2018 | 29136186 |
| CG1 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Micafungin (2), Anidulafungin (2) | 2018 | 29228268 |
| CG2 | C. glabrata | Clinical isolate | FKS2 | W715L | Single substitution | Q6FMZ3 | 1897 | Model |  | Micafungin (2), Anidulafungin (2) | 2018 | 29228268 |
| CG3 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Micafungin (4), Anidulafungin (4) | 2018 | 29228268 |
| CG4 | C. glabrata | Clinical isolate | FKS2 | F658del | Deletion | Q6FMZ3 | 1897 | Model |  | Micafungin (2), Anidulafungin (1) | 2018 | 29228268 |
| CG5 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Micafungin (4), Anidulafungin (2) | 2018 | 29228268 |
| ISOLATE 1-Micafungin | C. glabrata | Clinical isolate | FKS2FKS2 | E655AF658del | Single substitutionDeletion | Q6FMZ3Q6FMZ3 | 18971897 | ModelModel |  | Micafungin (0.25), Anidulafungin (0.5) Micafungin (4), Anidulafungin (2) | 2018 | 29311063 |
| ISOLATE 10-Anidulafungin | C. glabrata | Clinical isolate | FKS2 | F658del | Deletion | Q6FMZ3 | 1897 | Model |  | Micafungin (1), Anidulafungin (2) | 2018 | 29311063 |
| ISOLATE 11-Anidulafungin | C. glabrata | Clinical isolate | FKS2FKS2 | S663PS663P | Single substitutionSingle substitution | Q6FMZ3Q6FMZ3 | 18971897 | ModelModel |  | Micafungin (2), Anidulafungin (2) Micafungin (4), Anidulafungin (2) | 2018 | 29311063 |
| ISOLATE 12-Anidulafungin | C. glabrata | Clinical isolate | FKS2 | F658del | Deletion | Q6FMZ3 | 1897 | Model |  | Micafungin (4), Anidulafungin (2) | 2018 | 29311063 |
| ISOLATE 12-Micafungin | C. glabrata | Clinical isolate | FKS2FKS2 | F658delW715L | DeletionSingle substitution | Q6FMZ3Q6FMZ3 | 18971897 | ModelModel |  | Micafungin (2), Anidulafungin (4) Micafungin (4), Anidulafungin (2) | 2018 | 29311063 |
| ISOLATE 2-Anidulafungin | C. glabrata | Clinical isolate | FKS2 | F658del | Deletion | Q6FMZ3 | 1897 | Model |  | Micafungin (2), Anidulafungin (2) | 2018 | 29311063 |
| ISOLATE 2-Micafungin | C. glabrata | Clinical isolate | FKS2FKS2 | F658delW715L | DeletionSingle substitution | Q6FMZ3Q6FMZ3 | 18971897 | ModelModel |  | Micafungin (2), Anidulafungin (1) Micafungin (0.5), Anidulafungin (0.5) | 2018 | 29311063 |
| ISOLATE 3-Anidulafungin | C. glabrata | Clinical isolate | FKS2 | F658del | Deletion | Q6FMZ3 | 1897 | Model |  | Micafungin (2), Anidulafungin (4) | 2018 | 29311063 |
| ISOLATE 3-Micafungin | C. glabrata | Clinical isolate | FKS2 | F658del | Deletion | Q6FMZ3 | 1897 | Model |  | Micafungin (4), Anidulafungin (4) | 2018 | 29311063 |
| ISOLATE 4-Micafungin | C. glabrata | Clinical isolate | FKS2 | F658del | Deletion | Q6FMZ3 | 1897 | Model |  | Micafungin (4), Anidulafungin (2) | 2018 | 29311063 |
| ISOLATE 5-Anidulafungin | C. glabrata | Clinical isolate | FKS2 | F658del | Deletion | Q6FMZ3 | 1897 | Model |  | Micafungin (1), Anidulafungin (1) | 2018 | 29311063 |
| ISOLATE 6-Micafungin | C. glabrata | Clinical isolate | FKS2FKS2 | F658delS663P | DeletionSingle substitution | Q6FMZ3Q6FMZ3 | 18971897 | ModelModel |  | Micafungin (4), Anidulafungin (2) | 2018 | 29311063 |
| ISOLATE 7-Micafungin | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Micafungin (2), Anidulafungin (1) | 2018 | 29311063 |
| ISOLATE 8-Anidulafungin | C. glabrata | Clinical isolate | FKS2FKS2 | F658delF658del | DeletionDeletion | Q6FMZ3Q6FMZ3 | 18971897 | ModelModel |  | Micafungin (4), Anidulafungin (2) Micafungin (2), Anidulafungin (2) | 2018 | 29311063 |
| ISOLATE 9-Anidulafungin | C. glabrata | Clinical isolate | FKS2 | F658del | Deletion | Q6FMZ3 | 1897 | Model |  | Micafungin (1), Anidulafungin (2) | 2018 | 29311063 |
| VPCI 1/14 | C. auris | Clinical isolate | ERG11 | Y132F | Single substitution | A0A0L0NU49 | 524 | AF-A0A0L0NU49-F1 | Mismatch residue | Fluconazole (>64), Voriconazole (16) | 2018 | 29325167 |
| VPCI 10/15 | C. auris | Clinical isolate | ERG11 | K143R | Single substitution | A0A0L0NU49 | 524 | AF-A0A0L0NU49-F1 |  | Voriconazole (4), Fluconazole (>64) | 2018 | 29325167 |
| VPCI 11/15 | C. auris | Clinical isolate | ERG11 | Y132F | Single substitution | A0A0L0NU49 | 524 | AF-A0A0L0NU49-F1 | Mismatch residue | Voriconazole (4), Fluconazole (>64) | 2018 | 29325167 |
| VPCI 12/14 | C. auris | Clinical isolate | ERG11 | Y132F | Single substitution | A0A0L0NU49 | 524 | AF-A0A0L0NU49-F1 | Mismatch residue | Voriconazole (16), Isavuconazole (4), Fluconazole (32) | 2018 | 29325167 |
| VPCI 13/13 | C. auris | Clinical isolate | ERG11 | Y132F | Single substitution | A0A0L0NU49 | 524 | AF-A0A0L0NU49-F1 | Mismatch residue | Fluconazole (64), Voriconazole (4), Isavuconazole (4), Posaconazole (8) | 2018 | 29325167 |
| VPCI 14/13 | C. auris | Clinical isolate | ERG11 | Y132F | Single substitution | A0A0L0NU49 | 524 | AF-A0A0L0NU49-F1 | Mismatch residue | Voriconazole (4), Fluconazole (>64) | 2018 | 29325167 |
| VPCI 15/13 | C. auris | Clinical isolate | ERG11 | Y132F | Single substitution | A0A0L0NU49 | 524 | AF-A0A0L0NU49-F1 | Mismatch residue | Voriconazole (4), Fluconazole (>64) | 2018 | 29325167 |
| VPCI 16/15 | C. auris | Clinical isolate | ERG11 | Y132F | Single substitution | A0A0L0NU49 | 524 | AF-A0A0L0NU49-F1 | Mismatch residue | Voriconazole (4), Fluconazole (>64) | 2018 | 29325167 |
| VPCI 17/14 | C. auris | Clinical isolate | ERG11 | Y132F | Single substitution | A0A0L0NU49 | 524 | AF-A0A0L0NU49-F1 | Mismatch residue | Voriconazole (16), Isavuconazole (4), Fluconazole (64) | 2018 | 29325167 |
| VPCI 18/14 | C. auris | Clinical isolate | ERG11 | K143R | Single substitution | A0A0L0NU49 | 524 | AF-A0A0L0NU49-F1 |  | Voriconazole (16), Fluconazole (>64) | 2018 | 29325167 |
| VPCI 19/15 | C. auris | Clinical isolate | ERG11 | K143R | Single substitution | A0A0L0NU49 | 524 | AF-A0A0L0NU49-F1 |  | Voriconazole (4), Fluconazole (>64) | 2018 | 29325167 |
| VPCI 2/14 | C. auris | Clinical isolate | ERG11 | Y132F | Single substitution | A0A0L0NU49 | 524 | AF-A0A0L0NU49-F1 | Mismatch residue | Fluconazole (>64), Voriconazole (16), Isavuconazole (4), Posaconazole (4) | 2018 | 29325167 |
| VPCI 20/16 | C. auris | Clinical isolate | ERG11 | K143R | Single substitution | A0A0L0NU49 | 524 | AF-A0A0L0NU49-F1 |  | Voriconazole (4), Fluconazole (64) | 2018 | 29325167 |
| VPCI 21/14 | C. auris | Clinical isolate | ERG11 | K143R | Single substitution | A0A0L0NU49 | 524 | AF-A0A0L0NU49-F1 |  | Fluconazole (64), Voriconazole (4), Isavuconazole (4), Posaconazole (8) | 2018 | 29325167 |
| VPCI 22/14 | C. auris | Clinical isolate | ERG11 | K143R | Single substitution | A0A0L0NU49 | 524 | AF-A0A0L0NU49-F1 |  | Fluconazole (>64), Voriconazole (4), Isavuconazole (4), Posaconazole (8) | 2018 | 29325167 |
| VPCI 23/15 | C. auris | Clinical isolate | ERG11 | Y132F | Single substitution | A0A0L0NU49 | 524 | AF-A0A0L0NU49-F1 | Mismatch residue | Fluconazole (>64), Voriconazole (4), Isavuconazole (4), Posaconazole (8) | 2018 | 29325167 |
| VPCI 24/15 | C. auris | Clinical isolate | ERG11 | K143R | Single substitution | A0A0L0NU49 | 524 | AF-A0A0L0NU49-F1 |  | Fluconazole (>64), Voriconazole (4), Isavuconazole (4), Posaconazole (8) | 2018 | 29325167 |
| VPCI 25/15 | C. auris | Clinical isolate | ERG11 | Y132F | Single substitution | A0A0L0NU49 | 524 | AF-A0A0L0NU49-F1 | Mismatch residue | Fluconazole (64), Voriconazole (4), Isavuconazole (4), Posaconazole (8) | 2018 | 29325167 |
| VPCI 26/15 | C. auris | Clinical isolate | ERG11 | Y132F | Single substitution | A0A0L0NU49 | 524 | AF-A0A0L0NU49-F1 | Mismatch residue | Fluconazole (>64), Voriconazole (4), Isavuconazole (4), Posaconazole (8) | 2018 | 29325167 |
| VPCI 27/15 | C. auris | Clinical isolate | ERG11 | K143R | Single substitution | A0A0L0NU49 | 524 | AF-A0A0L0NU49-F1 |  | Fluconazole (32), Voriconazole (4), Isavuconazole (4), Posaconazole (8) | 2018 | 29325167 |
| VPCI 28/15 | C. auris | Clinical isolate | ERG11 | Y132F | Single substitution | A0A0L0NU49 | 524 | AF-A0A0L0NU49-F1 | Mismatch residue | Fluconazole (64), Voriconazole (4), Isavuconazole (4), Posaconazole (8) | 2018 | 29325167 |
| VPCI 29/12 | C. auris | Clinical isolate | ERG11 | K143R | Single substitution | A0A0L0NU49 | 524 | AF-A0A0L0NU49-F1 |  | Fluconazole (64), Voriconazole (4), Isavuconazole (4), Posaconazole (8) | 2018 | 29325167 |
| VPCI 3/14 | C. auris | Clinical isolate | ERG11 | Y132F | Single substitution | A0A0L0NU49 | 524 | AF-A0A0L0NU49-F1 | Mismatch residue | Voriconazole (4), Fluconazole (64) | 2018 | 29325167 |
| VPCI 30/12 | C. auris | Clinical isolate | ERG11 | K143R | Single substitution | A0A0L0NU49 | 524 | AF-A0A0L0NU49-F1 |  | Fluconazole (32), Voriconazole (4), Isavuconazole (4), Posaconazole (8) | 2018 | 29325167 |
| VPCI 31/13 | C. auris | Clinical isolate | ERG11 | K143R | Single substitution | A0A0L0NU49 | 524 | AF-A0A0L0NU49-F1 |  | Fluconazole (64), Voriconazole (4), Isavuconazole (4), Posaconazole (8) | 2018 | 29325167 |
| VPCI 32/14 | C. auris | Clinical isolate | ERG11 | K143R | Single substitution | A0A0L0NU49 | 524 | AF-A0A0L0NU49-F1 |  | Fluconazole (64), Voriconazole (4), Isavuconazole (4), Posaconazole (8) | 2018 | 29325167 |
| VPCI 33/14 | C. auris | Clinical isolate | ERG11 | K143R | Single substitution | A0A0L0NU49 | 524 | AF-A0A0L0NU49-F1 |  | Fluconazole (64), Voriconazole (4), Isavuconazole (4), Posaconazole (8) | 2018 | 29325167 |
| VPCI 34/14 | C. auris | Clinical isolate | ERG11 | K143R | Single substitution | A0A0L0NU49 | 524 | AF-A0A0L0NU49-F1 |  | Fluconazole (64), Voriconazole (4), Isavuconazole (4), Posaconazole (8) | 2018 | 29325167 |
| VPCI 35/12 | C. auris | Clinical isolate | ERG11 | Y132F | Single substitution | A0A0L0NU49 | 524 | AF-A0A0L0NU49-F1 | Mismatch residue | Fluconazole (8), Voriconazole (4), Isavuconazole (4), Posaconazole (8) | 2018 | 29325167 |
| VPCI 4/14 | C. auris | Clinical isolate | ERG11 | Y132F | Single substitution | A0A0L0NU49 | 524 | AF-A0A0L0NU49-F1 | Mismatch residue | Voriconazole (8), Fluconazole (>64) | 2018 | 29325167 |
| VPCI 45/13 | C. auris | Clinical isolate | FKS1 | S639F | Single substitution | A0A2H1A4W2 | 1888 | Model |  | Caspofungin (16), Micafungin (16), Anidulafungin (8), Fluconazole (64) | 2018 | 29325167 |
| VPCI 46/14 | C. auris | Clinical isolate | FKS1 | S639F | Single substitution | A0A2H1A4W2 | 1888 | Model |  | Caspofungin (8), Micafungin (16), Anidulafungin (8), Fluconazole (64) | 2018 | 29325167 |
| VPCI 47/14 | C. auris | Clinical isolate | FKS1 | S639F | Single substitution | A0A2H1A4W2 | 1888 | Model |  | Caspofungin (8), Micafungin (16), Anidulafungin (8), Fluconazole (64) | 2018 | 29325167 |
| VPCI 48/14 | C. auris | Clinical isolate | FKS1 | S639F | Single substitution | A0A2H1A4W2 | 1888 | Model |  | Caspofungin (4), Micafungin (16), Anidulafungin (8), Fluconazole (64) | 2018 | 29325167 |
| VPCI 5/14 | C. auris | Clinical isolate | ERG11 | Y132F | Single substitution | A0A0L0NU49 | 524 | AF-A0A0L0NU49-F1 | Mismatch residue | Voriconazole (4), Fluconazole (>64) | 2018 | 29325167 |
| VPCI 6/14 | C. auris | Clinical isolate | ERG11 | Y132F | Single substitution | A0A0L0NU49 | 524 | AF-A0A0L0NU49-F1 | Mismatch residue | Voriconazole (4), Fluconazole (64) | 2018 | 29325167 |
| VPCI 7/15 | C. auris | Clinical isolate | ERG11 | Y132F | Single substitution | A0A0L0NU49 | 524 | AF-A0A0L0NU49-F1 | Mismatch residue | Voriconazole (4), Fluconazole (>64) | 2018 | 29325167 |
| VPCI 8/15 | C. auris | Clinical isolate | ERG11 | Y132F | Single substitution | A0A0L0NU49 | 524 | AF-A0A0L0NU49-F1 | Mismatch residue | Voriconazole (4), Fluconazole (32) | 2018 | 29325167 |
| VPCI 9/15 | C. auris | Clinical isolate | ERG11 | Y132F | Single substitution | A0A0L0NU49 | 524 | AF-A0A0L0NU49-F1 | Mismatch residue | Voriconazole (4), Fluconazole (64) | 2018 | 29325167 |
| CMRL-12 | C. glabrata | Clinical isolate | PDR1CDR1FLR1 | N768DH58YV254I | Single substitutionSingle substitutionSingle substitution | Q6FXU7Q6FK23Q6FRT6 | 11071499557 | AF-Q6FXU7-F1AF-Q6FK23-F1AF-Q6FRT6-F1 |  | Fluconazole (128), Itraconazole (8), Voriconazole (2), Posaconazole (>8) | 2017 | 29364212 |
| CMRL-2 | C. glabrata | Clinical isolate | FKS1 | S629P | Single substitution | Q6FTN8 | 1863 | Model |  | Anidulafungin (1), Micafungin (1), Caspofungin (8) | 2017 | 29364212 |
| CMRL-4 | C. glabrata | Clinical isolate | FKS2 | S633P | Single substitution | Q6FMZ3 | 1897 | Model | Mismatch residue | Anidulafungin (1), Micafungin (1), Caspofungin (>8) | 2017 | 29364212 |
| CMRL-6-1 | C. glabrata | Clinical isolate | FCY2 | A237T | Single substitution | Q6FPL2 | 515 | AF-Q6FPL2-F1 |  | 5-Flucytosine (>64) | 2017 | 29364212 |
| CMRL-6-2 | C. glabrata | Clinical isolate | ERG9 | C128F | Single substitution | Q9HGZ6 | 443 | AF-Q9HGZ6-F1 |  | 5-Flucytosine (>64), Posaconazole (>8), Voriconazole (8), Itraconazole (>16), Fluconazole (256) | 2017 | 29364212 |
| CMRL-6-3 | C. glabrata | Clinical isolate | PDR1 | R376Q | Single substitution | Q6FXU7 | 1107 | AF-Q6FXU7-F1 |  | 5-Flucytosine (>64), Posaconazole (>8), Voriconazole (8), Itraconazole (>16), Fluconazole (256) | 2017 | 29364212 |
| CMRL-6-4 | C. glabrata | Clinical isolate | CDR1 | H58Y | Single substitution | Q6FK23 | 1499 | AF-Q6FK23-F1 |  | Fluconazole (256), Itraconazole (>16), Voriconazole (8), Posaconazole (>8) | 2017 | 29364212 |
| CMRL-7-1 | C. glabrata | Clinical isolate | PDR1 | G250N | Single substitution | Q6FXU7 | 1107 | AF-Q6FXU7-F1 | Mismatch residue | Fluconazole (256), Itraconazole (0.5), Voriconazole (8), Posaconazole (1) | 2017 | 29364212 |
| CMRL-7-2 | C. glabrata | Clinical isolate | CDR1 | M638I | Single substitution | Q6FK23 | 1499 | AF-Q6FK23-F1 |  | Fluconazole (256), Itraconazole (0.5), Voriconazole (8), Posaconazole (1) | 2017 | 29364212 |
| CMRL-7-3 | C. glabrata | Clinical isolate | CDR1 | N1108S | Single substitution | Q6FK23 | 1499 | AF-Q6FK23-F1 |  | Fluconazole (256), Itraconazole (0.5), Voriconazole (8), Posaconazole (1) | 2017 | 29364212 |
| CMRL-7-4 | C. glabrata | Clinical isolate | FLR1 | I116V | Single substitution | Q6FRT6 | 557 | AF-Q6FRT6-F1 |  | Fluconazole (256), Itraconazole (0.5), Voriconazole (8), Posaconazole (1) | 2017 | 29364212 |
| CA10 | C. albicans | Clinical isolate | CAP1MRR1 | A390TT917M, T923I, E1020Q, F1032L, S1037L | Single substitutionMultiple substitution | O94118Q5A4G2 | 4991108 | AF-O94118-F1AF-Q5A4G2-F1 |  | Fluconazole (>=32), Itraconazole (>=1), Voriconazole (>=4) | 2017 | 29434708 |
| CA14 | C. albicans | Clinical isolate | CAP1 | S381N | Single substitution | O94118 | 499 | AF-O94118-F1 |  | Fluconazole (>=32) | 2017 | 29434708 |
| CA42 | C. albicans | Clinical isolate | MRR1 | N937K, E1020Q, F1032L, S1037L | Multiple substitution | Q5A4G2 | 1108 | AF-Q5A4G2-F1 |  | Voriconazole (>=4) | 2017 | 29434708 |
| CA50 | C. albicans | Clinical isolate | MRR1 | T917M, T923I, E1020Q | Multiple substitution | Q5A4G2 | 1108 | AF-Q5A4G2-F1 |  | Itraconazole (>=1) | 2017 | 29434708 |
| CA51 | C. albicans | Clinical isolate | CAP1MRR1 | P311SN937K, E1020Q | Single substitutionDouble substitution | O94118Q5A4G2 | 4991108 | AF-O94118-F1AF-Q5A4G2-F1 |  | Itraconazole (>=1) | 2017 | 29434708 |
| CA52 | C. albicans | Clinical isolate | CAP1 | P311S | Single substitution | O94118 | 499 | AF-O94118-F1 |  | Itraconazole (>=1) | 2017 | 29434708 |
| CA53 | C. albicans | Clinical isolate | CAP1MRR1 | P311SN937K, E1020Q, F1032L, S1037L | Single substitutionMultiple substitution | O94118Q5A4G2 | 4991108 | AF-O94118-F1AF-Q5A4G2-F1 |  | Itraconazole (>=1), Voriconazole (>=4) | 2017 | 29434708 |
| CA62 | C. albicans | Clinical isolate | MRR1 | T923I, E1020Q | Double substitution | Q5A4G2 | 1108 | AF-Q5A4G2-F1 |  | Itraconazole (>=1) | 2017 | 29434708 |
| CA63 | C. albicans | Clinical isolate | CAP1MRR1 | P311SN937K, E1020Q, F1032L, S1037L | Single substitutionMultiple substitution | O94118Q5A4G2 | 4991108 | AF-O94118-F1AF-Q5A4G2-F1 |  | Itraconazole (>=1) | 2017 | 29434708 |
| CA67 | C. albicans | Clinical isolate | CAP1 | G481E | Single substitution | O94118 | 499 | AF-O94118-F1 |  | Voriconazole (>=4) | 2017 | 29434708 |
| Kw107/17 | C. tropicalis | Clinical isolate | FKS1 | S645P | Single substitution | B6S6L8 | 1904 | Model | Mismatch residue | Caspofungin (32), Anidulafungin (0.5), Micafungin (0.75) [Etest] Caspofungin (32), Anidulafungin (1), Micafungin (1) [CLSI] | 2018 | 29437623 |
| Kw3707/16 | C. tropicalis | Clinical isolate | FKS1 | S645P | Single substitution | B6S6L8 | 1904 | Model | Mismatch residue | Caspofungin (24), Anidulafungin (0.5), Micafungin (0.5) [Etest] Caspofungin (16), Anidulafungin (1), Micafungin (1) [CLSI] | 2018 | 29437623 |
| WT10 | C. glabrata | Clinical isolate | PDR1 | P927S | Single substitution | Q6FXU7 | 1107 | AF-Q6FXU7-F1 |  | Fluconazole (64), Voriconazole (2) | 2018 | 29464833 |
| WT2 | C. glabrata | Clinical isolate | PDR1 | G1099D | Single substitution | Q6FXU7 | 1107 | AF-Q6FXU7-F1 |  | Fluconazole (64), Voriconazole (1) | 2018 | 29464833 |
| WT6 | C. glabrata | Clinical isolate | PDR1 | G346D | Single substitution | Q6FXU7 | 1107 | AF-Q6FXU7-F1 |  | Fluconazole (128), Itraconazole (1), Voriconazole (4) | 2018 | 29464833 |
| WT8 | C. glabrata | Clinical isolate | PDR1 | L344S | Single substitution | Q6FXU7 | 1107 | AF-Q6FXU7-F1 |  | Fluconazole (128) | 2018 | 29464833 |
| n=1 ISOLATES | C. glabrata | Clinical isolate | MSH2 | V239L, D946E | Double substitution | Q6FQA9 | 957 | AF-Q6FQA9-F1 |  | Caspofungin (>0.5), Micafungin (>0.25), Anidulafungin (>0.5) | 2018 | 29610199 |
| n=2 ISOLATES | C. glabrata | Clinical isolate | MSH2 | T772S | Single substitution | Q6FQA9 | 957 | AF-Q6FQA9-F1 |  | Caspofungin (>0.5), Micafungin (>0.25), Anidulafungin (>0.5) | 2018 | 29610199 |
| n=34 ISOLATES | C. glabrata | Clinical isolate | MSH2 | V239L | Single substitution | Q6FQA9 | 957 | AF-Q6FQA9-F1 |  | Caspofungin (>0.5), Micafungin (>0.25), Anidulafungin (>0.5) | 2018 | 29610199 |
| n=5 ISOLATES | C. glabrata | Clinical isolate | MSH2 | Q386K | Single substitution | Q6FQA9 | 957 | AF-Q6FQA9-F1 |  | Caspofungin (>0.5), Micafungin (>0.25), Anidulafungin (>0.5) | 2018 | 29610199 |
| n=6 ISOLATES | C. glabrata | Clinical isolate | MSH2 | R847C | Single substitution | Q6FQA9 | 957 | AF-Q6FQA9-F1 |  | Caspofungin (>0.5), Micafungin (>0.25), Anidulafungin (>0.5) | 2018 | 29610199 |
| n=9 ISOLATES | C. glabrata | Clinical isolate | MSH2 | E459K | Single substitution | Q6FQA9 | 957 | AF-Q6FQA9-F1 |  | Caspofungin (>0.5), Micafungin (>0.25), Anidulafungin (>0.5) | 2018 | 29610199 |
| Ct01R | C. tropicalis | Clinical isolate | ERG11 | Y132F, S154F | Double substitution | P14263 | 528 | AF-P14263-F1 |  | Fluconazole (128), Voriconazole (4) | 2018 | 29631565 |
| Ct03R | C. tropicalis | Clinical isolate | ERG11 | Y132F, S154F | Double substitution | P14263 | 528 | AF-P14263-F1 |  | Fluconazole (256), Voriconazole (4) | 2018 | 29631565 |
| Ct04R | C. tropicalis | Clinical isolate | ERG11 | Y132F, S154F | Double substitution | P14263 | 528 | AF-P14263-F1 |  | Fluconazole (64), Voriconazole (2) | 2018 | 29631565 |
| Ct05R | C. tropicalis | Clinical isolate | ERG11 | Y132F, S154F | Double substitution | P14263 | 528 | AF-P14263-F1 |  | Fluconazole (128), Voriconazole (4) | 2018 | 29631565 |
| Ct06R | C. tropicalis | Clinical isolate | ERG11 | Y132F, S154F | Double substitution | P14263 | 528 | AF-P14263-F1 |  | Fluconazole (128), Voriconazole (4) | 2018 | 29631565 |
| Ct07R | C. tropicalis | Clinical isolate | ERG11 | Y132F, S154F | Double substitution | P14263 | 528 | AF-P14263-F1 |  | Fluconazole (256), Voriconazole (>8), Itraconazole (1), Posaconazole (1) | 2018 | 29631565 |
| Ct08R | C. tropicalis | Clinical isolate | ERG11 | Y132F, S154F | Double substitution | P14263 | 528 | AF-P14263-F1 |  | Fluconazole (64), Voriconazole (4), Posaconazole (1) | 2018 | 29631565 |
| Ct09R | C. tropicalis | Clinical isolate | ERG11 | Y132F, S154F | Double substitution | P14263 | 528 | AF-P14263-F1 |  | Fluconazole (256), Voriconazole (>8), Itraconazole (1), Posaconazole (1) | 2018 | 29631565 |
| Ct10R | C. tropicalis | Clinical isolate | ERG11 | Y132F, S154F | Double substitution | P14263 | 528 | AF-P14263-F1 |  | Fluconazole (256), Voriconazole (>8), Itraconazole (1), Posaconazole (1) | 2018 | 29631565 |
| Ct11R | C. tropicalis | Clinical isolate | ERG11 | Y132F, S154F | Double substitution | P14263 | 528 | AF-P14263-F1 |  | Fluconazole (64), Voriconazole (2) | 2018 | 29631565 |
| Ct12R | C. tropicalis | Clinical isolate | ERG11 | Y132F, S154F | Double substitution | P14263 | 528 | AF-P14263-F1 |  | Fluconazole (64), Voriconazole (4) | 2018 | 29631565 |
| VPCI 1133/P/13-R | C. auris | Clinical isolate | FKS1 | S639F | Single substitution | A0A2H1A4W2 | 1888 | Model |  | Anidulafungin (>16), Caspofungin (>16), Micafungin (>16) | 2018 | 29632013 |
| VPCI 265/P/14 | C. auris | Clinical isolate | FKS1 | S639F | Single substitution | A0A2H1A4W2 | 1888 | Model |  | Anidulafungin (16), Caspofungin (>16), Micafungin (>16) | 2018 | 29632013 |
| VPCI 462/P/14 | C. auris | Clinical isolate | FKS1 | S639F | Single substitution | A0A2H1A4W2 | 1888 | Model |  | Anidulafungin (>16), Caspofungin (>16), Micafungin (>16) | 2018 | 29632013 |
| VPCI 471a/P/14-R | C. auris | Clinical isolate | FKS1 | S639F | Single substitution | A0A2H1A4W2 | 1888 | Model |  | Anidulafungin (16), Caspofungin (16), Micafungin (>16) | 2018 | 29632013 |
| Co289 | C. orthopsilosis | Clinical isolate | ERG11 | Y132F | Single substitution | H8X874 | 522 | AF-H8X874-F1 |  | Fluconazole (4), Posaconazole (0.125), Voriconazole (0.125), Itraconazole (0.5) | 2018 | 29635519 |
| Co681 | C. orthopsilosis | Clinical isolate | ERG11 | Y132F | Single substitution | H8X874 | 522 | AF-H8X874-F1 |  | Fluconazole (64), Posaconazole (0.125), Voriconazole (2), Itraconazole (0.5) | 2018 | 29635519 |
| Co687 | C. orthopsilosis | Clinical isolate | ERG11 | Y132F | Single substitution | H8X874 | 522 | AF-H8X874-F1 |  | Fluconazole (64), Posaconazole (0.25), Voriconazole (2), Itraconazole (0.25) | 2018 | 29635519 |
| Rome22 | C. orthopsilosis | Clinical isolate | ERG11 | Y132F | Single substitution | H8X874 | 522 | AF-H8X874-F1 |  | Fluconazole (128), Posaconazole (0.5), Voriconazole (4), Itraconazole (0.5) | 2018 | 29635519 |
| Rome23 | C. orthopsilosis | Clinical isolate | ERG11 | Y132F | Single substitution | H8X874 | 522 | AF-H8X874-F1 |  | Fluconazole (64), Posaconazole (0.125), Voriconazole (2), Itraconazole (0.25) | 2018 | 29635519 |
| Rome24 | C. orthopsilosis | Clinical isolate | ERG11 | Y132F | Single substitution | H8X874 | 522 | AF-H8X874-F1 |  | Fluconazole (128), Posaconazole (0.125), Voriconazole (4), Itraconazole (0.125) | 2018 | 29635519 |
| Rome25 | C. orthopsilosis | Clinical isolate | ERG11 | Y132F | Single substitution | H8X874 | 522 | AF-H8X874-F1 |  | Fluconazole (128), Posaconazole (0.25), Voriconazole (2), Itraconazole (0.25) | 2018 | 29635519 |
| Rome26 | C. orthopsilosis | Clinical isolate | ERG11 | Y132F | Single substitution | H8X874 | 522 | AF-H8X874-F1 |  | Fluconazole (128), Posaconazole (0.125), Voriconazole (4), Itraconazole (0.5) | 2018 | 29635519 |
| Rome27 | C. orthopsilosis | Clinical isolate | ERG11 | Y132F | Single substitution | H8X874 | 522 | AF-H8X874-F1 |  | Fluconazole (64), Posaconazole (0.125), Voriconazole (4), Itraconazole (0.25) | 2018 | 29635519 |
| Rome28 | C. orthopsilosis | Clinical isolate | ERG11 | Y132F | Single substitution | H8X874 | 522 | AF-H8X874-F1 |  | Fluconazole (64), Posaconazole (0.25), Voriconazole (8), Itraconazole (0.25) | 2018 | 29635519 |
| Wild 6 | C. glabrata | Clinical isolate | PDR1 | G1037A | Single substitution | Q6FXU7 | 1107 | AF-Q6FXU7-F1 | Mismatch residue | Fluconazole (64), Voriconazole (4), Itraconazole (1) | 2018 | 29648590 |
| Ca | C. albicans | Clinical isolate | FKS1 | F641S | Single substitution | A0A1D8PCT0 | 1897 | AF-A0A1D8PCT0-F1 |  | Micafungin (1), Anidulafungin (0.25) | 2018 | 29712651 |
| Cg1 | C. glabrata | Clinical isolate | FKS2 | 659del | Deletion | E2GKZ6 | 1897 | Model | Mismatch residue | Micafungin (1), Anidulafungin (0.5) | 2018 | 29712651 |
| Cg10 | C. glabrata | Clinical isolate | FKS2 | 659del | Deletion | E2GKZ6 | 1897 | Model | Mismatch residue | Micafungin (1), Anidulafungin (2) | 2018 | 29712651 |
| Cg11 | C. glabrata | Clinical isolate | FKS2 | 659del | Deletion | E2GKZ6 | 1897 | Model | Mismatch residue | Micafungin (1), Anidulafungin (2) | 2018 | 29712651 |
| Cg12 | C. glabrata | Clinical isolate | FKS2 | 659del | Deletion | E2GKZ6 | 1897 | Model | Mismatch residue | Micafungin (1), Anidulafungin (1) | 2018 | 29712651 |
| Cg13 | C. glabrata | Clinical isolate | FKS2 | 659del | Deletion | E2GKZ6 | 1897 | Model | Mismatch residue | Micafungin (4), Anidulafungin (2) | 2018 | 29712651 |
| Cg14 | C. glabrata | Clinical isolate | FKS2 | 659del | Deletion | E2GKZ6 | 1897 | Model | Mismatch residue | Micafungin (2), Anidulafungin (4) | 2018 | 29712651 |
| Cg15 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | E2GKZ6 | 1897 | Model |  | Micafungin (2), Anidulafungin (1) | 2018 | 29712651 |
| Cg16 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | E2GKZ6 | 1897 | Model |  | Micafungin (2), Anidulafungin (2) | 2018 | 29712651 |
| Cg17 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | E2GKZ6 | 1897 | Model |  | Micafungin (4), Anidulafungin (4) | 2018 | 29712651 |
| Cg18 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | E2GKZ6 | 1897 | Model |  | Micafungin (4), Anidulafungin (2) | 2018 | 29712651 |
| Cg19 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | E2GKZ6 | 1897 | Model |  | Micafungin (4), Anidulafungin (2) | 2018 | 29712651 |
| Cg2 | C. glabrata | Clinical isolate | FKS2 | 659del | Deletion | E2GKZ6 | 1897 | Model | Mismatch residue | Micafungin (0.064), Anidulafungin (1) | 2018 | 29712651 |
| Cg20 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | E2GKZ6 | 1897 | Model |  | Micafungin (2), Anidulafungin (1) | 2018 | 29712651 |
| Cg21 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | E2GKZ6 | 1897 | Model |  | Micafungin (2), Anidulafungin (2) | 2018 | 29712651 |
| Cg22 | C. glabrata | Clinical isolate | FKS2 | W715L | Single substitution | E2GKZ6 | 1897 | Model |  | Micafungin (2), Anidulafungin (2) | 2018 | 29712651 |
| Cg23 | C. glabrata | Clinical isolate | FKS2 | W715L | Single substitution | E2GKZ6 | 1897 | Model |  | Micafungin (0.5), Anidulafungin (0.5) | 2018 | 29712651 |
| Cg24 | C. glabrata | Clinical isolate | FKS2 | W715L | Single substitution | E2GKZ6 | 1897 | Model |  | Micafungin (4), Anidulafungin (2) | 2018 | 29712651 |
| Cg25 | C. glabrata | Clinical isolate | FKS2 | D666N | Single substitution | E2GKZ6 | 1897 | Model |  | Micafungin (0.064), Anidulafungin (0.25) | 2018 | 29712651 |
| Cg26 | C. glabrata | Clinical isolate | FKS2 | D666N | Single substitution | E2GKZ6 | 1897 | Model |  | Micafungin (0.064), Anidulafungin (0.5) | 2018 | 29712651 |
| Cg27 | C. glabrata | Clinical isolate | FKS2 | S663Y | Single substitution | E2GKZ6 | 1897 | Model |  | Micafungin (1), Anidulafungin (2) | 2018 | 29712651 |
| Cg28 | C. glabrata | Clinical isolate | FKS2 | E655A | Single substitution | E2GKZ6 | 1897 | Model |  | Micafungin (0.25), Anidulafungin (0.5) | 2018 | 29712651 |
| Cg3 | C. glabrata | Clinical isolate | FKS2 | 659del | Deletion | E2GKZ6 | 1897 | Model | Mismatch residue | Micafungin (4), Anidulafungin (4) | 2018 | 29712651 |
| Cg4 | C. glabrata | Clinical isolate | FKS2 | 659del | Deletion | E2GKZ6 | 1897 | Model | Mismatch residue | Micafungin (2), Anidulafungin (1) | 2018 | 29712651 |
| Cg5 | C. glabrata | Clinical isolate | FKS2 | 659del | Deletion | E2GKZ6 | 1897 | Model | Mismatch residue | Micafungin (4), Anidulafungin (2) | 2018 | 29712651 |
| Cg6 | C. glabrata | Clinical isolate | FKS2 | 659del | Deletion | E2GKZ6 | 1897 | Model | Mismatch residue | Micafungin (2), Anidulafungin (1) | 2018 | 29712651 |
| Cg7 | C. glabrata | Clinical isolate | FKS2 | 659del | Deletion | E2GKZ6 | 1897 | Model | Mismatch residue | Micafungin (4), Anidulafungin (4) | 2018 | 29712651 |
| Cg8 | C. glabrata | Clinical isolate | FKS2 | 659del | Deletion | E2GKZ6 | 1897 | Model | Mismatch residue | Micafungin (4), Anidulafungin (2) | 2018 | 29712651 |
| Cg9 | C. glabrata | Clinical isolate | FKS2 | 659del | Deletion | E2GKZ6 | 1897 | Model | Mismatch residue | Micafungin (4), Anidulafungin (2) | 2018 | 29712651 |
| Ct1 | C. tropicalis | Clinical isolate | FKS1 | S647G | Single substitution | B6S6L8 | 1904 | Model |  | Micafungin (0.25), Anidulafungin (0.064) | 2018 | 29712651 |
| Ct2 | C. tropicalis | Clinical isolate | FKS1 | S645F | Single substitution | B6S6L8 | 1904 | Model | Mismatch residue | Micafungin (2), Anidulafungin (1) | 2018 | 29712651 |
| Ct3 | C. tropicalis | Clinical isolate | FKS1 | F641L | Single substitution | B6S6L8 | 1904 | Model | Mismatch residue | Micafungin (0.25), Anidulafungin (0.064) | 2018 | 29712651 |
| IHEM 26116 | C. glabrata | Clinical isolate | FKS2 | R665G | Single substitution | Q6FMZ3 | 1897 | Model |  | Micafungin (0.25) | 2018 | 29784839 |
| Ca | C. albicans | Clinical isolate | FKS1 | R1361G | Single substitution | A0A1D8PCT0 | 1897 | AF-A0A1D8PCT0-F1 |  | Caspofungin (1), Anidulafungin (0.5), Micafungin (0.5) | 2018 | 29909005 |
| Cg | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Caspofungin (8), Anidulafungin (2), Micafungin (4) | 2018 | 29909005 |
| isoalte 1 | C. albicans | Clinical isolate | FKS1 | S645F | Single substitution | A0A1D8PCT0 | 1897 | AF-A0A1D8PCT0-F1 |  | Caspofungin (0.38), Micafungin (0.08) | 2018 | 29941644 |
| isoalte 10 | C. glabrata | Clinical isolate | FKS2 | L1381S | Single substitution | Q6FMZ3 | 1897 | Model |  | Caspofungin (0.19), Anidulafungin (0.023), Micafungin (0.006) | 2018 | 29941644 |
| isoalte 2 | C. albicans | Clinical isolate | FKS1 | R1360K | Single substitution | A0A1D8PCT0 | 1897 | AF-A0A1D8PCT0-F1 |  | Caspofungin (0.38) | 2018 | 29941644 |
| isoalte 3 | C. albicans | Clinical isolate | FKS1 | R1360K | Single substitution | A0A1D8PCT0 | 1897 | AF-A0A1D8PCT0-F1 |  | Caspofungin (0.19) | 2018 | 29941644 |
| isoalte 4 | C. orthopsilosis | Clinical isolate | FKS1 | V1364I | Single substitution | H8X1R5 | 1902 | Model |  | Caspofungin (3), Anidulafungin (3), Anidulafungin (0.25) | 2018 | 29941644 |
| isoalte 5 | C. orthopsilosis | Clinical isolate | FKS1 | V1364I, R1365T | Double substitution | H8X1R5 | 1902 | Model |  | Caspofungin (3), Anidulafungin (0.75), Micafungin (0.19) | 2018 | 29941644 |
| isoalte 6 | C. parapsilosis | Clinical isolate | FKS1 | A660P | Single substitution | A9YLC3 | 1909 | Model |  | Caspofungin (>32), Anidulafungin (3), Micafungin (0.38) | 2018 | 29941644 |
| isoalte 7 | C. glabrata | Clinical isolate | FKS2 | L660F | Single substitution | Q6FMZ3 | 1897 | Model |  | Caspofungin (0.047).Anidulafungin (0.032), Micafungin (0.004) | 2018 | 29941644 |
| isoalte 8 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Caspofungin (32), Anidulafungin (8), Anidulafungin (4) | 2018 | 29941644 |
| isoalte 9 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Caspofungin (>32), Anidulafungin (32), Anidulafungin (12) | 2018 | 29941644 |
| R1 | C. parapsilosis | Clinical isolate | MRR1 | G583R | Single substitution | G8BAV4 | 1128 | AF-G8BAV4-F1 |  | Fluconazole (>64) | 2018 | 30124412 |
| R10 | C. parapsilosis | Clinical isolate | TAC1 | N900D | Single substitution | G8B9R1 | 980 | AF-G8B9R1-F1 |  | Fluconazole (8) | 2018 | 30124412 |
| R11 | C. parapsilosis | Clinical isolate | ERG11MRR1TAC1 | R398IP250SL877P | Single substitutionSingle substitutionSingle substitution | G8B9T3G8BAV4G8B9R1 | 5221128980 | AF-G8B9T3-F1AF-G8BAV4-F1AF-G8B9R1-F1 |  | Fluconazole (8) | 2018 | 30124412 |
| R12 | C. parapsilosis | Clinical isolate | ERG11MRR1TAC1 | R398IS1081PL877P | Single substitutionSingle substitutionSingle substitution | G8B9T3G8BAV4G8B9R1 | 5221128980 | AF-G8B9T3-F1AF-G8BAV4-F1AF-G8B9R1-F1 |  | Fluconazole (8) | 2018 | 30124412 |
| R13 | C. parapsilosis | Clinical isolate | ERG11UPC2 | R398ID394N | Single substitutionSingle substitution | G8B9T3G8BCU0 | 522847 | AF-G8B9T3-F1AF-G8BCU0-F1 |  | Fluconazole (8) | 2018 | 30124412 |
| R14 | C. parapsilosis | Clinical isolate | ERG11MRR1TAC1 | R398IP295RL877P | Single substitutionSingle substitutionSingle substitution | G8B9T3G8BAV4G8B9R1 | 5221128980 | AF-G8B9T3-F1AF-G8BAV4-F1AF-G8B9R1-F1 |  | Fluconazole (32) | 2018 | 30124412 |
| R15 | C. parapsilosis | Clinical isolate | ERG11 | R398I | Single substitution | G8B9T3 | 522 | AF-G8B9T3-F1 |  | Fluconazole (16) | 2018 | 30124412 |
| R16 | C. parapsilosis | Clinical isolate | ERG11MRR1 | K128NW872C | Single substitutionSingle substitution | G8B9T3G8BAV4 | 5221128 | AF-G8B9T3-F1AF-G8BAV4-F1 |  | Fluconazole (32) | 2018 | 30124412 |
| R17 | C. parapsilosis | Clinical isolate | MRR1 | G927D | Single substitution | G8BAV4 | 1128 | AF-G8BAV4-F1 |  | Fluconazole (16) | 2018 | 30124412 |
| R2 | C. parapsilosis | Clinical isolate | MRR1 | G583R | Single substitution | G8BAV4 | 1128 | AF-G8BAV4-F1 |  | Fluconazole (16) | 2018 | 30124412 |
| R3 | C. parapsilosis | Clinical isolate | ERG11TAC1 | R398IL877P | Single substitutionSingle substitution | G8B9T3G8B9R1 | 522980 | AF-G8B9T3-F1AF-G8B9R1-F1 |  | Fluconazole (8) | 2018 | 30124412 |
| R5 | C. parapsilosis | Clinical isolate | ERG11TAC1 | R398IL877P | Single substitutionSingle substitution | G8B9T3G8B9R1 | 522980 | AF-G8B9T3-F1AF-G8B9R1-F1 |  | Fluconazole (8) | 2018 | 30124412 |
| R6 | C. parapsilosis | Clinical isolate | ERG11TAC1 | R398IL877P | Single substitutionSingle substitution | G8B9T3G8B9R1 | 522980 | AF-G8B9T3-F1AF-G8B9R1-F1 |  | Fluconazole (16) | 2018 | 30124412 |
| R7 | C. parapsilosis | Clinical isolate | ERG11TAC1 | R398IL877P | Single substitutionSingle substitution | G8B9T3G8B9R1 | 522980 | AF-G8B9T3-F1AF-G8B9R1-F1 |  | Fluconazole (8) | 2018 | 30124412 |
| R8 | C. parapsilosis | Clinical isolate | ERG11TAC1 | R398IL877P | Single substitutionSingle substitution | G8B9T3G8B9R1 | 522980 | AF-G8B9T3-F1AF-G8B9R1-F1 |  | Fluconazole (8) | 2018 | 30124412 |
| R9 | C. parapsilosis | Clinical isolate | ERG11TAC1 | R398IL877P | Single substitutionSingle substitution | G8B9T3G8B9R1 | 522980 | AF-G8B9T3-F1AF-G8B9R1-F1 |  | Fluconazole (8) | 2018 | 30124412 |
| Y1 | C. parapsilosis | Clinical isolate | ERG11MRR1 | Y132FK177N | Single substitutionSingle substitution | G8B9T3G8BAV4 | 5221128 | AF-G8B9T3-F1AF-G8BAV4-F1 |  | Fluconazole (8-32) | 2018 | 30124412 |
| Y10 | C. parapsilosis | Clinical isolate | ERG11MRR1 | Y132FK177N | Single substitutionSingle substitution | G8B9T3G8BAV4 | 5221128 | AF-G8B9T3-F1AF-G8BAV4-F1 |  | Fluconazole (16-32) | 2018 | 30124412 |
| Y11 | C. parapsilosis | Clinical isolate | ERG11MRR1 | Y132FK177N | Single substitutionSingle substitution | G8B9T3G8BAV4 | 5221128 | AF-G8B9T3-F1AF-G8BAV4-F1 |  | Fluconazole (16-32) | 2018 | 30124412 |
| Y12 | C. parapsilosis | Clinical isolate | ERG11MRR1 | Y132FK177N | Single substitutionSingle substitution | G8B9T3G8BAV4 | 5221128 | AF-G8B9T3-F1AF-G8BAV4-F1 |  | Fluconazole (8-32) | 2018 | 30124412 |
| Y13 | C. parapsilosis | Clinical isolate | ERG11MRR1 | Y132FK177N | Single substitutionSingle substitution | G8B9T3G8BAV4 | 5221128 | AF-G8B9T3-F1AF-G8BAV4-F1 |  | Fluconazole (8-32) | 2018 | 30124412 |
| Y14 | C. parapsilosis | Clinical isolate | ERG11MRR1 | Y132FK177N | Single substitutionSingle substitution | G8B9T3G8BAV4 | 5221128 | AF-G8B9T3-F1AF-G8BAV4-F1 |  | Fluconazole (8-32) | 2018 | 30124412 |
| Y15 | C. parapsilosis | Clinical isolate | ERG11MRR1 | Y132FK177N | Single substitutionSingle substitution | G8B9T3G8BAV4 | 5221128 | AF-G8B9T3-F1AF-G8BAV4-F1 |  | Fluconazole (8-32) | 2018 | 30124412 |
| Y16 | C. parapsilosis | Clinical isolate | ERG11MRR1 | Y132FK177N | Single substitutionSingle substitution | G8B9T3G8BAV4 | 5221128 | AF-G8B9T3-F1AF-G8BAV4-F1 |  | Fluconazole (8-32) | 2018 | 30124412 |
| Y17 | C. parapsilosis | Clinical isolate | ERG11MRR1 | Y132FK177N | Single substitutionSingle substitution | G8B9T3G8BAV4 | 5221128 | AF-G8B9T3-F1AF-G8BAV4-F1 |  | Fluconazole (8-32) | 2018 | 30124412 |
| Y18 | C. parapsilosis | Clinical isolate | ERG11MRR1 | Y132FK177N | Single substitutionSingle substitution | G8B9T3G8BAV4 | 5221128 | AF-G8B9T3-F1AF-G8BAV4-F1 |  | Fluconazole (8-32) | 2018 | 30124412 |
| Y19 | C. parapsilosis | Clinical isolate | ERG11MRR1 | Y132FK177N | Single substitutionSingle substitution | G8B9T3G8BAV4 | 5221128 | AF-G8B9T3-F1AF-G8BAV4-F1 |  | Fluconazole (8-32) | 2018 | 30124412 |
| Y2 | C. parapsilosis | Clinical isolate | ERG11MRR1 | Y132FK177N | Single substitutionSingle substitution | G8B9T3G8BAV4 | 5221128 | AF-G8B9T3-F1AF-G8BAV4-F1 |  | Fluconazole (8-32) | 2018 | 30124412 |
| Y20 | C. parapsilosis | Clinical isolate | ERG11MRR1 | Y132FK177N | Single substitutionSingle substitution | G8B9T3G8BAV4 | 5221128 | AF-G8B9T3-F1AF-G8BAV4-F1 |  | Fluconazole (8-32) | 2018 | 30124412 |
| Y21 | C. parapsilosis | Clinical isolate | ERG11MRR1 | Y132FK177N | Single substitutionSingle substitution | G8B9T3G8BAV4 | 5221128 | AF-G8B9T3-F1AF-G8BAV4-F1 |  | Fluconazole (8-32) | 2018 | 30124412 |
| Y22 | C. parapsilosis | Clinical isolate | ERG11MRR1 | Y132FK177N, Q1053del | Single substitutionComplex | G8B9T3G8BAV4 | 5221128 | AF-G8B9T3-F1AF-G8BAV4-F1 |  | Fluconazole (8-16) | 2018 | 30124412 |
| Y23 | C. parapsilosis | Clinical isolate | ERG11MRR1 | Y132FK177N, Q1053del | Single substitutionComplex | G8B9T3G8BAV4 | 5221128 | AF-G8B9T3-F1AF-G8BAV4-F1 |  | Fluconazole (8-16) | 2018 | 30124412 |
| Y24 | C. parapsilosis | Clinical isolate | ERG11MRR1 | Y132FK177N, Q1053del | Single substitutionComplex | G8B9T3G8BAV4 | 5221128 | AF-G8B9T3-F1AF-G8BAV4-F1 |  | Fluconazole (8-16) | 2018 | 30124412 |
| Y25 | C. parapsilosis | Clinical isolate | ERG11MRR1 | Y132FK177N | Single substitutionSingle substitution | G8B9T3G8BAV4 | 5221128 | AF-G8B9T3-F1AF-G8BAV4-F1 |  | Fluconazole (8) | 2018 | 30124412 |
| Y26 | C. parapsilosis | Clinical isolate | ERG11MRR1 | Y132FK177N | Single substitutionSingle substitution | G8B9T3G8BAV4 | 5221128 | AF-G8B9T3-F1AF-G8BAV4-F1 |  | Fluconazole (64) | 2018 | 30124412 |
| Y27 | C. parapsilosis | Clinical isolate | ERG11MRR1 | Y132FK177N | Single substitutionSingle substitution | G8B9T3G8BAV4 | 5221128 | AF-G8B9T3-F1AF-G8BAV4-F1 |  | Fluconazole (32) | 2018 | 30124412 |
| Y28 | C. parapsilosis | Clinical isolate | ERG11MRR1 | Y132FK177N | Single substitutionSingle substitution | G8B9T3G8BAV4 | 5221128 | AF-G8B9T3-F1AF-G8BAV4-F1 |  | Fluconazole (8) | 2018 | 30124412 |
| Y29 | C. parapsilosis | Clinical isolate | ERG11MRR1 | Y132FK177N | Single substitutionSingle substitution | G8B9T3G8BAV4 | 5221128 | AF-G8B9T3-F1AF-G8BAV4-F1 |  | Fluconazole (8) | 2018 | 30124412 |
| Y3 | C. parapsilosis | Clinical isolate | ERG11MRR1 | Y132FK177N | Single substitutionSingle substitution | G8B9T3G8BAV4 | 5221128 | AF-G8B9T3-F1AF-G8BAV4-F1 |  | Fluconazole (8-32) | 2018 | 30124412 |
| Y30 | C. parapsilosis | Clinical isolate | ERG11 | Y132F | Single substitution | G8B9T3 | 522 | AF-G8B9T3-F1 | Mismatch residue | Fluconazole (64) | 2018 | 30124412 |
| Y4 | C. parapsilosis | Clinical isolate | ERG11MRR1 | Y132FK177N | Single substitutionSingle substitution | G8B9T3G8BAV4 | 5221128 | AF-G8B9T3-F1AF-G8BAV4-F1 |  | Fluconazole (8-32) | 2018 | 30124412 |
| Y5 | C. parapsilosis | Clinical isolate | ERG11MRR1 | Y132FK177N | Single substitutionSingle substitution | G8B9T3G8BAV4 | 5221128 | AF-G8B9T3-F1AF-G8BAV4-F1 |  | Fluconazole (8-32) | 2018 | 30124412 |
| Y6 | C. parapsilosis | Clinical isolate | ERG11MRR1 | Y132FK177N | Single substitutionSingle substitution | G8B9T3G8BAV4 | 5221128 | AF-G8B9T3-F1AF-G8BAV4-F1 |  | Fluconazole (8-32) | 2018 | 30124412 |
| Y7 | C. parapsilosis | Clinical isolate | ERG11MRR1 | Y132FK177N | Single substitutionSingle substitution | G8B9T3G8BAV4 | 5221128 | AF-G8B9T3-F1AF-G8BAV4-F1 |  | Fluconazole (8-32) | 2018 | 30124412 |
| Y8 | C. parapsilosis | Clinical isolate | ERG11MRR1 | Y132FK177N | Single substitutionSingle substitution | G8B9T3G8BAV4 | 5221128 | AF-G8B9T3-F1AF-G8BAV4-F1 |  | Fluconazole (8-32) | 2018 | 30124412 |
| Y9 | C. parapsilosis | Clinical isolate | ERG11MRR1 | Y132FK177N | Single substitutionSingle substitution | G8B9T3G8BAV4 | 5221128 | AF-G8B9T3-F1AF-G8BAV4-F1 |  | Fluconazole (16-32) | 2018 | 30124412 |
| AD/CaCDR1 | C. albicans | Laboratory strain | CDR1CDR1CDR1CDR1CDR1CDR1CDR1CDR1CDR1CDR1CDR1CDR1CDR1CDR1CDR1CDR1CDR1 | A713PC712SF1235CG547RN1240DN535IQ1388PQ714PR546TR546YS542LS542PT540IV1322AV1322GW1295SY544F | Single substitutionSingle substitutionSingle substitutionSingle substitutionSingle substitutionSingle substitutionSingle substitutionSingle substitutionSingle substitutionSingle substitutionSingle substitutionSingle substitutionSingle substitutionSingle substitutionSingle substitutionSingle substitutionSingle substitution | Q5ANA3Q5ANA3Q5ANA3Q5ANA3Q5ANA3Q5ANA3Q5ANA3Q5ANA3Q5ANA3Q5ANA3Q5ANA3Q5ANA3Q5ANA3Q5ANA3Q5ANA3Q5ANA3Q5ANA3 | 15011501150115011501150115011501150115011501150115011501150115011501 | AF-Q5ANA3-F1AF-Q5ANA3-F1AF-Q5ANA3-F1AF-Q5ANA3-F1AF-Q5ANA3-F1AF-Q5ANA3-F1AF-Q5ANA3-F1AF-Q5ANA3-F1AF-Q5ANA3-F1AF-Q5ANA3-F1AF-Q5ANA3-F1AF-Q5ANA3-F1AF-Q5ANA3-F1AF-Q5ANA3-F1AF-Q5ANA3-F1AF-Q5ANA3-F1AF-Q5ANA3-F1 |  | Fluconazole (512) Fluconazole (256) Fluconazole (1024) Fluconazole (128) | 2018 | 30348662 |
| 044Fluco45 | C. glabrata | Clinical isolate | PDR1 | Y372C | Single substitution | Q6FXU7 | 1107 | AF-Q6FXU7-F1 |  | Fluconazole (64), Voriconazole (8), Posaconazole (16), Clotrimazole (32) | 2018 | 30348666 |
| VPCI 1132/P/13 | C. auris | Clinical isolate | ERG11 | Y132F | Single substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 |  | Fluconazole (>128), Voriconazole (4) | 2019 | 30397051 |
| VPCI 1133/P/13-R | C. auris | Clinical isolate | ERG11FKS1 | K143RS639F | Single substitutionSingle substitution | A0A2H1A309A0A2H1A4W2 | 5241888 | AF-A0A2H1A309-F1Model |  | Fluconazole (>128), Voriconazole (0.5), Micafungin (16), Anidulafungin (>16), Caspofungin (8) | 2019 | 30397051 |
| Cg | C. glabrata | Clinical isolate | FKS1 | V1342I | Single substitution | Q6FTN8 | 1863 | Model |  | Micafungin (0.5) | 2019 | 30401513 |
| Kw1856/15 | C. glabrata | Clinical isolate | ERG2ERG6 | I207VW286del | Single substitutionDeletion | Q6FKL1Q6FRZ7 | 224372 | AF-Q6FKL1-F1AF-Q6FRZ7-F1 |  | Etest[Amphotericin B (1.5)], CLSI[Amphotericin B (1)] | 2019 | 30455247 |
| Kw2516/15 | C. glabrata | Clinical isolate | ERG2ERG6 | I207VC198F | Single substitutionSingle substitution | Q6FKL1Q6FRZ7 | 224372 | AF-Q6FKL1-F1AF-Q6FRZ7-F1 |  | Etest[Amphotericin B (1.5)], CLSI[Amphotericin B (1)] | 2019 | 30455247 |
| Kw2813/15 | C. glabrata | Clinical isolate | ERG2ERG6 | I207VY192del | Single substitutionDeletion | Q6FKL1Q6FRZ7 | 224372 | AF-Q6FKL1-F1AF-Q6FRZ7-F1 |  | Etest[Amphotericin B (4)], CLSI[Amphotericin B (1)] | 2019 | 30455247 |
| Kw3060/15 | C. glabrata | Clinical isolate | ERG2 | I207V, G119S | Double substitution | Q6FKL1 | 224 | AF-Q6FKL1-F1 |  | Etest[Amphotericin B (1.5)], CLSI[Amphotericin B (1)] | 2019 | 30455247 |
| Kw3357/15 | C. glabrata | Clinical isolate | ERG2ERG6 | I207VW286del | Single substitutionDeletion | Q6FKL1Q6FRZ7 | 224372 | AF-Q6FKL1-F1AF-Q6FRZ7-F1 |  | Etest[Amphotericin B (2)], CLSI[Amphotericin B (1)] | 2019 | 30455247 |
| Kw844/10 | C. glabrata | Clinical isolate | ERG2 | I207V, G122S | Double substitution | Q6FKL1 | 224 | AF-Q6FKL1-F1 |  | Etest[Amphotericin B (1.5)], CLSI[Amphotericin B (1)] | 2019 | 30455247 |
| Kw861/13 | C. glabrata | Clinical isolate | ERG11ERG2ERG6 | Y141H, L381MI207VL341del | Double substitutionSingle substitutionDeletion | P50859Q6FKL1Q6FRZ7 | 533224372 | 5JLCAF-Q6FKL1-F1AF-Q6FRZ7-F1 |  | Etest[Amphotericin B (1)], CLSI[Amphotericin B (1), Fluconazole (>64), Voriconazole (2), Itraconazole (0.5), Isavuconazole (0.5)] | 2019 | 30455247 |
| Kw96/15 | C. glabrata | Clinical isolate | ERG2ERG6 | I207VV126F | Single substitutionSingle substitution | Q6FKL1Q6FRZ7 | 224372 | AF-Q6FKL1-F1AF-Q6FRZ7-F1 |  | Etest[Amphotericin B (2)], CLSI[Amphotericin B (1)] | 2019 | 30455247 |
| N=1 isolate | C. tropicalis | Clinical isolate | ERG11ERG11 | G464SV125A | Single substitutionSingle substitution | C5MGS9C5MGS9 | 528528 | AF-C5MGS9-F1AF-C5MGS9-F1 |  | Fluconazole (8) | 2019 | 30472420 |
| N=16 isolates | C. tropicalis | Clinical isolate | ERG11 | Y132F | Single substitution | C5MGS9 | 528 | AF-C5MGS9-F1 |  | Fluconazole (32) | 2019 | 30472420 |
| N=38 isolates | C. tropicalis | Clinical isolate | ERG11 | Y132F | Single substitution | C5MGS9 | 528 | AF-C5MGS9-F1 |  | Fluconazole (128) | 2019 | 30472420 |
| N=5 isolates | C. tropicalis | Clinical isolate | ERG11 | Y257H | Single substitution | C5MGS9 | 528 | AF-C5MGS9-F1 |  | Fluconazole (8) | 2019 | 30472420 |
| CL1 | C. lusitaniae | Laboratory strain | FKS1 | F634V | Single substitution | A0A202G441 | 1886 | Model |  | Caspofungin (1.5) | 2019 | 30517635 |
| CL2 | C. lusitaniae | Laboratory strain | FKS1 | S638P | Single substitution | A0A202G441 | 1886 | Model |  | Caspofungin (≥32) | 2019 | 30517635 |
| CL3 | C. lusitaniae | Laboratory strain | FKS1 | R1352G | Single substitution | A0A202G441 | 1886 | Model |  | Caspofungin (≥32) | 2019 | 30517635 |
| CL4 | C. lusitaniae | Laboratory strain | FKS1 | F634del | Deletion | A0A202G441 | 1886 | Model |  | Caspofungin (32) | 2019 | 30517635 |
| CL5 | C. lusitaniae | Laboratory strain | FKS1 | P642A | Single substitution | A0A202G441 | 1886 | Model |  | Caspofungin (0.75) | 2019 | 30517635 |
| WM_ 03.419 | C. glabrata | Clinical isolate | FCY2FKS2FKS3PDR1 | A237TF384YR672KS76P, L98S, L139I, T143P | Single substitutionSingle substitutionSingle substitutionMultiple substitution | Q6FPL2Q6FMZ3Q6FIJ9Q6FXU7 | 515189718401107 | AF-Q6FPL2-F1ModelModelAF-Q6FXU7-F1 |  | Fluconazole (128), Voriconazole (2), Posaconazole (1) | 2018 | 30559734 |
| WM_ 03.449 | C. glabrata | Clinical isolate | FCY2FKS3FPS2PDR1 | A237TI3T, L884V, R1472Q, Y1731CQ533HS76P, L98S, T143P | Single substitutionMultiple substitutionSingle substitutionMultiple substitution | Q6FPL2Q6FIJ9Q6FV88Q6FXU7 | 51518406021107 | AF-Q6FPL2-F1ModelAF-Q6FV88-F1AF-Q6FXU7-F1 |  | Fluconazole (64), Voriconazole (1) | 2018 | 30559734 |
| WM_ 04.113 | C. glabrata | Clinical isolate | CDR1FKS1FKS3PDR1 | M638I, N1108SS502FI3T, A42G, L884V, R1472Q, A1645V, Y1731CP695L | Double substitutionSingle substitutionMultiple substitutionSingle substitution | Q6FK23Q6FTN8Q6FIJ9Q6FXU7 | 1499186318401107 | AF-Q6FK23-F1ModelModelAF-Q6FXU7-F1 |  | Fluconazole (128), Voriconazole (2), Posaconazole (2) | 2018 | 30559734 |
| WM_ 05.113 | C. glabrata | Clinical isolate | FCY2FKS3FPS1PDR1 | A237TI3T, L884V, R1472Q, Y1731CQ533HS76P, L98S, T143P | Single substitutionMultiple substitutionSingle substitutionMultiple substitution | Q6FPL2Q6FIJ9Q6FWS6Q6FXU7 | 51518406521107 | AF-Q6FPL2-F1ModelAF-Q6FWS6-F1AF-Q6FXU7-F1 |  | Fluconazole (64), Voriconazole (1) | 2018 | 30559734 |
| WM_ 18.24 | C. glabrata | Clinical isolate | FCY2FKS1FPS1FPS2MSH2PDR1 | I384FS629PA316SA409T, D517YL269FS76P, L98S, T143P | Single substitutionSingle substitutionSingle substitutionDouble substitutionSingle substitutionMultiple substitution | Q6FPL2Q6FTN8Q6FWS6Q6FV88Q6FQA9Q6FXU7 | 51518636526029571107 | AF-Q6FPL2-F1ModelAF-Q6FWS6-F1AF-Q6FV88-F1AF-Q6FQA9-F1AF-Q6FXU7-F1 |  | Caspofungin (8) | 2018 | 30559734 |
| WM_ 18.26 | C. glabrata | Clinical isolate | FKS2FPS1FPS2PDR1 | S663PA316SA409T, D517YS76P, L98S, T143P | Single substitutionSingle substitutionDouble substitutionMultiple substitution | Q6FMZ3Q6FWS6Q6FV88Q6FXU7 | 18976526021107 | ModelAF-Q6FWS6-F1AF-Q6FV88-F1AF-Q6FXU7-F1 |  | Amphotericin B (2), Caspofungin (>8) | 2018 | 30559734 |
| WM_ 18.27 | C. glabrata | Clinical isolate | CDR1ERG9FCY2FKS3FPS2PDR1 | H58YC128FA237TI3T, L884V, R1472Q, Y1731CQ533HS76P, L98S, T143P | Single substitutionSingle substitutionSingle substitutionMultiple substitutionSingle substitutionMultiple substitution | Q6FK23Q9HGZ6Q6FPL2Q6FIJ9Q6FV88Q6FXU7 | 149944351518406021107 | AF-Q6FK23-F1AF-Q9HGZ6-F1AF-Q6FPL2-F1ModelAF-Q6FV88-F1AF-Q6FXU7-F1 |  | Fluconazole (256), Voriconazole (8), Posaconazole (>8) | 2018 | 30559734 |
| WM_ 18.33 | C. glabrata | Clinical isolate | CDR1PDR1 | H58YN768D | Single substitutionSingle substitution | Q6FK23Q6FXU7 | 14991107 | AF-Q6FK23-F1AF-Q6FXU7-F1 |  | Fluconazole (128), Voriconazole (2), Posaconazole (>8) | 2018 | 30559734 |
| WM_ 18.40 | C. glabrata | Clinical isolate | CDR1FCY2FKS3FPS2PDR1 | H58Y, N813YA237TI3T, A42G, K206E, N865S, R1472Q, F1768IA409T, A227S, N18DS76P, L98S, T143P | Double substitutionSingle substitutionMultiple substitutionMultiple substitutionMultiple substitution | Q6FK23Q6FPL2Q6FIJ9Q6FV88Q6FXU7 | 149951518406021107 | AF-Q6FK23-F1AF-Q6FPL2-F1ModelAF-Q6FV88-F1AF-Q6FXU7-F1 |  | Fluconazole (128), Voriconazole (2), Posaconazole (>8) | 2018 | 30559734 |
| WM_ 18.42 | C. glabrata | Clinical isolate | CDR1FKS1FKS3PDR1 | M638I, N1108SS502FI3T, A42G, L884V, R1472Q, A1645V, Y1731CR250K, G943D | Double substitutionSingle substitutionMultiple substitutionDouble substitution | Q6FK23Q6FTN8Q6FIJ9Q6FXU7 | 1499186318401107 | AF-Q6FK23-F1ModelModelAF-Q6FXU7-F1 |  | Fluconazole (256), Voriconazole (8), Posaconazole (1) | 2018 | 30559734 |
| WM_ 18.49 | C. glabrata | Clinical isolate | CDR1ERG9FCY2FKS3FPS2PDR1 | H58YC128FA237TI3T, L884V, R1472Q, Y1731CQ533HS76P, L98S, T143P | Single substitutionSingle substitutionSingle substitutionMultiple substitutionSingle substitutionMultiple substitution | Q6FK23Q9HGZ6Q6FPL2Q6FIJ9Q6FV88Q6FXU7 | 149944351518406021107 | AF-Q6FK23-F1AF-Q9HGZ6-F1AF-Q6FPL2-F1ModelAF-Q6FV88-F1AF-Q6FXU7-F1 |  | Fluconazole (256), Voriconazole (8), Posaconazole (>8) | 2018 | 30559734 |
| WM_ 18.51 | C. glabrata | Clinical isolate | CDR1FCY2FKS3FPS1FPS2PDR1 | H58Y, I1478MA237TI3T, A42G, K206E, N865S, R1472Q, F1768IN27HA409T, A227S, N18DS76P, L98S, T143P, E259G | Double substitutionSingle substitutionMultiple substitutionSingle substitutionMultiple substitutionMultiple substitution | Q6FK23Q6FPL2Q6FIJ9Q6FWS6Q6FV88Q6FXU7 | 149951518406526021107 | AF-Q6FK23-F1AF-Q6FPL2-F1ModelAF-Q6FWS6-F1AF-Q6FV88-F1AF-Q6FXU7-F1 |  | Fluconazole (128), Voriconazole (2), Posaconazole (>8) | 2018 | 30559734 |
| WM_ 18.53 | C. glabrata | Clinical isolate | FKS1FKS3MSH2PDR1 | S502FI3T, A42G, L884V, R1472Q, A1645V, Y1731CE456DS76P, L98S, L139I, T143P | Single substitutionMultiple substitutionSingle substitutionMultiple substitution | Q6FTN8Q6FIJ9Q6FQA9Q6FXU7 | 186318409571107 | ModelModelAF-Q6FQA9-F1AF-Q6FXU7-F1 |  | Fluconazole (128), Voriconazole (4), Posaconazole (>8) | 2018 | 30559734 |
| WM_ 18.63 | C. glabrata | Clinical isolate | FKS1FKS2FKS3FPS1MSH2PDR1 | S629PE784GI3T, R1472Q, Y1731C, S1840YA316SV239L, A942TS76P, L98S, T143P | Single substitutionSingle substitutionMultiple substitutionSingle substitutionDouble substitutionMultiple substitution | Q6FTN8Q6FMZ3Q6FIJ9Q6FWS6Q6FQA9Q6FXU7 | 1863189718406529571107 | ModelModelModelAF-Q6FWS6-F1AF-Q6FQA9-F1AF-Q6FXU7-F1 |  | Caspofungin (2) | 2018 | 30559734 |
| WM_ 18.64 | C. glabrata | Clinical isolate | FKS1FKS2FKS3FPS1MSH2PDR1 | S629PE784GI3T, R1472Q, Y1731C, S1840YA316SV239L, A942TS76P, L98S, T143P | Single substitutionSingle substitutionMultiple substitutionSingle substitutionDouble substitutionMultiple substitution | Q6FTN8Q6FMZ3Q6FIJ9Q6FWS6Q6FQA9Q6FXU7 | 1863189718406529571107 | ModelModelModelAF-Q6FWS6-F1AF-Q6FQA9-F1AF-Q6FXU7-F1 |  | Caspofungin (2) | 2018 | 30559734 |
| WM_ 18.65 | C. glabrata | Clinical isolate | CDR1PDR1 | H58YS76P, L98S, T143P | Single substitutionMultiple substitution | Q6FK23Q6FXU7 | 14991107 | AF-Q6FK23-F1AF-Q6FXU7-F1 |  | Fluconazole (64), Voriconazole (1), Posaconazole (2) | 2018 | 30559734 |
| WM_ 18.66 | C. glabrata | Clinical isolate | FCY2FKS2FKS3PDR1 | A237TF384YN108Y, R672KS76P, L98S, L139I, T143P, W256G | Single substitutionSingle substitutionDouble substitutionMultiple substitution | Q6FPL2Q6FMZ3Q6FIJ9Q6FXU7 | 515189718401107 | AF-Q6FPL2-F1ModelModelAF-Q6FXU7-F1 |  | Fluconazole (256), Voriconazole (8), Posaconazole (2) | 2018 | 30559734 |
| 1131PC | C. parapsilosis | Clinical isolate | ERG11 | Y132F | Single substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (32), Voriconazole (0.5) | 2018 | 30568646 |
| 137H | C. parapsilosis | Clinical isolate | ERG11 | Y132F | Single substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (64), Voriconazole (1) | 2018 | 30568646 |
| 16PC | C. parapsilosis | Clinical isolate | ERG11 | Y132F | Single substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (64), Voriconazole (1) | 2018 | 30568646 |
| 340PC | C. parapsilosis | Clinical isolate | ERG11 | Y132F | Single substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (64), Voriconazole (1) | 2018 | 30568646 |
| 542AMO | C. parapsilosis | Clinical isolate | ERG11 | Y132F | Single substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (64), Voriconazole (1) | 2018 | 30568646 |
| 87H | C. parapsilosis | Clinical isolate | ERG11 | Y132F | Single substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (64), Voriconazole (2) | 2018 | 30568646 |
| 88H | C. parapsilosis | Clinical isolate | ERG11 | Y132F | Single substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (64), Voriconazole (1) | 2018 | 30568646 |
| Patient1/Isolate1 | C. tropicalis | Clinical isolate | ERG11FKS1MDR1 | Y132F, S154FF641L, M1235IP448L | Double substitutionDouble substitutionSingle substitution | P14263B6S6L8C5MAA0 | 5281904552 | AF-P14263-F1ModelAF-C5MAA0-F1 |  | Fluconazole (>256), Voriconazole (12), Anidulafungin (0.5) | 2019 | 30583013 |
| Patient2/Isolate2 | C. tropicalis | Clinical isolate | ERG11FKS1 | Y257HD648V | Single substitutionSingle substitution | P14263B6S6L8 | 5281904 | AF-P14263-F1Model |  | Anidulafungin (0.25) | 2019 | 30583013 |
| Patient3/Isolate3 | C. tropicalis | Clinical isolate | FKS1 | S645P | Single substitution | B6S6L8 | 1904 | Model | Mismatch residue | Anidulafungin (0.5) | 2019 | 30583013 |
| Ca10 | C. albicans | Clinical isolate | ERG11TAC1 | K143RG980E | Single substitutionSingle substitution | Q9P4W0A0A1D8PN96 | 528981 | AF-Q9P4W0-F1AF-A0A1D8PN96-F1 |  | Fluconazole (64), Posaconazole (1), Isavuconazole (0.5), Itraconazole (0.5), Voriconazole (0.25) | 2020 | 30629653 |
| Ca11 | C. albicans | Clinical isolate | ERG11TAC1 | K143RG649D, F974L | Single substitutionDouble substitution | Q9P4W0A0A1D8PN96 | 528981 | AF-Q9P4W0-F1AF-A0A1D8PN96-F1 |  | Fluconazole (64), Posaconazole (0.5), Isavuconazole (0.25), Itraconazole (1), Voriconazole (0.5) | 2020 | 30629653 |
| Ca12 | C. albicans | Clinical isolate | ERG3 | Y235stop, A353T | Complex | Q59VG6 | 386 | AF-Q59VG6-F1 | Structure not available | Anidulafungin (0.125), Caspofungin (0.064), Micafungin (0.064), | 2020 | 30629653 |
| Ca13 | C. albicans | Clinical isolate | ERG3GSC1 | A353TF641C | Single substitutionSingle substitution | Q59VG6A0A1D8PCT0 | 3861897 | AF-Q59VG6-F1AF-A0A1D8PCT0-F1 |  | Anidulafungin (0.125), Caspofungin (0.125), Micafungin (0.064) | 2020 | 30629653 |
| Ca14 | C. albicans | Clinical isolate | ERG3GSC1 | A353TF641C | Single substitutionSingle substitution | Q59VG6A0A1D8PCT0 | 3861897 | AF-Q59VG6-F1AF-A0A1D8PCT0-F1 |  | Anidulafungin (0.5), Caspofungin (1), Micafungin (1) | 2020 | 30629653 |
| Ca15 | C. albicans | Clinical isolate | GSC1 | S645P | Single substitution | A0A1D8PCT0 | 1897 | AF-A0A1D8PCT0-F1 |  | Anidulafungin (0.5), Caspofungin (2), Micafungin (1) | 2020 | 30629653 |
| Ca16 | C. albicans | Clinical isolate | GSC1 | S645P | Single substitution | A0A1D8PCT0 | 1897 | AF-A0A1D8PCT0-F1 |  | Anidulafungin (0.5), Caspofungin (1), Micafungin (0.5) | 2020 | 30629653 |
| Ca17 | C. albicans | Clinical isolate | GSC1 | S645P | Single substitution | A0A1D8PCT0 | 1897 | AF-A0A1D8PCT0-F1 |  | Anidulafungin (0.5), Caspofungin (2), Micafungin (2) | 2020 | 30629653 |
| Ca18 | C. albicans | Clinical isolate | GSC1 | P649H, M696V | Double substitution | A0A1D8PCT0 | 1897 | AF-A0A1D8PCT0-F1 |  | Anidulafungin (0.25), Caspofungin (0.5), Micafungin (0.5) | 2020 | 30629653 |
| Ca22 | C. albicans | Clinical isolate | ERG3 | Y190stop, A353T | Complex | Q59VG6 | 386 | AF-Q59VG6-F1 | Structure not available | Anidulafungin (0.25), Caspofungin (0.5), Micafungin (0.125), Fluconazole (>256), Posaconazole (>32), Isavuconazole (>16), Itraconazole (>16), Voriconazole (>8) | 2020 | 30629653 |
| Ca3 | C. albicans | Clinical isolate | ERG11ERG3TAC1 | F72L, Y132HA353T, T329SN977D | Double substitutionDouble substitutionSingle substitution | Q9P4W0Q59VG6A0A1D8PN96 | 528386981 | AF-Q9P4W0-F1AF-Q59VG6-F1AF-A0A1D8PN96-F1 |  | Fluconazole (128), Posaconazole (4), Isavuconazole (4), Itraconazole (>16), Voriconazole (8) | 2020 | 30629653 |
| Ca5 | C. albicans | Clinical isolate | ERG11 | V437I | Single substitution | Q9P4W0 | 528 | AF-Q9P4W0-F1 |  | Fluconazole (>256), Posaconazole (>32), Isavuconazole (>16), Itraconazole (>16), Voriconazole (>8) | 2020 | 30629653 |
| Ca6 | C. albicans | Clinical isolate | ERG11ERG3TAC1 | V437IS191PS937L | Single substitutionSingle substitutionSingle substitution | Q9P4W0Q59VG6A0A1D8PN96 | 528386981 | AF-Q9P4W0-F1AF-Q59VG6-F1AF-A0A1D8PN96-F1 |  | Fluconazole (128), Posaconazole (>32), Isavuconazole (>16), Itraconazole (>16), Voriconazole (>8) | 2020 | 30629653 |
| Ca8 | C. albicans | Clinical isolate | ERG11TAC1 | Y132HN740D | Single substitutionSingle substitution | Q9P4W0A0A1D8PN96 | 528981 | AF-Q9P4W0-F1AF-A0A1D8PN96-F1 |  | Fluconazole (128), Posaconazole (0.25), Isavuconazole (0.5), Itraconazole (1), Voriconazole (8) | 2020 | 30629653 |
| Ca9 | C. albicans | Clinical isolate | ERG11ERG3 | E208K, T525IG261E | Double substitutionSingle substitution | Q9P4W0Q59VG6 | 528386 | AF-Q9P4W0-F1AF-Q59VG6-F1 |  | Fluconazole (>256), Posaconazole (>32), Isavuconazole (>16), Itraconazole (>16), Voriconazole (>8) | 2020 | 30629653 |
| cg26 | C. glabrata | Clinical isolate | PDR1 | G1079R | Single substitution | Q6FXU7 | 1107 | AF-Q6FXU7-F1 |  | Fluconazole (128), Posaconazole (>32), Isavuconazole (8), Itraconazole (>16), Voriconazole (4) | 2020 | 30629653 |
| cg28 | C. glabrata | Clinical isolate | PDR1 | D876Y, G1079V | Double substitution | Q6FXU7 | 1107 | AF-Q6FXU7-F1 |  | Fluconazole (128), Posaconazole (>32), Isavuconazole (8), Itraconazole (>16), Voriconazole (4) | 2020 | 30629653 |
| cg29 | C. glabrata | Clinical isolate | FKS1 | K1323E | Single substitution | Q6FTN8 | 1863 | Model |  | Anidulafungin (0.125), Caspofungin (0.125), Micafungin (0.064), Fluconazole (128), Posaconazole (16), Isavuconazole (8), Itraconazole (8), Voriconazole (8) | 2020 | 30629653 |
| cg30 | C. glabrata | Clinical isolate | PDR1 | G348D | Single substitution | Q6FXU7 | 1107 | AF-Q6FXU7-F1 |  | Fluconazole (256), Posaconazole (>32), Isavuconazole (8), Itraconazole (>16), Voriconazole (8) | 2020 | 30629653 |
| cg31 | C. glabrata | Clinical isolate | PDR1 | L291P | Single substitution | Q6FXU7 | 1107 | AF-Q6FXU7-F1 |  | Fluconazole (256), Posaconazole (>32), Isavuconazole (8), Itraconazole (>16), Voriconazole (4) | 2020 | 30629653 |
| cg33 | C. glabrata | Clinical isolate | PDR1 | G348S | Single substitution | Q6FXU7 | 1107 | AF-Q6FXU7-F1 |  | Fluconazole (256), Posaconazole (>32), Isavuconazole (16), Itraconazole (>16), Voriconazole (8) | 2020 | 30629653 |
| cg34 | C. glabrata | Clinical isolate | PDR1 | Y372H | Single substitution | Q6FXU7 | 1107 | AF-Q6FXU7-F1 |  | Fluconazole (256), Posaconazole (>32), Isavuconazole (8), Itraconazole (>16, Voriconazole (8) | 2020 | 30629653 |
| cg35 | C. glabrata | Clinical isolate | PDR1 | G346D | Single substitution | Q6FXU7 | 1107 | AF-Q6FXU7-F1 |  | Fluconazole (256), Posaconazole (>32), Isavuconazole (8), Itraconazole (>16, Voriconazole (8) | 2020 | 30629653 |
| cg36 | C. glabrata | Clinical isolate | PDR1 | H288D | Single substitution | Q6FXU7 | 1107 | AF-Q6FXU7-F1 |  | Fluconazole (256), Posaconazole (>32), Isavuconazole (8), Itraconazole (>16, Voriconazole (8) | 2020 | 30629653 |
| cg37 | C. glabrata | Clinical isolate | PDR1 | G346A | Single substitution | Q6FXU7 | 1107 | AF-Q6FXU7-F1 |  | Fluconazole (256), Posaconazole (>32), Isavuconazole (16), Itraconazole (>16), Voriconazole (>8) | 2020 | 30629653 |
| cg38 | C. glabrata | Clinical isolate | PDR1 | G348S | Single substitution | Q6FXU7 | 1107 | AF-Q6FXU7-F1 |  | Fluconazole (256), Posaconazole (>32), Isavuconazole (8), Itraconazole (>16), Voriconazole (8) | 2020 | 30629653 |
| cg41 | C. glabrata | Clinical isolate | FKS2 | P667T | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (0.25), Caspofungin (2), Micafungin (0.016) | 2020 | 30629653 |
| cg45 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (2), Caspofungin (>16), Micafungin (2) | 2020 | 30629653 |
| cg46 | C. glabrata | Clinical isolate | FKS1PDR1 | F625SW297R | Single substitutionSingle substitution | Q6FTN8Q6FXU7 | 18631107 | ModelAF-Q6FXU7-F1 |  | Anidulafungin (1), Caspofungin (2), Micafungin (0.25), Fluconazole (128), Posaconazole (32), Isavuconazole (8), Itraconazole (>16), Voriconazole (4) | 2020 | 30629653 |
| cg47 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (4), Caspofungin (16), Micafungin (4), Fluconazole (128), Posaconazole (32), Isavuconazole (4), Itraconazole (>16), Voriconazole (4) | 2020 | 30629653 |
| cg48 | C. glabrata | Clinical isolate | FKS1 | K1323E | Single substitution | Q6FTN8 | 1863 | Model |  | Anidulafungin (0.25), Caspofungin (0.25), Micafungin (0.125), Fluconazole (128), Posaconazole (8), Isavuconazole (4), Itraconazole (8), Voriconazole (4) | 2020 | 30629653 |
| cg49 | C. glabrata | Clinical isolate | PDR1 | V329F | Single substitution | Q6FXU7 | 1107 | AF-Q6FXU7-F1 |  | Anidulafungin (0.064), Caspofungin (0.125), Micafungin (0.125), Fluconazole (128), Posaconazole (>32), Isavuconazole (16), Itraconazole (>16), Voriconazole (8) | 2020 | 30629653 |
| cg50 | C. glabrata | Clinical isolate | FKS2PDR1 | F659SG1088E | Single substitutionSingle substitution | Q6FMZ3Q6FXU7 | 18971107 | ModelAF-Q6FXU7-F1 |  | Anidulafungin (0.25), Caspofungin (0.5), Micafungin (0.064), Fluconazole (256), Posaconazole (16), Isavuconazole (8), Itraconazole (4), Voriconazole (4) | 2020 | 30629653 |
| cg51 | C. glabrata | Clinical isolate | FKS2 | F659del | Deletion | Q6FMZ3 | 1897 | Model |  | Anidulafungin (2), Caspofungin (>16), Micafungin (4) | 2020 | 30629653 |
| CG25 | C. glabrata | Clinical isolate | PDR1 | N768D | Single substitution | Q6FXU7 | 1107 | AF-Q6FXU7-F1 |  | Fluconazole (64), Itraconazole (1), Ketoconazole (2) | 2019 | 30658200 |
| CGL4 | C. glabrata | Clinical isolate | PDR1 | L139I, E818K | Double substitution | Q6FXU7 | 1107 | AF-Q6FXU7-F1 |  | Fluconazole (64), Itraconazole (1), Ketoconazole (1) | 2019 | 30658200 |
| A10 | C. auris | Clinical isolate | ERG11 | K143R | Single substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 |  | Fluconazole (≥32) | 2019 | 30728190 |
| A3 | C. auris | Clinical isolate | ERG11 | F126L, V125A | Double substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 |  | Fluconazole (≥32) | 2019 | 30728190 |
| A4 | C. auris | Clinical isolate | ERG11 | F126L, V125A | Double substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 |  | Fluconazole (≥32) | 2019 | 30728190 |
| A5 | C. auris | Clinical isolate | ERG11 | Y132F, K177R, N335S, E343D | Multiple substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 |  | Fluconazole (≥32) | 2019 | 30728190 |
| A6 | C. auris | Clinical isolate | ERG11 | Y132F, K177R, N335S, E343D | Multiple substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 |  | Fluconazole (≥32) | 2019 | 30728190 |
| A8 | C. auris | Clinical isolate | ERG11 | K143R | Single substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 |  | Fluconazole (≥32) | 2019 | 30728190 |
| A9 | C. auris | Clinical isolate | ERG11 | Y132F | Single substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 |  | Fluconazole (≥32) | 2019 | 30728190 |
| VPCI 29/15 | C. parapsilosis | Clinical isolate | ERG11 | K143R | Single substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (8) | 2019 | 30753525 |
| VPCI 30/16 | C. parapsilosis | Clinical isolate | ERG11 | K143R | Single substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (8) | 2019 | 30753525 |
| VPCI 31/17 | C. parapsilosis | Clinical isolate | ERG11 | K143R | Single substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (8) | 2019 | 30753525 |
| VPCI 32/16 | C. parapsilosis | Clinical isolate | ERG11 | K143R | Single substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (8) | 2019 | 30753525 |
| VPCI 33/16 | C. parapsilosis | Clinical isolate | ERG11 | K143R | Single substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (8) | 2019 | 30753525 |
| VPCI 34/15 | C. parapsilosis | Clinical isolate | ERG11 | K143R | Single substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (8) | 2019 | 30753525 |
| VPCI 35/15 | C. parapsilosis | Clinical isolate | ERG11 | K143R | Single substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (8) | 2019 | 30753525 |
| VPCI 36/15 | C. parapsilosis | Clinical isolate | ERG11 | K143R | Single substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (8) | 2019 | 30753525 |
| VPCI 37/15 | C. parapsilosis | Clinical isolate | ERG11 | K143R | Single substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (8) | 2019 | 30753525 |
| VPCI 38/15 | C. parapsilosis | Clinical isolate | ERG11 | K143R | Single substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (8) | 2019 | 30753525 |
| VPCI 39/15 | C. parapsilosis | Clinical isolate | ERG11 | Y132F | Single substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (8) | 2019 | 30753525 |
| VPCI 40/15 | C. parapsilosis | Clinical isolate | ERG11 | K143R | Single substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (8) | 2019 | 30753525 |
| VPCI 41/15 | C. parapsilosis | Clinical isolate | ERG11 | K143R | Single substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (8) | 2019 | 30753525 |
| VPCI 42/15 | C. parapsilosis | Clinical isolate | ERG11 | K143R | Single substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (8) | 2019 | 30753525 |
| VPCI 43/15 | C. parapsilosis | Clinical isolate | ERG11 | K143R | Single substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (8) | 2019 | 30753525 |
| VPCI 44/16 | C. parapsilosis | Clinical isolate | ERG11 | K143R | Single substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (8) | 2019 | 30753525 |
| VPCI 45/16 | C. parapsilosis | Clinical isolate | ERG11 | K143R | Single substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (8) | 2019 | 30753525 |
| VPCI 46/16 | C. parapsilosis | Clinical isolate | ERG11 | K143R | Single substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (8) | 2019 | 30753525 |
| VPCI 47/17 | C. parapsilosis | Clinical isolate | ERG11 | K143R | Single substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (8) | 2019 | 30753525 |
| VPCI 48/15 | C. parapsilosis | Clinical isolate | ERG11 | K143R | Single substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (8) | 2019 | 30753525 |
| VPCI 49/16 | C. parapsilosis | Clinical isolate | ERG11 | K143R | Single substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (8) | 2019 | 30753525 |
| VPCI 50/17 | C. parapsilosis | Clinical isolate | ERG11 | K143R | Single substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (8) | 2019 | 30753525 |
| VPCI 51/17 | C. parapsilosis | Clinical isolate | ERG11 | K143R | Single substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (8) | 2019 | 30753525 |
| VPCI 52/17 | C. parapsilosis | Clinical isolate | ERG11 | K143R | Single substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (8) | 2019 | 30753525 |
| VPCI 53/15 | C. parapsilosis | Clinical isolate | ERG11 | K143R | Single substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (8) | 2019 | 30753525 |
| VPCI 54/16 | C. parapsilosis | Clinical isolate | ERG11 | K143R | Single substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (8) | 2019 | 30753525 |
| VPCI 55/16 | C. parapsilosis | Clinical isolate | ERG11 | K143R | Single substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (16) | 2019 | 30753525 |
| VPCI 56/15 | C. parapsilosis | Clinical isolate | ERG11 | K143R | Single substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (16) | 2019 | 30753525 |
| VPCI 57/15 | C. parapsilosis | Clinical isolate | ERG11 | K143R | Single substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (16) | 2019 | 30753525 |
| VPCI 58/15 | C. parapsilosis | Clinical isolate | ERG11 | K143R | Single substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (16) | 2019 | 30753525 |
| VPCI 59/15 | C. parapsilosis | Clinical isolate | ERG11 | K143R | Single substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (16) | 2019 | 30753525 |
| VPCI 60/15 | C. parapsilosis | Clinical isolate | ERG11 | K143R | Single substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (16) | 2019 | 30753525 |
| VPCI 61/16 | C. parapsilosis | Clinical isolate | ERG11 | K143R | Single substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (16) | 2019 | 30753525 |
| VPCI 62/16 | C. parapsilosis | Clinical isolate | ERG11 | K143R | Single substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (16) | 2019 | 30753525 |
| VPCI 63/15 | C. parapsilosis | Clinical isolate | ERG11 | K143R | Single substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (16) | 2019 | 30753525 |
| VPCI 64/15 | C. parapsilosis | Clinical isolate | ERG11 | K143R | Single substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (16) | 2019 | 30753525 |
| VPCI 65/16 | C. parapsilosis | Clinical isolate | ERG11 | K143R | Single substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (16) | 2019 | 30753525 |
| VPCI 66/16 | C. parapsilosis | Clinical isolate | ERG11 | K143R | Single substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (16) | 2019 | 30753525 |
| VPCI 67/17 | C. parapsilosis | Clinical isolate | ERG11 | K143R | Single substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (16) | 2019 | 30753525 |
| VPCI 68/17 | C. parapsilosis | Clinical isolate | ERG11 | K143R | Single substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (16) | 2019 | 30753525 |
| VPCI 69/16 | C. parapsilosis | Clinical isolate | ERG11 | K143R | Single substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (16) | 2019 | 30753525 |
| VPCI 70/16 | C. parapsilosis | Clinical isolate | ERG11 | K143R | Single substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (16) | 2019 | 30753525 |
| VPCI 71/15 | C. parapsilosis | Clinical isolate | ERG11 | K143R | Single substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (16) | 2019 | 30753525 |
| VPCI 72/16 | C. parapsilosis | Clinical isolate | ERG11 | K143R | Single substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (16) | 2019 | 30753525 |
| VPCI 73/16 | C. parapsilosis | Clinical isolate | ERG11 | K143R | Single substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (16) | 2019 | 30753525 |
| VPCI 74/16 | C. parapsilosis | Clinical isolate | ERG11 | K143R | Single substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (16) | 2019 | 30753525 |
| VPCI 75/15 | C. parapsilosis | Clinical isolate | ERG11 | K143R | Single substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (16) | 2019 | 30753525 |
| VPCI 76/16 | C. parapsilosis | Clinical isolate | ERG11 | K143R | Single substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (16) | 2019 | 30753525 |
| VPCI 77/15 | C. parapsilosis | Clinical isolate | ERG11 | Y132F | Single substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (16) | 2019 | 30753525 |
| VPCI 78/15 | C. parapsilosis | Clinical isolate | ERG11 | K143R | Single substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (16) | 2019 | 30753525 |
| VPCI 79/15 | C. parapsilosis | Clinical isolate | ERG11 | K143R | Single substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (16) | 2019 | 30753525 |
| VPCI 80/15 | C. parapsilosis | Clinical isolate | ERG11 | K143R | Single substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (16) | 2019 | 30753525 |
| VPCI 81/15 | C. parapsilosis | Clinical isolate | ERG11 | Y132F | Single substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (16) | 2019 | 30753525 |
| VPCI 82/16 | C. parapsilosis | Clinical isolate | ERG11 | K143R | Single substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (32) | 2019 | 30753525 |
| VPCI 83/15 | C. parapsilosis | Clinical isolate | ERG11 | K143R | Single substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (32) | 2019 | 30753525 |
| IB014 | C. albicans | Clinical isolate | FKS1 | L644V, R647K, R1360L | Multiple substitution | A0A1D8PCT0 | 1897 | AF-A0A1D8PCT0-F1 |  | Caspofungin (1.5) | 2019 | 30794951 |
| IB059 | C. albicans | Clinical isolate | FKS1 | L642V, L644V, D648S, T1363G | Multiple substitution | A0A1D8PCT0 | 1897 | AF-A0A1D8PCT0-F1 |  | Caspofungin (1) | 2019 | 30794951 |
| IB075 | C. albicans | Clinical isolate | FKS1 | T643I, R1360L, R1361L | Multiple substitution | A0A1D8PCT0 | 1897 | AF-A0A1D8PCT0-F1 |  | Caspofungin (1) | 2019 | 30794951 |
| IB108 | C. albicans | Clinical isolate | FKS1 | T643I, L644G, D648S, W1358S, R1361L | Multiple substitution | A0A1D8PCT0 | 1897 | AF-A0A1D8PCT0-F1 |  | Caspofungin (1.5) | 2019 | 30794951 |
| Ca1 | C. albicans | Clinical isolate | FKS1 | F641I | Single substitution | A0A1D8PCT0 | 1897 | AF-A0A1D8PCT0-F1 |  | Caspofungin (1) | 2019 | 30895218 |
| Ca2 | C. albicans | Clinical isolate | FKS1 | S629P | Single substitution | A0A1D8PCT0 | 1897 | AF-A0A1D8PCT0-F1 | Mismatch residue | Anidulafungin (0.5), Caspofungin (2), Micafungin (1) | 2019 | 30895218 |
| Ca3 | C. albicans | Clinical isolate | FKS1 | S654P | Single substitution | A0A1D8PCT0 | 1897 | AF-A0A1D8PCT0-F1 |  | Anidulafungin (0.5), Caspofungin (1), Micafungin (1) | 2019 | 30895218 |
| Ca4 | C. albicans | Clinical isolate | FKS1 | F641S | Single substitution | A0A1D8PCT0 | 1897 | AF-A0A1D8PCT0-F1 |  | Anidulafungin (0.5), Caspofungin (0.5), Micafungin (0.5) | 2019 | 30895218 |
| Ca5 | C. albicans | Clinical isolate | FKS1 | S645P | Single substitution | A0A1D8PCT0 | 1897 | AF-A0A1D8PCT0-F1 |  | Anidulafungin (0.5), Caspofungin (1), Micafungin (1) | 2019 | 30895218 |
| Ca6 | C. albicans | Clinical isolate | FKS1 | S645P | Single substitution | A0A1D8PCT0 | 1897 | AF-A0A1D8PCT0-F1 |  | Anidulafungin (0.12), Caspofungin (1), Micafungin (1) | 2019 | 30895218 |
| Ca7 | C. albicans | Clinical isolate | FKS1 | S645P | Single substitution | A0A1D8PCT0 | 1897 | AF-A0A1D8PCT0-F1 |  | Anidulafungin (0.25), Caspofungin (1), Micafungin (1) | 2019 | 30895218 |
| Ca8 | C. albicans | Clinical isolate | FKS1 | S645P | Single substitution | A0A1D8PCT0 | 1897 | AF-A0A1D8PCT0-F1 |  | Anidulafungin (0.25), Caspofungin (1), Micafungin (1) | 2019 | 30895218 |
| Cd | C. dubliniensis | Clinical isolate | FKS1 | S645P | Single substitution | D3IZZ7 | 1897 | Model | Structure not available | Anidulafungin (2), Caspofungin (2), Micafungin (1) | 2019 | 30895218 |
| Cg1 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (1), Caspofungin (1), Micafungin (0.25) | 2019 | 30895218 |
| Cg10 | C. glabrata | Clinical isolate | FKS1 | F625S | Single substitution | Q6FTN8 | 1863 | Model |  | Anidulafungin (0.5), Caspofungin (0.25), Micafungin (0.12) | 2019 | 30895218 |
| Cg11 | C. glabrata | Clinical isolate | FKS2 | S659Y | Single substitution | Q6FMZ3 | 1897 | Model | Mismatch residue | Anidulafungin (1), Caspofungin (1), Micafungin (0.25) | 2019 | 30895218 |
| Cg12 | C. glabrata | Clinical isolate | FKS2 | L662W | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (1), Caspofungin (0.5), Micafungin (0.5) | 2019 | 30895218 |
| Cg13 | C. glabrata | Clinical isolate | FKS2 | L644W | Single substitution | Q6FMZ3 | 1897 | Model | Mismatch residue | Anidulafungin (1), Caspofungin (0.5), Micafungin (0.5) | 2019 | 30895218 |
| Cg14 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (2), Caspofungin (1), Micafungin (1) | 2019 | 30895218 |
| Cg15 | C. glabrata | Clinical isolate | FKS2 | F659V | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (1), Caspofungin (4) | 2019 | 30895218 |
| Cg16 | C. glabrata | Clinical isolate | FKS2 | F641V | Single substitution | Q6FMZ3 | 1897 | Model | Mismatch residue | Anidulafungin (1), Caspofungin (4) | 2019 | 30895218 |
| Cg17 | C. glabrata | Clinical isolate | FKS2 | S663Y | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (1), Caspofungin (0.5), Micafungin (0.5) | 2019 | 30895218 |
| Cg18 | C. glabrata | Clinical isolate | FKS1 | S629P | Single substitution | Q6FTN8 | 1863 | Model |  | Anidulafungin (4), Caspofungin (16), Micafungin (2) | 2019 | 30895218 |
| Cg19 | C. glabrata | Clinical isolate | FKS2 | D648E | Single substitution | Q6FMZ3 | 1897 | Model | Mismatch residue | Anidulafungin (0.25), Caspofungin (0.5) | 2019 | 30895218 |
| Cg2 | C. glabrata | Clinical isolate | FKS1 | R631S, S629P | Double substitution | Q6FTN8 | 1863 | Model |  | Anidulafungin (1), Caspofungin (1), Micafungin (0.5) | 2019 | 30895218 |
| Cg20 | C. glabrata | Clinical isolate | FKS1 | F625Y | Single substitution | Q6FTN8 | 1863 | Model |  | Anidulafungin (0.5), Caspofungin (0.25) | 2019 | 30895218 |
| Cg21 | C. glabrata | Clinical isolate | FKS2 | F641Y | Single substitution | Q6FMZ3 | 1897 | Model | Mismatch residue | Anidulafungin (0.5), Caspofungin (0.25) | 2019 | 30895218 |
| Cg22 | C. glabrata | Clinical isolate | FKS2 | F659del | Deletion | Q6FMZ3 | 1897 | Model |  | Anidulafungin (2), Caspofungin (1), Micafungin (1) | 2019 | 30895218 |
| Cg23 | C. glabrata | Clinical isolate | FKS2 | F659del | Deletion | Q6FMZ3 | 1897 | Model |  | Anidulafungin (1), Caspofungin (0.5), Micafungin (0.5) | 2019 | 30895218 |
| Cg24 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (2), Caspofungin (1), Micafungin (0.5) | 2019 | 30895218 |
| Cg25 | C. glabrata | Clinical isolate | FKS2 | D666E, K753Q | Double substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (0.5), Caspofungin (0.5) | 2019 | 30895218 |
| Cg26 | C. glabrata | Clinical isolate | FKS1 | D632V | Single substitution | Q6FTN8 | 1863 | Model |  | Anidulafungin (2), Caspofungin (2), Micafungin (0.5) | 2019 | 30895218 |
| Cg27 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (2), Caspofungin (4), Micafungin (2) | 2019 | 30895218 |
| Cg28 | C. glabrata | Clinical isolate | FKS2 | S663F | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (4), Caspofungin (16), Micafungin (4) | 2019 | 30895218 |
| Cg29 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (2), Caspofungin (0.5), Micafungin (1) | 2019 | 30895218 |
| Cg3 | C. glabrata | Clinical isolate | FKS2 | F659S | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (1), Caspofungin (1) | 2019 | 30895218 |
| Cg30 | C. glabrata | Clinical isolate | FKS2 | S663F | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (2), Caspofungin (2), Micafungin (1) | 2019 | 30895218 |
| Cg31 | C. glabrata | Clinical isolate | FKS1 | S629P | Single substitution | Q6FTN8 | 1863 | Model |  | Anidulafungin (2), Caspofungin (8), Micafungin (2) | 2019 | 30895218 |
| Cg32 | C. glabrata | Clinical isolate | FKS2 | F659S | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (0.25), Caspofungin (0.5), Micafungin (0.25) | 2019 | 30895218 |
| Cg33 | C. glabrata | Clinical isolate | FKS1 | F625S | Single substitution | Q6FTN8 | 1863 | Model |  | Anidulafungin (1), Caspofungin (1), Micafungin (0.25) | 2019 | 30895218 |
| Cg34 | C. glabrata | Clinical isolate | FKS1FKS2 | S629PS663P | Single substitutionSingle substitution | Q6FTN8Q6FMZ3 | 18631897 | ModelModel |  | Anidulafungin (4), Caspofungin (>8), Micafungin (4) | 2019 | 30895218 |
| Cg35 | C. glabrata | Clinical isolate | FKS1FKS2 | S629PS663P | Single substitutionSingle substitution | Q6FTN8Q6FMZ3 | 18631897 | ModelModel |  | Anidulafungin (4), Caspofungin (>8), Micafungin (4) | 2019 | 30895218 |
| Cg36 | C. glabrata | Clinical isolate | FKS2 | F659S | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (1), Caspofungin (1), Micafungin (0.25) | 2019 | 30895218 |
| Cg37 | C. glabrata | Clinical isolate | FKS1 | F625S | Single substitution | Q6FTN8 | 1863 | Model |  | Anidulafungin (2), Caspofungin (2), Micafungin (0.5) | 2019 | 30895218 |
| Cg38 | C. glabrata | Clinical isolate | FKS1FKS2 | F625SF659Y | Single substitutionSingle substitution | Q6FTN8Q6FMZ3 | 18631897 | ModelModel |  | Anidulafungin (2), Caspofungin (2), Micafungin (0.5) | 2019 | 30895218 |
| Cg39 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (4), Caspofungin (4), Micafungin (1) | 2019 | 30895218 |
| Cg4 | C. glabrata | Clinical isolate | FKS1 | L630I | Single substitution | Q6FTN8 | 1863 | Model |  | Anidulafungin (0.5), Caspofungin (1), Micafungin (0.12) | 2019 | 30895218 |
| Cg40 | C. glabrata | Clinical isolate | FKS2 | F659S | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (2), Caspofungin (2), Micafungin (2) | 2019 | 30895218 |
| Cg41 | C. glabrata | Clinical isolate | FKS2 | L662W | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (0.25), Caspofungin (0.5) | 2019 | 30895218 |
| Cg42 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (1), Caspofungin (1), Micafungin (1) | 2019 | 30895218 |
| Cg43 | C. glabrata | Clinical isolate | FKS2 | F659del | Deletion | Q6FMZ3 | 1897 | Model |  | Anidulafungin (4), Caspofungin (>8), Micafungin (4) | 2019 | 30895218 |
| Cg44 | C. glabrata | Clinical isolate | FKS2 | P667T | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (0.25), Caspofungin (0.5) | 2019 | 30895218 |
| Cg45 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (0.5), Caspofungin (0.25), Micafungin (0.25) | 2019 | 30895218 |
| Cg46 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (2), Caspofungin (2), Micafungin (2) | 2019 | 30895218 |
| Cg47 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (2), Caspofungin (1), Micafungin (1) | 2019 | 30895218 |
| Cg48 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (2), Caspofungin (1), Micafungin (2) | 2019 | 30895218 |
| Cg49 | C. glabrata | Clinical isolate | FKS2 | F658del | Deletion | Q6FMZ3 | 1897 | Model |  | Anidulafungin (0.5), Micafungin (0.12) | 2019 | 30895218 |
| Cg5 | C. glabrata | Clinical isolate | FKS1 | S629P | Single substitution | Q6FTN8 | 1863 | Model |  | Anidulafungin (2), Caspofungin (16), Micafungin (2) | 2019 | 30895218 |
| Cg50 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (2), Caspofungin (8), Micafungin (2) | 2019 | 30895218 |
| Cg51 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (2), Caspofungin (4), Micafungin (1) | 2019 | 30895218 |
| Cg6 | C. glabrata | Clinical isolate | FKS2 | F659V | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (1), Caspofungin (2) | 2019 | 30895218 |
| Cg7 | C. glabrata | Clinical isolate | FKS2 | S663F | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (1), Caspofungin (1), Micafungin (0.25) | 2019 | 30895218 |
| Cg8 | C. glabrata | Clinical isolate | FKS1 | S629P | Single substitution | Q6FTN8 | 1863 | Model |  | Anidulafungin (2), Caspofungin (4), Micafungin (2) | 2019 | 30895218 |
| Cg9 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (1), Caspofungin (1), Micafungin (0.5) | 2019 | 30895218 |
| Ck1 | C. kefyr | Clinical isolate | FKS1 | R1344S | Single substitution | Not available | Not available | Not available | Structure not available | Anidulafungin (2), Caspofungin (0.5), Micafungin (1) | 2019 | 30895218 |
| Ct1 | C. tropicalis | Clinical isolate | FKS1 | S645P | Single substitution | C5M4K6 | 1640 | Model | Mismatch residue | Anidulafungin (1), Caspofungin (0.5), Micafungin (0.5) | 2019 | 30895218 |
| Ct2 | C. tropicalis | Clinical isolate | FKS1 | F641S | Single substitution | C5M4K6 | 1640 | Model | Mismatch residue | Anidulafungin (2), Caspofungin (2), Micafungin (1) | 2019 | 30895218 |
| Ct3 | C. tropicalis | Clinical isolate | FKS1 | F641L | Single substitution | C5M4K6 | 1640 | Model | Mismatch residue | Anidulafungin (1), Caspofungin (0.5), Micafungin (0.5) | 2019 | 30895218 |
| Ct4 | C. tropicalis | Clinical isolate | FKS1 | F650S | Single substitution | C5M4K6 | 1640 | Model | Mismatch residue | Anidulafungin (1), Caspofungin (2), Micafungin (1) | 2019 | 30895218 |
| Ct5 | C. tropicalis | Clinical isolate | FKS1 | S654P | Single substitution | C5M4K6 | 1640 | Model | Mismatch residue | Anidulafungin (1), Caspofungin (>8), Micafungin (2) | 2019 | 30895218 |
| Ct6 | C. tropicalis | Clinical isolate | FKS1 | S645P | Single substitution | C5M4K6 | 1640 | Model | Mismatch residue | Anidulafungin (0.5), Caspofungin (4), Micafungin (1) | 2019 | 30895218 |
| Ct7 | C. tropicalis | Clinical isolate | FKS1 | S654P | Single substitution | C5M4K6 | 1640 | Model | Mismatch residue | Anidulafungin (0.5), Caspofungin (4), Micafungin (1) | 2019 | 30895218 |
| Ct8 | C. tropicalis | Clinical isolate | FKS1 | S654P | Single substitution | C5M4K6 | 1640 | Model | Mismatch residue | Anidulafungin (2), Caspofungin (4), Micafungin (2) | 2019 | 30895218 |
| Ct9 | C. tropicalis | Clinical isolate | FKS1 | S654P | Single substitution | C5M4K6 | 1640 | Model | Mismatch residue | Anidulafungin (2), Caspofungin (4), Micafungin (2) | 2019 | 30895218 |
| 159MIR | C. glabrata | Clinical isolate | PDR1 | E555K | Single substitution | Q66WF3 | 1107 | AF-Q66WF3-F1 | Structure not available | Caspofungin (1), Voriconazole (4) | 2019 | 30936110 |
| 22BC | C. glabrata | Clinical isolate | ERG11PDR1 | K456R, G457C, V458FN162S, F944S | Multiple substitutionDouble substitution | P50859Q66WF3 | 5331107 | 5JLCAF-Q66WF3-F1 |  | Caspofungin (1) | 2019 | 30936110 |
| 2BC | C. glabrata | Clinical isolate | ERG11PDR1 | N368TT745A, C930R | Single substitutionDouble substitution | P50859Q66WF3 | 5331107 | 5JLCAF-Q66WF3-F1 |  | Caspofungin (0.5) | 2019 | 30936110 |
| 33BC | C. glabrata | Clinical isolate | PDR1 | G574S | Single substitution | Q66WF3 | 1107 | AF-Q66WF3-F1 | Structure not available | Caspofungin (1) | 2019 | 30936110 |
| 348MIR | C. glabrata | Clinical isolate | ERG11 | N368T | Single substitution | P50859 | 533 | 5JLC | Structure not available | Caspofungin (1), Voriconazole (2) | 2019 | 30936110 |
| 40BC | C. glabrata | Clinical isolate | PDR1 | P68S, P135T, D235N | Multiple substitution | Q66WF3 | 1107 | AF-Q66WF3-F1 | Mismatch residue | Caspofungin (1) | 2019 | 30936110 |
| 42BC | C. glabrata | Clinical isolate | PDR1 | P68S, P135T, D235N | Multiple substitution | Q66WF3 | 1107 | AF-Q66WF3-F1 | Mismatch residue | Caspofungin (1) | 2019 | 30936110 |
| 44BC | C. glabrata | Clinical isolate | ERG11PDR1 | N368TC930R | Single substitutionSingle substitution | P50859Q66WF3 | 5331107 | 5JLCAF-Q66WF3-F1 |  | Caspofungin (1) | 2019 | 30936110 |
| 45-1BC | C. glabrata | Clinical isolate | PDR1 | C930R | Single substitution | Q66WF3 | 1107 | AF-Q66WF3-F1 | Structure not available | Caspofungin (1) | 2019 | 30936110 |
| 45-2BC | C. glabrata | Clinical isolate | PDR1 | C930R | Single substitution | Q66WF3 | 1107 | AF-Q66WF3-F1 | Structure not available | Caspofungin (0.5) | 2019 | 30936110 |
| 51 -1BC | C. glabrata | Clinical isolate | PDR1 | P117S | Single substitution | Q66WF3 | 1107 | AF-Q66WF3-F1 | Mismatch residue | Caspofungin (0.5) | 2019 | 30936110 |
| 692MIR | C. glabrata | Clinical isolate | PDR1 | K67N | Single substitution | Q66WF3 | 1107 | AF-Q66WF3-F1 | Mismatch residue | Voriconazole (2) | 2019 | 30936110 |
| 70BC | C. glabrata | Clinical isolate | ERG11 | N368T, H430P | Double substitution | P50859 | 533 | 5JLC | Structure not available | Caspofungin (0.5) | 2019 | 30936110 |
| 721MIR | C. glabrata | Clinical isolate | ERG11 | N368T | Single substitution | P50859 | 533 | 5JLC | Structure not available | Voriconazole (1), Caspofungin (0.5) | 2019 | 30936110 |
| 88 -2BC | C. glabrata | Clinical isolate | PDR1 | C930R | Single substitution | Q66WF3 | 1107 | AF-Q66WF3-F1 | Structure not available | Voriconazole (1), Caspofungin (1) | 2019 | 30936110 |
| N145 | C. glabrata | Clinical isolate | PDR1 | P76S, P143T, D243N | Multiple substitution | Q66WF3 | 1107 | AF-Q66WF3-F1 | Structure not available | Caspofungin (0.5) | 2019 | 30936110 |
| N172 | C. glabrata | Clinical isolate | ERG11PDR1 | N368TT745A | Single substitutionSingle substitution | P50859Q66WF3 | 5331107 | 5JLCAF-Q66WF3-F1 |  | Voriconazole (1), Caspofungin (0.5) | 2019 | 30936110 |
| N177 | C. glabrata | Clinical isolate | PDR1 | P76S, P143T, D243N | Multiple substitution | Q66WF3 | 1107 | AF-Q66WF3-F1 | Structure not available | Caspofungin (1) | 2019 | 30936110 |
| N194 | C. glabrata | Clinical isolate | ERG11PDR1 | N368TT745A | Single substitutionSingle substitution | P50859Q66WF3 | 5331107 | 5JLCAF-Q66WF3-F1 |  | Caspofungin (0.5) | 2019 | 30936110 |
| N198s | C. glabrata | Clinical isolate | ERG11PDR1 | N368TT745A | Single substitutionSingle substitution | P50859Q66WF3 | 5331107 | 5JLCAF-Q66WF3-F1 |  | Caspofungin (0.5) | 2019 | 30936110 |
| N73 | C. glabrata | Clinical isolate | PDR1 | P76S, P143T, D243N | Multiple substitution | Q66WF3 | 1107 | AF-Q66WF3-F1 | Structure not available | Caspofungin (0.5) | 2019 | 30936110 |
| SU -103 | C. glabrata | Clinical isolate | PDR1 | K430M, L454P | Double substitution | Q66WF3 | 1107 | AF-Q66WF3-F1 | Structure not available | Caspofungin (0.5) | 2019 | 30936110 |
| SU -113 | C. glabrata | Clinical isolate | PDR1 | K430M, E441K | Double substitution | Q66WF3 | 1107 | AF-Q66WF3-F1 | Structure not available | Caspofungin (0.5) | 2019 | 30936110 |
| SU -232(2) | C. glabrata | Clinical isolate | ERG11PDR1 | D196NA1004S | Single substitutionSingle substitution | P50859Q66WF3 | 5331107 | 5JLCAF-Q66WF3-F1 |  | Caspofungin (1) | 2019 | 30936110 |
| Su 261 | C. glabrata | Clinical isolate | PDR1 | A828T | Single substitution | Q66WF3 | 1107 | AF-Q66WF3-F1 | Structure not available | Caspofungin (0.5) | 2019 | 30936110 |
| SU-227(1) | C. glabrata | Clinical isolate | PDR1 | P76S, P143T, D243N | Multiple substitution | Q66WF3 | 1107 | AF-Q66WF3-F1 | Structure not available | Fluconazole (64) | 2019 | 30936110 |
| SU-227(2) | C. glabrata | Clinical isolate | PDR1 | P76S, P143T, D243N | Multiple substitution | Q66WF3 | 1107 | AF-Q66WF3-F1 | Structure not available | Caspofungin (1) | 2019 | 30936110 |
| SU-249 | C. glabrata | Clinical isolate | PDR1 | T745A | Single substitution | Q66WF3 | 1107 | AF-Q66WF3-F1 | Structure not available | Caspofungin (1) | 2019 | 30936110 |
| SU-260 | C. glabrata | Clinical isolate | ERG11 | N368T | Single substitution | P50859 | 533 | 5JLC | Structure not available | Caspofungin (0.5) | 2019 | 30936110 |
| SU-39 | C. glabrata | Clinical isolate | ERG11PDR1 | H430PG189V | Single substitutionSingle substitution | P50859Q66WF3 | 5331107 | 5JLCAF-Q66WF3-F1 |  | Caspofungin (0.5) | 2019 | 30936110 |
| SU-72 | C. glabrata | Clinical isolate | ERG11PDR1 | H430PG128E, G493A | Single substitutionDouble substitution | P50859Q66WF3 | 5331107 | 5JLCAF-Q66WF3-F1 |  | Caspofungin (1) | 2019 | 30936110 |
| SU-80 | C. glabrata | Clinical isolate | ERG11PDR1 | H430PG128E | Single substitutionSingle substitution | P50859Q66WF3 | 5331107 | 5JLCAF-Q66WF3-F1 |  | Caspofungin (0.5) | 2019 | 30936110 |
| isolate no. 61 | C. glabrata | Clinical isolate | FKS1 | S629P | Single substitution | W8CTF4 | 233 | AF-W8CTF4-F1 | Structure not available | Caspofungin (8), Micafungin (1) | 2020 | 31111912 |
| isolate no. 71 | C. glabrata | Clinical isolate | FKS1FKS2 | S629PS663F | Single substitutionSingle substitution | W8CTF4E2GKZ6 | 2331897 | AF-W8CTF4-F1Model |  | Anidulafungin (0.5), Caspofungin (1) | 2020 | 31111912 |
| isolate no. 72 | C. glabrata | Clinical isolate | FKS1FKS2 | S629PS663F | Single substitutionSingle substitution | W8CTF4E2GKZ6 | 2331897 | AF-W8CTF4-F1Model |  | Anidulafungin (2), Caspofungin (32), Micafungin (4) | 2020 | 31111912 |
| isolate no. 73 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | E2GKZ6 | 1897 | Model |  | Anidulafungin (2), Caspofungin (4) | 2020 | 31111912 |
| isolate no. 74 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | E2GKZ6 | 1897 | Model |  | Anidulafungin (2), Caspofungin (2) | 2020 | 31111912 |
| isolate no. 75 | C. glabrata | Clinical isolate | FKS1 | S629P | Single substitution | W8CTF4 | 233 | AF-W8CTF4-F1 | Structure not available | Anidulafungin (0.5), Caspofungin (2), Micafungin (0.25) | 2020 | 31111912 |
| isolate no. 76 | C. glabrata | Clinical isolate | FKS1 | S629P | Single substitution | W8CTF4 | 233 | AF-W8CTF4-F1 | Structure not available | Anidulafungin (0.5), Caspofungin (4), Micafungin (0.5) | 2020 | 31111912 |
| isolate no. 78 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | E2GKZ6 | 1897 | Model |  | Anidulafungin (2), Caspofungin (2), Micafungin (0.75) | 2020 | 31111912 |
| isolate no. 79 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | E2GKZ6 | 1897 | Model |  | Anidulafungin (2), Caspofungin (2), Micafungin (0.5) | 2020 | 31111912 |
| isolate no. 81 | C. glabrata | Clinical isolate | FKS1 | S629P | Single substitution | W8CTF4 | 233 | AF-W8CTF4-F1 | Structure not available | Anidulafungin (0.5), Caspofungin (2), Micafungin (0.125) | 2020 | 31111912 |
| NCPF no. 8814 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | E2GKZ6 | 1897 | Model |  | Anidulafungin (4), Caspofungin (6), Micafungin (1) | 2020 | 31111912 |
| NCPF no. 8919 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | E2GKZ6 | 1897 | Model |  | Anidulafungin (6), Caspofungin (>32), Micafungin (6) | 2020 | 31111912 |
| 35 | C. glabrata | Clinical isolate | PDR1 | D876N | Single substitution | Q66WF3 | 1107 | AF-Q66WF3-F1 |  | 5-Flucytosine (>4), Voriconazole (8), Itraconazole (>4), Fluconazole (128) | 2019 | 31118695 |
| 44 | C. glabrata | Clinical isolate | PDR1 | N764D | Single substitution | Q66WF3 | 1107 | AF-Q66WF3-F1 |  | 5-Flucytosine (>4), Voriconazole (8), Itraconazole (4), Fluconazole (128) | 2019 | 31118695 |
| 50 | C. glabrata | Clinical isolate | PDR1 | A848V | Single substitution | Q66WF3 | 1107 | AF-Q66WF3-F1 |  | 5-Flucytosine (>4), Voriconazole (8), Itraconazole (>4), Fluconazole (64) | 2019 | 31118695 |
| 51 | C. glabrata | Clinical isolate | PDR1 | A848V | Single substitution | Q66WF3 | 1107 | AF-Q66WF3-F1 |  | 5-Flucytosine (>4), Voriconazole (4), Itraconazole (>4), Fluconazole (64) | 2019 | 31118695 |
| 53 | C. glabrata | Clinical isolate | PDR1 | A848V | Single substitution | Q66WF3 | 1107 | AF-Q66WF3-F1 |  | 5-Flucytosine (>4), Voriconazole (8), Itraconazole (>4), Fluconazole (128) | 2019 | 31118695 |
| 54 | C. glabrata | Clinical isolate | PDR1 | G348C | Single substitution | Q66WF3 | 1107 | AF-Q66WF3-F1 |  | 5-Flucytosine (>4), Voriconazole (8), Itraconazole (>4), Fluconazole (64) | 2019 | 31118695 |
| 55 | C. glabrata | Clinical isolate | PDR1 | A848V | Single substitution | Q66WF3 | 1107 | AF-Q66WF3-F1 |  | 5-Flucytosine (>4), Voriconazole (4), Itraconazole (>4), Fluconazole (64) | 2019 | 31118695 |
| 56 | C. glabrata | Clinical isolate | PDR1 | A848V | Single substitution | Q66WF3 | 1107 | AF-Q66WF3-F1 |  | 5-Flucytosine (>4), Voriconazole (4), Itraconazole (>4), Fluconazole (64) | 2019 | 31118695 |
| 57 | C. glabrata | Clinical isolate | PDR1 | A848V | Single substitution | Q66WF3 | 1107 | AF-Q66WF3-F1 |  | 5-Flucytosine (>4), Voriconazole (4), Itraconazole (>4), Fluconazole (64) | 2019 | 31118695 |
| 58 | C. glabrata | Clinical isolate | PDR1 | A848V | Single substitution | Q66WF3 | 1107 | AF-Q66WF3-F1 |  | 5-Flucytosine (>4), Voriconazole (4), Itraconazole (>4), Fluconazole (64) | 2019 | 31118695 |
| 59 | C. glabrata | Clinical isolate | PDR1 | A848V | Single substitution | Q66WF3 | 1107 | AF-Q66WF3-F1 |  | 5-Flucytosine (>4), Voriconazole (4), Itraconazole (>4), Fluconazole (64) | 2019 | 31118695 |
| CA-n1 | C. albicans | Clinical isolate | ERG11 | P56S, V88I | Double substitution | Q9P4W0 | 528 | AF-Q9P4W0-F1 | Mismatch residue | Posaconazole, Itraconazole, Fluconazole | 2019 | 31174994 |
| CA-n3 | C. albicans | Clinical isolate | ERG11 | A114S, Y257H | Double substitution | Q9P4W0 | 528 | AF-Q9P4W0-F1 |  | Posaconazole, Itraconazole, Fluconazole | 2019 | 31174994 |
| CT-n1 | C. tropicalis | Clinical isolate | ERG11 | Y132F | Single substitution | P14263 | 528 | AF-P14263-F1 |  | Posaconazole, Fluconazole | 2019 | 31174994 |
| RCPF1821 | C. auris | Clinical isolate | ERG11 | F105L, K143R | Double substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 | Mismatch residue | Fluconazole (>256) | 2020 | 31290551 |
| CDC0383_Africa1 | C. auris | Clinical isolate | ERG11 | F124L | Single substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 | Mismatch residue | Fluconazole (128), Voriconazole (4) | 2019 | 31325309 |
| CDC0384_Africa2 | C. auris | Clinical isolate | ERG11 | F124L | Single substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 | Mismatch residue | Fluconazole (128), Voriconazole (1) | 2019 | 31325309 |
| CDC0385_South America1 | C. auris | Clinical isolate | ERG11 | Y132F | Single substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 |  | Fluconazole (>256), Voriconazole (16) | 2019 | 31325309 |
| CDC0385_South America2 | C. auris | Clinical isolate | ERG11 | Y132F | Single substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 |  | Fluconazole (>256), Voriconazole (16) | 2019 | 31325309 |
| CDC0385_South America3 | C. auris | Clinical isolate | ERG11 | K143R | Single substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 |  | Fluconazole (>256), Voriconazole (2) | 2019 | 31325309 |
| CDC0385_South America4 | C. auris | Clinical isolate | ERG11 | Y132F | Single substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 |  | Fluconazole (128), Voriconazole (4) | 2019 | 31325309 |
| CDC0385_South America5 | C. auris | Clinical isolate | ERG11 | K143R | Single substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 |  | Fluconazole (>256), Voriconazole (8) | 2019 | 31325309 |
| cg | C. glabrata | Clinical isolate | FKS2 | F659Y | Single substitution | Q6FMZ3 | 1897 | Model |  | Caspofungin (1) | 2019 | 31345844 |
| CNM-CL10047 | C. glabrata | Clinical isolate | FKS2 | F659del, D666N | Complex | Q6FMZ3 | 1897 | Model |  | Anidulafungin (>4), Micafungin (2), Fluconazole (64) | 2019 | 31354675 |
| CNM-CL9646 | C. glabrata | Clinical isolate | FKS2 | D666N | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (0.125), Micafungin (0.06), Fluconazole (64) | 2019 | 31354675 |
| CNM-CL9775 | C. glabrata | Clinical isolate | FKS2 | D666N | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (0.125), Micafungin (0.06) | 2019 | 31354675 |
| CNM-CL9877 | C. glabrata | Clinical isolate | FKS2 | L664R | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (0.125), Micafungin (0.06) | 2019 | 31354675 |
| CNM-CL9883 | C. glabrata | Clinical isolate | FKS2 | D666E | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (0.25), Micafungin (0.06) | 2019 | 31354675 |
| CNM-CL9889 | C. glabrata | Clinical isolate | FKS2 | L664R | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (0.125), Micafungin (0.125) | 2019 | 31354675 |
| CNM-CL9897 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (2), Micafungin (>2) | 2019 | 31354675 |
| CNM-CL9931 | C. glabrata | Clinical isolate | FKS2 | F659del | Deletion | Q6FMZ3 | 1897 | Model |  | Anidulafungin (2), Micafungin (2) | 2019 | 31354675 |
| CNM-CL9932 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (2), Micafungin (2) | 2019 | 31354675 |
| CNM-CL9939 | C. glabrata | Clinical isolate | FKS2 | F659del | Deletion | Q6FMZ3 | 1897 | Model |  | Anidulafungin (2), Micafungin (2), Fluconazole (64) | 2019 | 31354675 |
| CNM-CL9975 | C. glabrata | Clinical isolate | FKS2 | D666H | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (0.125) | 2019 | 31354675 |
| CNM-CL9981 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (2), Micafungin (>2) | 2019 | 31354675 |
| CNM-CL9988 | C. glabrata | Clinical isolate | FKS2 | D666N | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (0.25), Micafungin (0.06) | 2019 | 31354675 |
| CNM-CL9991 | C. glabrata | Clinical isolate | FKS2 | F659del | Deletion | Q6FMZ3 | 1897 | Model |  | Anidulafungin (2), Micafungin (2), Fluconazole (>64) | 2019 | 31354675 |
| CNM-CL9992 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (2), Micafungin (>2), Fluconazole (64) | 2019 | 31354675 |
| ISOALTE 32 | C. glabrata | Clinical isolate | FKS1 | S629P | Single substitution | Not available | Not available | Not available | Structure not available | Anidulafungin (4), Caspofungin (>16), Micafungin (2) | 2019 | 31481447 |
| ISOALTE 46 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Not available | Not available | Not available | Structure not available | Anidulafungin (1), Caspofungin (4), Micafungin (1) | 2019 | 31481447 |
| ISOALTE 8 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Not available | Not available | Not available | Structure not available | Anidulafungin (1), Caspofungin (16), Micafungin (4) | 2019 | 31481447 |
| ISOALTE 89 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Not available | Not available | Not available | Structure not available | Anidulafungin (2), Caspofungin (4), Micafungin (2) | 2019 | 31481447 |
| ISOLATE 1 | C. glabrata | Clinical isolate | FKS1 | S629P | Single substitution | Not available | Not available | Not available | Structure not available | Anidulafungin (1), Caspofungin (0.5), Micafungin (1) | 2019 | 31481447 |
| ISOLATE 10 | C. glabrata | Clinical isolate | FKS2 | F659Y | Single substitution | Not available | Not available | Not available | Structure not available | Anidulafungin (1), Caspofungin (0.5), Micafungin (0.25) | 2019 | 31481447 |
| ISOLATE 11 | C. glabrata | Clinical isolate | FKS2 | F659Y | Single substitution | Not available | Not available | Not available | Structure not available | Anidulafungin (1), Caspofungin (2), Micafungin (0.25) | 2019 | 31481447 |
| ISOLATE 12 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Not available | Not available | Not available | Structure not available | Anidulafungin (2), Caspofungin (2), Micafungin (0.5) | 2019 | 31481447 |
| ISOLATE 13 | C. glabrata | Clinical isolate | FKS2 | S663F | Single substitution | Not available | Not available | Not available | Structure not available | Anidulafungin (0.5), Caspofungin (0.25), Micafungin (0.125) | 2019 | 31481447 |
| ISOLATE 14 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Not available | Not available | Not available | Structure not available | Anidulafungin (0.5), Caspofungin (1), Micafungin (2) | 2019 | 31481447 |
| ISOLATE 15 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Not available | Not available | Not available | Structure not available | Anidulafungin (4), Caspofungin (>16), Micafungin (4) | 2019 | 31481447 |
| ISOLATE 16 | C. glabrata | Clinical isolate | FKS1FKS2 | R631GD666V | Single substitutionSingle substitution | Not availableNot available | Not availableNot available | Not availableNot available |  | Anidulafungin (0.5), Caspofungin (0.25), Micafungin (0.5) | 2019 | 31481447 |
| ISOLATE 17 | C. glabrata | Clinical isolate | FKS1 | R631G | Single substitution | Not available | Not available | Not available | Structure not available | Anidulafungin (0.25), Caspofungin (0.25), Micafungin (0.5) | 2019 | 31481447 |
| ISOLATE 18 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Not available | Not available | Not available | Structure not available | Anidulafungin (4), Caspofungin (8), Micafungin (2) | 2019 | 31481447 |
| ISOLATE 19 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Not available | Not available | Not available | Structure not available | Anidulafungin (2), Caspofungin (1), Micafungin (2) | 2019 | 31481447 |
| ISOLATE 2 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Not available | Not available | Not available | Structure not available | Anidulafungin (2), Caspofungin (4), Micafungin (2) | 2019 | 31481447 |
| ISOLATE 20 | C. glabrata | Clinical isolate | FKS1 | R631G | Single substitution | Not available | Not available | Not available | Structure not available | Anidulafungin (0.06), Caspofungin (0.125), Micafungin (0.25) | 2019 | 31481447 |
| ISOLATE 21 | C. glabrata | Clinical isolate | FKS1 | R631G | Single substitution | Not available | Not available | Not available | Structure not available | Anidulafungin (0.25), Caspofungin (0.5), Micafungin (1) | 2019 | 31481447 |
| ISOLATE 22 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Not available | Not available | Not available | Structure not available | Anidulafungin (2), Caspofungin (>16), Micafungin (2) | 2019 | 31481447 |
| ISOLATE 23 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Not available | Not available | Not available | Structure not available | Anidulafungin (2), Caspofungin (>16), Micafungin (2) | 2019 | 31481447 |
| ISOLATE 24 | C. glabrata | Clinical isolate | FKS1 | S629P | Single substitution | Not available | Not available | Not available | Structure not available | Anidulafungin (2), Caspofungin (8), Micafungin (1) | 2019 | 31481447 |
| ISOLATE 25 | C. glabrata | Clinical isolate | FKS2 | S663F | Single substitution | Not available | Not available | Not available | Structure not available | Anidulafungin (2), Caspofungin (2), Micafungin (0.25) | 2019 | 31481447 |
| ISOLATE 28 | C. glabrata | Clinical isolate | FKS1 | S629P | Single substitution | Not available | Not available | Not available | Structure not available | Anidulafungin (0.5), Caspofungin (0.5), Micafungin (0.125) | 2019 | 31481447 |
| ISOLATE 29 | C. glabrata | Clinical isolate | FKS1 | R631G | Single substitution | Not available | Not available | Not available | Structure not available | Anidulafungin (0.06), Caspofungin (0.125), Micafungin (0.25) | 2019 | 31481447 |
| ISOLATE 3 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Not available | Not available | Not available | Structure not available | Anidulafungin (4), Caspofungin (>16), Micafungin (4) | 2019 | 31481447 |
| ISOLATE 30 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Not available | Not available | Not available | Structure not available | Anidulafungin (4), Caspofungin (>16), Micafungin (2) | 2019 | 31481447 |
| ISOLATE 31 | C. glabrata | Clinical isolate | FKS1 | S629P | Single substitution | Not available | Not available | Not available | Structure not available | Anidulafungin (0.5), Caspofungin (0.125), Micafungin (0.125) | 2019 | 31481447 |
| ISOLATE 33 | C. glabrata | Clinical isolate | FKS2 | del658F | Deletion | Not available | Not available | Not available | Structure not available | Anidulafungin (0.5), Caspofungin (0.5), Micafungin (0.25) | 2019 | 31481447 |
| ISOLATE 36 | C. glabrata | Clinical isolate | FKS1FKS2 | R631GS663P | Single substitutionSingle substitution | Not availableNot available | Not availableNot available | Not availableNot available |  | Anidulafungin (2), Caspofungin (16), Micafungin (4) | 2019 | 31481447 |
| ISOLATE 37 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Not available | Not available | Not available | Structure not available | Anidulafungin (4), Caspofungin (16), Micafungin (2) | 2019 | 31481447 |
| ISOLATE 38 | C. glabrata | Clinical isolate | FKS1FKS2 | S629PD666V | Single substitutionSingle substitution | Not availableNot available | Not availableNot available | Not availableNot available |  | Anidulafungin (2), Caspofungin (4), Micafungin (1) | 2019 | 31481447 |
| ISOLATE 39 | C. glabrata | Clinical isolate | FKS2 | del658F | Deletion | Not available | Not available | Not available | Structure not available | Anidulafungin (4), Caspofungin (16), Micafungin (>16) | 2019 | 31481447 |
| ISOLATE 4 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Not available | Not available | Not available | Structure not available | Anidulafungin (2), Caspofungin (8), Micafungin (4) | 2019 | 31481447 |
| ISOLATE 40 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Not available | Not available | Not available | Structure not available | Anidulafungin (1), Caspofungin (2), Micafungin (1) | 2019 | 31481447 |
| ISOLATE 41 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Not available | Not available | Not available | Structure not available | Anidulafungin (4), Caspofungin (16), Micafungin (4) | 2019 | 31481447 |
| ISOLATE 42 | C. glabrata | Clinical isolate | FKS1 | D632V | Single substitution | Not available | Not available | Not available | Structure not available | Anidulafungin (1), Caspofungin (1), Micafungin (0.25) | 2019 | 31481447 |
| ISOLATE 45 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Not available | Not available | Not available | Structure not available | Anidulafungin (1), Caspofungin (16), Micafungin (2) | 2019 | 31481447 |
| ISOLATE 48 | C. glabrata | Clinical isolate | FKS1FKS2 | S629PD666V | Single substitutionSingle substitution | Not availableNot available | Not availableNot available | Not availableNot available |  | Anidulafungin (0.125), Caspofungin (0.125), Micafungin (0.5) | 2019 | 31481447 |
| ISOLATE 5 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Not available | Not available | Not available | Structure not available | Anidulafungin (0.5), Caspofungin (16), Micafungin (4) | 2019 | 31481447 |
| ISOLATE 50 | C. glabrata | Clinical isolate | FKS1FKS2 | S629TF659Y | Single substitutionSingle substitution | Not availableNot available | Not availableNot available | Not availableNot available |  | Anidulafungin (2), Caspofungin (4), Micafungin (0.125) | 2019 | 31481447 |
| ISOLATE 53 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Not available | Not available | Not available | Structure not available | Anidulafungin (4), Caspofungin (>16), Micafungin (2) | 2019 | 31481447 |
| ISOLATE 54 | C. glabrata | Clinical isolate | FKS1 | I634V | Single substitution | Not available | Not available | Not available | Structure not available | Anidulafungin (0.03), Caspofungin (0.06), Micafungin (0.25) | 2019 | 31481447 |
| ISOLATE 55 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Not available | Not available | Not available | Structure not available | Anidulafungin (2), Caspofungin (8), Micafungin (2) | 2019 | 31481447 |
| ISOLATE 57 | C. glabrata | Clinical isolate | FKS2 | F659Y | Single substitution | Not available | Not available | Not available | Structure not available | Anidulafungin (1), Caspofungin (2), Micafungin (0.25) | 2019 | 31481447 |
| ISOLATE 59 | C. glabrata | Clinical isolate | FKS2 | F659Y | Single substitution | Not available | Not available | Not available | Structure not available | Anidulafungin (0.5), Caspofungin (1), Micafungin (0.25) | 2019 | 31481447 |
| ISOLATE 6 | C. glabrata | Clinical isolate | FKS2 | P667H | Single substitution | Not available | Not available | Not available | Structure not available | Anidulafungin (2), Caspofungin (2), Micafungin (0.25) | 2019 | 31481447 |
| ISOLATE 61 | C. glabrata | Clinical isolate | FKS1 | D632Y | Single substitution | Not available | Not available | Not available | Structure not available | Anidulafungin (1), Caspofungin (2), Micafungin (0.25) | 2019 | 31481447 |
| ISOLATE 62 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Not available | Not available | Not available | Structure not available | Anidulafungin (2), Caspofungin (8), Micafungin (1) | 2019 | 31481447 |
| ISOLATE 63 | C. glabrata | Clinical isolate | FKS1FKS2 | S629PD666V | Single substitutionSingle substitution | Not availableNot available | Not availableNot available | Not availableNot available |  | Anidulafungin (1), Caspofungin (2), Micafungin (1) | 2019 | 31481447 |
| ISOLATE 67 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Not available | Not available | Not available | Structure not available | Anidulafungin (2), Caspofungin (8), Micafungin (2) | 2019 | 31481447 |
| ISOLATE 68 | C. glabrata | Clinical isolate | FKS1 | S629P | Single substitution | Not available | Not available | Not available | Structure not available | Anidulafungin (2), Caspofungin (2), Micafungin (0.5) | 2019 | 31481447 |
| ISOLATE 69 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Not available | Not available | Not available | Structure not available | Anidulafungin (2), Caspofungin (8), Micafungin (1) | 2019 | 31481447 |
| ISOLATE 7 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Not available | Not available | Not available | Structure not available | Anidulafungin (2), Caspofungin (16), Micafungin (4) | 2019 | 31481447 |
| ISOLATE 70 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Not available | Not available | Not available | Structure not available | Anidulafungin (2), Caspofungin (8), Micafungin (1) | 2019 | 31481447 |
| ISOLATE 71 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Not available | Not available | Not available | Structure not available | Anidulafungin (2), Caspofungin (>16), Micafungin (4) | 2019 | 31481447 |
| ISOLATE 72 | C. glabrata | Clinical isolate | FKS1 | S629P | Single substitution | Not available | Not available | Not available | Structure not available | Anidulafungin (2), Caspofungin (16), Micafungin (4) | 2019 | 31481447 |
| ISOLATE 73 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Not available | Not available | Not available | Structure not available | Anidulafungin (1), Caspofungin (8), Micafungin (1) | 2019 | 31481447 |
| ISOLATE 74 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Not available | Not available | Not available | Structure not available | Anidulafungin (1), Caspofungin (8), Micafungin (1) | 2019 | 31481447 |
| ISOLATE 75 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Not available | Not available | Not available | Structure not available | Anidulafungin (4), Caspofungin (>16), Micafungin (4) | 2019 | 31481447 |
| ISOLATE 76 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Not available | Not available | Not available | Structure not available | Anidulafungin (2), Caspofungin (4), Micafungin (2) | 2019 | 31481447 |
| ISOLATE 80 | C. glabrata | Clinical isolate | FKS1FKS2 | S629PS663P | Single substitutionSingle substitution | Not availableNot available | Not availableNot available | Not availableNot available |  | Anidulafungin (1), Caspofungin (8), Micafungin (1) | 2019 | 31481447 |
| ISOLATE 82 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Not available | Not available | Not available | Structure not available | Anidulafungin (2), Caspofungin (4), Micafungin (2) | 2019 | 31481447 |
| ISOLATE 84 | C. glabrata | Clinical isolate | FKS1 | S629P | Single substitution | Not available | Not available | Not available | Structure not available | Anidulafungin (4), Caspofungin (8), Micafungin (2) | 2019 | 31481447 |
| ISOLATE 85 | C. glabrata | Clinical isolate | FKS1 | S629P | Single substitution | Not available | Not available | Not available | Structure not available | Anidulafungin (2), Caspofungin (>16), Micafungin (2) | 2019 | 31481447 |
| ISOLATE 86 | C. glabrata | Clinical isolate | FKS2 | del658F | Deletion | Not available | Not available | Not available | Structure not available | Anidulafungin (2), Caspofungin (>16), Micafungin (2) | 2019 | 31481447 |
| ISOLATE 87 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Not available | Not available | Not available | Structure not available | Anidulafungin (1), Caspofungin (4), Micafungin (1) | 2019 | 31481447 |
| ISOLATE 88 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Not available | Not available | Not available | Structure not available | Anidulafungin (2), Caspofungin (>16), Micafungin (1) | 2019 | 31481447 |
| ISOLATE 9 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Not available | Not available | Not available | Structure not available | Anidulafungin (4), Caspofungin (>16), Micafungin (4) | 2019 | 31481447 |
| ISOLATE 90 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Not available | Not available | Not available | Structure not available | Anidulafungin (2), Caspofungin (4), Micafungin (1) | 2019 | 31481447 |
| Alberta 2014 | C. glabrata | Clinical isolate | FKS1FKS2 | S629PS663P | Single substitutionSingle substitution | Q6FTN8Q6FMZ3 | 18631897 | ModelModel |  | Micafungin (2) | 2019 | 31505645 |
| Alberta 2016 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Micafungin (0.5) | 2019 | 31505645 |
| British Columbia 2013-1 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Micafungin (4) | 2019 | 31505645 |
| British Columbia 2013-2 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Micafungin (0.5) | 2019 | 31505645 |
| Manitoba 2014 | C. glabrata | Clinical isolate | FKS1 | S629P | Single substitution | Q6FTN8 | 1863 | Model |  | Micafungin (1) | 2019 | 31505645 |
| Brazil | C. tropicalis | Clinical isolate | FKS1 | F650S | Single substitution | C5M4K6 | 1640 | Model | Mismatch residue | Anidulafungin (1), Caspofungin (2), Micafungin (1) | 2020 | 31520783 |
| CA, USA | C. parapsilosis | Clinical isolate | FKS2ERG11 | Y657del, F658YY132F | ComplexSingle substitution | Q6FMZ3C7EXA5 | 1897522 | ModelAF-C7EXA5-F1 |  | Anidulafungin (1), Caspofungin (0.5), Micafungin (0.25) Fluconazole (32) | 2020 | 31520783 |
| CO, USA | C. tropicalis | Clinical isolate | FKS2FKS1 | F659SS654P | Single substitutionSingle substitution | Q6FMZ3C5M4K6 | 18971640 | ModelModel |  | Anidulafungin (1), Caspofungin (1), Micafungin (0.25) Anidulafungin (1), Caspofungin (>8), Micafungin (2) | 2020 | 31520783 |
| Czech Republic | C. tropicalis | Clinical isolate | MDR1 | E133D | Single substitution | C5MAA0 | 552 | AF-C5MAA0-F1 |  | Fluconazole (16), Voriconazole (1) | 2020 | 31520783 |
| France | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (2), Caspofungin (0.5), Micafungin (0.5) | 2020 | 31520783 |
| France-2016 | C. tropicalis | Clinical isolate | MDR1 | V76A | Single substitution | C5MAA0 | 552 | AF-C5MAA0-F1 |  | Fluconazole (8) | 2020 | 31520783 |
| France-2017 | C. parapsilosis | Clinical isolate | ERG11 | Y132F | Single substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (32) | 2020 | 31520783 |
| IN, USA | C. parapsilosis | Clinical isolate | ERG11 | Y132F | Single substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (32) | 2020 | 31520783 |
| Ireland | C. parapsilosis | Clinical isolate | ERG11MDR1 | R398II396V | Single substitutionSingle substitution | C7EXA5G8B987 | 522558 | AF-C7EXA5-F1AF-G8B987-F1 |  | Fluconazole (8) | 2020 | 31520783 |
| Ireland1 | C. albicans | Clinical isolate | FKS1 | S645P | Single substitution | A0A1D8PCT0 | 1897 | AF-A0A1D8PCT0-F1 |  | Caspofungin (1), Micafungin (1) | 2020 | 31520783 |
| Ireland2 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (0.5) | 2020 | 31520783 |
| Ireland3 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (4), Caspofungin (2), Micafungin (0.5) | 2020 | 31520783 |
| Italy | C. albicans | Clinical isolate | FKS1 | S645P | Single substitution | A0A1D8PCT0 | 1897 | AF-A0A1D8PCT0-F1 |  | Anidulafungin (1), Caspofungin (4), Micafungin (2) | 2020 | 31520783 |
| Italy-2016-1 | C. parapsilosis | Clinical isolate | ERG11 | Y132F | Single substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (32) | 2020 | 31520783 |
| Italy-2016-2 | C. parapsilosis | Clinical isolate | CDR1ERG11MDR1 | S79NY132F, R398II396V | Single substitutionDouble substitutionSingle substitution | G8BJB0C7EXA5G8B987 | 1504522558 | ModelAF-C7EXA5-F1AF-G8B987-F1 |  | Fluconazole (128), Voriconazole (1) | 2020 | 31520783 |
| Italy-2016-2017 | C. parapsilosis | Clinical isolate | ERG11 | Y132F | Single substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (32-64) | 2020 | 31520783 |
| Italy-2017-1 | C. parapsilosis | Clinical isolate | ERG11 | Y132F | Single substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (8) | 2020 | 31520783 |
| Italy-2017-2 | C. parapsilosis | Clinical isolate | ERG11 | Y132F | Single substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (16) | 2020 | 31520783 |
| Mexico | C. glabrata | Clinical isolate | FKS1 | S625S | Single substitution | Q6FTN8 | 1863 | Model | Mismatch residue | Anidulafungin (0.5) | 2020 | 31520783 |
| NY, USA | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (2), Caspofungin (1), Micafungin (1) | 2020 | 31520783 |
| Spain1 | C. glabrata | Clinical isolate | FKS2 | Y657del, F658Y | Complex | Q6FMZ3 | 1897 | Model |  | Anidulafungin (1), Caspofungin (0.5), Micafungin (0.25) | 2020 | 31520783 |
| Spain2 | C. glabrata | Clinical isolate | FKS2 | Y657del, F658Y | Complex | Q6FMZ3 | 1897 | Model |  | Anidulafungin (1), Caspofungin (0.25), Micafungin (0.25) | 2020 | 31520783 |
| Thailand-2016-1 | C. tropicalis | Clinical isolate | ERG11 | Y132F, S154F | Double substitution | Q58J66 | 528 | AF-Q58J66-F1 |  | Fluconazole (32), Voriconazole (1) | 2020 | 31520783 |
| Thailand-2016-2 | C. tropicalis | Clinical isolate | ERG11 | Y132F, S154F | Double substitution | Q58J66 | 528 | AF-Q58J66-F1 |  | Fluconazole (64), Voriconazole (4) | 2020 | 31520783 |
| Thailand-2017 | C. tropicalis | Clinical isolate | ERG11 | Y132F, S154F | Double substitution | Q58J66 | 528 | AF-Q58J66-F1 |  | Fluconazole (32), Voriconazole (1) | 2020 | 31520783 |
| Turkey | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (2), Caspofungin (1), Micafungin (1) | 2020 | 31520783 |
| TX, USA | C. parapsilosis | Clinical isolate | ERG11 | Y132F | Single substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (8) | 2020 | 31520783 |
| VA, USA | C. glabrata | Clinical isolate | FKS2 | F658del | Deletion | Q6FMZ3 | 1897 | Model |  | Anidulafungin (0.5) | 2020 | 31520783 |
| WA, USA | C. glabrata | Clinical isolate | FKS1FKS2 | S629PR665G | Single substitutionSingle substitution | Q6FTN8Q6FMZ3 | 18631897 | ModelModel |  | Anidulafungin (1), Caspofungin (0.5), Micafungin (1) | 2020 | 31520783 |
| Cg | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Fluconazole (>256), Caspofungin (16), Anidulafungin (4), Micafungin (2), Voriconazole (16), Posaconazole (>8), Itraconazole (>16), Amphotericin B (1) | 2019 | 31545778 |
| ca01 | C. auris | Clinical isolate | ERG11 | Y132F | Single substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 |  | Fluconazole (256), Caspofungin (≥8), Amphotericin B (2) | 2019 | 31600556 |
| ca02 | C. auris | Clinical isolate | ERG11 | K143R | Single substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 |  | Fluconazole (>256), Amphotericin B (2) | 2019 | 31600556 |
| ca03 | C. auris | Clinical isolate | ERG11 | Y132F | Single substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 |  | Fluconazole (>256), Amphotericin B (2) | 2019 | 31600556 |
| ca04 | C. auris | Clinical isolate | ERG11 | Y132F | Single substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 |  | Fluconazole (256) | 2019 | 31600556 |
| ca06 | C. auris | Clinical isolate | ERG11 | K143R | Single substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 |  | Fluconazole (256) | 2019 | 31600556 |
| C. albicans 90028 strain 4.15 | C. albicans | Laboratory strain | GWT1 | V162A | Single substitution | Q873N2 | 485 | AF-Q873N2-F1 |  | Manogepix (0.25) | 2019 | 31611349 |
| C. glabrata 2001 strain 5.1 | C. glabrata | Laboratory strain | GWT1 | V163A | Single substitution | Q6FLH2 | 486 | AF-Q6FLH2-F1 |  | Manogepix (1) | 2019 | 31611349 |
| C. glabrata 2001 strain 5.2 | C. glabrata | Laboratory strain | GWT1 | V163A | Single substitution | Q6FLH2 | 486 | AF-Q6FLH2-F1 |  | Manogepix (1) | 2019 | 31611349 |
| C. glabrata 2001 strain 5.3 | C. glabrata | Laboratory strain | GWT1 | V163A | Single substitution | Q6FLH2 | 486 | AF-Q6FLH2-F1 |  | Manogepix (1) | 2019 | 31611349 |
| C. glabrata 2001 strain 5.4 | C. glabrata | Laboratory strain | GWT1 | V163A | Single substitution | Q6FLH2 | 486 | AF-Q6FLH2-F1 |  | Manogepix (1) | 2019 | 31611349 |
| C. glabrata 2001 strain RNP1 | C. glabrata | Laboratory strain | GWT1 | V163A | Single substitution | Q6FLH2 | 486 | AF-Q6FLH2-F1 |  | Manogepix (1) | 2019 | 31611349 |
| ISOLATE51 | C. albicans | Clinical isolate | MRR2 | A459T, S480P | Double substitution | A0A411I718 | 710 | AF-A0A411I718-F1 | Mismatch residue | Fluconazole (64) | 2020 | 31705810 |
| ISOLATE52 | C. albicans | Clinical isolate | MRR2 | H31Y | Single substitution | A0A411I718 | 710 | AF-A0A411I718-F1 |  | Fluconazole (64) | 2020 | 31705810 |
| ISOLATE54 | C. albicans | Clinical isolate | MRR2 | T145A, S165N | Double substitution | A0A411I718 | 710 | AF-A0A411I718-F1 | Mismatch residue | Fluconazole (64) | 2020 | 31705810 |
| ISOLATE57 | C. albicans | Clinical isolate | MRR2 | T386I | Single substitution | A0A411I718 | 710 | AF-A0A411I718-F1 |  | Fluconazole (64) | 2020 | 31705810 |
| ISOLATE58 | C. albicans | Clinical isolate | MRR2 | A459T, S480P | Double substitution | A0A411I718 | 710 | AF-A0A411I718-F1 | Mismatch residue | Fluconazole (64) | 2020 | 31705810 |
| ISOLATE59 | C. albicans | Clinical isolate | MRR2 | L144V, T145A, S165N, S480P | Multiple substitution | A0A411I718 | 710 | AF-A0A411I718-F1 | Mismatch residue | Fluconazole (64) | 2020 | 31705810 |
| ISOLATE66 | C. albicans | Clinical isolate | MRR2 | S165N, A459T | Double substitution | A0A411I718 | 710 | AF-A0A411I718-F1 |  | Fluconazole (64) | 2020 | 31705810 |
| ISOLATE67 | C. albicans | Clinical isolate | MRR2 | S165N, A459T | Double substitution | A0A411I718 | 710 | AF-A0A411I718-F1 |  | Fluconazole (64) | 2020 | 31705810 |
| ISOLATE68 | C. albicans | Clinical isolate | MRR2 | T145A, S165N | Double substitution | A0A411I718 | 710 | AF-A0A411I718-F1 | Mismatch residue | Fluconazole (64) | 2020 | 31705810 |
| ISOLATE69 | C. albicans | Clinical isolate | MRR2 | L144V, T145A, S165N | Multiple substitution | A0A411I718 | 710 | AF-A0A411I718-F1 | Mismatch residue | Fluconazole (64) | 2020 | 31705810 |
| ISOLATE70 | C. albicans | Clinical isolate | MRR2 | L144V, T145A, S165N, A459T, S480P | Multiple substitution | A0A411I718 | 710 | AF-A0A411I718-F1 | Mismatch residue | Fluconazole (64) | 2020 | 31705810 |
| ISOLATE72 | C. albicans | Clinical isolate | MRR2 | T386I | Single substitution | A0A411I718 | 710 | AF-A0A411I718-F1 |  | Fluconazole (64) | 2020 | 31705810 |
| ISOLATE73 | C. albicans | Clinical isolate | MRR2 | T83A, T145A, S165N, S480P | Multiple substitution | A0A411I718 | 710 | AF-A0A411I718-F1 | Mismatch residue | Fluconazole (64) | 2020 | 31705810 |
| ISOLATE74 | C. albicans | Clinical isolate | MRR2 | T145A | Single substitution | A0A411I718 | 710 | AF-A0A411I718-F1 | Mismatch residue | Fluconazole (64) | 2020 | 31705810 |
| CRISPR-31 | C. glabrata | Laboratory strain | FKS2 | E655K | Single substitution | Q6FMZ3 | 1897 | Model |  | Caspofungin (0.25), Micafungin (0.25), Anidulafungin (0.25) | 2019 | 31711370 |
| fks1del/Fks2-E655K | C. glabrata | Laboratory strain | FKS2 | E655K | Single substitution | Q6FMZ3 | 1897 | Model |  | Caspofungin (8), Micafungin (16), Anidulafungin (8) | 2019 | 31711370 |
| L74 | C. glabrata | Clinical isolate | FKS1FKS2 | W508stopE655K | StopSingle substitution | Q6FTN8Q6FMZ3 | 18631897 | ModelModel |  | Caspofungin (16), Micafungin (16), Anidulafungin (8) | 2019 | 31711370 |
| isolate 28 | C. albicans | Clinical isolate | ERG3 | W219C | Single substitution | Q59VG6 | 386 | AF-Q59VG6-F1 | Mismatch residue | Fluconazole (64), Itraconazole (16), Voriconazole (8) | 2019 | 31762516 |
| isolate 6 | C. albicans | Clinical isolate | ERG3 | R352H | Single substitution | Q59VG6 | 386 | AF-Q59VG6-F1 | Mismatch residue | Fluconazole (64), Itraconazole (4), Voriconazole (8) | 2019 | 31762516 |
| isolate 89 | C. albicans | Clinical isolate | ERG3 | W219C | Single substitution | Q59VG6 | 386 | AF-Q59VG6-F1 | Mismatch residue | Fluconazole (64), Itraconazole (1), Voriconazole (16) | 2019 | 31762516 |
| CK | C. krusei | Clinical isolate | FKS1 | L701M | Single substitution | Q4U2W2 | 1885 | Model |  | Anidulafungin (2), Micafungin (1) | 2020 | 31782486 |
| 113-2BC | C. tropicalis | Clinical isolate | UPC2 | T241A | Single substitution | C5MAR7 | 782 | AF-C5MAR7-F1 |  | Fluconazole (8) | 2020 | 31828316 |
| 262E | C. tropicalis | Clinical isolate | TAC1UPC2 | R47Q, N164IQ340H, T381S | Double substitutionDouble substitution | C5MGV3C5MAR7 | 943782 | AF-C5MGV3-F1AF-C5MAR7-F1 |  | Fluconazole (64), Voriconazole (4), Itraconazole (16) | 2020 | 31828316 |
| 527E | C. tropicalis | Clinical isolate | MRR1TAC1 | T255PR47Q, N164I | Single substitutionDouble substitution | C5M9V7C5MGV3 | 1150943 | AF-C5M9V7-F1AF-C5MGV3-F1 |  | Fluconazole (8), Voriconazole (1) | 2020 | 31828316 |
| 99-BC | C. tropicalis | Clinical isolate | MRR1 | A647S | Single substitution | C5M9V7 | 1150 | AF-C5M9V7-F1 |  | Fluconazole (8), Voriconazole (1) | 2020 | 31828316 |
| CEC4503 | C. albicans | Clinical isolate | ERG11TAC1 | D9V, R157KH263Y, H839Y, C858Y | Double substitutionMultiple substitution | P10613A0A1D8PN96 | 528981 | 5V5ZAF-A0A1D8PN96-F1 |  | Fluconazole (>256), Itraconazole (>32), Voriconazole (>2) | 2020 | 31923309 |
| CEC4504 | C. albicans | Clinical isolate | ERG11TAC1 | R157KH263Y, H839Y, C858Y | Single substitutionMultiple substitution | P10613A0A1D8PN96 | 528981 | 5V5ZAF-A0A1D8PN96-F1 |  | Fluconazole (24), Itraconazole (4) | 2020 | 31923309 |
| CEC4515 | C. albicans | Clinical isolate | ERG11TAC1UPC2 | Y132HH263Y, P971SG648D | Single substitutionDouble substitutionSingle substitution | P10613A0A1D8PN96Q59QC7 | 528981712 | 5V5ZAF-A0A1D8PN96-F1AF-Q59QC7-F1 |  | Fluconazole (>256), Itraconazole (>32), Voriconazole (>32) | 2020 | 31923309 |
| CEC4516 | C. albicans | Clinical isolate | ERG11TAC1 | Y132HH263Y, P971S | Single substitutionDouble substitution | P10613A0A1D8PN96 | 528981 | 5V5ZAF-A0A1D8PN96-F1 |  | Fluconazole (>256), Itraconazole (>32), Voriconazole (>32) | 2020 | 31923309 |
| CEC4521 | C. albicans | Clinical isolate | ERG11TAC1UPC2 | Y132H, R467IH263Y, P971SD654N | Double substitutionDouble substitutionSingle substitution | P10613A0A1D8PN96Q59QC7 | 528981712 | 5V5ZAF-A0A1D8PN96-F1AF-Q59QC7-F1 |  | Fluconazole (>256), Itraconazole (>12), Voriconazole (>4) | 2020 | 31923309 |
| CEC4522 | C. albicans | Clinical isolate | ERG11TAC1UPC2 | Y132H, R467IH263Y, P971SD654N | Double substitutionDouble substitutionSingle substitution | P10613A0A1D8PN96Q59QC7 | 528981712 | 5V5ZAF-A0A1D8PN96-F1AF-Q59QC7-F1 |  | Fluconazole (>256), Itraconazole (>32), Voriconazole (>12) | 2020 | 31923309 |
| CEC4524 | C. albicans | Clinical isolate | ERG11TAC1UPC2 | Y64H, T123I, Y132H, R467IH263Y, P971SD654N | Multiple substitutionDouble substitutionSingle substitution | P10613A0A1D8PN96Q59QC7 | 528981712 | 5V5ZAF-A0A1D8PN96-F1AF-Q59QC7-F1 |  | Fluconazole (>256), Itraconazole (>32), Voriconazole (>3), Caspofungin (0.5) | 2020 | 31923309 |
| CEC4527 | C. albicans | Clinical isolate | ERG11TAC1 | G448EA736T, N823K, C858Y | Single substitutionMultiple substitution | P10613A0A1D8PN96 | 528981 | 5V5ZAF-A0A1D8PN96-F1 |  | Fluconazole (>8), Itraconazole (>3) | 2020 | 31923309 |
| CEC718 | C. albicans | Clinical isolate | ERG11TAC1UPC2 | Y132H, P236S, S405FA736TG657D | Multiple substitutionSingle substitutionSingle substitution | P10613A0A1D8PN96Q59QC7 | 528981712 | 5V5ZAF-A0A1D8PN96-F1AF-Q59QC7-F1 |  | Fluconazole (>128), Voriconazole (1), Posaconazole (0.25), Itraconazole (1) | 2020 | 31923309 |
| CEC723 | C. albicans | Clinical isolate | ERG11TAC1 | P30S, S405FA790V | Double substitutionSingle substitution | P10613A0A1D8PN96 | 528981 | 5V5ZAF-A0A1D8PN96-F1 |  | Fluconazole (16), Itraconazole (1) | 2020 | 31923309 |
| CK21 | C. krusei | Clinical isolate | ERG11 | A122S | Single substitution | A9YUC7 | 528 | AF-A9YUC7-F1 |  | Voriconazole (8) | 2020 | 31932372 |
| CK24 | C. krusei | Clinical isolate | ERG11 | Y140H | Single substitution | A9YUC7 | 528 | AF-A9YUC7-F1 |  | Voriconazole (4) | 2020 | 31932372 |
| CK32 | C. krusei | Clinical isolate | ERG11 | A122V | Single substitution | A9YUC7 | 528 | AF-A9YUC7-F1 |  | Voriconazole (2), Posaconazole (2) | 2020 | 31932372 |
| CK42 | C. krusei | Clinical isolate | ERG11 | A364V, Y140H | Double substitution | A9YUC7 | 528 | AF-A9YUC7-F1 |  | Voriconazole (4) | 2020 | 31932372 |
| Ca1 | C. auris | Clinical isolate | FKS1FKS1 | S645PS639F | Single substitutionSingle substitution | A0A1D8PCT0A0A2H1A4W2 | 18971888 | AF-A0A1D8PCT0-F1Model |  | Rezafungin (1), Anidulafungin (0.25), Micafungin (2) Rezafungin (16), Anidulafungin (4), Micafungin (>32), Fluconazole (>256) | 2020 | 32015032 |
| Ca2 | C. auris | Clinical isolate | FKS1FKS1 | D648YS639F | Single substitutionSingle substitution | A0A1D8PCT0A0A2H1A4W2 | 18971888 | AF-A0A1D8PCT0-F1Model |  | Rezafungin (0.5), Anidulafungin (0.06), Micafungin (0.125) Rezafungin (16), Anidulafungin (>32), Micafungin (>32), Fluconazole (>256) | 2020 | 32015032 |
| Ca3 | C. auris | Clinical isolate | FKS1FKS1 | P1354SS639F | Single substitutionSingle substitution | A0A1D8PCT0A0A2H1A4W2 | 18971888 | AF-A0A1D8PCT0-F1Model |  | Rezafungin (0.5), Anidulafungin (0.06), Micafungin (0.125), Fluconazole (>64) Rezafungin (8), Anidulafungin (>32), Micafungin (>32), Fluconazole (>256) | 2020 | 32015032 |
| Ca4 | C. albicans | Clinical isolate | FKS1 | P1354S | Single substitution | A0A1D8PCT0 | 1897 | AF-A0A1D8PCT0-F1 |  | Rezafungin (0.25), Micafungin (0.06), Fluconazole (>32) | 2020 | 32015032 |
| Ca5 | C. albicans | Clinical isolate | FKS1 | P1354S | Single substitution | A0A1D8PCT0 | 1897 | AF-A0A1D8PCT0-F1 |  | Rezafungin (0.25), Micafungin (0.06), Fluconazole (64) | 2020 | 32015032 |
| Ca6 | C. albicans | Clinical isolate | FKS1 | P1354S | Single substitution | A0A1D8PCT0 | 1897 | AF-A0A1D8PCT0-F1 |  | Rezafungin (0.25), Micafungin (0.06), Fluconazole (>64) | 2020 | 32015032 |
| Ca7 | C. albicans | Clinical isolate | FKS1 | P1354S | Single substitution | A0A1D8PCT0 | 1897 | AF-A0A1D8PCT0-F1 |  | Rezafungin (0.25), Anidulafungin (0.06), Micafungin (0.06), Fluconazole (64) | 2020 | 32015032 |
| Ca8 | C. albicans | Clinical isolate | FKS1 | R1361S | Single substitution | A0A1D8PCT0 | 1897 | AF-A0A1D8PCT0-F1 |  | Rezafungin (0.25), Anidulafungin (0.06), Micafungin (0.125) | 2020 | 32015032 |
| Ca9 | C. albicans | Clinical isolate | FKS1 | R1361G | Single substitution | A0A1D8PCT0 | 1897 | AF-A0A1D8PCT0-F1 |  | Rezafungin (0.25), Anidulafungin (0.06), Micafungin (0.125) | 2020 | 32015032 |
| Cd1 | C. dubliniensis | Clinical isolate | FKS1 | S645P | Single substitution | B9W729 | 1897 | Model | Structure not available | Rezafungin (2), Anidulafungin (0.25), Micafungin (2) | 2020 | 32015032 |
| Cd2 | C. dubliniensis | Clinical isolate | FKS1 | S645P | Single substitution | B9W729 | 1897 | Model | Structure not available | Rezafungin (1), Anidulafungin (0.25), Micafungin (2) | 2020 | 32015032 |
| Cg1 | C. glabrata | Clinical isolate | FKS1FKS2 | L630QS663F | Single substitutionSingle substitution | Q6FTN8Q6FMZ3 | 18631897 | ModelModel |  | Rezafungin (2), Anidulafungin (1), Micafungin (0.5) | 2020 | 32015032 |
| Cg2 | C. glabrata | Clinical isolate | FKS2 | S663F | Single substitution | Q6FMZ3 | 1897 | Model |  | Rezafungin (2), Anidulafungin (1), Micafungin (0.5) | 2020 | 32015032 |
| Cg3 | C. glabrata | Clinical isolate | FKS2 | S663F | Single substitution | Q6FMZ3 | 1897 | Model |  | Rezafungin (1), Anidulafungin (0.25), Micafungin (0.125) | 2020 | 32015032 |
| Cg4 | C. glabrata | Clinical isolate | FKS2 | S663F | Single substitution | Q6FMZ3 | 1897 | Model |  | Rezafungin (0.5), Anidulafungin (0.25), Micafungin (0.125) | 2020 | 32015032 |
| Cg5 | C. glabrata | Clinical isolate | FKS2 | S663F | Single substitution | Q6FMZ3 | 1897 | Model |  | Rezafungin (0.5), Micafungin (0.06) | 2020 | 32015032 |
| Cg6 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Rezafungin (0.5), Anidulafungin (0.125), Micafungin (0.125) | 2020 | 32015032 |
| Cg7 | C. glabrata | Clinical isolate | FKS1FKS2 | Y1429XY658N | Single substitutionSingle substitution | Q6FTN8Q6FMZ3 | 18631897 | ModelModel |  | Rezafungin (0.5), Anidulafungin (0.125), Micafungin (0.06), Fluconazole (>32) | 2020 | 32015032 |
| Cg8 | C. glabrata | Clinical isolate | FKS1FKS2 | Y1429XL664Q | Single substitutionSingle substitution | Q6FTN8Q6FMZ3 | 18631897 | ModelModel |  | Rezafungin (0.5), Anidulafungin (0.125), Micafungin (0.06), Fluconazole (>32) | 2020 | 32015032 |
| Cg9 | C. glabrata | Clinical isolate | FKS2 | F659del | Deletion | Q6FMZ3 | 1897 | Model |  | Rezafungin (0.5), Micafungin (0.06), Fluconazole (>64) | 2020 | 32015032 |
| Ck | C. krusei | Clinical isolate | FKS1 | S659F | Single substitution | Q4U2W2 | 1885 | Model |  | Rezafungin (1), Anidulafungin (0.25), Micafungin (4) | 2020 | 32015032 |
| Ct1 | C. tropicalis | Clinical isolate | FKS1 | F650S | Single substitution | B6S6L8 | 1904 | Model |  | Rezafungin (1), Anidulafungin (0.25), Micafungin (1) | 2020 | 32015032 |
| Ct2 | C. tropicalis | Clinical isolate | FKS1 | S654P | Single substitution | B6S6L8 | 1904 | Model |  | Rezafungin (2), Anidulafungin (2), Micafungin (2) | 2020 | 32015032 |
| 1015009 | C. glabrata | Clinical isolate | FKS2 | Y657del, F658Y | Complex | Q6FMZ3 | 1897 | Model |  | Rezafungin (0.5), Anidulafungin (1), Caspofungin (0.5), Micafungin (0.25) | 2020 | 32015043 |
| 1021070 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Rezafungin (1), Anidulafungin (2), Caspofungin (0.5)Micafungin90.5) | 2020 | 32015043 |
| 1025460 | C. glabrata | Clinical isolate | FKS1FKS2 | S629PR665G | Single substitutionSingle substitution | Q6FTN8Q6FMZ3 | 18631897 | ModelModel |  | Rezafungin (0.5), Anidulafungin (1), Caspofungin (0.5), Micafungin (1) | 2020 | 32015043 |
| 1026179 | C. glabrata | Clinical isolate | FKS2 | Y657del, F658Y | Complex | Q6FMZ3 | 1897 | Model |  | Rezafungin (1), Anidulafungin (10, Caspofungin (0.25), Micafungin (0.25) | 2020 | 32015043 |
| 1034513 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Rezafungin (2), Anidulafungin (4), Caspofungin (2), Micafungin (0.5) | 2020 | 32015043 |
| 1034514 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Rezafungin (0.25), Anidulafungin (0.5), Caspofungin (0.12), Micafungin (0.12) | 2020 | 32015043 |
| 1051641 | C. glabrata | Clinical isolate | FKS2 | F659del | Deletion | Q6FMZ3 | 1897 | Model |  | Rezafungin (1), Anidulafungin (1), Caspofungin (1), Micafungin (0.5) | 2020 | 32015043 |
| 1078854 | C. glabrata | Clinical isolate | FKS2 | F659del | Deletion | Q6FMZ3 | 1897 | Model |  | Rezafungin (0.06), Anidulafungin (0.06), Caspofungin (0.06), Micafungin (0.06) | 2020 | 32015043 |
| 1078861 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Rezafungin (2), Anidulafungin (2), Caspofungin (1), Micafungin (1) | 2020 | 32015043 |
| 1087598 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Rezafungin (2), Anidulafungin (4), Caspofungin (4), Micafungin (4) | 2020 | 32015043 |
| 970382 | C. glabrata | Clinical isolate | FKS1 | S629P | Single substitution | Q6FTN8 | 1863 | Model |  | Rezafungin (0.25), Anidulafungin (0.25), Caspofungin (0.12), Micafungin (0.12) | 2020 | 32015043 |
| 970388 | C. tropicalis | Clinical isolate | FKS1 | S645P | Single substitution | B6S6L8 | 1904 | Model | Mismatch residue | Rezafungin (2), Anidulafungin (1), Caspofungin (>8), Micafungin (2) | 2020 | 32015043 |
| 970397 | C. glabrata | Clinical isolate | FKS2 | P667H | Single substitution | Q6FMZ3 | 1897 | Model |  | Rezafungin (0.12), Anidulafungin (0.25), Caspofungin (0.25), Micafungin (0.12) | 2020 | 32015043 |
| 974239 | C. glabrata | Clinical isolate | FKS1 | S629P | Single substitution | Q6FTN8 | 1863 | Model |  | Rezafungin (0.25), Anidulafungin (0.25), Caspofungin (0.06), Micafungin (0.12) | 2020 | 32015043 |
| 974249 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Rezafungin (2), Anidulafungin (20), Caspofungin (10), Micafungin (1) | 2020 | 32015043 |
| 977041 | C. tropicalis | Clinical isolate | FKS1 | F650S | Single substitution | B6S6L8 | 1904 | Model |  | Rezafungin (1), Anidulafungin (1), Caspofungin (2), Micafungin (1) | 2020 | 32015043 |
| 983007 | C. glabrata | Clinical isolate | FKS2 | F658del | Deletion | Q6FMZ3 | 1897 | Model |  | Rezafungin (0.12), Anidulafungin (0.5), Caspofungin (0.06), Micafungin (0.12) | 2020 | 32015043 |
| 984357 | C. albicans | Clinical isolate | FKS1 | S645P | Single substitution | O13428 | 1897 | Model |  | Rezafungin (0.25), Anidulafungin (0.12), Caspofungin (1), Micafungin (1) | 2020 | 32015043 |
| 985673 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Rezafungin (0.06), Anidulafungin (0.12), Caspofungin (0.06), Micafungin (0.06) | 2020 | 32015043 |
| 997524 | C. glabrata | Clinical isolate | FKS1 | F625S | Single substitution | Q6FTN8 | 1863 | Model |  | Rezafungin (0.5), Anidulafungin (0.5), Caspofungin (0.25), Micafungin (0.06) | 2020 | 32015043 |
| Index case 1 | C. tropicalis | Clinical isolate | FKS1 | S654P | Single substitution | B6S6L8 | 1904 | Model |  | Anidulafungin (1), Caspofungin (4), Micafungin (2), Fluconazole (128) | 2020 | 32024039 |
| Index case 2 | C. tropicalis | Clinical isolate | FKS1 | S654P | Single substitution | B6S6L8 | 1904 | Model |  | Anidulafungin (2), Caspofungin (16), Micafungin (4) | 2020 | 32024039 |
| Ct10 | C. tropicalis | Clinical isolate | ERG11 | G464S | Single substitution | C5MGS9 | 528 | AF-C5MGS9-F1 |  | Fluconazole (128) | 2020 | 32084606 |
| Ct16 | C. tropicalis | Clinical isolate | ERG11 | Y132F, S154F | Double substitution | C5MGS9 | 528 | AF-C5MGS9-F1 |  | Fluconazole (128) | 2020 | 32084606 |
| C. albicans LC191 | C. albicans | Laboratory strain | ZCF29 | W986L | Single substitution | A0A1D8PRB7 | 1105 | AF-A0A1D8PRB7-F1 |  | Beauvericin (100) | 2020 | 32179530 |
| RPCA14 | C. albicans | Clinical isolate | ERG11 | A317T | Single substitution | Q9P4W0 | 528 | AF-Q9P4W0-F1 |  | Fluconazole (>128) | 2020 | 32219719 |
| RPCA30 | C. albicans | Clinical isolate | ERG11 | V437I | Single substitution | Q9P4W0 | 528 | AF-Q9P4W0-F1 |  | Fluconazole (>128) | 2020 | 32219719 |
| RPCA4 | C. albicans | Clinical isolate | ERG11 | D266D | Single substitution | Q9P4W0 | 528 | AF-Q9P4W0-F1 | Mismatch residue | Fluconazole (32) | 2020 | 32219719 |
| RPCA41 | C. albicans | Clinical isolate | ERG11 | V437I | Single substitution | Q9P4W0 | 528 | AF-Q9P4W0-F1 |  | Fluconazole (>128) | 2020 | 32219719 |
| RPCA45 | C. albicans | Clinical isolate | ERG11 | F145L | Single substitution | Q9P4W0 | 528 | AF-Q9P4W0-F1 |  | Fluconazole (64) | 2020 | 32219719 |
| RPCA47 | C. albicans | Clinical isolate | ERG11 | F145L | Single substitution | Q9P4W0 | 528 | AF-Q9P4W0-F1 |  | Fluconazole (>128) | 2020 | 32219719 |
| RPCA6 | C. albicans | Clinical isolate | ERG11 | V437I | Single substitution | Q9P4W0 | 528 | AF-Q9P4W0-F1 |  | Fluconazole (>128) | 2020 | 32219719 |
| RPCA61 | C. albicans | Clinical isolate | ERG11 | G129R | Single substitution | Q9P4W0 | 528 | AF-Q9P4W0-F1 |  | Fluconazole (>128) | 2020 | 32219719 |
| RPCA9 | C. albicans | Clinical isolate | ERG11 | Y132C, F145L, A114V | Multiple substitution | Q9P4W0 | 528 | AF-Q9P4W0-F1 | Structure not available | Fluconazole (64) | 2020 | 32219719 |
| Kw164/15 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | EUCAST[Micafungin (2)], Etest[Micafungin (0.125), Caspofungin (0.75), Fluconazole (64)] | 2020 | 32277126 |
| Kw2138/17 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | EUCAST[Micafungin (0.25)], Etest[Micafungin (0.25)] | 2020 | 32277126 |
| Kw3554/16 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | EUCAST[Micafungin (1)], ETEST[Micafungin (0.125)] | 2020 | 32277126 |
| Kw3646/15 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | EUCAST[Micafungin (2)], Etest[Micafungin (0.125), Caspofungin (0.75)] | 2020 | 32277126 |
| Kw458/16 | C. glabrata | Clinical isolate | FKS2 | F659del | Deletion | Q6FMZ3 | 1897 | Model |  | EUCAST[Micafungin (2)], Etest[Micafungin (0.125), Caspofungin (0.75)] | 2020 | 32277126 |
| Ca1 | C. auris | Clinical isolate | ERG11 | Y132F, K143R | Double substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 |  | Azole | 2020 | 32345637 |
| Ca2 | C. auris | Clinical isolate | ERG11 | F126L, V125A | Double substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 |  | Fluconazole (>=32) | 2020 | 32345637 |
| Ca3 | C. auris | Clinical isolate | FKS1 | S639P | Single substitution | A0A2H1A4W2 | 1888 | Model |  | Micafungin (>=4 ) | 2020 | 32345637 |
| Ca4 | C. auris | Clinical isolate | FKS1 | S639F | Single substitution | A0A2H1A4W2 | 1888 | Model |  | Micafungin (>=4 ) | 2020 | 32345637 |
| Ca5 | C. auris | Clinical isolate | FKS1 | S639Y | Single substitution | A0A2H1A4W2 | 1888 | Model |  | Micafungin (>=4 ) | 2020 | 32345637 |
| G103 | C. glabrata | Clinical isolate | FKS2PDR1 | S663PS76P, L98S, T143P, 226-Ins_KLTQAVN-227 | Single substitutionComplex | Q6FMZ3Q6FXU7 | 18971107 | ModelAF-Q6FXU7-F1 |  | Fluconazole (64), Micafungin (0.125), Anidulafungin (0.25) | 2020 | 32413170 |
| G107 | C. glabrata | Clinical isolate | PDR1 | S76P, L98S, T143P, F439I, D554E, E590D, P927R | Multiple substitution | Q6FXU7 | 1107 | AF-Q6FXU7-F1 |  | Fluconazole (64) | 2020 | 32413170 |
| G29 | C. glabrata | Clinical isolate | FKS1PDR1 | S629PS76P, L98S, T143P, E590D | Single substitutionMultiple substitution | Q6FTN8Q6FXU7 | 18631107 | ModelAF-Q6FXU7-F1 |  | Anidulafungin (0.064) | 2020 | 32413170 |
| G51 | C. glabrata | Clinical isolate | PDR1 | S76P, L98S, T143P | Multiple substitution | Q6FXU7 | 1107 | AF-Q6FXU7-F1 |  | Fluconazole (32) | 2020 | 32413170 |
| G53 | C. glabrata | Clinical isolate | FKS2PDR1 | S663PL98S, D243N | Single substitutionDouble substitution | Q6FMZ3Q6FXU7 | 18971107 | ModelAF-Q6FXU7-F1 |  | Fluconazole (64), Anidulafungin (0.064) | 2020 | 32413170 |
| G55 | C. glabrata | Clinical isolate | PDR1 | S76P, L98S, T143P, N768I | Multiple substitution | Q6FXU7 | 1107 | AF-Q6FXU7-F1 |  | Fluconazole (64) | 2020 | 32413170 |
| G6 | C. glabrata | Clinical isolate | PDR1 | S76P, L98S, T143P, P695R | Multiple substitution | Q6FXU7 | 1107 | AF-Q6FXU7-F1 |  | Fluconazole (>64) | 2020 | 32413170 |
| G98 | C. glabrata | Clinical isolate | PDR1 | L98S, D243N, L281V, E590D | Multiple substitution | Q6FXU7 | 1107 | AF-Q6FXU7-F1 |  | Fluconazole (32) | 2020 | 32413170 |
| wild 2 | C. glabrata | Clinical isolate | PDR1 | L280F | Single substitution | Q6FXU7 | 1107 | AF-Q6FXU7-F1 |  | Fluconazole (128), Voriconazole (0.5), Itraconazole (0.5) | 2020 | 32563123 |
| wild 4 | C. glabrata | Clinical isolate | PDR1 | L344S | Single substitution | Q6FXU7 | 1107 | AF-Q6FXU7-F1 |  | Fluconazole (64), Voriconazole (0.5), Itraconazole (0.5) | 2020 | 32563123 |
| wild 6 | C. glabrata | Clinical isolate | PDR1 | G346D | Single substitution | Q6FXU7 | 1107 | AF-Q6FXU7-F1 |  | Fluconazole (64), Voriconazole (1), Itraconazole (2) | 2020 | 32563123 |
| 52015 | C. glabrata | Clinical isolate | PDR1 | Y1094H | Single substitution | Q66WF3 | 1107 | AF-Q66WF3-F1 |  | Fluconazole (>64) | 2020 | 32571826 |
| 56530 | C. glabrata | Clinical isolate | PDR1 | P76S, P143T, D243N | Multiple substitution | Q66WF3 | 1107 | AF-Q66WF3-F1 |  | Caspofungin (0.5) | 2020 | 32571826 |
| 60089 | C. glabrata | Clinical isolate | FKS1 | S629P | Single substitution | Q6FTN8 | 1863 | Model |  | Micafungin (1), Caspofungin (8) | 2020 | 32571826 |
| 61000 | C. glabrata | Clinical isolate | PDR1 | E555D | Single substitution | Q66WF3 | 1107 | AF-Q66WF3-F1 |  | Caspofungin (0.5) | 2020 | 32571826 |
| 61169 | C. glabrata | Clinical isolate | PDR1 | G493D | Single substitution | Q66WF3 | 1107 | AF-Q66WF3-F1 |  | Caspofungin (0.5) | 2020 | 32571826 |
| 61186 | C. glabrata | Clinical isolate | PDR1 | G493D | Single substitution | Q66WF3 | 1107 | AF-Q66WF3-F1 |  | Caspofungin (0.5) | 2020 | 32571826 |
| 61193 | C. glabrata | Clinical isolate | PDR1 | W1098C | Single substitution | Q66WF3 | 1107 | AF-Q66WF3-F1 |  | Caspofungin (0.5) | 2020 | 32571826 |
| 61756 | C. glabrata | Clinical isolate | PDR1 | T370I | Single substitution | Q66WF3 | 1107 | AF-Q66WF3-F1 |  | Caspofungin (0.5), Fluconazole (>64) | 2020 | 32571826 |
| 64679 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Caspofungin (1) | 2020 | 32571826 |
| 64680 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Caspofungin (1) | 2020 | 32571826 |
| 64683 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Caspofungin (1) | 2020 | 32571826 |
| 64684 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Caspofungin (1) | 2020 | 32571826 |
| 64685 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Caspofungin (1) | 2020 | 32571826 |
| 64686 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Micafungin (2), Caspofungin (2) | 2020 | 32571826 |
| 64687 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Caspofungin (0.5) | 2020 | 32571826 |
| 64688 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Caspofungin (0.5) | 2020 | 32571826 |
| 64689 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Micafungin (2), Caspofungin (8) | 2020 | 32571826 |
| 64903 | C. glabrata | Clinical isolate | PDR1 | L139I | Single substitution | Q66WF3 | 1107 | AF-Q66WF3-F1 |  | Caspofungin (0.5) | 2020 | 32571826 |
| 64904 | C. glabrata | Clinical isolate | PDR1 | L139I | Single substitution | Q66WF3 | 1107 | AF-Q66WF3-F1 |  | Caspofungin (0.5) | 2020 | 32571826 |
| 64905 | C. glabrata | Clinical isolate | PDR1 | L139I | Single substitution | Q66WF3 | 1107 | AF-Q66WF3-F1 |  | Caspofungin (0.5) | 2020 | 32571826 |
| Episode 1st | C. glabrata | Clinical isolate | FKS1FKS1FKS1FKS2FKS2 | R1361GS645PS645PF659stopS663P | Single substitutionSingle substitutionSingle substitutionStopSingle substitution | O13428O13428O13428Q6FMZ3Q6FMZ3 | 18971897189718971897 | ModelModelModelModelModel |  | Anidulafungin (2), Micafungin (1), Caspofungin (1) Anidulafungin (2), Micafungin (4), Caspofungin (8) Anidulafungin (2), Micafungin (4), Caspofungin (>16) Anidulafungin (4), Micafungin (4), Caspofungin (16) | 2020 | 32661647 |
| Episode 2nd | C. glabrata | Clinical isolate | FKS1FKS2FKS2 | S645PS629PS663P | Single substitutionSingle substitutionSingle substitution | O13428Q6FMZ3Q6FMZ3 | 189718971897 | ModelModelModel |  | Anidulafungin (2), Micafungin (2), Caspofungin (4) Micafungin (4), Caspofungin (16) Anidulafungin (4), Micafungin (4), Caspofungin (>16) | 2020 | 32661647 |
| 101FS | C. parapsilosis | Clinical isolate | ERG11UPC2 | Y132F, K143RL38I, A793S | Double substitutionDouble substitution | C7EXA5G8BCU0 | 522847 | AF-C7EXA5-F1AF-G8BCU0-F1 |  | Fluconazole (>32) Voriconazole (1) | 2020 | 32690638 |
| 106FS | C. parapsilosis | Clinical isolate | ERG11UPC2 | Y132F, K143RA793S | Double substitutionSingle substitution | C7EXA5G8BCU0 | 522847 | AF-C7EXA5-F1AF-G8BCU0-F1 |  | Fluconazole (>32), Voriconazole (1) | 2020 | 32690638 |
| 107FS | C. parapsilosis | Clinical isolate | ERG11TAC1 | Y132F, K143RA21V | Double substitutionSingle substitution | C7EXA5G8B8R4 | 522347 | AF-C7EXA5-F1AF-G8B8R4-F1 |  | Fluconazole (>32), Voriconazole (1) | 2020 | 32690638 |
| 108FS | C. parapsilosis | Clinical isolate | ERG11TAC1 | Y132FA21V | Single substitutionSingle substitution | C7EXA5G8B8R4 | 522347 | AF-C7EXA5-F1AF-G8B8R4-F1 |  | Fluconazole (8) | 2020 | 32690638 |
| 10P | C. parapsilosis | Clinical isolate | ERG11UPC2 | G458S, T519AA793S | Double substitutionSingle substitution | C7EXA5G8BCU0 | 522847 | AF-C7EXA5-F1AF-G8BCU0-F1 |  | Fluconazole (16) | 2020 | 32690638 |
| 112FS | C. parapsilosis | Clinical isolate | ERG11TAC1UPC2 | K143RA21VA793S | Single substitutionSingle substitutionSingle substitution | C7EXA5G8B8R4G8BCU0 | 522347847 | AF-C7EXA5-F1AF-G8B8R4-F1AF-G8BCU0-F1 |  | Fluconazole (>32) | 2020 | 32690638 |
| 15FS | C. parapsilosis | Clinical isolate | ERG11UPC2 | Y132F, K143RA793S | Double substitutionSingle substitution | C7EXA5G8BCU0 | 522847 | AF-C7EXA5-F1AF-G8BCU0-F1 |  | Fluconazole (>32), Voriconazole (2) | 2020 | 32690638 |
| 15P | C. parapsilosis | Clinical isolate | ERG11UPC2 | Y132FA793S | Single substitutionSingle substitution | C7EXA5G8BCU0 | 522847 | AF-C7EXA5-F1AF-G8BCU0-F1 |  | Fluconazole (8) | 2020 | 32690638 |
| 19P | C. parapsilosis | Clinical isolate | ERG11 | Y132F | Single substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (8) | 2020 | 32690638 |
| 1R | C. parapsilosis | Clinical isolate | ERG11UPC2 | Y132F, K143RL38I | Double substitutionSingle substitution | C7EXA5G8BCU0 | 522847 | AF-C7EXA5-F1AF-G8BCU0-F1 |  | Fluconazole (>32), Voriconazole (2) | 2020 | 32690638 |
| 22R | C. parapsilosis | Clinical isolate | UPC2 | G342S | Single substitution | G8BCU0 | 847 | AF-G8BCU0-F1 |  | Fluconazole (16) | 2020 | 32690638 |
| 25P | C. parapsilosis | Clinical isolate | ERG11MRR1TAC1 | Y132FG427VP150H | Single substitutionSingle substitutionSingle substitution | C7EXA5G8BAV4G8B8R4 | 5221128347 | AF-C7EXA5-F1AF-G8BAV4-F1AF-G8B8R4-F1 |  | Fluconazole (8) | 2020 | 32690638 |
| 26R | C. parapsilosis | Clinical isolate | ERG11MRR1TAC1 | Q250K, R398I, G458SP295L, Q1074stopL390I | Multiple substitutionComplexSingle substitution | C7EXA5G8BAV4G8B8R4 | 5221128347 | AF-C7EXA5-F1AF-G8BAV4-F1AF-G8B8R4-F1 |  | Fluconazole (16) | 2020 | 32690638 |
| 2P | C. parapsilosis | Clinical isolate | ERG11TAC1UPC2 | Y132FL578MA793S | Single substitutionSingle substitutionSingle substitution | C7EXA5G8B8R4G8BCU0 | 522347847 | AF-C7EXA5-F1AF-G8B8R4-F1AF-G8BCU0-F1 |  | Fluconazole (8) | 2020 | 32690638 |
| 30P | C. parapsilosis | Clinical isolate | ERG11 | Y132F | Single substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (16) | 2020 | 32690638 |
| 30R | C. parapsilosis | Clinical isolate | ERG11 | Y132F, K143R | Double substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (>32), Voriconazole (1) | 2020 | 32690638 |
| 31P | C. parapsilosis | Clinical isolate | ERG11 | G458S | Single substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (>32), Voriconazole (1) | 2020 | 32690638 |
| 34R | C. parapsilosis | Clinical isolate | ERG11TAC1 | R398IG490R | Single substitutionSingle substitution | C7EXA5G8B8R4 | 522347 | AF-C7EXA5-F1AF-G8B8R4-F1 |  | Fluconazole (32) | 2020 | 32690638 |
| 35P | C. parapsilosis | Clinical isolate | ERG11 | Y132F, G307A | Double substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (>32), Voriconazole (2) | 2020 | 32690638 |
| 36P | C. parapsilosis | Clinical isolate | ERG11 | G458S | Single substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (16) | 2020 | 32690638 |
| 37P | C. parapsilosis | Clinical isolate | ERG11 | Y132F | Single substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (>32) | 2020 | 32690638 |
| 37R | C. parapsilosis | Clinical isolate | ERG11 | R398I | Single substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (>32) | 2020 | 32690638 |
| 38R | C. parapsilosis | Clinical isolate | ERG11TAC1 | R398IG490R, S760R, A761G | Single substitutionMultiple substitution | C7EXA5G8B8R4 | 522347 | AF-C7EXA5-F1AF-G8B8R4-F1 |  | Fluconazole (>32) | 2020 | 32690638 |
| 3P | C. parapsilosis | Clinical isolate | ERG11TAC1UPC2 | Y132FN7Y, L578MA793S | Single substitutionDouble substitutionSingle substitution | C7EXA5G8B8R4G8BCU0 | 522347847 | AF-C7EXA5-F1AF-G8B8R4-F1AF-G8BCU0-F1 |  | Fluconazole (8) | 2020 | 32690638 |
| 40P | C. parapsilosis | Clinical isolate | ERG11UPC2 | Y132FL38I | Single substitutionSingle substitution | C7EXA5G8BCU0 | 522847 | AF-C7EXA5-F1AF-G8BCU0-F1 |  | Fluconazole (16) | 2020 | 32690638 |
| 41P | C. parapsilosis | Clinical isolate | ERG11UPC2 | Y132FA793S | Single substitutionSingle substitution | C7EXA5G8BCU0 | 522847 | AF-C7EXA5-F1AF-G8BCU0-F1 |  | Fluconazole (8) | 2020 | 32690638 |
| 41R | C. parapsilosis | Clinical isolate | ERG11UPC2 | Y132F, K143RL38I | Double substitutionSingle substitution | C7EXA5G8BCU0 | 522847 | AF-C7EXA5-F1AF-G8BCU0-F1 |  | Fluconazole (32) | 2020 | 32690638 |
| 42P | C. parapsilosis | Clinical isolate | ERG11UPC2 | Y132FE7stop | Single substitutionStop | C7EXA5G8BCU0 | 522847 | AF-C7EXA5-F1AF-G8BCU0-F1 |  | Fluconazole (8) | 2020 | 32690638 |
| 43P | C. parapsilosis | Clinical isolate | ERG11 | Y132F, K143R | Double substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (>32), Voriconazole (1) | 2020 | 32690638 |
| 43R | C. parapsilosis | Clinical isolate | ERG11UPC2 | K143RL38I | Single substitutionSingle substitution | C7EXA5G8BCU0 | 522847 | AF-C7EXA5-F1AF-G8BCU0-F1 |  | Fluconazole (16) | 2020 | 32690638 |
| 45P | C. parapsilosis | Clinical isolate | ERG11 | Y132F | Single substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (8) | 2020 | 32690638 |
| 47P | C. parapsilosis | Clinical isolate | ERG11UPC2 | Y132FP45H | Single substitutionSingle substitution | C7EXA5G8BCU0 | 522847 | AF-C7EXA5-F1AF-G8BCU0-F1 |  | Fluconazole (8) | 2020 | 32690638 |
| 49P | C. parapsilosis | Clinical isolate | ERG11 | Y132F, G307A | Double substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (>32), Voriconazole (2) | 2020 | 32690638 |
| 50P | C. parapsilosis | Clinical isolate | ERG11UPC2 | Y132FP45H, A793S | Single substitutionDouble substitution | C7EXA5G8BCU0 | 522847 | AF-C7EXA5-F1AF-G8BCU0-F1 |  | Fluconazole (8) | 2020 | 32690638 |
| 50R | C. parapsilosis | Clinical isolate | ERG11UPC2 | Y132F, K143RL38I | Double substitutionSingle substitution | C7EXA5G8BCU0 | 522847 | AF-C7EXA5-F1AF-G8BCU0-F1 |  | Fluconazole (>32), Voriconazole (1) | 2020 | 32690638 |
| 54P | C. parapsilosis | Clinical isolate | ERG11TAC1 | Y132F, K143RQ965K, M966V | Double substitutionDouble substitution | C7EXA5G8B8R4 | 522347 | AF-C7EXA5-F1AF-G8B8R4-F1 |  | Fluconazole (>32), Voriconazole (1) | 2020 | 32690638 |
| 55P | C. parapsilosis | Clinical isolate | MRR1 | L419F | Single substitution | G8BAV4 | 1128 | AF-G8BAV4-F1 |  | Fluconazole (8) | 2020 | 32690638 |
| 56FS | C. parapsilosis | Clinical isolate | ERG11 | Y132F | Single substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (>32), Voriconazole (1) | 2020 | 32690638 |
| 59FS | C. parapsilosis | Clinical isolate | ERG11 | Y132F, K143R | Double substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (>32), Voriconazole (1) | 2020 | 32690638 |
| 59P | C. parapsilosis | Clinical isolate | ERG11UPC2 | Y132FQ372H | Single substitutionSingle substitution | C7EXA5G8BCU0 | 522847 | AF-C7EXA5-F1AF-G8BCU0-F1 |  | Fluconazole (8) | 2020 | 32690638 |
| 5FS | C. parapsilosis | Clinical isolate | ERG11UPC2 | Y132FL38I, A793S | Single substitutionDouble substitution | C7EXA5G8BCU0 | 522847 | AF-C7EXA5-F1AF-G8BCU0-F1 |  | Fluconazole (>32) | 2020 | 32690638 |
| 60P | C. parapsilosis | Clinical isolate | ERG11MRR1TAC1 | Y132FQ1027RD603V, P803L | Single substitutionSingle substitutionDouble substitution | C7EXA5G8BAV4G8B8R4 | 5221128347 | AF-C7EXA5-F1AF-G8BAV4-F1AF-G8B8R4-F1 |  | Fluconazole (8) | 2020 | 32690638 |
| 65P | C. parapsilosis | Clinical isolate | ERG11UPC2 | G458SQ371H | Single substitutionSingle substitution | C7EXA5G8BCU0 | 522847 | AF-C7EXA5-F1AF-G8BCU0-F1 |  | Fluconazole (16) | 2020 | 32690638 |
| 67FS | C. parapsilosis | Clinical isolate | ERG11 | Y132F | Single substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (32) | 2020 | 32690638 |
| 68FS | C. parapsilosis | Clinical isolate | ERG11 | Y132F, K143R | Double substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (32) | 2020 | 32690638 |
| 69FS | C. parapsilosis | Clinical isolate | ERG11UPC2 | Y132F, K143RL38I, A793S | Double substitutionDouble substitution | C7EXA5G8BCU0 | 522847 | AF-C7EXA5-F1AF-G8BCU0-F1 |  | Fluconazole (>32) Voriconazole (1) | 2020 | 32690638 |
| 6FS | C. parapsilosis | Clinical isolate | ERG11UPC2 | Y132F, K143RL38I, A793S | Double substitutionDouble substitution | C7EXA5G8BCU0 | 522847 | AF-C7EXA5-F1AF-G8BCU0-F1 |  | Fluconazole (>32), Voriconazole (1) | 2020 | 32690638 |
| 75P | C. parapsilosis | Clinical isolate | ERG11MRR1 | Y132FQ1027R | Single substitutionSingle substitution | C7EXA5G8BAV4 | 5221128 | AF-C7EXA5-F1AF-G8BAV4-F1 |  | Fluconazole (8) | 2020 | 32690638 |
| 77P | C. parapsilosis | Clinical isolate | ERG11UPC2 | Y132F, G307AL38I, Q371H | Double substitutionDouble substitution | C7EXA5G8BCU0 | 522847 | AF-C7EXA5-F1AF-G8BCU0-F1 |  | Fluconazole (16) | 2020 | 32690638 |
| 7P | C. parapsilosis | Clinical isolate | ERG11MRR1 | Y132F, K143RL926stop | Double substitutionStop | C7EXA5G8BAV4 | 5221128 | AF-C7EXA5-F1AF-G8BAV4-F1 |  | Fluconazole (>32) | 2020 | 32690638 |
| 81P | C. parapsilosis | Clinical isolate | ERG11MRR1 | Y132F, K143RG472V | Double substitutionSingle substitution | C7EXA5G8BAV4 | 5221128 | AF-C7EXA5-F1AF-G8BAV4-F1 |  | Fluconazole (>32) | 2020 | 32690638 |
| 87P | C. parapsilosis | Clinical isolate | ERG11UPC2 | Y132F, K143RP45H | Double substitutionSingle substitution | C7EXA5G8BCU0 | 522847 | AF-C7EXA5-F1AF-G8BCU0-F1 |  | Fluconazole (>32), Voriconazole (1) | 2020 | 32690638 |
| 91P | C. parapsilosis | Clinical isolate | ERG11 | G458S | Single substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (16) | 2020 | 32690638 |
| 94FS | C. parapsilosis | Clinical isolate | ERG11UPC2 | Y132FL38I, A793S | Single substitutionDouble substitution | C7EXA5G8BCU0 | 522847 | AF-C7EXA5-F1AF-G8BCU0-F1 |  | Fluconazole (>32) | 2020 | 32690638 |
| 96P | C. parapsilosis | Clinical isolate | ERG11 | Y132F, K143R | Double substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (>32), Voriconazole (1) | 2020 | 32690638 |
| 97FS | C. parapsilosis | Clinical isolate | ERG11 | Y132F | Single substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (32) | 2020 | 32690638 |
| 9P | C. parapsilosis | Clinical isolate | ERG11UPC2 | Y132FA793S | Single substitutionSingle substitution | C7EXA5G8BCU0 | 522847 | AF-C7EXA5-F1AF-G8BCU0-F1 |  | Fluconazole (>32), Voriconazole (2) | 2020 | 32690638 |
| CG Isolate 2 | C. glabrata | Clinical isolate | FKS2 | F659Y, I1333F | Double substitution | Q6FMZ3 | 1897 | Model | Mismatch residue | Anidulafungin (2), Caspofungin (8), Micafungin (8), Fluconazole (8) | 2020 | 32899996 |
| FMR 14602 | C. tropicalis | Clinical isolate | ERG11 | D448G | Single substitution | P14263 | 528 | AF-P14263-F1 | Mismatch residue | MIC90[Voriconazole (16), Posaconazole (0.25), Itraconazole (8)] | 2020 | 33077654 |
| FMR 14603 | C. tropicalis | Clinical isolate | ERG11 | D445V | Single substitution | P14263 | 528 | AF-P14263-F1 | Mismatch residue | MIC90[Voriconazole (2), Posaconazole (0.5), Itraconazole (2)] | 2020 | 33077654 |
| FMR 8898 | C. tropicalis | Clinical isolate | ERG11 | L403-V528del | Deletion | P14263 | 528 | AF-P14263-F1 | Structure not available | MIC90[Voriconazole (16), Posaconazole (>16), Itraconazole (16)] | 2020 | 33077654 |
| 123 | C. tropicalis | Clinical isolate | ERG11 | R245K | Double substitution | P14263 | 528 | AF-P14263-F1 | Structure not available | Fluconazole (256) | 2020 | 33123116 |
| 30 | C. tropicalis | Clinical isolate | ERG11 | Y132F, S154F | Double substitution | P14263 | 528 | AF-P14263-F1 |  | Fluconazole (64), Voriconazole (2) | 2020 | 33123116 |
| 31 | C. tropicalis | Clinical isolate | ERG11 | Y132F, S154F | Double substitution | P14263 | 528 | AF-P14263-F1 |  | Fluconazole (32), Voriconazole (1) | 2020 | 33123116 |
| MICR1 | C. parapsilosis | Clinical isolate | FKS1 | R658G | Single substitution | A9YLC3 | 1909 | Model |  | Micafungin (>8) | 2021 | 33175162 |
| MICR2 | C. parapsilosis | Clinical isolate | ERG11FKS1 | Y132F, K143RR658G | Double substitutionSingle substitution | G8B9T3A9YLC3 | 5221909 | AF-G8B9T3-F1Model |  | Micafungin (>8), Fluconazole (32) | 2021 | 33175162 |
| MICR3 | C. parapsilosis | Clinical isolate | ERG11FKS1 | Y132F, K143RR658G | Double substitutionSingle substitution | G8B9T3A9YLC3 | 5221909 | AF-G8B9T3-F1Model |  | Micafungin (>8), Fluconazole (32) | 2021 | 33175162 |
| MICR4 | C. parapsilosis | Clinical isolate | ERG11FKS1 | Y132F, K143RR658G | Double substitutionSingle substitution | G8B9T3A9YLC3 | 5221909 | AF-G8B9T3-F1Model |  | Micafungin (>8), Fluconazole (32) | 2021 | 33175162 |
| All isolates | C. auris | Clinical isolate | ERG11 | Y132F | Single substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 |  | Fluconazole (64), Voriconazole (4), Itraconazole (4), Posaconazole (2) | 2020 | 33233388 |
| PATIENT C18 | C. auris | Clinical isolate | ERG11FKS1 | Y132FF635del | Single substitutionDeletion | A0A2H1A309A0A0L0P0U2 | 5241888 | AF-A0A2H1A309-F1Model |  | Fluconazole (64), Voriconazole (4), Itraconazole (4), Posaconazole (2), Echinocandin | 2020 | 33233388 |
| PATIENT C5 | C. auris | Clinical isolate | ERG11FKS1 | Y132F, K143RS639F | Double substitutionSingle substitution | A0A2H1A309A0A0L0P0U2 | 5241888 | AF-A0A2H1A309-F1Model |  | Fluconazole (64), Voriconazole (4), Itraconazole (4), Posaconazole (2), Echinocandin | 2020 | 33233388 |
| isoalte 78 | C. parapsilosis | Clinical isolate | ERG11 | Y132F | Single substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (8) | 2021 | 33305313 |
| isolate 23 | C. parapsilosis | Clinical isolate | ERG11 | Y132F | Single substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (32), Voriconazole (2) | 2021 | 33305313 |
| isolate 44 | C. parapsilosis | Clinical isolate | ERG11 | Y132F | Single substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (16), Voriconazole (0.5) | 2021 | 33305313 |
| isolate 47 | C. parapsilosis | Clinical isolate | ERG11 | Y132F | Single substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (32), Voriconazole (0.5) | 2021 | 33305313 |
| isolate 67 | C. parapsilosis | Clinical isolate | ERG11 | Y132F | Single substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (32) | 2021 | 33305313 |
| isolate 68 | C. parapsilosis | Clinical isolate | ERG11 | Y132F | Single substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (16) | 2021 | 33305313 |
| isolate 76 | C. parapsilosis | Clinical isolate | ERG11 | Y132F | Single substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (16), Voriconazole (1) | 2021 | 33305313 |
| CA1 | C. auris | Clinical isolate | ERG11 | F132Y, K143R | Double substitution | A0A2H4QC40 | 524 | AF-A0A2H4QC40-F1 |  | Fluconazole (16) | 2020 | 33396402 |
| CA3 | C. auris | Clinical isolate | ERG11 | F132Y, K143R | Double substitution | A0A2H4QC40 | 524 | AF-A0A2H4QC40-F1 |  | Fluconazole (32) | 2020 | 33396402 |
| CA4 | C. auris | Clinical isolate | ERG11 | F132Y, K143R | Double substitution | A0A2H4QC40 | 524 | AF-A0A2H4QC40-F1 |  | Fluconazole (32) | 2020 | 33396402 |
| CA5 | C. auris | Clinical isolate | ERG11 | F132Y, K143R | Double substitution | A0A2H4QC40 | 524 | AF-A0A2H4QC40-F1 |  | Fluconazole (32) | 2020 | 33396402 |
| CA7 | C. auris | Clinical isolate | ERG11 | F132Y, K143R | Double substitution | A0A2H4QC40 | 524 | AF-A0A2H4QC40-F1 |  | Fluconazole (32) | 2020 | 33396402 |
| CA8 | C. auris | Clinical isolate | ERG11 | F132Y, K143R | Double substitution | A0A2H4QC40 | 524 | AF-A0A2H4QC40-F1 |  | Fluconazole (8) | 2020 | 33396402 |
| NCCPF ID 420189 | C. tropicalis | Clinical isolate | ERG11 | Y132F, S154F | Double substitution | C5MGS9 | 528 | AF-C5MGS9-F1 |  | Fluconazole (128), Voriconazole (4) | 2021 | 33439909 |
| NCCPF ID 420227 | C. tropicalis | Clinical isolate | ERG11 | Y132F, S154F | Double substitution | C5MGS9 | 528 | AF-C5MGS9-F1 |  | Fluconazole (128) | 2021 | 33439909 |
| NCCPF ID 420232 | C. tropicalis | Clinical isolate | ERG11 | Y132F, S154F | Double substitution | C5MGS9 | 528 | AF-C5MGS9-F1 |  | Fluconazole (32) | 2021 | 33439909 |
| NCCPF ID 420233 | C. tropicalis | Clinical isolate | ERG11 | Y132F, S154F | Double substitution | C5MGS9 | 528 | AF-C5MGS9-F1 |  | Fluconazole (32), Voriconazole (1) | 2021 | 33439909 |
| NCCPF ID 420234 | C. tropicalis | Clinical isolate | ERG11 | Y132F, S154F | Double substitution | C5MGS9 | 528 | AF-C5MGS9-F1 |  | Fluconazole (64), Voriconazole (1) | 2021 | 33439909 |
| NCCPF ID 420235 | C. tropicalis | Clinical isolate | ERG11 | Y132F, S154F | Double substitution | C5MGS9 | 528 | AF-C5MGS9-F1 |  | Fluconazole (32) | 2021 | 33439909 |
| NCCPF ID 420236 | C. tropicalis | Clinical isolate | ERG11 | Y132F, S154F | Double substitution | C5MGS9 | 528 | AF-C5MGS9-F1 |  | Fluconazole (32) | 2021 | 33439909 |
| NCCPF ID 420237 | C. tropicalis | Clinical isolate | ERG11 | Y132F, S154F | Double substitution | C5MGS9 | 528 | AF-C5MGS9-F1 |  | Fluconazole (64), Voriconazole (1) | 2021 | 33439909 |
| NCCPF ID 420238 | C. tropicalis | Clinical isolate | ERG11 | Y132F, S154F | Double substitution | C5MGS9 | 528 | AF-C5MGS9-F1 |  | Fluconazole (256), Voriconazole (16), Itraconazole (16), Posaconazole (2) | 2021 | 33439909 |
| NCCPF ID 420239 | C. tropicalis | Clinical isolate | ERG11 | Y132F, S154F | Double substitution | C5MGS9 | 528 | AF-C5MGS9-F1 |  | Fluconazole (256), Voriconazole (16), Itraconazole (16) | 2021 | 33439909 |
| NCCPF ID 420245 | C. tropicalis | Clinical isolate | ERG11 | Y132F, S154F | Double substitution | C5MGS9 | 528 | AF-C5MGS9-F1 |  | Fluconazole (128), Voriconazole (4) | 2021 | 33439909 |
| NCCPF ID 420247 | C. tropicalis | Clinical isolate | ERG11 | Y132F, S154F | Double substitution | C5MGS9 | 528 | AF-C5MGS9-F1 |  | Fluconazole (128), Voriconazole (4) | 2021 | 33439909 |
| CA-170 | C. albicans | Clinical isolate | ERG3 | V351A | Single substitution | Q59VG6 | 386 | AF-Q59VG6-F1 | Mismatch residue | Fluconazole (>64) | 2021 | 33468487 |
| CA-276 | C. albicans | Clinical isolate | ERG11ERG3 | A114S, Y257H, G464SV351A | Multiple substitutionSingle substitution | Q9P4W0Q59VG6 | 528386 | AF-Q9P4W0-F1AF-Q59VG6-F1 |  | Fluconazole (8) | 2021 | 33468487 |
| CA-313 | C. albicans | Clinical isolate | ERG3 | T291I, V351A | Double substitution | Q59VG6 | 386 | AF-Q59VG6-F1 | Mismatch residue | Fluconazole (>64) | 2021 | 33468487 |
| CA-413 | C. albicans | Clinical isolate | ERG3 | V351A | Single substitution | Q59VG6 | 386 | AF-Q59VG6-F1 | Mismatch residue | Fluconazole (>64) | 2021 | 33468487 |
| CG-024 | C. glabrata | Clinical isolate | FKS2 | F659S | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (0.125) | 2021 | 33468487 |
| CT-033 | C. tropicalis | Clinical isolate | FKS1 | R656G | Single substitution | B6S6L8 | 1904 | Model |  | Micafungin (0.125) | 2021 | 33468487 |
| CT-165 | C. tropicalis | Clinical isolate | FKS1 | S654F | Single substitution | B6S6L8 | 1904 | Model |  | Micafungin (2), Anidulafungin (2) | 2021 | 33468487 |
| IV.3 | C. auris | Laboratory strain | ERG11TAC1B | F444LS611P | Single substitutionSingle substitution | A0A411K953A0A894YV30 | 524868 | AF-A0A411K953-F1AF-A0A894YV30-F1 |  | Fluconazole (128) | 2023 | 33619054 |
| IV.4 | C. auris | Laboratory strain | ERG11TAC1B | F444LS611P | Single substitutionSingle substitution | A0A411K953A0A894YV30 | 524868 | AF-A0A411K953-F1AF-A0A894YV30-F1 |  | Fluconazole (128) | 2023 | 33619054 |
| IV.5 | C. auris | Laboratory strain | ERG11TAC1B | F444LS611P | Single substitutionSingle substitution | A0A411K953A0A894YV30 | 524868 | AF-A0A411K953-F1AF-A0A894YV30-F1 |  | Fluconazole (128) | 2023 | 33619054 |
| IV.6 | C. auris | Laboratory strain | ERG11TAC1B | F444LS611P | Single substitutionSingle substitution | A0A411K953A0A894YV30 | 524868 | AF-A0A411K953-F1AF-A0A894YV30-F1 |  | Fluconazole (128) | 2023 | 33619054 |
| L09 | C. lusitaniae | Clinical isolate | MRR1 | Y813N | Single substitution | C4XX69 | 1392 | Model | Mismatch residue | Fluconazole (16) | 2021 | 33785623 |
| L10 | C. lusitaniae | Clinical isolate | MRR1 | Y813N | Single substitution | C4XX69 | 1392 | Model | Mismatch residue | Fluconazole (8-16) | 2021 | 33785623 |
| L11 | C. lusitaniae | Clinical isolate | MRR1 | R1066S, K912N | Double substitution | C4XX69 | 1392 | Model | Mismatch residue | Fluconazole (8) | 2021 | 33785623 |
| L12 | C. lusitaniae | Clinical isolate | MRR1 | R1066S, Y1061stop | Complex | C4XX69 | 1392 | Model | Mismatch residue | Fluconazole (8) | 2021 | 33785623 |
| L13 | C. lusitaniae | Clinical isolate | MRR1 | I599T | Single substitution | C4XX69 | 1392 | Model | Mismatch residue | Fluconazole (0.5-1) | 2021 | 33785623 |
| L14 | C. lusitaniae | Clinical isolate | MRR1 | L1191H, Q1197stop | Complex | C4XX69 | 1392 | Model | Mismatch residue | Fluconazole (1) | 2021 | 33785623 |
| L15 | C. lusitaniae | Clinical isolate | MRR1 | Y1126N, P1174P | Double substitution | C4XX69 | 1392 | Model | Mismatch residue | Fluconazole (0.5-1) | 2021 | 33785623 |
| L16 | C. lusitaniae | Clinical isolate | MRR1 | R1066S, G1231stop | Complex | C4XX69 | 1392 | Model | Mismatch residue | Fluconazole (8) | 2021 | 33785623 |
| L17 | C. lusitaniae | Clinical isolate | MRR1 | H467L | Single substitution | C4XX69 | 1392 | Model | Mismatch residue | Fluconazole (16) | 2021 | 33785623 |
| S18 | C. lusitaniae | Clinical isolate | MRR1 | H467L | Single substitution | C4XX69 | 1392 | Model | Mismatch residue | Fluconazole (16) | 2021 | 33785623 |
| S19 | C. lusitaniae | Clinical isolate | MRR1 | Y813N | Single substitution | C4XX69 | 1392 | Model | Mismatch residue | Fluconazole (16) | 2021 | 33785623 |
| S20 | C. lusitaniae | Clinical isolate | MRR1 | H467L | Single substitution | C4XX69 | 1392 | Model | Mismatch residue | Fluconazole (16) | 2021 | 33785623 |
| S21 | C. lusitaniae | Clinical isolate | MRR1 | L1191H, Q1197stop | Complex | C4XX69 | 1392 | Model | Mismatch residue | Fluconazole (0.5-1) | 2021 | 33785623 |
| U02 | C. lusitaniae | Clinical isolate | MRR1 | Y1126N, P1174P | Double substitution | C4XX69 | 1392 | Model | Mismatch residue | Fluconazole (1-2) | 2021 | 33785623 |
| U03 | C. lusitaniae | Clinical isolate | MRR1 | R1066S, A550V | Double substitution | C4XX69 | 1392 | Model | Mismatch residue | Fluconazole (2-4) | 2021 | 33785623 |
| U04 | C. lusitaniae | Clinical isolate | MRR1 | Y813C | Single substitution | C4XX69 | 1392 | Model | Mismatch residue | Fluconazole (16-32) | 2021 | 33785623 |
| U05 | C. lusitaniae | Clinical isolate | MRR1 | L1191H, Q1197stop | Complex | C4XX69 | 1392 | Model | Mismatch residue | Fluconazole (0.5-1) | 2021 | 33785623 |
| U06 | C. lusitaniae | Clinical isolate | MRR1 | Y1126N, S359stop | Complex | C4XX69 | 1392 | Model | Mismatch residue | Fluconazole (8-16) | 2021 | 33785623 |
| U07 | C. lusitaniae | Clinical isolate | MRR1 | Y1126N, P1174P | Double substitution | C4XX69 | 1392 | Model | Mismatch residue | Fluconazole (0.5-1) | 2021 | 33785623 |
| U08 | C. lusitaniae | Clinical isolate | MRR1 | E722K | Single substitution | C4XX69 | 1392 | Model | Mismatch residue | Fluconazole (16-32) | 2021 | 33785623 |
| CAS12 | C. auris | Clinical isolate | ERG11 | Y132F | Single substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 |  | Fluconazole (256) | 2021 | 33807036 |
| CAS14 | C. auris | Clinical isolate | ERG11 | Y132F | Single substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 |  | Fluconazole (32), Amphotericin B (2) | 2021 | 33807036 |
| CAS16 | C. auris | Clinical isolate | ERG11 | Y132F | Single substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 |  | Fluconazole (128), Voriconazole (8), Amphotericin B (2) | 2021 | 33807036 |
| CAS17 | C. auris | Clinical isolate | ERG11 | K143R | Single substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 |  | Fluconazole (128), Amphotericin B (2) | 2021 | 33807036 |
| CAS20 | C. auris | Clinical isolate | ERG11 | K143R | Single substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 |  | Fluconazole (256), Amphotericin B (4) | 2021 | 33807036 |
| CAS20044 | C. auris | Clinical isolate | ERG11 | Y132F | Single substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 |  | Fluconazole (128), Amphotericin B (2) | 2021 | 33807036 |
| CAS25 | C. auris | Clinical isolate | ERG11 | Y132F | Single substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 |  | Fluconazole (128), Itraconazole (16), Posaconazole (8), Voriconazole (8), Amphotericin B (2) | 2021 | 33807036 |
| CAS27 | C. auris | Clinical isolate | ERG11 | Y132F | Single substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 |  | Fluconazole (64), Amphotericin B (2) | 2021 | 33807036 |
| CAS33 | C. auris | Clinical isolate | ERG11 | Y132F | Single substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 |  | Fluconazole (128), Voriconazole (8), Amphotericin B (2) | 2021 | 33807036 |
| CAS34 | C. auris | Clinical isolate | ERG11 | Y132F | Single substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 |  | Fluconazole (128), Amphotericin B (2) | 2021 | 33807036 |
| CAS41 | C. auris | Clinical isolate | ERG11 | Y132F | Single substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 |  | Fluconazole (32), Amphotericin B (2) | 2021 | 33807036 |
| 10-26/19 | C. parapsilosis | Clinical isolate | ERG11 | Y132F, R398I | Double substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (>64), Voriconazole (>4) | 2021 | 33808442 |
| 101-26/19 | C. parapsilosis | Clinical isolate | ERG11 | Y132F, R398I | Double substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (>64), Voriconazole (>4) | 2021 | 33808442 |
| 105-26/19 | C. parapsilosis | Clinical isolate | ERG11 | Y132F, R398I | Double substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (>64), Voriconazole (>4) | 2021 | 33808442 |
| 108-26/19 | C. parapsilosis | Clinical isolate | ERG11 | Y132F, R398I | Double substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (>64), Voriconazole (>4) | 2021 | 33808442 |
| 109-26/19 | C. parapsilosis | Clinical isolate | ERG11 | Y132F, R398I | Double substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (>64), Voriconazole (>4) | 2021 | 33808442 |
| 11-26/19 | C. parapsilosis | Clinical isolate | ERG11 | Y132F, R398I | Double substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (>64), Voriconazole (>4) | 2021 | 33808442 |
| 110-26/19 | C. parapsilosis | Clinical isolate | ERG11 | Y132F, R398I | Double substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (>64), Voriconazole (>4) | 2021 | 33808442 |
| 115-26/19 | C. parapsilosis | Clinical isolate | ERG11 | Y132F, R398I | Double substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (>64), Voriconazole (>4) | 2021 | 33808442 |
| 116-26/19 | C. parapsilosis | Clinical isolate | ERG11 | Y132F, R398I | Double substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (>64), Voriconazole (>4) | 2021 | 33808442 |
| 118-26/19 | C. parapsilosis | Clinical isolate | ERG11 | Y132F, R398I | Double substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (>64), Voriconazole (>4) | 2021 | 33808442 |
| 119-26/19 | C. parapsilosis | Clinical isolate | ERG11 | Y132F, R398I | Double substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (>64), Voriconazole (>4) | 2021 | 33808442 |
| 11E | C. parapsilosis | Clinical isolate | ERG11 | Y132F, R398I | Double substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (>64), Voriconazole (>4) | 2021 | 33808442 |
| 122-26/19 | C. parapsilosis | Clinical isolate | ERG11 | Y132F, R398I | Double substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (>64), Voriconazole (>4) | 2021 | 33808442 |
| 14-26/19 | C. parapsilosis | Clinical isolate | ERG11 | Y132F, R398I | Double substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (>64), Voriconazole (>4) | 2021 | 33808442 |
| 16-26/19 | C. parapsilosis | Clinical isolate | ERG11 | Y132F, R398I | Double substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (>64), Voriconazole (>4) | 2021 | 33808442 |
| 17D | C. parapsilosis | Clinical isolate | ERG11 | Y132F, R398I | Double substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (>64), Voriconazole (>4) | 2021 | 33808442 |
| 17E | C. parapsilosis | Clinical isolate | ERG11 | Y132F, R398I | Double substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (>64), Voriconazole (>4) | 2021 | 33808442 |
| 19-26/19 | C. parapsilosis | Clinical isolate | ERG11 | Y132F, R398I | Double substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (>64), Voriconazole (>4) | 2021 | 33808442 |
| 2-26/19 | C. parapsilosis | Clinical isolate | ERG11 | Y132F, R398I | Double substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (>64), Voriconazole (>4) | 2021 | 33808442 |
| 22-26/19 | C. parapsilosis | Clinical isolate | ERG11 | Y132F, R398I | Double substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (>64), Voriconazole (>4) | 2021 | 33808442 |
| 25-26/19 | C. parapsilosis | Clinical isolate | ERG11 | Y132F, R398I | Double substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (>64), Voriconazole (>4) | 2021 | 33808442 |
| 26-26/19 | C. parapsilosis | Clinical isolate | ERG11 | Y132F, R398I | Double substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (>64), Voriconazole (>4) | 2021 | 33808442 |
| 27-26/19 | C. parapsilosis | Clinical isolate | ERG11 | Y132F, R398I | Double substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (>64), Voriconazole (>4) | 2021 | 33808442 |
| 3-26/19 | C. parapsilosis | Clinical isolate | ERG11 | Y132F, R398I | Double substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (>64), Voriconazole (>4) | 2021 | 33808442 |
| 31-26/19 | C. parapsilosis | Clinical isolate | ERG11 | Y132F, R398I | Double substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (>64), Voriconazole (>4) | 2021 | 33808442 |
| 32-26/19 | C. parapsilosis | Clinical isolate | ERG11 | Y132F, R398I | Double substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (>64), Voriconazole (>4) | 2021 | 33808442 |
| 33-26/19 | C. parapsilosis | Clinical isolate | ERG11 | Y132F, R398I | Double substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (>64), Voriconazole (>4) | 2021 | 33808442 |
| 34-26/19 | C. parapsilosis | Clinical isolate | ERG11 | Y132F, R398I | Double substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (>64), Voriconazole (>4) | 2021 | 33808442 |
| 36-26/19 | C. parapsilosis | Clinical isolate | ERG11 | Y132F, R398I | Double substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (>64), Voriconazole (>4) | 2021 | 33808442 |
| 38-26/19 | C. parapsilosis | Clinical isolate | ERG11 | Y132F, R398I | Double substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (>64), Voriconazole (>4) | 2021 | 33808442 |
| 4-26/19 | C. parapsilosis | Clinical isolate | ERG11 | Y132F, R398I | Double substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (>64), Voriconazole (>4) | 2021 | 33808442 |
| 41-26/19 | C. parapsilosis | Clinical isolate | ERG11 | Y132F, R398I | Double substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (>64), Voriconazole (>4) | 2021 | 33808442 |
| 45-26/19 | C. parapsilosis | Clinical isolate | ERG11 | Y132F, R398I | Double substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (>64), Voriconazole (>4) | 2021 | 33808442 |
| 46-26/19 | C. parapsilosis | Clinical isolate | ERG11 | Y132F, R398I | Double substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (8) | 2021 | 33808442 |
| 47-26/19 | C. parapsilosis | Clinical isolate | ERG11 | Y132F, R398I | Double substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (>64), Voriconazole (>4) | 2021 | 33808442 |
| 49-26/19 | C. parapsilosis | Clinical isolate | ERG11 | Y132F, R398I | Double substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (>64), Voriconazole (>4) | 2021 | 33808442 |
| 51-26/19 | C. parapsilosis | Clinical isolate | ERG11 | Y132F, R398I | Double substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (>64), Voriconazole (>4) | 2021 | 33808442 |
| 52-26/19 | C. parapsilosis | Clinical isolate | ERG11 | Y132F, R398I | Double substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (>64), Voriconazole (>4) | 2021 | 33808442 |
| 53-26/19 | C. parapsilosis | Clinical isolate | ERG11 | Y132F, R398I | Double substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (>64), Voriconazole (>4) | 2021 | 33808442 |
| 55-26/19 | C. parapsilosis | Clinical isolate | ERG11 | Y132F, R398I | Double substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (>64), Voriconazole (>4) | 2021 | 33808442 |
| 57-26/19 | C. parapsilosis | Clinical isolate | ERG11 | Y132F, R398I | Double substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (>64), Voriconazole (>4) | 2021 | 33808442 |
| 59-26/19 | C. parapsilosis | Clinical isolate | ERG11 | Y132F, R398I | Double substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (>64), Voriconazole (>4) | 2021 | 33808442 |
| 62-26/19 | C. parapsilosis | Clinical isolate | ERG11 | Y132F, R398I | Double substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (>64), Voriconazole (>4) | 2021 | 33808442 |
| 63-26/19 | C. parapsilosis | Clinical isolate | ERG11 | Y132F, R398I | Double substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (>64), Voriconazole (>4) | 2021 | 33808442 |
| 64-26/19 | C. parapsilosis | Clinical isolate | ERG11 | Y132F, R398I | Double substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (>64), Voriconazole (>4) | 2021 | 33808442 |
| 70-26/19 | C. parapsilosis | Clinical isolate | ERG11 | Y132F, R398I | Double substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (>64), Voriconazole (>4) | 2021 | 33808442 |
| 71-26/19 | C. parapsilosis | Clinical isolate | ERG11 | Y132F, R398I | Double substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (>64), Voriconazole (>4) | 2021 | 33808442 |
| 73-26/19 | C. parapsilosis | Clinical isolate | ERG11 | Y132F, R398I | Double substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (>64), Voriconazole (>4) | 2021 | 33808442 |
| 75-26/19 | C. parapsilosis | Clinical isolate | ERG11 | Y132F, R398I | Double substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (>64), Voriconazole (>4) | 2021 | 33808442 |
| 77-26/19 | C. parapsilosis | Clinical isolate | ERG11 | Y132F, R398I | Double substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (>64), Voriconazole (>4) | 2021 | 33808442 |
| 78-26/19 | C. parapsilosis | Clinical isolate | ERG11 | Y132F, R398I | Double substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (>64), Voriconazole (>4) | 2021 | 33808442 |
| 79-26/19 | C. parapsilosis | Clinical isolate | ERG11 | Y132F, R398I | Double substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (>64), Voriconazole (>4) | 2021 | 33808442 |
| 80-26/19 | C. parapsilosis | Clinical isolate | ERG11 | Y132F, R398I | Double substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (>64), Voriconazole (>4) | 2021 | 33808442 |
| 81-26/19 | C. parapsilosis | Clinical isolate | ERG11 | Y132F, R398I | Double substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (>64), Voriconazole (>4) | 2021 | 33808442 |
| 82-26/19 | C. parapsilosis | Clinical isolate | ERG11 | Y132F, R398I | Double substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (>64), Voriconazole (>4) | 2021 | 33808442 |
| 85-26/19 | C. parapsilosis | Clinical isolate | ERG11 | Y132F, R398I | Double substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (>64), Voriconazole (>4) | 2021 | 33808442 |
| 87-26/19 | C. parapsilosis | Clinical isolate | ERG11 | Y132F, R398I | Double substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (>64), Voriconazole (>4) | 2021 | 33808442 |
| 9-26/19 | C. parapsilosis | Clinical isolate | ERG11 | Y132F, R398I | Double substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (>64), Voriconazole (>4) | 2021 | 33808442 |
| 90-26/19 | C. parapsilosis | Clinical isolate | ERG11 | Y132F, R398I | Double substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (>64), Voriconazole (>4) | 2021 | 33808442 |
| 91-26/19 | C. parapsilosis | Clinical isolate | ERG11 | Y132F, R398I | Double substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (>64), Voriconazole (>4) | 2021 | 33808442 |
| C935 | C. parapsilosis | Clinical isolate | ERG11 | Y132F, R398I | Double substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (>64), Voriconazole (>4) | 2021 | 33808442 |
| C936 | C. parapsilosis | Clinical isolate | ERG11 | Y132F, R398I | Double substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (>64), Voriconazole (>4) | 2021 | 33808442 |
| CBL1017 | C. parapsilosis | Clinical isolate | ERG11 | Y132F, R398I | Double substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (>64), Voriconazole (>4) | 2021 | 33808442 |
| CBL1028 | C. parapsilosis | Clinical isolate | ERG11 | Y132F, R398I | Double substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (>64), Voriconazole (>4) | 2021 | 33808442 |
| P10/9S | C. parapsilosis | Clinical isolate | ERG11 | Y132F, R398I | Double substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (>64), Voriconazole (>4) | 2021 | 33808442 |
| A21(C.auris B11220) | C. auris | Laboratory strain | ERG11ERG3 | E429stopW182stop | StopStop | A0A2H1A309A0A2H0ZNC5 | 524363 | AF-A0A2H1A309-F1AF-A0A2H0ZNC5-F1 |  | Fluconazole (>64), Amphotericin B (2) | 2021 | 33820824 |
| A27 | C. auris | Laboratory strain | ERG11ERG3MEC3 | E429stopW182stopA272V | StopStopSingle substitution | A0A2H1A309A0A2H0ZNC5A0A2H0ZSE9 | 524363320 | AF-A0A2H1A309-F1AF-A0A2H0ZNC5-F1AF-A0A2H0ZSE9-F1 |  | Fluconazole (>64), Amphotericin B (4) | 2021 | 33820824 |
| A29 | C. auris | Laboratory strain | ERG11ERG3FLO8MEC3 | E429stopW182stopQ384stopA272V | StopStopStopSingle substitution | A0A2H1A309A0A2H0ZNC5A0A2H1A8R7A0A2H0ZSE9 | 524363537320 | AF-A0A2H1A309-F1AF-A0A2H0ZNC5-F1AF-A0A2H1A8R7-F1AF-A0A2H0ZSE9-F1 |  | Fluconazole (>64), Amphotericin B (4) | 2021 | 33820824 |
| C15 | C. auris | Laboratory strain | FKS1 | F365L, M690I | Double substitution | A0A2H1A4W2 | 1888 | Model | Mismatch residue | Caspofungin (64) | 2021 | 33820824 |
| C20 | C. auris | Laboratory strain | ERG3FKS1 | L207IF365L, M690I | Single substitutionDouble substitution | A0A2H0ZNC5A0A2H1A4W2 | 3631888 | AF-A0A2H0ZNC5-F1Model |  | Caspofungin (>64) | 2021 | 33820824 |
| C3 | C. auris | Laboratory strain | FKS1 | F635L | Single substitution | A0A2H1A4W2 | 1888 | Model | Structure not available | Caspofungin (64) | 2021 | 33820824 |
| CF16 | C. auris | Laboratory strain | ERG3FKS1 | L207IF365L, M690I | Single substitutionDouble substitution | A0A2H0ZNC5A0A2H1A4W2 | 3631888 | AF-A0A2H0ZNC5-F1Model |  | Fluconazole (16), Caspofungin (64) | 2021 | 33820824 |
| F13 | C. auris | Laboratory strain | TAC1 | S191fs | Frameshift | A0A2H0ZHW2 | 868 | AF-A0A2H0ZHW2-F1 |  | Fluconazole (32) | 2021 | 33820824 |
| F30 | C. auris | Laboratory strain | TAC1 | S191fs | Frameshift | A0A2H0ZHW2 | 868 | AF-A0A2H0ZHW2-F1 |  | Fluconazole (>64), Amphotericin B (1) | 2021 | 33820824 |
| FC16 | C. auris | Laboratory strain | CIS2FKS1TAC1 | A27TF635LS191fs | Single substitutionSingle substitutionFrameshift | A0A2H0ZLW4A0A2H1A4W2A0A2H0ZHW2 | 6251888868 | AF-A0A2H0ZLW4-F1ModelAF-A0A2H0ZHW2-F1 |  | Fluconazole (>64), Caspofungin (>64), | 2021 | 33820824 |
| FC17 | C. auris | Laboratory strain | CIS2FKS1PEA2TAC1 | A27TF635LD367VS191fs | Single substitutionSingle substitutionSingle substitutionFrameshift | A0A2H0ZLW4A0A2H1A4W2A0A2H1A1Q3A0A2H0ZHW2 | 6251888540868 | AF-A0A2H0ZLW4-F1ModelAF-A0A2H1A1Q3-F1AF-A0A2H0ZHW2-F1 |  | Fluconazole (>64), Caspofungin (>64), Amphotericin B (1) | 2021 | 33820824 |
| PATIENT1-S1 | C. parapsilosis | Clinical isolate | ERG11 | G458S | Single substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (32), Voriconazole (1) | 2021 | 33934400 |
| PATIENT2-S2 | C. parapsilosis | Clinical isolate | ERG11MRR1 | Y132FR405K | Single substitutionSingle substitution | C7EXA5A0A0K0NQY2 | 5221128 | AF-C7EXA5-F1AF-A0A2H1A1Q3-F1 |  | Fluconazole (16), Voriconazole (0.25), Posaconazole (0.125) | 2021 | 33934400 |
| PATIENT3-S3 | C. parapsilosis | Clinical isolate | ERG11MRR1 | Y132FR405K | Single substitutionSingle substitution | C7EXA5A0A0K0NQY2 | 5221128 | AF-C7EXA5-F1AF-A0A2H1A1Q3-F1 |  | Fluconazole (64), Voriconazole (0.25) | 2021 | 33934400 |
| PATIENT3-S4 | C. parapsilosis | Clinical isolate | ERG11 | Y132F | Single substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (32), Voriconazole (0.125) | 2021 | 33934400 |
| PATIENT4-S1 | C. parapsilosis | Clinical isolate | ERG11 | Y132F | Single substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (16), Voriconazole (0.25) | 2021 | 33934400 |
| CA-18 | C. albicans | Clinical isolate | ERG11 | T123I | Single substitution | P10613 | 528 | 5V5Z |  | Fluconazole (64), Itraconazole, Voriconazole | 2021 | 33951330 |
| CA-26 | C. albicans | Clinical isolate | ERG11 | A516P | Single substitution | P10613 | 528 | 5V5Z |  | Fluconazole (64), Itraconazole, Voriconazole | 2021 | 33951330 |
| CA-29 | C. albicans | Clinical isolate | ERG11 | K128T | Single substitution | P10613 | 528 | 5V5Z |  | Itraconazole | 2021 | 33951330 |
| CA-32 | C. albicans | Clinical isolate | ERG11 | K128T | Single substitution | P10613 | 528 | 5V5Z |  | Fluconazole (32) | 2021 | 33951330 |
| CA-40 | C. albicans | Clinical isolate | ERG11 | K128T | Single substitution | P10613 | 528 | 5V5Z |  | Fluconazole (16), Itraconazole, Voriconazole | 2021 | 33951330 |
| CA-56 | C. albicans | Clinical isolate | ERG11 | K128T, Y132H | Double substitution | P10613 | 528 | 5V5Z |  | Fluconazole (64), Itraconazole, Voriconazole | 2021 | 33951330 |
| CA-9 | C. albicans | Clinical isolate | ERG11 | K128T | Single substitution | P10613 | 528 | 5V5Z |  | Fluconazole (64), Fluconazole, Voriconazole | 2021 | 33951330 |
| n=1 isolates | C. parapsilosis | Clinical isolate | ERG11 | G307A, G458S | Double substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (>64) | 2021 | 33968809 |
| n=17 isolates | C. parapsilosis | Clinical isolate | ERG11 | Y132F | Single substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (4-32) | 2021 | 33968809 |
| n=3 isolates | C. parapsilosis | Clinical isolate | ERG11 | Y132F, G307A | Double substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (>64) | 2021 | 33968809 |
| n=4 isolates | C. parapsilosis | Clinical isolate | ERG11 | G458S | Single substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (16->64) | 2021 | 33968809 |
| C12_A109 | C. auris | Clinical isolate | ERG11 | F126L, I74L | Double substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 | Mismatch residue | Fluconazole (256) | 2021 | 34027824 |
| NICU10_A58 | C. auris | Clinical isolate | ERG11 | F126L, I74L | Double substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 | Mismatch residue | Fluconazole (>256) | 2021 | 34027824 |
| NICU11_A77 | C. auris | Clinical isolate | ERG11 | F126L, I74L | Double substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 | Mismatch residue | Fluconazole (>256) | 2021 | 34027824 |
| NICU12_A79 | C. auris | Clinical isolate | ERG11 | F126L, I74L | Double substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 | Mismatch residue | Fluconazole (256) | 2021 | 34027824 |
| NICU13_A93 | C. auris | Clinical isolate | ERG11 | F126L, I74L | Double substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 | Mismatch residue | Fluconazole (256) | 2021 | 34027824 |
| NICU13_A94 | C. auris | Clinical isolate | ERG11 | F126L, I74L | Double substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 | Mismatch residue | Fluconazole (>256) | 2021 | 34027824 |
| NICU14_A96 | C. auris | Clinical isolate | ERG11 | F126L, I74L | Double substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 | Mismatch residue | Fluconazole (256) | 2021 | 34027824 |
| NICU15_A100 | C. auris | Clinical isolate | ERG11 | F126L, I74L | Double substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 | Mismatch residue | Fluconazole (256) | 2021 | 34027824 |
| NICU16_A101 | C. auris | Clinical isolate | ERG11 | F126L, I74L | Double substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 | Mismatch residue | Fluconazole (>256) | 2021 | 34027824 |
| NICU16_A102 | C. auris | Clinical isolate | ERG11 | F126L, I74L | Double substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 | Mismatch residue | Fluconazole (256) | 2021 | 34027824 |
| NICU16_A103 | C. auris | Clinical isolate | ERG11 | F126L, I74L | Double substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 | Mismatch residue | Fluconazole (>256) | 2021 | 34027824 |
| NICU16_A104 | C. auris | Clinical isolate | ERG11 | F126L, I74L | Double substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 | Mismatch residue | Fluconazole (>256), Voriconazole (4) | 2021 | 34027824 |
| NICU2_A13 | C. auris | Clinical isolate | ERG11 | F126L, I74L | Double substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 | Mismatch residue | Fluconazole (256) | 2021 | 34027824 |
| NICU3_A15 | C. auris | Clinical isolate | ERG11 | F126L, I74L | Double substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 | Mismatch residue | Fluconazole (256) | 2021 | 34027824 |
| NICU3_A16 | C. auris | Clinical isolate | ERG11 | F126L, I74L | Double substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 | Mismatch residue | Fluconazole (256) | 2021 | 34027824 |
| NICU3_A17 | C. auris | Clinical isolate | ERG11 | F126L, I74L | Double substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 | Mismatch residue | Fluconazole (256) | 2021 | 34027824 |
| NICU3_A18 | C. auris | Clinical isolate | ERG11 | F126L, I74L | Double substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 | Mismatch residue | Fluconazole (256) | 2021 | 34027824 |
| NICU4_A19 | C. auris | Clinical isolate | ERG11 | F126L, I74L | Double substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 | Mismatch residue | Fluconazole (256) | 2021 | 34027824 |
| NICU4_A20 | C. auris | Clinical isolate | ERG11 | F126L, I74L | Double substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 | Mismatch residue | Fluconazole (>256), Voriconazole (4) | 2021 | 34027824 |
| NICU5_A36 | C. auris | Clinical isolate | ERG11 | F126L, I74L | Double substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 | Mismatch residue | Fluconazole (256) | 2021 | 34027824 |
| NICU5_A37 | C. auris | Clinical isolate | ERG11 | F126L, I74L | Double substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 | Mismatch residue | Fluconazole (>256) | 2021 | 34027824 |
| NICU6_A41 | C. auris | Clinical isolate | ERG11 | F126L, I74L | Double substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 | Mismatch residue | Fluconazole (256) | 2021 | 34027824 |
| NICU7_A42 | C. auris | Clinical isolate | ERG11 | F126L, I74L | Double substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 | Mismatch residue | Fluconazole (256) | 2021 | 34027824 |
| NICU7_A44 | C. auris | Clinical isolate | ERG11 | F126L, I74L | Double substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 | Mismatch residue | Fluconazole (256) | 2021 | 34027824 |
| NICU8_A43 | C. auris | Clinical isolate | ERG11 | F126L, I74L | Double substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 | Mismatch residue | Fluconazole (256) | 2021 | 34027824 |
| NICU8_A45 | C. auris | Clinical isolate | ERG11 | F126L, I74L | Double substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 | Mismatch residue | Fluconazole (256) | 2021 | 34027824 |
| NICU8_A46 | C. auris | Clinical isolate | ERG11 | F126L, I74L | Double substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 | Mismatch residue | Fluconazole (256) | 2021 | 34027824 |
| NICU8_A47 | C. auris | Clinical isolate | ERG11 | F126L, I74L | Double substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 | Mismatch residue | Fluconazole (256) | 2021 | 34027824 |
| NICU8_A48 | C. auris | Clinical isolate | ERG11 | F126L, I74L | Double substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 | Mismatch residue | Fluconazole (256) | 2021 | 34027824 |
| NICU9_A50 | C. auris | Clinical isolate | ERG11 | F126L, I74L | Double substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 | Mismatch residue | Fluconazole (256) | 2021 | 34027824 |
| NICU9_A51 | C. auris | Clinical isolate | ERG11 | F126L, I74L | Double substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 | Mismatch residue | Fluconazole (256) | 2021 | 34027824 |
| NSICU1_A24 | C. auris | Clinical isolate | ERG11 | F126L, I74L | Double substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 | Mismatch residue | Fluconazole (256) | 2021 | 34027824 |
| NSICU1_A31 | C. auris | Clinical isolate | ERG11 | F126L, I74L | Double substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 | Mismatch residue | Fluconazole (>256) | 2021 | 34027824 |
| RI-A112 | C. auris | Clinical isolate | ERG11 | F126L, I74L | Double substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 | Mismatch residue | Fluconazole (>256) | 2021 | 34027824 |
| RI-A114 | C. auris | Clinical isolate | ERG11 | F126L, I74L | Double substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 | Mismatch residue | Fluconazole (>256) | 2021 | 34027824 |
| RICU10_A57 | C. auris | Clinical isolate | ERG11 | F126L, I74L | Double substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 | Mismatch residue | Fluconazole (>256) | 2021 | 34027824 |
| RICU11_A62 | C. auris | Clinical isolate | ERG11 | F126L, I74L | Double substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 | Mismatch residue | Fluconazole (>256) | 2021 | 34027824 |
| RICU11_A63 | C. auris | Clinical isolate | ERG11 | F126L, I74L | Double substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 | Mismatch residue | Fluconazole (256) | 2021 | 34027824 |
| RICU11_A64 | C. auris | Clinical isolate | ERG11 | F126L, I74L | Double substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 | Mismatch residue | Fluconazole (>256) | 2021 | 34027824 |
| RICU11_A74 | C. auris | Clinical isolate | ERG11 | F126L, I74L | Double substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 | Mismatch residue | Fluconazole (>256) | 2021 | 34027824 |
| RICU11_A75 | C. auris | Clinical isolate | ERG11 | F126L, I74L | Double substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 | Mismatch residue | Fluconazole (>256) | 2021 | 34027824 |
| RICU11_A76 | C. auris | Clinical isolate | ERG11 | F126L, I74L | Double substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 | Mismatch residue | Fluconazole (>256) | 2021 | 34027824 |
| RICU11_A81 | C. auris | Clinical isolate | ERG11 | F126L, I74L | Double substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 | Mismatch residue | Fluconazole (>256) | 2021 | 34027824 |
| RICU12_A80 | C. auris | Clinical isolate | ERG11 | F126L, I74L | Double substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 | Mismatch residue | Fluconazole (>256) | 2021 | 34027824 |
| RICU13_A83 | C. auris | Clinical isolate | ERG11 | F126L, I74L | Double substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 | Mismatch residue | Fluconazole (>256) | 2021 | 34027824 |
| RICU13_A85 | C. auris | Clinical isolate | ERG11 | F126L, I74L | Double substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 | Mismatch residue | Fluconazole (>256) | 2021 | 34027824 |
| RICU13_A86 | C. auris | Clinical isolate | ERG11 | F126L, I74L | Double substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 | Mismatch residue | Fluconazole (256) | 2021 | 34027824 |
| RICU14_A95 | C. auris | Clinical isolate | ERG11 | F126L, I74L | Double substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 | Mismatch residue | Fluconazole (256) | 2021 | 34027824 |
| RICU15_A105 | C. auris | Clinical isolate | ERG11 | F126L, I74L | Double substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 | Mismatch residue | Fluconazole (256) | 2021 | 34027824 |
| RICU15_A110 | C. auris | Clinical isolate | ERG11 | F126L, I74L | Double substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 | Mismatch residue | Fluconazole (256) | 2021 | 34027824 |
| RICU16_A106 | C. auris | Clinical isolate | ERG11 | F126L, I74L | Double substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 | Mismatch residue | Fluconazole (256) | 2021 | 34027824 |
| RICU16_A107 | C. auris | Clinical isolate | ERG11 | F126L, I74L | Double substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 | Mismatch residue | Fluconazole (256) | 2021 | 34027824 |
| RICU17_A108 | C. auris | Clinical isolate | ERG11 | F126L, I74L | Double substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 | Mismatch residue | Fluconazole (256) | 2021 | 34027824 |
| RICU18_A113 | C. auris | Clinical isolate | ERG11 | F126L, I74L | Double substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 | Mismatch residue | Fluconazole (>256) | 2021 | 34027824 |
| RICU19_A115 | C. auris | Clinical isolate | ERG11 | F126L, I74L | Double substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 | Mismatch residue | Fluconazole (256) | 2021 | 34027824 |
| RICU1_A1 | C. auris | Clinical isolate | ERG11 | F126L, I74L | Double substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 | Mismatch residue | Fluconazole (256) | 2021 | 34027824 |
| RICU2_A2 | C. auris | Clinical isolate | ERG11 | F126L, I74L | Double substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 | Mismatch residue | Fluconazole (256) | 2021 | 34027824 |
| RICU2_A4 | C. auris | Clinical isolate | ERG11 | F126L, I74L | Double substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 | Mismatch residue | Fluconazole (>256), Voriconazole (4), Itraconazole (1) | 2021 | 34027824 |
| RICU2_A5 | C. auris | Clinical isolate | ERG11 | F126L, I74L | Double substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 | Mismatch residue | Amphotericin B (2), Fluconazole (>256) | 2021 | 34027824 |
| RICU3_A3 | C. auris | Clinical isolate | ERG11 | F126L, I74L | Double substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 | Mismatch residue | Fluconazole (256) | 2021 | 34027824 |
| RICU4_A10 | C. auris | Clinical isolate | ERG11 | F126L, I74L | Double substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 | Mismatch residue | Fluconazole (>256) | 2021 | 34027824 |
| RICU4_A7 | C. auris | Clinical isolate | ERG11 | F126L, I74L | Double substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 | Mismatch residue | Fluconazole (>256), Voriconazole (4) | 2021 | 34027824 |
| RICU4_A8 | C. auris | Clinical isolate | ERG11 | F126L, I74L | Double substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 | Mismatch residue | Fluconazole (256) | 2021 | 34027824 |
| RICU5_A12 | C. auris | Clinical isolate | ERG11 | F126L, I74L | Double substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 | Mismatch residue | Fluconazole (256) | 2021 | 34027824 |
| RICU6_A14 | C. auris | Clinical isolate | ERG11 | F126L, I74L | Double substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 | Mismatch residue | Fluconazole (128) | 2021 | 34027824 |
| RICU7_A22 | C. auris | Clinical isolate | ERG11 | F126L, I74L | Double substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 | Mismatch residue | Fluconazole (256) | 2021 | 34027824 |
| RICU7_A23 | C. auris | Clinical isolate | ERG11 | F126L, I74L | Double substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 | Mismatch residue | Fluconazole (>256) | 2021 | 34027824 |
| RICU7_A25 | C. auris | Clinical isolate | ERG11 | F126L, I74L | Double substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 | Mismatch residue | Fluconazole (256) | 2021 | 34027824 |
| RICU7_A29 | C. auris | Clinical isolate | ERG11 | F126L, I74L | Double substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 | Mismatch residue | Fluconazole (>256) | 2021 | 34027824 |
| RICU7_A33 | C. auris | Clinical isolate | ERG11FKS1 | F126L, I74LS639F | Double substitutionSingle substitution | A0A2H1A309A0A3G2LW13 | 5241888 | AF-A0A2H1A309-F1Model |  | Fluconazole (>256), Anidulafungin (8), Micafungin (8), Caspofungin (4) | 2021 | 34027824 |
| RICU7_A34 | C. auris | Clinical isolate | ERG11FKS1 | F126L, I74LS639F | Double substitutionSingle substitution | A0A2H1A309A0A3G2LW13 | 5241888 | AF-A0A2H1A309-F1Model |  | Fluconazole (>256), Anidulafungin (8), Micafungin (8), Caspofungin (4) | 2021 | 34027824 |
| RICU8_A38 | C. auris | Clinical isolate | ERG11 | F126L, I74L | Double substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 | Mismatch residue | Fluconazole (256) | 2021 | 34027824 |
| RICU8_A39 | C. auris | Clinical isolate | ERG11 | F126L, I74L | Double substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 | Mismatch residue | Fluconazole (>256) | 2021 | 34027824 |
| RICU9_A111 | C. auris | Clinical isolate | ERG11 | F126L, I74L | Double substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 | Mismatch residue | Fluconazole (256) | 2021 | 34027824 |
| RICU9_A116 | C. auris | Clinical isolate | ERG11 | F126L, I74L | Double substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 | Mismatch residue | Fluconazole (>256) | 2021 | 34027824 |
| RICU9_A52 | C. auris | Clinical isolate | ERG11 | F126L, I74L | Double substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 | Mismatch residue | Fluconazole (>256) | 2021 | 34027824 |
| RICU9_A54 | C. auris | Clinical isolate | ERG11 | F126L, I74L | Double substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 | Mismatch residue | Fluconazole (256) | 2021 | 34027824 |
| RICU9_A56 | C. auris | Clinical isolate | ERG11 | F126L, I74L | Double substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 | Mismatch residue | Fluconazole (256) | 2021 | 34027824 |
| RICU9_A59 | C. auris | Clinical isolate | ERG11 | F126L, I74L | Double substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 | Mismatch residue | Fluconazole (256) | 2021 | 34027824 |
| RICU9_A61 | C. auris | Clinical isolate | ERG11 | F126L, I74L | Double substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 | Mismatch residue | Fluconazole (>256) | 2021 | 34027824 |
| RICU9_A65 | C. auris | Clinical isolate | ERG11 | F126L, I74L | Double substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 | Mismatch residue | Fluconazole (>256) | 2021 | 34027824 |
| RICU9_A82 | C. auris | Clinical isolate | ERG11 | F126L, I74L | Double substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 | Mismatch residue | Fluconazole (>256) | 2021 | 34027824 |
| SICU1_A66 | C. auris | Clinical isolate | ERG11 | F126L, I74L | Double substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 | Mismatch residue | Fluconazole (>256) | 2021 | 34027824 |
| SICU1_A67 | C. auris | Clinical isolate | ERG11 | F126L, I74L | Double substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 | Mismatch residue | Fluconazole (256) | 2021 | 34027824 |
| SICU1_A68 | C. auris | Clinical isolate | ERG11 | F126L, I74L | Double substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 | Mismatch residue | Fluconazole (256) | 2021 | 34027824 |
| SICU1_A70 | C. auris | Clinical isolate | ERG11 | F126L, I74L | Double substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 | Mismatch residue | Fluconazole (256) | 2021 | 34027824 |
| SICU1_A71 | C. auris | Clinical isolate | ERG11 | F126L, I74L | Double substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 | Mismatch residue | Fluconazole (>256) | 2021 | 34027824 |
| SICU1_A72 | C. auris | Clinical isolate | ERG11 | F126L, I74L | Double substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 | Mismatch residue | Fluconazole (>256) | 2021 | 34027824 |
| SICU2_A89 | C. auris | Clinical isolate | ERG11 | F126L, I74L | Double substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 | Mismatch residue | Fluconazole (256) | 2021 | 34027824 |
| SICU2_A90 | C. auris | Clinical isolate | ERG11 | F126L, I74L | Double substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 | Mismatch residue | Fluconazole (256) | 2021 | 34027824 |
| SICU2_A91 | C. auris | Clinical isolate | ERG11 | F126L, I74L | Double substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 | Mismatch residue | Fluconazole (256) | 2021 | 34027824 |
| SICU2_A97 | C. auris | Clinical isolate | ERG11 | F126L, I74L | Double substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 | Mismatch residue | Fluconazole (256) | 2021 | 34027824 |
| SICU2_A98 | C. auris | Clinical isolate | ERG11 | F126L, I74L | Double substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 | Mismatch residue | Fluconazole (256) | 2021 | 34027824 |
| ISOLATE 10 (SC5314) | C. albicans | Clinical isolate | ERG11 | S16V, P68L, D269E | Multiple substitution | P10613 | 528 | 5V5Z |  | Fluconazole | 2021 | 34033880 |
| ISOLATE 7 (SC5314) | C. albicans | Clinical isolate | ERG11 | N490T | Single substitution | P10613 | 528 | 5V5Z |  | Fluconazole | 2021 | 34033880 |
| ISOLATE 9 (SC5314) | C. albicans | Clinical isolate | ERG11 | Q250S, K252E | Double substitution | P10613 | 528 | 5V5Z |  | Fluconazole | 2021 | 34033880 |
| 10262 | C. tropicalis | Clinical isolate | ERG11 | Y132F | Single substitution | C5MGS9 | 528 | AF-C5MGS9-F1 |  | Fluconazole (128) | 2021 | 34060660 |
| 23591 | C. auris | Clinical isolate | ERG11 | K143R | Single substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 |  | Fluconazole (>256) | 2021 | 34060660 |
| 31052 | C. tropicalis | Clinical isolate | ERG11 | Y132F, S154F | Double substitution | C5MGS9 | 528 | AF-C5MGS9-F1 |  | Fluconazole (256) | 2021 | 34060660 |
| 42372 | C. auris | Clinical isolate | ERG11FKS1 | Y132FS639F | Single substitutionSingle substitution | A0A2H1A309A0A2H1A4W2 | 5241888 | AF-A0A2H1A309-F1Model |  | Micafungin (8), Fluconazole (32) | 2021 | 34060660 |
| 73089 | C. auris | Clinical isolate | ERG11FKS1 | Y132FS639F | Single substitutionSingle substitution | A0A2H1A309A0A2H1A4W2 | 5241888 | AF-A0A2H1A309-F1Model |  | Anidulafungin (4), Micafungin (8), Fluconazole (16) | 2021 | 34060660 |
| 84109 | C. glabrata | Clinical isolate | FKS2 | D666V, L1303F, V1305I | Multiple substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (2), Micafungin (0.5), Fluconazole (256) | 2021 | 34060660 |
| 87120 | C. parapsilosis | Clinical isolate | ERG11 | T504S, W244L | Double substitution | G8B9T3 | 522 | AF-G8B9T3-F1 |  | Fluconazole (8) | 2021 | 34060660 |
| 89659 | C. parapsilosis | Clinical isolate | ERG11 | T504L | Single substitution | G8B9T3 | 522 | AF-G8B9T3-F1 |  | Fluconazole (8) | 2021 | 34060660 |
| ATCC MYA-3404 | C. tropicalis | Laboratory strain | ERG11 | Y132F | Single substitution | C5MGS9 | 528 | AF-C5MGS9-F1 |  | Fluconazole (>256) | 2021 | 34060660 |
| ATCC MYA-574 | C. albicans | Laboratory strain | ERG11 | F126L, K128T | Double substitution | P10613 | 528 | 5V5Z |  | Fluconazole (256) | 2021 | 34060660 |
| ATCC64124 | C. albicans | Laboratory strain | ERG11ERG3 | Y132HT329S | Single substitutionSingle substitution | P10613Q59VG6 | 528386 | 5V5ZAF-Q59VG6-F1 |  | Fluconazole (256) | 2021 | 34060660 |
| ATCC96901 | C. albicans | Laboratory strain | ERG11 | K128T, K143R | Double substitution | P10613 | 528 | 5V5Z | Structure not available | Fluconazole (256) | 2021 | 34060660 |
| I96 | C. auris | Clinical isolate | ERG11 | Y132F | Single substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 |  | Fluconazole (>256) | 2021 | 34060660 |
| K1 | C. tropicalis | Clinical isolate | ERG11 | Y132F | Single substitution | C5MGS9 | 528 | AF-C5MGS9-F1 |  | Fluconazole (256) | 2021 | 34060660 |
| K2 | C. tropicalis | Clinical isolate | ERG11 | S154F | Single substitution | C5MGS9 | 528 | AF-C5MGS9-F1 |  | Fluconazole (256) | 2021 | 34060660 |
| K4 | C. tropicalis | Clinical isolate | ERG11 | Y132F, S154F | Double substitution | C5MGS9 | 528 | AF-C5MGS9-F1 |  | Fluconazole (>256) | 2021 | 34060660 |
| K5 | C. tropicalis | Clinical isolate | ERG11 | Y132F, S154F | Double substitution | C5MGS9 | 528 | AF-C5MGS9-F1 |  | Fluconazole (256) | 2021 | 34060660 |
| Ca | C. albicans | Clinical isolate | FKS1 | S645P | Single substitution | A0A1D8PCT0 | 1897 | AF-A0A1D8PCT0-F1 |  | Anidulafungin (1), Caspofungin (8), Micafungin (4) | 2021 | 34064200 |
| Cg | C. glabrata | Clinical isolate | ERG11 | I465T, F466S | Double substitution | Q58J63 | 533 | AF-Q58J63-F1 | Mismatch residue | AZOLE | 2021 | 34101035 |
| Clade-I | C. auris | Clinical isolate | ERG11 | Y132F | Single substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 |  | Fluconazole (≥32) | 2021 | 34176429 |
| Clade-II | C. auris | Clinical isolate | ERG11FKS1 | F126LS639P | Single substitutionSingle substitution | A0A2H1A309A0A3G2LW13 | 5241888 | AF-A0A2H1A309-F1Model |  | Fluconazole (≥32), Micafungin (≥4) | 2021 | 34176429 |
| Clade-III | C. auris | Clinical isolate | ERG11 | E343D, N335S, K177A | Multiple substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 |  | Fluconazole (≥32) | 2021 | 34176429 |
| Cd | C. dubliniensis | Clinical isolate | FKS1 | S645P | Single substitution | B9W729 | 1897 | Model | Structure not available | Echinocandin | 2021 | 34205349 |
| Cg1 | C. glabrata | Clinical isolate | FKS1 | F625S | Single substitution | Q6FTN8 | 1863 | Model |  | Echinocandin | 2021 | 34205349 |
| Cg2 | C. glabrata | Clinical isolate | FKS1FKS2 | L630QS663F | Single substitutionSingle substitution | Q6FTN8Q6FMZ3 | 18631897 | ModelModel |  | Echinocandin | 2021 | 34205349 |
| Cg3 | C. glabrata | Clinical isolate | FKS2 | F659S | Single substitution | Q6FMZ3 | 1897 | Model |  | Echinocandin | 2021 | 34205349 |
| Cg4 | C. glabrata | Clinical isolate | FKS2 | F659del | Deletion | Q6FMZ3 | 1897 | Model |  | Echinocandin | 2021 | 34205349 |
| Cg5 | C. glabrata | Clinical isolate | FKS2 | L662W | Single substitution | Q6FMZ3 | 1897 | Model |  | Echinocandin | 2021 | 34205349 |
| Cg6 | C. glabrata | Clinical isolate | FKS2 | S663F | Single substitution | Q6FMZ3 | 1897 | Model |  | Echinocandin | 2021 | 34205349 |
| Cg7 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Echinocandin | 2021 | 34205349 |
| Ck | C. krusei | Clinical isolate | FKS1 | S659F | Single substitution | Q4U2W2 | 1885 | Model |  | Echinocandin | 2021 | 34205349 |
| UMS01 | C. auris | Clinical isolate | ERG11 | Y132F | Single substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 |  | Amphotericin B (2), Fluconazole (32), Caspofungin (0.5), Anidulafungin (0.5), Micafungin (0.5) | 2021 | 34340186 |
| UMS08 | C. auris | Clinical isolate | ERG11 | Y132F | Single substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 |  | Amphotericin B (2), Fluconazole (32), Caspofungin (0.5), Anidulafungin (0.25), Micafungin (0.25) | 2021 | 34340186 |
| UMS27 | C. auris | Clinical isolate | ERG11 | Y132F | Single substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 |  | Amphotericin B (2), Fluconazole (32), Caspofungin (0.5), Anidulafungin (0.5), Micafungin (0.5) | 2021 | 34340186 |
| UMS41 | C. auris | Clinical isolate | ERG11 | Y132F | Single substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 |  | Amphotericin B (2), Fluconazole (32), Caspofungin (0.5), Anidulafungin (0.5), Micafungin (0.5) | 2021 | 34340186 |
| UMS44 | C. auris | Clinical isolate | ERG11 | Y132F | Single substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 |  | Amphotericin B (2), Fluconazole (32), Caspofungin (0.5), Anidulafungin (0.5), Micafungin (0.5) | 2021 | 34340186 |
| UMS46 | C. auris | Clinical isolate | ERG11 | Y132F | Single substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 |  | Amphotericin B (2), Fluconazole (32), Caspofungin (0.5), Anidulafungin (0.5), Micafungin (0.5) | 2021 | 34340186 |
| UMS47 | C. auris | Clinical isolate | ERG11 | Y132F | Single substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 |  | Amphotericin B (2), Fluconazole (16), Caspofungin (0.5), Anidulafungin (0.5), Micafungin (0.25) | 2021 | 34340186 |
| UMS48 | C. auris | Clinical isolate | ERG11 | Y132F | Single substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 |  | Amphotericin B (2), Fluconazole (16), Caspofungin (0.5), Anidulafungin (0.5), Micafungin (0.25) | 2021 | 34340186 |
| UMS50 | C. auris | Environmental source | ERG11 | Y132F | Single substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 |  | Amphotericin B (2), Fluconazole (32), Caspofungin (0.5), Anidulafungin (0.5), Micafungin (0.5) | 2021 | 34340186 |
| UMS51 | C. auris | Environmental source | ERG11 | Y132F | Single substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 |  | Amphotericin B (2), Fluconazole (16), Caspofungin (0.25), Anidulafungin (0.25), Micafungin (0.5) | 2021 | 34340186 |
| 2016-058 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | E2GKZ6 | 1897 | Model |  | Anidulafungin (4), Caspofungin (>8), Fluconazole (>64) | 2021 | 34377983 |
| 2016-064 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | E2GKZ6 | 1897 | Model |  | Anidulafungin (4), Caspofungin (>8), Fluconazole (>64) | 2021 | 34377983 |
| 2016-144 | C. glabrata | Clinical isolate | FKS2 | F659S | Single substitution | E2GKZ6 | 1897 | Model |  | Anidulafungin (0.5), Caspofungin (2), Fluconazole (>64) | 2021 | 34377983 |
| 2017-041 | C. glabrata | Clinical isolate | FKS2 | F659del | Deletion | E2GKZ6 | 1897 | Model |  | Anidulafungin (2), Caspofungin (>8), Fluconazole (32) | 2021 | 34377983 |
| 2017-252 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | E2GKZ6 | 1897 | Model |  | Anidulafungin (2), Caspofungin (>8), Fluconazole (64) | 2021 | 34377983 |
| 2017-312 | C. glabrata | Clinical isolate | FKS2 | D666N | Single substitution | E2GKZ6 | 1897 | Model |  | Anidulafungin (0.125), Caspofungin (0.5), Fluconazole (>64) | 2021 | 34377983 |
| 2018-067 | C. glabrata | Clinical isolate | FKS1 | F625C | Single substitution | E2GKZ3 | 1863 | Model |  | Anidulafungin (1), Caspofungin (8), Fluconazole (>64) | 2021 | 34377983 |
| 2018-462 | C. glabrata | Clinical isolate | FKS2 | P667T | Single substitution | E2GKZ6 | 1897 | Model |  | Anidulafungin (0.5), Caspofungin (2), Fluconazole (64) | 2021 | 34377983 |
| 2019-615 | C. glabrata | Clinical isolate | FKS2 | F659del | Deletion | E2GKZ6 | 1897 | Model |  | Anidulafungin (1), Caspofungin (>8), Fluconazole (32) | 2021 | 34377983 |
| NCU_B011 | C. haemulonii | Clinical isolate | ERG11 | Y132H | Single substitution | A0A2V1B011 | 524 | AF-A0A2V1B011-F1 |  | Fluconazole (128)Voriconazole (8) | 2021 | 34604110 |
| NCU_B128 | C. tropicalis | Clinical isolate | ERG11 | Y132F, S154F | Double substitution | P14263 | 528 | AF-P14263-F1 |  | Fluconazole (2), Voriconazole (0.12) | 2021 | 34604110 |
| NCU_B136 | C. parapsilosis | Clinical isolate | ERG11 | Y132F, R398I | Double substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (0.5) | 2021 | 34604110 |
| NCU_B138 | C. albicans | Clinical isolate | ERG11 | T123I, Y132H | Double substitution | P10613 | 528 | 5V5Z |  | Fluconazole (0.25) | 2021 | 34604110 |
| NCU_B147 | C. tropicalis | Clinical isolate | ERG11 | S154F, D454N | Double substitution | P14263 | 528 | AF-P14263-F1 | Mismatch residue | Fluconazole (2), Voriconazole (0.12) | 2021 | 34604110 |
| NCU_B149 | C. albicans | Clinical isolate | ERG11 | A114S | Single substitution | P10613 | 528 | 5V5Z |  | Fluconazole (0.25), Voriconazole (≤0.08) | 2021 | 34604110 |
| NCU_B154 | C. albicans | Clinical isolate | ERG11 | A114S | Single substitution | P10613 | 528 | 5V5Z |  | Fluconazole (0.25), Voriconazole (≤0.08) | 2021 | 34604110 |
| A3 | C. auris | Clinical isolate | ERG11 | V125A, F126L | Double substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 |  | Fluconazole (>128), Voriconazole (1), Posaconazole (0.25), Itraconazole (1) | 2022 | 34633842 |
| A4 | C. auris | Clinical isolate | ERG11 | V125A, F126L | Double substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 |  | Fluconazole (>128), Voriconazole (1), Posaconazole (0.25), Itraconazole (1) | 2022 | 34633842 |
| A6 | C. auris | Clinical isolate | ERG11 | V125A, F126L | Double substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 |  | Fluconazole (>128), Voriconazole (0.25), Posaconazole (0.125), Itraconazole (1) | 2022 | 34633842 |
| A7 | C. auris | Clinical isolate | ERG11 | V125A, F126L | Double substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 |  | Fluconazole (>128), Voriconazole (0.25), Posaconazole (0.25), Itraconazole (1) | 2022 | 34633842 |
| A8 | C. auris | Clinical isolate | ERG11 | V125A, F126L | Double substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 |  | Fluconazole (>128), Voriconazole (0.5), Posaconazole (0.25), Itraconazole (1) | 2022 | 34633842 |
| AR-0383 | C. auris | Clinical isolate | ERG11 | V125A, F126L | Double substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 |  | Fluconazole (>128), Voriconazole (1), Itraconazole (0.125) | 2022 | 34633842 |
| AR-0384 | C. auris | Clinical isolate | ERG11 | V125A, F126L | Double substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 |  | Fluconazole (>128), Voriconazole (1), Itraconazole (0.25) | 2022 | 34633842 |
| SA1 | C. auris | Clinical isolate | ERG11 | V125A, F126L | Double substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 |  | Fluconazole (>128), Voriconazole (1), Posaconazole (0.125), Itraconazole (0.25) | 2022 | 34633842 |
| SA10 | C. auris | Clinical isolate | ERG11 | V125A, F126L | Double substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 |  | Fluconazole (>128), Voriconazole (1), Posaconazole (0.125), Itraconazole (0.5) | 2022 | 34633842 |
| SA11 | C. auris | Clinical isolate | ERG11 | V125A, F126L | Double substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 |  | Fluconazole (>128), Voriconazole (1), Itraconazole (1) | 2022 | 34633842 |
| SA12 | C. auris | Clinical isolate | ERG11 | V125A, F126L | Double substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 |  | Fluconazole (>128), Voriconazole (1), Itraconazole (0.25) | 2022 | 34633842 |
| SA13 | C. auris | Clinical isolate | ERG11 | V125A, F126L | Double substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 |  | Fluconazole (8), Voriconazole (1), Itraconazole (0.25) | 2022 | 34633842 |
| SA14 | C. auris | Clinical isolate | ERG11 | V125A, F126L | Double substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 |  | Fluconazole (>128), Voriconazole (2), Itraconazole (0.5) | 2022 | 34633842 |
| SA15 | C. auris | Clinical isolate | ERG11 | V125A, F126L | Double substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 |  | Fluconazole (8), Voriconazole (1), Itraconazole (0.5) | 2022 | 34633842 |
| SA16 | C. auris | Clinical isolate | ERG11 | V125A, F126L | Double substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 |  | Fluconazole (8), Voriconazole (1), Itraconazole (0.5) | 2022 | 34633842 |
| SA17 | C. auris | Clinical isolate | ERG11 | V125A, F126L | Double substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 |  | Fluconazole (>128), Voriconazole (1), Itraconazole (0.25) | 2022 | 34633842 |
| SA18 | C. auris | Clinical isolate | ERG11 | V125A, F126L | Double substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 |  | Fluconazole (128), Voriconazole (0.5), Itraconazole (0.5) | 2022 | 34633842 |
| SA19 | C. auris | Clinical isolate | ERG11 | V125A, F126L | Double substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 |  | Fluconazole (128), Voriconazole (2), Itraconazole (0.25) | 2022 | 34633842 |
| SA2 | C. auris | Clinical isolate | ERG11 | V125A, F126L | Double substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 |  | Fluconazole (>128), Voriconazole (0.5), Posaconazole (0.125), Itraconazole (0.5) | 2022 | 34633842 |
| SA22 | C. auris | Clinical isolate | ERG11 | V125A, F126L | Double substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 |  | Fluconazole (128), Voriconazole (0.5), Posaconazole (0.25), Itraconazole (0.5) | 2022 | 34633842 |
| SA23 | C. auris | Clinical isolate | ERG11 | V125A, F126L | Double substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 |  | Fluconazole (>128), Voriconazole (8), Posaconazole (0.25), Itraconazole (0.5) | 2022 | 34633842 |
| SA3 | C. auris | Clinical isolate | ERG11 | V125A, F126L | Double substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 |  | Fluconazole (>128), Voriconazole (1), Itraconazole (0.5) | 2022 | 34633842 |
| SA4 | C. auris | Clinical isolate | ERG11 | V125A, F126L | Double substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 |  | Fluconazole (>128), Voriconazole (1), Itraconazole (0.5) | 2022 | 34633842 |
| SA5 | C. auris | Clinical isolate | ERG11 | V125A, F126L | Double substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 |  | Fluconazole (>128), Voriconazole (2), Itraconazole (0.5) | 2022 | 34633842 |
| SA6 | C. auris | Clinical isolate | ERG11 | V125A, F126L | Double substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 |  | Fluconazole (>128), Voriconazole (1), Itraconazole (0.5) | 2022 | 34633842 |
| SA7 | C. auris | Clinical isolate | ERG11 | V125A, F126L | Double substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 |  | Fluconazole (>128), Voriconazole (1), Posaconazole (0.125), Itraconazole (0.5) | 2022 | 34633842 |
| SA8 | C. auris | Clinical isolate | ERG11 | V125A, F126L | Double substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 |  | Fluconazole (>128), Voriconazole (1), Itraconazole (0.25) | 2022 | 34633842 |
| SA9 | C. auris | Clinical isolate | ERG11 | V125A, F126L | Double substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 |  | Fluconazole (>128), Voriconazole (1), Itraconazole (0.5) | 2022 | 34633842 |
| BMU10720 | C. glabrata | Clinical isolate | FKS2PDR1 | S663PP76S, P143T, D243N | Single substitutionMultiple substitution | Q6FMZ3Q66WF3 | 18971107 | ModelAF-Q66WF3-F1 |  | Posaconazole (4), Itraconazole (2), Caspofungin (32), Micafungin (8), Anidulafungin (4) | 2021 | 34680798 |
| BMU10722 | C. glabrata | Clinical isolate | FKS2PDR1 | S663PP76S, P143T, D243N | Single substitutionMultiple substitution | Q6FMZ3Q66WF3 | 18971107 | ModelAF-Q66WF3-F1 |  | Posaconazole (4), Itraconazole (2), Caspofungin (32), Micafungin (8), Anidulafungin (4) | 2021 | 34680798 |
| NCCPF470197 | C. auris | Clinical isolate | FKS1 | F635Y | Single substitution | A0A0L0P0U2 | 1888 | Model |  | Caspofungin (16) | 2022 | 34780273 |
| NCCPF470198 | C. auris | Clinical isolate | FKS1 | S639F | Single substitution | A0A0L0P0U2 | 1888 | Model |  | Caspofungin (4), Anidulafungin (4) | 2022 | 34780273 |
| NCCPF470199 | C. auris | Clinical isolate | FKS1 | S639F | Single substitution | A0A0L0P0U2 | 1888 | Model |  | Caspofungin (4), Anidulafungin (4) | 2022 | 34780273 |
| NCCPF470200 | C. auris | Clinical isolate | FKS1 | R1354S | Single substitution | A0A0L0P0U2 | 1888 | Model |  | Caspofungin (16) | 2022 | 34780273 |
| NCCPF470203 | C. auris | Clinical isolate | FKS1 | S639F | Single substitution | A0A0L0P0U2 | 1888 | Model |  | Caspofungin (2), Anidulafungin (8), Micafungin (16) | 2022 | 34780273 |
| NCCPF470209 | C. auris | Clinical isolate | FKS1 | F635Y | Single substitution | A0A0L0P0U2 | 1888 | Model |  | Caspofungin (4) | 2022 | 34780273 |
| AR0390 | C. auris | Clinical isolate | ERG11TAC1 | K143RA640V | Single substitutionSingle substitution | A0A411K953A0A2H0ZLE8 | 524418 | AF-A0A411K953-F1AF-A0A2H0ZLE8-F1 |  | Fluconazole (256) | 2021 | 34878305 |
| AR0390-ERG11k143r | C. auris | Laboratory strain | ERG11 | K143R | Single substitution | A0A411K953 | 524 | AF-A0A411K953-F1 | Mismatch residue | Fluconazole (128) | 2021 | 34878305 |
| CAGL1256 | C. glabrata | Clinical isolate | FKS2 | F659del | Deletion | Q6FMZ3 | 1897 | Model |  | Caspofungin (>0.5) | 2022 | 34893830 |
| CAGL1875 | C. glabrata | Clinical isolate | FKS2 | F659del | Deletion | Q6FMZ3 | 1897 | Model |  | Caspofungin (>0.5) | 2022 | 34893830 |
| Ca1 | C. auris | Clinical isolate | ERG11 | Y132F, K143R | Double substitution | A0A2Z4EHX0 | 524 | AF-A0A2Z4EHX0-F1 |  | Fluconazole (>=32), Itraconazole (0.125), Voriconazole (0.5) | 2021 | 34904116 |
| Ca10 | C. auris | Clinical isolate | ERG11 | Y132F, K143R | Double substitution | A0A2Z4EHX0 | 524 | AF-A0A2Z4EHX0-F1 |  | Fluconazole (>=32), 5-Flucytosine (>=32) | 2021 | 34904116 |
| Ca11 | C. auris | Clinical isolate | ERG11 | Y132F, K143R | Double substitution | A0A2Z4EHX0 | 524 | AF-A0A2Z4EHX0-F1 |  | Fluconazole (>=32), 5-Flucytosine (>=32), Amphotericin B (>=2) | 2021 | 34904116 |
| Ca12 | C. auris | Clinical isolate | ERG11 | Y132F, K143R | Double substitution | A0A2Z4EHX0 | 524 | AF-A0A2Z4EHX0-F1 |  | Fluconazole (>=32), 5-Flucytosine (>=32), Amphotericin B (>=2) | 2021 | 34904116 |
| Ca13 | C. auris | Clinical isolate | ERG11 | Y132F, K143R | Double substitution | A0A2Z4EHX0 | 524 | AF-A0A2Z4EHX0-F1 |  | Fluconazole (>=32), 5-Flucytosine (>=32), Amphotericin B (>=2) | 2021 | 34904116 |
| Ca14 | C. auris | Clinical isolate | ERG11 | Y132F, K143R | Double substitution | A0A2Z4EHX0 | 524 | AF-A0A2Z4EHX0-F1 |  | Fluconazole (>=32) | 2021 | 34904116 |
| Ca2 | C. auris | Clinical isolate | ERG11 | Y132F, K143R | Double substitution | A0A2Z4EHX0 | 524 | AF-A0A2Z4EHX0-F1 |  | Fluconazole (>=32), Itraconazole (0.125), Voriconazole (0.5) | 2021 | 34904116 |
| Ca3 | C. auris | Clinical isolate | ERG11 | Y132F, K143R | Double substitution | A0A2Z4EHX0 | 524 | AF-A0A2Z4EHX0-F1 |  | Fluconazole (>=32), Itraconazole (0.125), Voriconazole (0.5) | 2021 | 34904116 |
| Ca4 | C. auris | Clinical isolate | ERG11 | Y132F, K143R | Double substitution | A0A2Z4EHX0 | 524 | AF-A0A2Z4EHX0-F1 |  | Fluconazole (>=32), 5-Flucytosine (>=32) | 2021 | 34904116 |
| Ca5 | C. auris | Clinical isolate | ERG11 | Y132F, K143R | Double substitution | A0A2Z4EHX0 | 524 | AF-A0A2Z4EHX0-F1 |  | Fluconazole (>=32), 5-Flucytosine (>=32) | 2021 | 34904116 |
| Ca6 | C. auris | Clinical isolate | ERG11 | Y132F, K143R | Double substitution | A0A2Z4EHX0 | 524 | AF-A0A2Z4EHX0-F1 |  | Fluconazole (>=32), 5-Flucytosine (>=32) | 2021 | 34904116 |
| Ca7 | C. auris | Clinical isolate | ERG11 | Y132F, K143R | Double substitution | A0A2Z4EHX0 | 524 | AF-A0A2Z4EHX0-F1 |  | Fluconazole (>=32), 5-Flucytosine (>=32) | 2021 | 34904116 |
| Ca8 | C. auris | Clinical isolate | ERG11 | Y132F, K143R | Double substitution | A0A2Z4EHX0 | 524 | AF-A0A2Z4EHX0-F1 |  | Fluconazole (>=32), 5-Flucytosine (>=32) | 2021 | 34904116 |
| Ca9 | C. auris | Clinical isolate | ERG11 | Y132F, K143R | Double substitution | A0A2Z4EHX0 | 524 | AF-A0A2Z4EHX0-F1 |  | Fluconazole (>=32), 5-Flucytosine (>=32) | 2021 | 34904116 |
| Ct | C. tropicalis | Clinical isolate | ERG11 | Y132F, S154F | Double substitution | P14263 | 528 | AF-P14263-F1 |  | Fluconazole (128), Voriconazole (2) | 2021 | 34904116 |
| isolate2 | C. glabrata | Clinical isolate | FKS2 | R1377K | Single substitution | E2GKZ6 | 1897 | Model |  | Micafungin (0.0625), Anidulafungin (0.125) | 2021 | 34976835 |
| isolate3 | C. glabrata | Clinical isolate | FKS2 | F659del, R1377K | Complex | E2GKZ6 | 1897 | Model | Structure not available | Micafungin (0.25), Anidulafungin (0.5) | 2021 | 34976835 |
| A2 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Micafungin (4), Caspofungin (8) | 2022 | 35107318 |
| B2 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Micafungin (4), Caspofungin (8) | 2022 | 35107318 |
| patient 3 | C. tropicalis | Clinical isolate | ERG11 | Y132F, S154F | Double substitution | C5MGS9 | 528 | AF-C5MGS9-F1 |  | Fluconazole (64), Itraconazole (1), Voriconazole (0.5) | 2022 | 35140478 |
| 10C1B1I1 | C. albicans | Clinical isolate | ERG11 | K143R | Single substitution | P10613 | 528 | 5V5Z |  | Fluconazole | 2022 | 35163552 |
| 17-02/20 | C. parapsilosis | Clinical isolate | ERG11 | Y132F, R398I | Double substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole | 2022 | 35205855 |
| 19-02/20 | C. parapsilosis | Clinical isolate | ERG11 | Y132F, R398I | Double substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole | 2022 | 35205855 |
| 22-02/20 | C. parapsilosis | Clinical isolate | ERG11 | Y132F, R398I | Double substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole | 2022 | 35205855 |
| 27-02/20 | C. parapsilosis | Clinical isolate | ERG11 | Y132F, R398I | Double substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole | 2022 | 35205855 |
| 28-02/20 | C. parapsilosis | Clinical isolate | ERG11 | Y132F, R398I | Double substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole | 2022 | 35205855 |
| 35-02/20 | C. parapsilosis | Clinical isolate | ERG11 | Y132F, R398I | Double substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole | 2022 | 35205855 |
| 36-02/20 | C. parapsilosis | Clinical isolate | ERG11 | Y132F, R398I | Double substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole | 2022 | 35205855 |
| 40-02/20 | C. parapsilosis | Clinical isolate | ERG11 | Y132F, R398I | Double substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole | 2022 | 35205855 |
| 43864 | C. parapsilosis | Clinical isolate | ERG11 | Y132F, R398I | Double substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole | 2022 | 35205855 |
| 43865 | C. parapsilosis | Clinical isolate | ERG11 | Y132F, R398I | Double substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole | 2022 | 35205855 |
| 44-02/20 | C. parapsilosis | Clinical isolate | ERG11 | Y132F, R398I | Double substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole | 2022 | 35205855 |
| 47-02/20 | C. parapsilosis | Clinical isolate | ERG11 | Y132F, R398I | Double substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole | 2022 | 35205855 |
| 49-02/20 | C. parapsilosis | Clinical isolate | ERG11 | Y132F, R398I | Double substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole | 2022 | 35205855 |
| 50-02/20 | C. parapsilosis | Clinical isolate | ERG11 | Y132F, R398I | Double substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole | 2022 | 35205855 |
| 51-02/20 | C. parapsilosis | Clinical isolate | ERG11 | Y132F, R398I | Double substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole | 2022 | 35205855 |
| 54-02/20 | C. parapsilosis | Clinical isolate | ERG11 | Y132F, R398I | Double substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole | 2022 | 35205855 |
| 57-02/20 | C. parapsilosis | Clinical isolate | ERG11 | R398I | Single substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole | 2022 | 35205855 |
| 63-02/20 | C. parapsilosis | Clinical isolate | ERG11 | Y132F, R398I | Double substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole | 2022 | 35205855 |
| 65-02/20 | C. parapsilosis | Clinical isolate | ERG11 | Y132F, R398I | Double substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole | 2022 | 35205855 |
| 77-02/20 | C. parapsilosis | Clinical isolate | ERG11 | Y132F, R398I | Double substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole | 2022 | 35205855 |
| 81-02/20 | C. parapsilosis | Clinical isolate | ERG11 | Y132F, R398I | Double substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole | 2022 | 35205855 |
| 83-02/20 | C. parapsilosis | Clinical isolate | ERG11 | Y132F, R398I | Double substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole | 2022 | 35205855 |
| 84-02/20 | C. parapsilosis | Clinical isolate | ERG11 | Y132F, R398I | Double substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole | 2022 | 35205855 |
| AUH-379 | C. glabrata | Clinical isolate | FKS2 | S663F | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (1) | 2022 | 35323941 |
| SSI-2250 | C. glabrata | Clinical isolate | FKS2 | S663F | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (2) | 2022 | 35323941 |
| SSI-3203 | C. glabrata | Clinical isolate | FKS1 | S629P | Single substitution | Q6FTN8 | 1863 | Model |  | Anidulafungin (2), Fluconazole (>32) | 2022 | 35323941 |
| SSI-3775 | C. glabrata | Clinical isolate | FKS2 | F659S | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (2) | 2022 | 35323941 |
| SSI-4843 | C. glabrata | Clinical isolate | FKS1FKS2 | L630QS663F | Single substitutionSingle substitution | Q6FTN8Q6FMZ3 | 18631897 | ModelModel |  | Anidulafungin (1) | 2022 | 35323941 |
| SSI-4857 | C. glabrata | Clinical isolate | FKS2 | L712stop, F659del | Complex | Q6FMZ3 | 1897 | Model | Mismatch residue | Anidulafungin (4), Fluconazole (>32) | 2022 | 35323941 |
| SSI-5128 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (2), Fluconazole (>32) | 2022 | 35323941 |
| SSI-5324 | C. glabrata | Clinical isolate | FKS2 | F659del | Deletion | Q6FMZ3 | 1897 | Model |  | Anidulafungin (2), Fluconazole (32) | 2022 | 35323941 |
| SSI-6133 | C. glabrata | Clinical isolate | FKS2 | D663E | Single substitution | Q6FMZ3 | 1897 | Model | Mismatch residue | Anidulafungin (0.25), Fluconazole (32) | 2022 | 35323941 |
| SSI-7033 | C. glabrata | Clinical isolate | FKS2 | I662W | Single substitution | Q6FMZ3 | 1897 | Model | Mismatch residue | Anidulafungin (0.5), Fluconazole (>32) | 2022 | 35323941 |
| KW108/18 | C. auris | Clinical isolate | ERG11FKS1 | K143RS639T | Single substitutionSingle substitution | A0A2H1A309A0A3G2LW13 | 5241888 | AF-A0A2H1A309-F1Model |  | Fluconazole (>=128), Micafungin (0.125), Anidulafungin (0.25) | 2022 | 35330269 |
| KW3506/17 | C. auris | Clinical isolate | ERG11 | K143R | Single substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 |  | Fluconazole (>=128) | 2022 | 35330269 |
| KW3525/17 | C. auris | Clinical isolate | ERG11 | K143R | Single substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 |  | Fluconazole (>=128) | 2022 | 35330269 |
| KW3584/17 | C. auris | Clinical isolate | ERG11 | K143R | Single substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 |  | Fluconazole (>=128), Itraconazole (1) | 2022 | 35330269 |
| KW60/18 | C. auris | Clinical isolate | ERG11 | K143R | Single substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 |  | Fluconazole (>=128) | 2022 | 35330269 |
| KW87/18 | C. auris | Clinical isolate | ERG11FKS1 | K143RS639T | Single substitutionSingle substitution | A0A2H1A309A0A3G2LW13 | 5241888 | AF-A0A2H1A309-F1Model |  | Fluconazole (>=128), Micafungin (0.125), Anidulafungin (0.25) | 2022 | 35330269 |
| KW93/18 | C. auris | Clinical isolate | ERG11FKS1 | K143RS639T | Single substitutionSingle substitution | A0A2H1A309A0A3G2LW13 | 5241888 | AF-A0A2H1A309-F1Model |  | Fluconazole (>=128), Anidulafungin (1), Micafungin (1) | 2022 | 35330269 |
| III.7 | C. auris | Clinical isolate | ERG11MRR1 | F126LN647T | Single substitutionSingle substitution | A0A2H1A309UMZ08618.1 (NCBI) | 5241133 | AF-A0A2H1A309-F1Model |  | Fluconazole (>256) | 2022 | 35343781 |
| III.8 | C. auris | Clinical isolate | ERG11MRR1 | F126LN647T | Single substitutionSingle substitution | A0A2H1A309UMZ08618.1 (NCBI) | 5241133 | AF-A0A2H1A309-F1Model |  | Fluconazole (512), Voriconazole (2), Itraconazole (4) | 2022 | 35343781 |
| III.9 | C. auris | Clinical isolate | ERG11MRR1 | F126LN647T | Single substitutionSingle substitution | A0A2H1A309UMZ08618.1 (NCBI) | 5241133 | AF-A0A2H1A309-F1Model |  | Fluconazole (>256) | 2022 | 35343781 |
| ISOLATE 35 | C. parapsilosis | Clinical isolate | ERG11 | Y132F | Single substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (>=4) | 2022 | 35345665 |
| ISOLATE 37 | C. parapsilosis | Clinical isolate | ERG11 | Y132F | Single substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (>=4) | 2022 | 35345665 |
| FFUL443 | C. glabrata | Clinical isolate | PDR1 | S76P, L98S, T143P, I392M | Multiple substitution | Q6FXU7 | 1107 | AF-Q6FXU7-F1 |  | Fluconazole (>64), Voriconazole (2) | 2022 | 35532173 |
| FFUL674 | C. glabrata | Clinical isolate | PDR1 | L98S, D243N, I803T | Multiple substitution | Q6FXU7 | 1107 | AF-Q6FXU7-F1 |  | Fluconazole (>64), Voriconazole (2) | 2022 | 35532173 |
| FFUL866 | C. glabrata | Clinical isolate | PDR1 | L98S, D243N, E555K | Multiple substitution | Q6FXU7 | 1107 | AF-Q6FXU7-F1 |  | | 2022 | 35532173 |
| ISTA56 | C. glabrata | Clinical isolate | PDR1 | L98S, D243N, G558C | Multiple substitution | Q6FXU7 | 1107 | AF-Q6FXU7-F1 |  | Fluconazole (>64), Voriconazole (>8) | 2022 | 35532173 |
| ISTB218 | C. glabrata | Clinical isolate | PDR1 | L98S, D243N | Double substitution | Q6FXU7 | 1107 | AF-Q6FXU7-F1 |  | Fluconazole (>64), Voriconazole (4) | 2022 | 35532173 |
| ISTB556 | C. glabrata | Clinical isolate | PDR1 | L98S, D243N, R376W | Multiple substitution | Q6FXU7 | 1107 | AF-Q6FXU7-F1 |  | Fluconazole (>64), Voriconazole (4) | 2022 | 35532173 |
| ISTB607 | C. glabrata | Clinical isolate | PDR1 | L98S, D243N, R376W | Multiple substitution | Q6FXU7 | 1107 | AF-Q6FXU7-F1 |  | Fluconazole (>64), Voriconazole (4) | 2022 | 35532173 |
| 10 (United Kingdom) | C. glabrata | Clinical isolate | MSH2PDR1 | P208S, N890IS942F | Double substitutionSingle substitution | Q6FQA9Q6FXU7 | 9571107 | AF-Q6FQA9-F1AF-Q6FXU7-F1 |  | Fluconazole (64) | 2022 | 35577042 |
| 10 (USA) | C. glabrata | Clinical isolate | MSH2PDR1 | P208S, N890IS391L | Double substitutionSingle substitution | Q6FQA9Q6FXU7 | 9571107 | AF-Q6FQA9-F1AF-Q6FXU7-F1 |  | Fluconazole (128) | 2022 | 35577042 |
| 11 (USA) | C. glabrata | Clinical isolate | MSH2PDR1 | A942T, V239LG346S | Double substitutionSingle substitution | Q6FQA9Q6FXU7 | 9571107 | AF-Q6FQA9-F1AF-Q6FXU7-F1 |  | Fluconazole (128) | 2022 | 35577042 |
| 16 (USA) | C. glabrata | Clinical isolate | MSH2PDR1PDR1FKS2MSH2PDR1 | E231G, L269FR761ST292KF663PE231G, L269FS216R | Double substitutionSingle substitutionSingle substitutionSingle substitutionDouble substitutionSingle substitution | Q6FQA9Q6FXU7Q6FXU7Q6FMZ3Q6FQA9Q6FXU7 | 9571107110718979571107 | AF-Q6FQA9-F1AF-Q6FXU7-F1AF-Q6FXU7-F1ModelAF-Q6FQA9-F1AF-Q6FXU7-F1 |  | Fluconazole (64) Fluconazole (128), Anidulafungin (1), Caspofungin (0.5), Micafungin (0.5) | 2022 | 35577042 |
| 177 (Germany) | C. glabrata | Clinical isolate | PDR1 | G334W, E492K, N496S | Multiple substitution | Q6FXU7 | 1107 | AF-Q6FXU7-F1 |  | Fluconazole (128) | 2022 | 35577042 |
| 19 (Canada) | C. glabrata | Clinical isolate | PDR1 | D554G | Single substitution | Q6FXU7 | 1107 | AF-Q6FXU7-F1 |  | Fluconazole (128) | 2022 | 35577042 |
| 19 (USA) | C. glabrata | Clinical isolate | FKS2PDR1PDR1 | S663PN1086YW297C | Single substitutionSingle substitutionSingle substitution | Q6FMZ3Q6FXU7Q6FXU7 | 189711071107 | ModelAF-Q6FXU7-F1AF-Q6FXU7-F1 |  | Fluconazole (128), Anidulafungin (0.25), Micafungin (0.12) Fluconazole (64) | 2022 | 35577042 |
| 2 (Germany) | C. glabrata | Clinical isolate | MSH2PDR1 | A942T, V239LA731E | Double substitutionSingle substitution | Q6FQA9Q6FXU7 | 9571107 | AF-Q6FQA9-F1AF-Q6FXU7-F1 |  | Fluconazole (64) | 2022 | 35577042 |
| 2 (Sweden) | C. glabrata | Clinical isolate | MSH2PDR1 | A942T, V239LE369D | Double substitutionSingle substitution | Q6FQA9Q6FXU7 | 9571107 | AF-Q6FQA9-F1AF-Q6FXU7-F1 |  | Fluconazole (128) | 2022 | 35577042 |
| 200 (Korea) | C. glabrata | Clinical isolate | MSH2PDR1 | V239LR956G | Single substitutionSingle substitution | Q6FQA9Q6FXU7 | 9571107 | AF-Q6FQA9-F1AF-Q6FXU7-F1 |  | Fluconazole (64) | 2022 | 35577042 |
| 26 (Korea) | C. glabrata | Clinical isolate | PDR1 | E555K | Single substitution | Q6FXU7 | 1107 | AF-Q6FXU7-F1 |  | Fluconazole (128) | 2022 | 35577042 |
| 26 (USA) | C. glabrata | Clinical isolate | PDR1 | G611S, S1048F | Double substitution | Q6FXU7 | 1107 | AF-Q6FXU7-F1 |  | Fluconazole (64) | 2022 | 35577042 |
| 3 (Spain) | C. glabrata | Clinical isolate | PDR1PDR1PDR1 | P76S, P143T, D243N, L344SP76S, P143T, D243N, W297LP76S, P143T, D243N, W297L | Multiple substitutionMultiple substitutionMultiple substitution | Q6FXU7Q6FXU7Q6FXU7 | 110711071107 | AF-Q6FXU7-F1AF-Q6FXU7-F1AF-Q6FXU7-F1 |  | Fluconazole (128) Fluconazole (64) | 2022 | 35577042 |
| 3 (USA) | C. glabrata | Clinical isolate | FKS2PDR1PDR1PDR1PDR1 | F659delP76S, P143T, D243NP76S, P143T, D243N, G583SP76S, P143T, D243N, S337FP76S, P143T, D243N, S391L | DeletionMultiple substitutionMultiple substitutionMultiple substitutionMultiple substitution | Q6FMZ3Q6FXU7Q6FXU7Q6FXU7Q6FXU7 | 18971107110711071107 | ModelAF-Q6FXU7-F1AF-Q6FXU7-F1AF-Q6FXU7-F1AF-Q6FXU7-F1 |  | Fluconazole (64), Micafungin (0.25) Fluconazole (64) Fluconazole (128) | 2022 | 35577042 |
| 45 (Czech republic) | C. glabrata | Clinical isolate | PDR1 | R250K, L280F | Double substitution | Q6FXU7 | 1107 | AF-Q6FXU7-F1 |  | Fluconazole (64) | 2022 | 35577042 |
| 55 (USA) | C. glabrata | Clinical isolate | PDR1 | E259G, G1099S | Double substitution | Q6FXU7 | 1107 | AF-Q6FXU7-F1 |  | Fluconazole (64) | 2022 | 35577042 |
| 6 (Slovenia) | C. glabrata | Clinical isolate | FKS2PDR1 | F659YG346D | Single substitutionSingle substitution | Q6FMZ3Q6FXU7 | 18971107 | ModelAF-Q6FXU7-F1 |  | Fluconazole (128), Anidulafungin (1) Fluconazole (128) | 2022 | 35577042 |
| 6 (Spain) | C. glabrata | Clinical isolate | MSH2PDR1PDR1 | I720TH576YK778E | Single substitutionSingle substitutionSingle substitution | Q6FQA9Q6FXU7Q6FXU7 | 95711071107 | AF-Q6FQA9-F1AF-Q6FXU7-F1AF-Q6FXU7-F1 |  | Fluconazole (128) Fluconazole (64) | 2022 | 35577042 |
| 7 (Belgium) | C. glabrata | Clinical isolate | MSH2PDR1 | V239LV329A, T885A | Single substitutionDouble substitution | Q6FQA9Q6FXU7 | 9571107 | AF-Q6FQA9-F1AF-Q6FXU7-F1 |  | Fluconazole (64) | 2022 | 35577042 |
| 7 (Ireland) | C. glabrata | Clinical isolate | MSH2PDR1 | V239LN928I | Single substitutionSingle substitution | Q6FQA9Q6FXU7 | 9571107 | AF-Q6FQA9-F1AF-Q6FXU7-F1 |  | Fluconazole (64) | 2022 | 35577042 |
| 7 (Slovenia) | C. glabrata | Clinical isolate | MSH2PDR1 | V239LT1080I | Single substitutionSingle substitution | Q6FQA9Q6FXU7 | 9571107 | AF-Q6FQA9-F1AF-Q6FXU7-F1 |  | Fluconazole (64) | 2022 | 35577042 |
| 7 (USA) | C. glabrata | Clinical isolate | MSH2PDR1 | V239LS316I | Single substitutionSingle substitution | Q6FQA9Q6FXU7 | 9571107 | AF-Q6FQA9-F1AF-Q6FXU7-F1 |  | Fluconazole (64) | 2022 | 35577042 |
| 8 (USA) | C. glabrata | Clinical isolate | MSH2PDR1MSH2 | A942T, V239LD554GA942T, V239L | Double substitutionSingle substitutionDouble substitution | Q6FQA9Q6FXU7Q6FQA9 | 9571107957 | AF-Q6FQA9-F1AF-Q6FXU7-F1AF-Q6FQA9-F1 |  | Fluconazole (128) Fluconazole (64) | 2022 | 35577042 |
| Cp1 | C. parapsilosis | Clinical isolate | MRR1 | A854V | Single substitution | G8BAV4 | 1128 | AF-G8BAV4-F1 |  | Fluconazole (16) | 2022 | 35699442 |
| Cp10 | C. parapsilosis | Clinical isolate | MRR1 | A854V | Single substitution | G8BAV4 | 1128 | AF-G8BAV4-F1 |  | Fluconazole (16) | 2022 | 35699442 |
| Cp12 | C. parapsilosis | Clinical isolate | MRR1 | P255L, A854V | Double substitution | G8BAV4 | 1128 | AF-G8BAV4-F1 |  | Fluconazole (16) | 2022 | 35699442 |
| Cp2 | C. parapsilosis | Clinical isolate | MRR1 | A854V | Single substitution | G8BAV4 | 1128 | AF-G8BAV4-F1 |  | Fluconazole (16) | 2022 | 35699442 |
| Cp20 | C. parapsilosis | Clinical isolate | MRR1 | A854V | Single substitution | G8BAV4 | 1128 | AF-G8BAV4-F1 |  | Fluconazole (16) | 2022 | 35699442 |
| Cp27 | C. parapsilosis | Clinical isolate | MRR1 | K129fs, G982R | Complex | G8BAV4 | 1128 | AF-G8BAV4-F1 |  | Fluconazole (32) | 2022 | 35699442 |
| Cp28 | C. parapsilosis | Clinical isolate | MRR1 | A854V | Single substitution | G8BAV4 | 1128 | AF-G8BAV4-F1 |  | Fluconazole (64) | 2022 | 35699442 |
| Cp29 | C. parapsilosis | Clinical isolate | MRR1 | A854V | Single substitution | G8BAV4 | 1128 | AF-G8BAV4-F1 |  | Fluconazole (64) | 2022 | 35699442 |
| Cp30 | C. parapsilosis | Clinical isolate | MRR1 | R479K | Single substitution | G8BAV4 | 1128 | AF-G8BAV4-F1 |  | Fluconazole (64) | 2022 | 35699442 |
| Cp36 | C. parapsilosis | Clinical isolate | MRR1 | I283R | Single substitution | G8BAV4 | 1128 | AF-G8BAV4-F1 |  | Fluconazole (64) | 2022 | 35699442 |
| Cp39 | C. parapsilosis | Clinical isolate | MRR1 | G294E | Single substitution | G8BAV4 | 1128 | AF-G8BAV4-F1 |  | Fluconazole (32) | 2022 | 35699442 |
| Cp9 | C. parapsilosis | Clinical isolate | MRR1 | A854V | Single substitution | G8BAV4 | 1128 | AF-G8BAV4-F1 |  | Fluconazole (16) | 2022 | 35699442 |
| Can Iso–001 | C. albicans | Clinical isolate | ERG11 | L370S, P375H | Double substitution | P10613 | 528 | 5V5Z |  | Fluconazole (70.2) | 2022 | 35747333 |
| 19-4 | C. auris | Clinical isolate | CDR1ERG11FKS1 | V704LK143RS639Y | Single substitutionSingle substitutionSingle substitution | A0A2H1A768A0A2H1A309A0A2H1A4W2 | 15085241888 | ModelAF-A0A2H1A309-F1Model |  | Fluconazole (>256) | 2022 | 35770999 |
| 19-42 | C. auris | Clinical isolate | CDR1ERG11FKS1 | V704LK143RS639P | Single substitutionSingle substitutionSingle substitution | A0A2H1A768A0A2H1A309A0A2H1A4W2 | 15085241888 | ModelAF-A0A2H1A309-F1Model |  | Fluconazole (>256) | 2022 | 35770999 |
| 19-43 | C. auris | Clinical isolate | CDR1ERG11FKS1 | V704LK143RS639P | Single substitutionSingle substitutionSingle substitution | A0A2H1A768A0A2H1A309A0A2H1A4W2 | 15085241888 | ModelAF-A0A2H1A309-F1Model |  | Fluconazole (>256) | 2022 | 35770999 |
| 19-61 | C. auris | Clinical isolate | CDR1ERG11FKS1 | V704LK143RS639Y | Single substitutionSingle substitutionSingle substitution | A0A2H1A768A0A2H1A309A0A2H1A4W2 | 15085241888 | ModelAF-A0A2H1A309-F1Model |  | Fluconazole (>256) | 2022 | 35770999 |
| 20-15 | C. auris | Clinical isolate | CDR1ERG11FKS1 | V704LK143RF635C | Single substitutionSingle substitutionSingle substitution | A0A2H1A768A0A2H1A309A0A2H1A4W2 | 15085241888 | ModelAF-A0A2H1A309-F1Model |  | Fluconazole (>256), Anidulafungin (4), Caspofungin (2), Micafungin (4) [CLSI] | 2022 | 35770999 |
| 20-16 | C. auris | Clinical isolate | CDR1ERG11FKS1 | V704LK143RF635C | Single substitutionSingle substitutionSingle substitution | A0A2H1A768A0A2H1A309A0A2H1A4W2 | 15085241888 | ModelAF-A0A2H1A309-F1Model |  | Fluconazole (>256), Anidulafungin (4), Caspofungin (2), Micafungin (4) [CLSI] | 2022 | 35770999 |
| 20-17 | C. auris | Clinical isolate | CDR1ERG11 | V704LK143R | Single substitutionSingle substitution | A0A2H1A768A0A2H1A309 | 1508524 | ModelAF-A0A2H1A309-F1 |  | Fluconazole (>256), Anidulafungin (2) [CLSI] | 2022 | 35770999 |
| 20-18 | C. auris | Clinical isolate | CDR1ERG11FKS1 | V704LK143RF635C | Single substitutionSingle substitutionSingle substitution | A0A2H1A768A0A2H1A309A0A2H1A4W2 | 15085241888 | ModelAF-A0A2H1A309-F1Model |  | Fluconazole (>256), Anidulafungin (4), Caspofungin (2), Micafungin (4) [CLSI] | 2022 | 35770999 |
| 20-19 | C. auris | Clinical isolate | CDR1ERG11FKS1 | V704LK143RF635C | Single substitutionSingle substitutionSingle substitution | A0A2H1A768A0A2H1A309A0A2H1A4W2 | 15085241888 | ModelAF-A0A2H1A309-F1Model |  | Fluconazole (>256), Anidulafungin (4), Caspofungin (2), Micafungin (4) [CLSI] | 2022 | 35770999 |
| 20-20 | C. auris | Clinical isolate | CDR1ERG11 | V704LK143R | Single substitutionSingle substitution | A0A2H1A768A0A2H1A309 | 1508524 | ModelAF-A0A2H1A309-F1 |  | Fluconazole (>256), Anidulafungin (4), Caspofungin (2), Micafungin (4) [CLSI] | 2022 | 35770999 |
| 20-21 | C. auris | Clinical isolate | CDR1ERG11FKS1 | V704LK143RS639Y | Single substitutionSingle substitutionSingle substitution | A0A2H1A768A0A2H1A309A0A2H1A4W2 | 15085241888 | ModelAF-A0A2H1A309-F1Model |  | Fluconazole (>256), Anidulafungin (0.5), Micafungin (0.25) [CLSI] Amphotericin B (2) [Etest] | 2022 | 35770999 |
| 20-22 | C. auris | Clinical isolate | CDR1ERG11 | V704LK143R | Single substitutionSingle substitution | A0A2H1A768A0A2H1A309 | 1508524 | ModelAF-A0A2H1A309-F1 |  | Fluconazole (>256), Anidulafungin (0.5), Micafungin (0.25) [CLSI] | 2022 | 35770999 |
| 20-23 | C. auris | Clinical isolate | CDR1ERG11 | V704LK143R | Single substitutionSingle substitution | A0A2H1A768A0A2H1A309 | 1508524 | ModelAF-A0A2H1A309-F1 |  | Fluconazole (>256), Anidulafungin (0.5) [CLSI] Amphotericin B (2) [Etest] | 2022 | 35770999 |
| 20-24 | C. auris | Clinical isolate | CDR1ERG11FKS1 | V704LK143RS639Y | Single substitutionSingle substitutionSingle substitution | A0A2H1A768A0A2H1A309A0A2H1A4W2 | 15085241888 | ModelAF-A0A2H1A309-F1Model |  | Fluconazole (>256), Anidulafungin (4), Caspofungin (2), Micafungin (4) [CLSI] | 2022 | 35770999 |
| 20-25 | C. auris | Clinical isolate | CDR1ERG11FKS1 | V704LK143RF635C | Single substitutionSingle substitutionSingle substitution | A0A2H1A768A0A2H1A309A0A2H1A4W2 | 15085241888 | ModelAF-A0A2H1A309-F1Model |  | Fluconazole (>256), Anidulafungin (4), Caspofungin (2), Micafungin (4) [CLSI] | 2022 | 35770999 |
| 20-26 | C. auris | Clinical isolate | ADE17CDR1ERG11FCY1FKS1 | G45VV704LK143RS70RF635C | Single substitutionSingle substitutionSingle substitutionSingle substitutionSingle substitution | A0A2H0ZQ96A0A2H1A768A0A2H1A309A0A2H0ZDJ1A0A2H1A4W2 | 58915085241501888 | AF-A0A2H0ZQ96-F1ModelAF-A0A2H1A309-F1AF-A0A2H0ZDJ1-F1Model |  | Fluconazole (>256), Posaconazole (1), Anidulafungin (4), Caspofungin (2), Micafungin (4) [CLSI] 5-Flucytosine (>512) [Etest] | 2022 | 35770999 |
| 20-27 | C. auris | Clinical isolate | CDR1ERG11FCY1FCY2FKS1 | V704LK143RS70RM128fsF635C | Single substitutionSingle substitutionSingle substitutionFrameshiftSingle substitution | A0A2H1A768A0A2H1A309A0A2H0ZDJ1Not availableA0A2H1A4W2 | 1508524150Not available1888 | ModelAF-A0A2H1A309-F1AF-A0A2H0ZDJ1-F1Not availableModel |  | Fluconazole (>256), Posaconazole (1), Anidulafungin (4), Caspofungin (2), Micafungin (4) [CLSI] 5-Flucytosine (256) [Etest] | 2022 | 35770999 |
| 20-28 | C. auris | Clinical isolate | CDR1ERG11FCY1FKS1FUR1 | V704LK143RS70RF635CS84L | Single substitutionSingle substitutionSingle substitutionSingle substitutionSingle substitution | A0A2H1A768A0A2H1A309A0A2H0ZDJ1A0A2H1A4W2A0A0L0P8H5 | 15085241501888218 | ModelAF-A0A2H1A309-F1AF-A0A2H0ZDJ1-F1ModelAF-A0A0L0P8H5-F1 |  | Fluconazole (>256), Voriconazole (8), Anidulafungin (4), Caspofungin (>16), Micafungin (8) [CLSI] 5-Flucytosine (>512) [Etest] | 2022 | 35770999 |
| 20-29 | C. auris | Clinical isolate | CDR1ERG11FCY1FCY2FKS1 | V704LK143RS70RM128fsF635C | Single substitutionSingle substitutionSingle substitutionFrameshiftSingle substitution | A0A2H1A768A0A2H1A309A0A2H0ZDJ1Not availableA0A2H1A4W2 | 1508524150Not available1888 | ModelAF-A0A2H1A309-F1AF-A0A2H0ZDJ1-F1Not availableModel |  | Fluconazole (>256), Anidulafungin (4), Caspofungin (2), Micafungin (4) [CLSI 5-Flucytosine (256) [Etest] | 2022 | 35770999 |
| 20-30 | C. auris | Clinical isolate | ADE17CDR1ERG11FCY1FKS1 | G45VV704LK143RS70RF635C | Single substitutionSingle substitutionSingle substitutionSingle substitutionSingle substitution | A0A2H0ZQ96A0A2H1A768A0A2H1A309A0A2H0ZDJ1A0A2H1A4W2 | 58915085241501888 | AF-A0A2H0ZQ96-F1ModelAF-A0A2H1A309-F1AF-A0A2H0ZDJ1-F1Model |  | Fluconazole (>256), Voriconazole (8), Isavuconazole (4), Anidulafungin (4), Caspofungin (16), Micafungin (8) [CLSI] 5-Flucytosine (>512) [Etest] | 2022 | 35770999 |
| 20-31 | C. auris | Clinical isolate | ADE17CDR1ERG11FCY1FKS1 | G45VV704LK143RS70RF635C | Single substitutionSingle substitutionSingle substitutionSingle substitutionSingle substitution | A0A2H0ZQ96A0A2H1A768A0A2H1A309A0A2H0ZDJ1A0A2H1A4W2 | 58915085241501888 | AF-A0A2H0ZQ96-F1ModelAF-A0A2H1A309-F1AF-A0A2H0ZDJ1-F1Model |  | Fluconazole (>256), Voriconazole (16), Isavuconazole (4), Anidulafungin (4), Caspofungin (16), Micafungin (8) [CLSI] Amphotericin B (2), 5-Flucytosine (>512) [Etest] | 2022 | 35770999 |
| 20-32 | C. auris | Clinical isolate | ADE17CDR1ERG11FCY1FKS1 | G45VV704LK143RS70RF635C | Single substitutionSingle substitutionSingle substitutionSingle substitutionSingle substitution | A0A2H0ZQ96A0A2H1A768A0A2H1A309A0A2H0ZDJ1A0A2H1A4W2 | 58915085241501888 | AF-A0A2H0ZQ96-F1ModelAF-A0A2H1A309-F1AF-A0A2H0ZDJ1-F1Model |  | Fluconazole (>256), Voriconazole (8), Isavuconazole (4), Posaconazole (1), Anidulafungin (4), Caspofungin (16), Micafungin (8) [CLSI] Amphotericin B (2), 5-Flucytosine (>512) [Etest] | 2022 | 35770999 |
| 20-34 | C. auris | Clinical isolate | CDR1ERG11 | V704LK143R | Single substitutionSingle substitution | A0A2H1A768A0A2H1A309 | 1508524 | ModelAF-A0A2H1A309-F1 |  | Fluconazole (>256) [CLSI] | 2022 | 35770999 |
| 420189 | C. tropicalis | Clinical isolate | ERG1ERG11UPC2 | N74HY132F, S154FL168P, A251T | Single substitutionDouble substitutionDouble substitution | C5MHC9C5MGS9C5MAR7 | 497528782 | AF-C5MHC9-F1AF-C5MGS9-F1AF-C5MAR7-F1 |  | Fluconazole (128), Voriconazole (4) | 2022 | 35819969 |
| 420227 | C. tropicalis | Clinical isolate | ERG1ERG11UPC2 | N74HY132F, S154FL168P, A251T | Single substitutionDouble substitutionDouble substitution | C5MHC9C5MGS9C5MAR7 | 497528782 | AF-C5MHC9-F1AF-C5MGS9-F1AF-C5MAR7-F1 |  | Fluconazole (128) | 2022 | 35819969 |
| 420232 | C. tropicalis | Clinical isolate | ERG1ERG11UPC2 | N74HY132F, S154FL168P, A251T | Single substitutionDouble substitutionDouble substitution | C5MHC9C5MGS9C5MAR7 | 497528782 | AF-C5MHC9-F1AF-C5MGS9-F1AF-C5MAR7-F1 |  | Fluconazole (32) | 2022 | 35819969 |
| 420233 | C. tropicalis | Clinical isolate | ERG1ERG11UPC2 | N74HY132F, S154FL168P, A251T | Single substitutionDouble substitutionDouble substitution | C5MHC9C5MGS9C5MAR7 | 497528782 | AF-C5MHC9-F1AF-C5MGS9-F1AF-C5MAR7-F1 |  | Fluconazole (32), Voriconazole (1) | 2022 | 35819969 |
| 420234 | C. tropicalis | Clinical isolate | ERG1ERG11UPC2 | N74HY132F, S154FL168P, A251T | Single substitutionDouble substitutionDouble substitution | C5MHC9C5MGS9C5MAR7 | 497528782 | AF-C5MHC9-F1AF-C5MGS9-F1AF-C5MAR7-F1 |  | Fluconazole (64), Voriconazole (1) | 2022 | 35819969 |
| 420235 | C. tropicalis | Clinical isolate | ERG1ERG11UPC2 | N74HY132F, S154FL168P, A251T | Single substitutionDouble substitutionDouble substitution | C5MHC9C5MGS9C5MAR7 | 497528782 | AF-C5MHC9-F1AF-C5MGS9-F1AF-C5MAR7-F1 |  | Fluconazole (32) | 2022 | 35819969 |
| 420236 | C. tropicalis | Clinical isolate | ERG1ERG11UPC2 | N74HY132F, S154FL168P, A251T | Single substitutionDouble substitutionDouble substitution | C5MHC9C5MGS9C5MAR7 | 497528782 | AF-C5MHC9-F1AF-C5MGS9-F1AF-C5MAR7-F1 |  | Fluconazole (32) | 2022 | 35819969 |
| 420237 | C. tropicalis | Clinical isolate | ERG1ERG11UPC2 | N74HY132F, S154FL168P, A251T | Single substitutionDouble substitutionDouble substitution | C5MHC9C5MGS9C5MAR7 | 497528782 | AF-C5MHC9-F1AF-C5MGS9-F1AF-C5MAR7-F1 |  | Fluconazole (64), Voriconazole (1) | 2022 | 35819969 |
| 420238 | C. tropicalis | Clinical isolate | ERG1ERG11UPC2 | N74HY132F, S154FL168P, A251T | Single substitutionDouble substitutionDouble substitution | C5MHC9C5MGS9C5MAR7 | 497528782 | AF-C5MHC9-F1AF-C5MGS9-F1AF-C5MAR7-F1 |  | Fluconazole (256), Voriconazole (16), Itraconazole (16), Posaconazole (2) | 2022 | 35819969 |
| 420239 | C. tropicalis | Clinical isolate | ERG1ERG11UPC2 | N74HY132F, S154FL168P, A251T | Single substitutionDouble substitutionDouble substitution | C5MHC9C5MGS9C5MAR7 | 497528782 | AF-C5MHC9-F1AF-C5MGS9-F1AF-C5MAR7-F1 |  | Fluconazole (256), Voriconazole (16), Itraconazole (16) | 2022 | 35819969 |
| 420245 | C. tropicalis | Clinical isolate | ERG1ERG11UPC2 | N74HY132F, S154FL168P, A251T | Single substitutionDouble substitutionDouble substitution | C5MHC9C5MGS9C5MAR7 | 497528782 | AF-C5MHC9-F1AF-C5MGS9-F1AF-C5MAR7-F1 |  | Fluconazole (128), Voriconazole (2), Itraconazole (1) | 2022 | 35819969 |
| 420247 | C. tropicalis | Clinical isolate | ERG1ERG11UPC2 | N74HY132F, S154FL168P, A251T | Single substitutionDouble substitutionDouble substitution | C5MHC9C5MGS9C5MAR7 | 497528782 | AF-C5MHC9-F1AF-C5MGS9-F1AF-C5MAR7-F1 |  | Fluconazole (128), Voriconazole (4), Itraconazole (2) | 2022 | 35819969 |
| ML72254 | C. glabrata | Clinical isolate | AUS1ERG1PDR1 | F1380Y, H35YP314fsS76P, L98S, T143P | Double substitutionFrameshiftMultiple substitution | Q6FUR1O13306Q6FXU7 | 13984891107 | ModelAF-O13306-F1AF-Q6FXU7-F1 |  | Amphotericin B (>32), Fluconazole (>256), Voriconazole (>32) | 2022 | 35867406 |
| CG1 | C. glabrata | Clinical isolate | FKS1 | S629P | Single substitution | Q6FTN8 | 1863 | Model |  | Caspofungin (0.75), Fluconazole (>256), Voriconazole (4) | 2022 | 35907476 |
| CG10 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Caspofungin (>32) | 2022 | 35907476 |
| CG11 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Caspofungin (>32) | 2022 | 35907476 |
| CG12 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Caspofungin (12), Fluconazole (>256) | 2022 | 35907476 |
| CG2 | C. glabrata | Clinical isolate | FKS1FKS2 | R631GS663P | Single substitutionSingle substitution | Q6FTN8Q6FMZ3 | 18631897 | ModelModel |  | Caspofungin (>32) | 2022 | 35907476 |
| CG3 | C. glabrata | Clinical isolate | FKS1 | D632V | Single substitution | Q6FTN8 | 1863 | Model |  | Caspofungin (2) | 2022 | 35907476 |
| CG4 | C. glabrata | Clinical isolate | FKS2 | F659Y | Single substitution | Q6FMZ3 | 1897 | Model |  | Caspofungin (1), Fluconazole (>256), Voriconazole (1.5) | 2022 | 35907476 |
| CG5 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Caspofungin (>32), Fluconazole (>256), Voriconazole (1.5) | 2022 | 35907476 |
| CG6 | C. glabrata | Clinical isolate | FKS2 | S629P | Single substitution | Q6FMZ3 | 1897 | Model |  | Caspofungin (>32) | 2022 | 35907476 |
| CG7 | C. glabrata | Clinical isolate | FKS2 | F658del | Deletion | Q6FMZ3 | 1897 | Model |  | Caspofungin (>32) | 2022 | 35907476 |
| CG8 | C. glabrata | Clinical isolate | FKS1FKS2 | S629PD666V | Single substitutionSingle substitution | Q6FTN8Q6FMZ3 | 18631897 | ModelModel |  | Caspofungin (12), Fluconazole (>256) | 2022 | 35907476 |
| CG9 | C. glabrata | Clinical isolate | FKS2 | P667H | Single substitution | Q6FMZ3 | 1897 | Model |  | Caspofungin (>32) | 2022 | 35907476 |
| Cp | C. parapsilosis | Clinical isolate | ERG11 | R398I | Single substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | MIC90[Fluconazole (64), Voriconazole (2), Itraconazole (0.5)] | 2022 | 35909934 |
| Ct | C. tropicalis | Clinical isolate | ERG11 | Y132F, S154F | Double substitution | C5MGS9 | 528 | AF-C5MGS9-F1 |  | MIC90[Fluconazole (64), Voriconazole (4), Itraconazole (2)] | 2022 | 35909934 |
| 1133/P/13-R | C. auris | Clinical isolate | FKS1 | S639F | Single substitution | A0A2H1A4W2 | 1888 | Model |  | Caspofungin (8), Micafungin (8), Anidulafungin (8), Fluconazole (64), Amphotericin B (8) | 2022 | 35968956 |
| 462/P/14 | C. auris | Clinical isolate | FKS1 | S639F | Single substitution | A0A2H1A4W2 | 1888 | Model |  | Caspofungin (4), Micafungin (8), Anidulafungin (8), Fluconazole (64), Amphotericin B (0.5) | 2022 | 35968956 |
| 471a/P/14-R | C. auris | Clinical isolate | FKS1 | S639F | Single substitution | A0A2H1A4W2 | 1888 | Model |  | Caspofungin (8), Micafungin (8), Anidulafungin (8), Fluconazole (64), Amphotericin B (0.5) | 2022 | 35968956 |
| case 1 | C. auris | Clinical isolate | ERG11 | N335S, E343D | Double substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 |  | Fluconazole (16), Voriconazole (0.25), Posaconazole (0.016) | 2022 | 36012776 |
| case 2 | C. auris | Clinical isolate | ERG11FKS1 | Y132F, L125FL148I, R937S, I701V, I694V | Double substitutionMultiple substitution | A0A2H1A309A0A2H1A4W2 | 5241888 | AF-A0A2H1A309-F1Model |  | Fluconazole (64), Voriconazole (1), Posaconazole (0.031), Micafungin (0.125), Anidulafungin (0.25) | 2022 | 36012776 |
| case 4 | C. auris | Clinical isolate | ERG11ERG2 | L125F, Y132FE39D | Double substitutionSingle substitution | A0A2H1A309XP_028888031.1 (NCBI) | 524218 | AF-A0A2H1A309-F1Model |  | Fluconazole (32), Voriconazole (1), Posaconazole (0.031) | 2022 | 36012776 |
| CPS-C | C. parapsilosis | Clinical isolate | MRR1 | G604R | Single substitution | G8BAV4 | 1128 | AF-G8BAV4-F1 |  | Fluconazole (64), Voriconazole (1) | 2022 | 36028086 |
| MRR1RI | C. parapsilosis | Clinical isolate | MRR1 | G604R | Single substitution | G8BAV4 | 1128 | AF-G8BAV4-F1 |  | Fluconazole (32), Voriconazole (1) | 2022 | 36028086 |
| strain 1 | C. parapsilosis | Clinical isolate | FKS1TAC1 | E1393GL518F | Single substitutionSingle substitution | A9YLC3G8B9R1 | 1909980 | ModelAF-G8B9R1-F1 |  | Fluconazole (8) | 2022 | 36066554 |
| strain 27 | C. parapsilosis | Clinical isolate | ERG11FKS1TAC1 | K143RE1393GL518F | Single substitutionSingle substitutionSingle substitution | C7EXA5A9YLC3G8B9R1 | 5221909980 | AF-C7EXA5-F1ModelAF-G8B9R1-F1 |  | Fluconazole (16) | 2022 | 36066554 |
| strain 33 | C. parapsilosis | Clinical isolate | FKS1TAC1 | E1393GL518F | Single substitutionSingle substitution | A9YLC3G8B9R1 | 1909980 | ModelAF-G8B9R1-F1 |  | Fluconazole (16) | 2022 | 36066554 |
| strain 40 | C. parapsilosis | Clinical isolate | FKS1TAC1 | E1393GL518F | Single substitutionSingle substitution | A9YLC3G8B9R1 | 1909980 | ModelAF-G8B9R1-F1 |  | Fluconazole (8) | 2022 | 36066554 |
| strain 51 | C. parapsilosis | Clinical isolate | FKS1TAC1 | E1393GL518F | Single substitutionSingle substitution | A9YLC3G8B9R1 | 1909980 | ModelAF-G8B9R1-F1 |  | Fluconazole (8) | 2022 | 36066554 |
| strain 7 | C. parapsilosis | Clinical isolate | ERG11FKS1TAC1 | K143RE1393GL518F | Single substitutionSingle substitutionSingle substitution | C7EXA5A9YLC3G8B9R1 | 5221909980 | AF-C7EXA5-F1ModelAF-G8B9R1-F1 |  | Fluconazole (8) | 2022 | 36066554 |
| 19-008-0005 | C. tropicalis | Clinical isolate | ERG11 | Y257H | Single substitution | C5MGS9 | 528 | AF-C5MGS9-F1 |  | Fluconazole (8), Posaconazole (1), Itraconazole (1) | 2022 | 36135621 |
| 19-008-0006 | C. tropicalis | Clinical isolate | ERG11 | S154F, Y132F | Double substitution | C5MGS9 | 528 | AF-C5MGS9-F1 |  | Fluconazole (>256), Voriconazole (>8), Posaconazole (2), Itraconazole (>16) | 2022 | 36135621 |
| 19-008-0007 | C. tropicalis | Clinical isolate | ERG11 | S154F, Y132F | Double substitution | C5MGS9 | 528 | AF-C5MGS9-F1 |  | Fluconazole (>256), Voriconazole (>8), Posaconazole (1), Itraconazole (1) | 2022 | 36135621 |
| 19-008-0008 | C. tropicalis | Clinical isolate | ERG11 | S154F, Y132F | Double substitution | C5MGS9 | 528 | AF-C5MGS9-F1 |  | Fluconazole (>256), Voriconazole (>8), Posaconazole (1), Itraconazole (1) | 2022 | 36135621 |
| 19-008-0015 | C. tropicalis | Clinical isolate | ERG11 | S154F, Y132F | Double substitution | C5MGS9 | 528 | AF-C5MGS9-F1 |  | Fluconazole (32), Voriconazole (2) | 2022 | 36135621 |
| 19-008-0016 | C. tropicalis | Clinical isolate | ERG11 | S154F, Y132F | Double substitution | C5MGS9 | 528 | AF-C5MGS9-F1 |  | Fluconazole (>256), Voriconazole (8), Posaconazole (1), Itraconazole (4) | 2022 | 36135621 |
| 19-008-0017 | C. tropicalis | Clinical isolate | ERG11 | S154F, Y132F | Double substitution | C5MGS9 | 528 | AF-C5MGS9-F1 |  | Fluconazole (>256), Voriconazole (>8), Posaconazole (1), Itraconazole (1) | 2022 | 36135621 |
| 19-008-0018 | C. tropicalis | Clinical isolate | FKS1 | S30P | Single substitution | C5MF18 | 1280 | AF-C5MF18-F1 |  | Micafungin (4), Anidulafungin (0.5_), Caspofungin (4) | 2022 | 36135621 |
| 19-008-0045 | C. tropicalis | Clinical isolate | ERG11 | Y132F | Double substitution | C5MGS9 | 528 | AF-C5MGS9-F1 |  | Fluconazole (64_), Voriconazole (2) | 2022 | 36135621 |
| 19-008-0055 | C. tropicalis | Clinical isolate | ERG11 | S154F, Y132F | Double substitution | C5MGS9 | 528 | AF-C5MGS9-F1 |  | Fluconazole (128), Voriconazole (4) | 2022 | 36135621 |
| 19-5326-037-0003 | C. tropicalis | Clinical isolate | ERG11 | S154F, Y132F | Double substitution | C5MGS9 | 528 | AF-C5MGS9-F1 |  | Fluconazole (>256), Voriconazole (>8), Posaconazole (0.5), Itraconazole (1) | 2022 | 36135621 |
| SRR11235416 | C. tropicalis | Clinical isolate | FKS1 | S30P | Single substitution | C5MF18 | 1280 | AF-C5MF18-F1 |  | Micafungin (2), Anidulafungin (1), Caspofungin (8) | 2022 | 36135621 |
| AUH1957 | C. parapsilosis | Clinical isolate | FKS1 | F652S | Single substitution | A9YLC3 | 1909 | Model |  | Anidulafungin (>8), Caspofungin (>8), Micafungin (>8), Rezafungin (>8) | 2022 | 36135656 |
| IFRC4050 | C. auris | Laboratory strain | ERG11TAC1 | Y132FD599G | Single substitutionSingle substitution | A0A2H1A309A0A2H0ZLE8 | 524418 | AF-A0A2H1A309-F1AF-A0A2H0ZLE8-F1 |  | Fluconazole (64) | 2022 | 36154919 |
| MRL40 | C. auris | Laboratory strain | ERG11 | I466L | Single substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 |  | Fluconazole (64) | 2022 | 36154919 |
| CLE0951 | C. catenulata | Clinical isolate | ERG11 | Y132F | Single substitution | Not available | Not available | Not available | Structure not available | Fluconazole (16) | 2023 | 36209989 |
| CLE2101 | C. catenulata | Clinical isolate | ERG11 | Y132F | Single substitution | Not available | Not available | Not available | Structure not available | Fluconazole (256) | 2023 | 36209989 |
| CLE5348 | C. catenulata | Clinical isolate | ERG11 | Y132F | Single substitution | Not available | Not available | Not available | Structure not available | Fluconazole (256) | 2023 | 36209989 |
| CLE9871-2 | C. catenulata | Clinical isolate | ERG11 | Y132F | Single substitution | Not available | Not available | Not available | Structure not available | Fluconazole (256) | 2023 | 36209989 |
| ROC2119 | C. catenulata | Clinical isolate | ERG11 | Y132F | Single substitution | Not available | Not available | Not available | Structure not available | Fluconazole (256) | 2023 | 36209989 |
| SM01 | C. parapsilosis | Clinical isolate | ERG11MRR1 | Y132FK177N, G982R | Single substitutionDouble substitution | G8B9T3G8BAV4 | 5221128 | AF-G8B9T3-F1AF-G8BAV4-F1 |  | Fluconazole (64) | 2022 | 36226945 |
| SM05 | C. parapsilosis | Clinical isolate | ERG11 | Y132F, R398I | Double substitution | G8B9T3 | 522 | AF-G8B9T3-F1 | Mismatch residue | Fluconazole (64), Voriconazole (2) | 2022 | 36226945 |
| SM06 | C. parapsilosis | Clinical isolate | ERG11MRR1 | Y132FK177N, S614P | Single substitutionDouble substitution | G8B9T3G8BAV4 | 5221128 | AF-G8B9T3-F1AF-G8BAV4-F1 |  | Fluconazole (16) | 2022 | 36226945 |
| SM07 | C. parapsilosis | Clinical isolate | ERG11MRR1 | Y132FK177N | Single substitutionSingle substitution | G8B9T3G8BAV4 | 5221128 | AF-G8B9T3-F1AF-G8BAV4-F1 |  | Fluconazole (8) | 2022 | 36226945 |
| SM08 | C. parapsilosis | Clinical isolate | ERG11MRR1 | Y132FK177N, S614P | Single substitutionDouble substitution | G8B9T3G8BAV4 | 5221128 | AF-G8B9T3-F1AF-G8BAV4-F1 |  | Fluconazole (256), Voriconazole (1) | 2022 | 36226945 |
| SM10 | C. parapsilosis | Clinical isolate | ERG11MRR1 | Y132FK177N, S614P | Single substitutionDouble substitution | G8B9T3G8BAV4 | 5221128 | AF-G8B9T3-F1AF-G8BAV4-F1 |  | Fluconazole (16) | 2022 | 36226945 |
| SM11 | C. parapsilosis | Clinical isolate | CDR1 | N1132D | Single substitution | G8BJB0 | 1504 | Model |  | Fluconazole (64), Voriconazole (1) | 2022 | 36226945 |
| SM18 | C. parapsilosis | Clinical isolate | ERG11MRR1 | Y132FK177N | Single substitutionSingle substitution | G8B9T3G8BAV4 | 5221128 | AF-G8B9T3-F1AF-G8BAV4-F1 |  | Fluconazole (8) | 2022 | 36226945 |
| SM23 | C. parapsilosis | Clinical isolate | ERG11MRR1 | Y132FK177N, S614P | Single substitutionDouble substitution | G8B9T3G8BAV4 | 5221128 | AF-G8B9T3-F1AF-G8BAV4-F1 |  | Fluconazole (256), Voriconazole (2) | 2022 | 36226945 |
| SM24 | C. parapsilosis | Clinical isolate | ERG11MRR1 | Y132FK177N, S614P | Single substitutionDouble substitution | G8B9T3G8BAV4 | 5221128 | AF-G8B9T3-F1AF-G8BAV4-F1 |  | Fluconazole (256), Voriconazole (2) | 2022 | 36226945 |
| SM25 | C. parapsilosis | Clinical isolate | ERG11MRR1 | Y132FK177N, S614P | Single substitutionDouble substitution | G8B9T3G8BAV4 | 5221128 | AF-G8B9T3-F1AF-G8BAV4-F1 |  | Fluconazole (256), Voriconazole (4) | 2022 | 36226945 |
| SM26 | C. parapsilosis | Clinical isolate | ERG11MRR1 | Y132FK177N, S614P | Single substitutionDouble substitution | G8B9T3G8BAV4 | 5221128 | AF-G8B9T3-F1AF-G8BAV4-F1 |  | Fluconazole (256), Voriconazole (2) | 2022 | 36226945 |
| SM27 | C. parapsilosis | Clinical isolate | ERG11MRR1 | Y132FK177N, S614P | Single substitutionDouble substitution | G8B9T3G8BAV4 | 5221128 | AF-G8B9T3-F1AF-G8BAV4-F1 |  | Fluconazole (256), Voriconazole (4) | 2022 | 36226945 |
| SM28 | C. parapsilosis | Clinical isolate | ERG11MRR1 | Y132FK177N, S614P | Single substitutionDouble substitution | G8B9T3G8BAV4 | 5221128 | AF-G8B9T3-F1AF-G8BAV4-F1 |  | Fluconazole (>256), Voriconazole (4) | 2022 | 36226945 |
| SM29 | C. parapsilosis | Clinical isolate | ERG11MRR1 | Y132FK177N, S614P | Single substitutionDouble substitution | G8B9T3G8BAV4 | 5221128 | AF-G8B9T3-F1AF-G8BAV4-F1 |  | Fluconazole (>256), Voriconazole (4) | 2022 | 36226945 |
| SM30 | C. parapsilosis | Clinical isolate | CDR1 | N1132D | Single substitution | G8BJB0 | 1504 | Model |  | Fluconazole (16) | 2022 | 36226945 |
| SM32 | C. parapsilosis | Clinical isolate | ERG11MRR1 | Y132FK177N, S614P | Single substitutionDouble substitution | G8B9T3G8BAV4 | 5221128 | AF-G8B9T3-F1AF-G8BAV4-F1 |  | Fluconazole (>256), Voriconazole (4) | 2022 | 36226945 |
| SM33 | C. parapsilosis | Clinical isolate | CDR1 | N1132D | Single substitution | G8BJB0 | 1504 | Model |  | Fluconazole (32) | 2022 | 36226945 |
| SM36 | C. parapsilosis | Clinical isolate | ERG11MRR1 | Y132FK177N, S614P | Single substitutionDouble substitution | G8B9T3G8BAV4 | 5221128 | AF-G8B9T3-F1AF-G8BAV4-F1 |  | Fluconazole (64) | 2022 | 36226945 |
| SM37 | C. parapsilosis | Clinical isolate | CDR1 | N1132D | Single substitution | G8BJB0 | 1504 | Model |  | Fluconazole (32) | 2022 | 36226945 |
| Y9-2012 | C. parapsilosis | Clinical isolate | ERG11MRR1 | Y132FK177N | Single substitutionSingle substitution | G8B9T3G8BAV4 | 5221128 | AF-G8B9T3-F1AF-G8BAV4-F1 |  | Fluconazole (8) | 2022 | 36226945 |
| 10055 | C. glabrata | Clinical isolate | PDR1 | R250K | Single substitution | Q6FXU7 | 1107 | AF-Q6FXU7-F1 |  | Voriconazole (1), Posaconazole (2) | 2022 | 36274705 |
| 10081 | C. albicans | Clinical isolate | ERG11 | T123I, Y132H | Double substitution | P10613 | 528 | 5V5Z |  | Fluconazole (8), 5-Flucytosine (>64) | 2022 | 36274705 |
| 10116 | C. tropicalis | Clinical isolate | ERG11 | Y132F, S154F | Double substitution | C5MGS9 | 528 | AF-C5MGS9-F1 |  | Fluconazole (>256), Itraconazole (1), Voriconazole (>16), Posaconazole (2) | 2022 | 36274705 |
| 10123 | C. glabrata | Clinical isolate | PDR1 | Y682C | Single substitution | Q6FXU7 | 1107 | AF-Q6FXU7-F1 |  | Fluconazole (128), Itraconazole9>8), Voriconazole (4), Posaconazole (>8) | 2022 | 36274705 |
| 10573 | C. albicans | Clinical isolate | ERG11 | K128T | Single substitution | P10613 | 528 | 5V5Z |  | Posaconazole (0.12) | 2022 | 36274705 |
| 10574 | C. albicans | Clinical isolate | ERG11 | K128T, Y132H, G465S | Multiple substitution | P10613 | 528 | 5V5Z |  | Posaconazole (0.12) | 2022 | 36274705 |
| 10576 | C. albicans | Clinical isolate | ERG11 | K128T, Y132H, G465S | Multiple substitution | P10613 | 528 | 5V5Z |  | Posaconazole (0.12) | 2022 | 36274705 |
| 10578 | C. glabrata | Clinical isolate | PDR1 | P76S, P143T, D243N | Multiple substitution | Q6FXU7 | 1107 | AF-Q6FXU7-F1 | Mismatch residue | Voriconazole (2), Posaconazole (2) | 2022 | 36274705 |
| 10582 | C. tropicalis | Clinical isolate | ERG11 | Y132F, S154F | Double substitution | C5MGS9 | 528 | AF-C5MGS9-F1 |  | Fluconazole (32), Voriconazole (2), Posaconazole (2) | 2022 | 36274705 |
| 10641 | C. tropicalis | Clinical isolate | ERG11 | Y132F, S154F | Double substitution | C5MGS9 | 528 | AF-C5MGS9-F1 |  | Fluconazole (64), Voriconazole (2), Posaconazole (1) | 2022 | 36274705 |
| 10717 | C. parapsilosis | Clinical isolate | ERG11 | R398I | Single substitution | G8B9T3 | 522 | AF-G8B9T3-F1 |  | Fluconazole (8), Posaconazole (0.5) | 2022 | 36274705 |
| 10720 | C. glabrata | Clinical isolate | FKS2PDR1 | S663PP76S, P143T, D243N | Single substitutionMultiple substitution | Q6FMZ3Q6FXU7 | 18971107 | ModelAF-Q6FXU7-F1 |  | Posaconazole (4), Anidulafungin (4), Micafungin (8), Caspofungin (>16) | 2022 | 36274705 |
| 10722 | C. glabrata | Clinical isolate | FKS2PDR1 | S663PP76S, P143T, D243N | Single substitutionMultiple substitution | Q6FMZ3Q6FXU7 | 18971107 | ModelAF-Q6FXU7-F1 |  | Posaconazole (4), Anidulafungin (4), Micafungin (8), Caspofungin (>16) | 2022 | 36274705 |
| 10751 | C. albicans | Clinical isolate | ERG11 | T123I, Y132H | Double substitution | P10613 | 528 | 5V5Z |  | Posaconazole (0.12) | 2022 | 36274705 |
| 10813 | C. albicans | Clinical isolate | ERG11 | K128T, Y132H, G465S | Multiple substitution | P10613 | 528 | 5V5Z |  | Posaconazole (0.12) | 2022 | 36274705 |
| 10832 | C. tropicalis | Clinical isolate | ERG11 | S154F | Single substitution | C5MGS9 | 528 | AF-C5MGS9-F1 |  | Voriconazole (4), Posaconazole (1) | 2022 | 36274705 |
| 10837 | C. albicans | Clinical isolate | ERG11 | T123I, Y132H | Double substitution | P10613 | 528 | 5V5Z |  | Posaconazole (0.12) | 2022 | 36274705 |
| 9956 | C. tropicalis | Clinical isolate | ERG11 | Y132F, S154F | Double substitution | C5MGS9 | 528 | AF-C5MGS9-F1 |  | Fluconazole (>256), Itraconazole (1), Voriconazole (>16), Posaconazole (2) | 2022 | 36274705 |
| 9969 | C. tropicalis | Clinical isolate | ERG11 | Y132F, S154F | Double substitution | C5MGS9 | 528 | AF-C5MGS9-F1 |  | Fluconazole (32), Voriconazole (1), Posaconazole (1) | 2022 | 36274705 |
| Taiwan | C. albicans | Clinical isolate | FKS1 | S645P | Single substitution | A0A1D8PCT0 | 1897 | AF-A0A1D8PCT0-F1 |  | Micafungin (2) | 2022 | 36286491 |
| USA1 | C. glabrata | Clinical isolate | FKS1 | D632E | Single substitution | Q6FTN8 | 1863 | Model |  | Micafungin (0.25) | 2022 | 36286491 |
| USA2 | C. glabrata | Clinical isolate | FKS2 | R665G | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (0.5), Micafungin (0.25) | 2022 | 36286491 |
| USA3 | C. glabrata | Clinical isolate | FKS1 | S629P | Single substitution | Q6FTN8 | 1863 | Model |  | Anidulafungin (2), Micafungin (1) | 2022 | 36286491 |
| USA4 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (1), Micafungin (0.5) | 2022 | 36286491 |
| USA5 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (4), Micafungin (4) | 2022 | 36286491 |
| USA6 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (2), Micafungin (0.5) | 2022 | 36286491 |
| isolarte 141 | C. tropicalis | Clinical isolate | ERG11 | Y132F, S154F | Double substitution | C5MGS9 | 528 | AF-C5MGS9-F1 |  | SYO[Fluconazole (>256), , Itraconazole (>8), Voriconazole (1), Posaconazole (1)], CLSI[Fluconazole (>256)] | 2022 | 36294548 |
| isolate 10 | C. tropicalis | Clinical isolate | ERG11 | Y132F, S154F | Double substitution | C5MGS9 | 528 | AF-C5MGS9-F1 |  | SYO[Fluconazole (>256), Itraconazole (>8), Voriconazole (1)], CLSI[Fluconazole (>256)] | 2022 | 36294548 |
| isolate 116 | C. tropicalis | Clinical isolate | ERG11 | Y132F, S154F | Double substitution | C5MGS9 | 528 | AF-C5MGS9-F1 |  | SYO[Fluconazole (64), Itraconazole (2)], CLSI[Fluconazole (64)] | 2022 | 36294548 |
| isolate 123 | C. tropicalis | Clinical isolate | ERG11 | Y132F, S154F | Double substitution | C5MGS9 | 528 | AF-C5MGS9-F1 |  | SYO[Fluconazole (>256), Itraconazole (>8), Voriconazole (1), Posaconazole (1)], CLSI[Fluconazole (>256)] | 2022 | 36294548 |
| isolate 127 | C. tropicalis | Clinical isolate | ERG11 | Y132F, S154F | Double substitution | C5MGS9 | 528 | AF-C5MGS9-F1 |  | SYO[Fluconazole (>256), Itraconazole (>8), Voriconazole (1), Posaconazole (1)], CLSI[Fluconazole (>256)] | 2022 | 36294548 |
| isolate 147 | C. tropicalis | Clinical isolate | ERG11 | Y132F, S154F | Double substitution | C5MGS9 | 528 | AF-C5MGS9-F1 |  | SYO[Fluconazole (>256), Itraconazole (>8), Voriconazole (1), Posaconazole (2)], CLSI[Fluconazole (>256)] | 2022 | 36294548 |
| isolate 149 | C. tropicalis | Clinical isolate | ERG11 | Y132F, S154F | Double substitution | C5MGS9 | 528 | AF-C5MGS9-F1 |  | SYO[Fluconazole (>256), Itraconazole (>8), Voriconazole (1), Posaconazole (1)], CLSI[Fluconazole (>256)] | 2022 | 36294548 |
| isolate 150 | C. tropicalis | Clinical isolate | ERG11 | Y132F, S154F | Double substitution | C5MGS9 | 528 | AF-C5MGS9-F1 |  | SYO[Fluconazole (>256), Itraconazole (>8), Voriconazole (1), Posaconazole (1)], CLSI[Fluconazole (>256)] | 2022 | 36294548 |
| isolate 159 | C. tropicalis | Clinical isolate | ERG11 | Y132F, S154F | Double substitution | C5MGS9 | 528 | AF-C5MGS9-F1 |  | SYO[Fluconazole (32)], CLSI[Fluconazole (64)] | 2022 | 36294548 |
| isolate 16 | C. tropicalis | Clinical isolate | ERG11 | Y132F, S154F | Double substitution | C5MGS9 | 528 | AF-C5MGS9-F1 |  | SYO[Fluconazole (>256), Itraconazole (>8)], CLSI[Fluconazole (>256)] | 2022 | 36294548 |
| isolate 17 | C. tropicalis | Clinical isolate | ERG11 | Y132F, S154F | Double substitution | C5MGS9 | 528 | AF-C5MGS9-F1 |  | SYO[Fluconazole (256), Itraconazole (>8)], CLSI[Fluconazole (256)] | 2022 | 36294548 |
| isolate 178 | C. tropicalis | Clinical isolate | ERG11 | Y132F, S154F | Double substitution | C5MGS9 | 528 | AF-C5MGS9-F1 |  | SYO[Fluconazole (>256), Itraconazole (>8), Voriconazole (1), Posaconazole (1)], CLSI[Fluconazole (>256)] | 2022 | 36294548 |
| isolate 19 | C. tropicalis | Clinical isolate | ERG11 | Y132F, S154F | Double substitution | C5MGS9 | 528 | AF-C5MGS9-F1 |  | SYO[Fluconazole (>256), Itraconazole (>8), Voriconazole (1), Posaconazole (1)], CLSI[Fluconazole (>256)] | 2022 | 36294548 |
| isolate 20 | C. tropicalis | Clinical isolate | ERG11 | Y132F, S154F | Double substitution | C5MGS9 | 528 | AF-C5MGS9-F1 |  | SYO[Fluconazole (256), Itraconazole (>8), Voriconazole (1), Posaconazole (1)], CLSI[Fluconazole (>256)] | 2022 | 36294548 |
| isolate 200 | C. tropicalis | Clinical isolate | ERG11 | Y132F, S154F | Double substitution | C5MGS9 | 528 | AF-C5MGS9-F1 |  | SYO[Fluconazole (>256), Itraconazole (>8), Voriconazole (1), Posaconazole (1)], CLSI[Fluconazole (256)] | 2022 | 36294548 |
| isolate 23 | C. tropicalis | Clinical isolate | ERG11 | Y132F, S154F | Double substitution | C5MGS9 | 528 | AF-C5MGS9-F1 |  | SYO[Fluconazole (>256), Itraconazole (>8)], CLSI[Fluconazole (64)] | 2022 | 36294548 |
| isolate 233 | C. tropicalis | Clinical isolate | ERG11 | Y132F, S154F | Double substitution | C5MGS9 | 528 | AF-C5MGS9-F1 |  | SYO[Fluconazole (>256), Itraconazole (>8), Voriconazole (1), Posaconazole (1)], CLSI[Fluconazole (>256)] | 2022 | 36294548 |
| isolate 235 | C. tropicalis | Clinical isolate | ERG11 | Y132F, S154F | Double substitution | C5MGS9 | 528 | AF-C5MGS9-F1 |  | SYO[Fluconazole (>256), Itraconazole (>8), Voriconazole (1), Posaconazole (1)], CLSI[Fluconazole (>256)] | 2022 | 36294548 |
| isolate 30 | C. tropicalis | Clinical isolate | ERG11 | Y132F, S154F | Double substitution | C5MGS9 | 528 | AF-C5MGS9-F1 |  | SYO[Fluconazole (>256), Itraconazole (>8), Voriconazole (1), Posaconazole (1)], CLSI[Fluconazole (>256)] | 2022 | 36294548 |
| isolate 4 | C. tropicalis | Clinical isolate | ERG11 | Y132F, S154F, Y257H | Multiple substitution | C5MGS9 | 528 | AF-C5MGS9-F1 |  | SYO[Fluconazole (128), Itraconazole (4)], CLSI[Fluconazole (>256)] | 2022 | 36294548 |
| isolate 41 | C. tropicalis | Clinical isolate | ERG11 | Y132F, S154F | Double substitution | C5MGS9 | 528 | AF-C5MGS9-F1 |  | SYO[Fluconazole (>256), Itraconazole (>8), Voriconazole (1), Posaconazole (1)], CLSI[Fluconazole (256)] | 2022 | 36294548 |
| isolate 43 | C. tropicalis | Clinical isolate | ERG11 | K143R | Single substitution | C5MGS9 | 528 | AF-C5MGS9-F1 |  | SYO[Fluconazole (64), Itraconazole (2), Voriconazole (1), Posaconazole (1)], CLSI[Fluconazole (128)] | 2022 | 36294548 |
| isolate 49 | C. tropicalis | Clinical isolate | ERG11 | Y132F, S154F | Double substitution | C5MGS9 | 528 | AF-C5MGS9-F1 |  | SYO[Fluconazole (128), Itraconazole (4)], CLSI[Fluconazole (128)] | 2022 | 36294548 |
| isolate 56 | C. tropicalis | Clinical isolate | ERG11 | Y132F, S154F | Double substitution | C5MGS9 | 528 | AF-C5MGS9-F1 |  | SYO[Fluconazole (>256), Itraconazole (>8), Voriconazole (1), Posaconazole (1)], CLSI[Fluconazole (>256)] | 2022 | 36294548 |
| isolate 64 | C. tropicalis | Clinical isolate | ERG11 | Y132F, S154F | Double substitution | C5MGS9 | 528 | AF-C5MGS9-F1 |  | SYO[Fluconazole (>256), Itraconazole (>8), Voriconazole (1), Posaconazole (1)], CLSI[Fluconazole (>256)] | 2022 | 36294548 |
| isolate 67 | C. tropicalis | Clinical isolate | ERG11 | Y132F, S154F | Double substitution | C5MGS9 | 528 | AF-C5MGS9-F1 |  | SYO[Fluconazole (>256), Itraconazole (>8), Voriconazole (2), Posaconazole (2)], CLSI[Fluconazole (>256)] | 2022 | 36294548 |
| isolate 68 | C. tropicalis | Clinical isolate | ERG11 | Y132F, S154F | Double substitution | C5MGS9 | 528 | AF-C5MGS9-F1 |  | SYO[Fluconazole (>256), Itraconazole (>8), Voriconazole (1), Posaconazole (1)], CLSI[Fluconazole (>256)] | 2022 | 36294548 |
| isolate 78 | C. tropicalis | Clinical isolate | ERG11 | K143R | Single substitution | C5MGS9 | 528 | AF-C5MGS9-F1 |  | SYO[Fluconazole (64), Itraconazole (1), Voriconazole (1), Posaconazole (1)], CLSI[Fluconazole (64)] | 2022 | 36294548 |
| isolate 8 | C. tropicalis | Clinical isolate | ERG11 | Y132F, S154F | Double substitution | C5MGS9 | 528 | AF-C5MGS9-F1 |  | SYO[Fluconazole (>256), Itraconazole (>8), Voriconazole (1)], CLSI[Fluconazole (>256)] | 2022 | 36294548 |
| isolate 84 | C. tropicalis | Clinical isolate | ERG11 | Y132F, S154F | Double substitution | C5MGS9 | 528 | AF-C5MGS9-F1 |  | SYO[Fluconazole (>256), Itraconazole (4)] | 2022 | 36294548 |
| isolate99 | C. tropicalis | Clinical isolate | ERG11 | Y132F, S154F | Double substitution | C5MGS9 | 528 | AF-C5MGS9-F1 |  | SYO[Fluconazole (>256), Itraconazole (>8), Voriconazole (1), Posaconazole (1)], CLSI[Fluconazole (>256)] | 2022 | 36294548 |
| Cg1 | C. glabrata | Clinical isolate | PDR1 | E259G | Single substitution | Q66WF3 | 1107 | AF-Q66WF3-F1 |  | Fluconazole (64), Voriconazole (1), Posaconazole (2), Itraconazole (2) | 2022 | 36294562 |
| Cg2 | C. glabrata | Clinical isolate | PDR1 | C469R | Single substitution | Q66WF3 | 1107 | AF-Q66WF3-F1 |  | Fluconazole (256), Voriconazole (4), Posaconazole (>8), Itraconazole (>16) | 2022 | 36294562 |
| Cg3 | C. glabrata | Clinical isolate | PDR1 | F559S | Single substitution | Q66WF3 | 1107 | AF-Q66WF3-F1 |  | Fluconazole (128), Voriconazole (2), Posaconazole (>8), Itraconazole (>16) | 2022 | 36294562 |
| Cg4 | C. glabrata | Clinical isolate | PDR1 | T745A | Single substitution | Q66WF3 | 1107 | AF-Q66WF3-F1 |  | Fluconazole (128), Voriconazole (2), Posaconazole (2), Itraconazole (2) | 2022 | 36294562 |
| Cg5 | C. glabrata | Clinical isolate | PDR1 | E259G | Single substitution | Q66WF3 | 1107 | AF-Q66WF3-F1 |  | Fluconazole (64), Voriconazole (1), Posaconazole (2), Itraconazole (1) | 2022 | 36294562 |
| Cg6 | C. glabrata | Clinical isolate | PDR1 | S942F | Single substitution | Q66WF3 | 1107 | AF-Q66WF3-F1 |  | Fluconazole (128), Voriconazole (4), Posaconazole (>8), Itraconazole (>16) | 2022 | 36294562 |
| Cg7 | C. glabrata | Clinical isolate | FKS2 | F659Y | Single substitution | E2GKZ6 | 1897 | Model |  | Caspofungin (0.5) | 2022 | 36294562 |
| Cp1 | C. parapsilosis | Clinical isolate | ERG11 | Y132F | Single substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (8) | 2022 | 36294562 |
| Cp2 | C. parapsilosis | Clinical isolate | ERG11 | K143R | Single substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (64) | 2022 | 36294562 |
| Cp3 | C. parapsilosis | Clinical isolate | ERG11 | Y132F | Single substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (32) | 2022 | 36294562 |
| Cp4 | C. parapsilosis | Clinical isolate | ERG11 | Y132F | Single substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (32) | 2022 | 36294562 |
| Cp5 | C. parapsilosis | Clinical isolate | CDR1 | N1132D | Single substitution | G8BJB0 | 1504 | Model |  | Fluconazole (16) | 2022 | 36294562 |
| Cp6 | C. parapsilosis | Clinical isolate | ERG11 | Y132F | Single substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (4) | 2022 | 36294562 |
| Ct1 | C. tropicalis | Clinical isolate | ERG11 | Y132F | Single substitution | C5MGS9 | 528 | AF-C5MGS9-F1 |  | Fluconazole (32) | 2022 | 36294562 |
| Ct2 | C. tropicalis | Clinical isolate | ERG11 | Y257H | Single substitution | C5MGS9 | 528 | AF-C5MGS9-F1 |  | Fluconazole (4) | 2022 | 36294562 |
| C. albicans AUH1202 | C. albicans | Clinical isolate | FKS1 | D1337Y | Single substitution | A0A1D8PCT0 | 1897 | AF-A0A1D8PCT0-F1 |  | Rezafungin (0.125), Micafungin (0.06) | 2022 | 36329639 |
| C. glabrata AUH379 | C. glabrata | Clinical isolate | FKS2 | S663F | Single substitution | Q6FMZ3 | 1897 | Model |  | Rezafungin (0.06), Anidulafungin (1), Micafungin (0.25) | 2022 | 36329639 |
| C. krusei AUH1940 | C. krusei | Clinical isolate | FKS1 | S659P | Single substitution | Q4U2W2 | 1885 | Model |  | Rezafungin (0.06), Anidulafungin (0.125), Micafungin (2) | 2022 | 36329639 |
| C. krusei SSI-77.20 | C. krusei | Clinical isolate | FKS1 | S659P | Single substitution | Q4U2W2 | 1885 | Model |  | Micafungin (0.5) | 2022 | 36329639 |
| C. parapsilosis AUH1957 | C. parapsilosis | Clinical isolate | FKS1 | F652S | Single substitution | A9YLC3 | 1909 | Model |  | Rezafungin (>8), Anidulafungin (>4), Micafungin (>4) | 2022 | 36329639 |
| Ca_1 | C. auris | Clinical isolate | FKS1 | R1354H | Single substitution | A0A2H1A4W2 | 1888 | Model |  | Caspofungin (>2) | 2022 | 36421245 |
| Ca_2 | C. auris | Clinical isolate | FKS1 | R1354H | Single substitution | A0A2H1A4W2 | 1888 | Model |  | Caspofungin (>2) | 2022 | 36421245 |
| Ca_3 | C. auris | Clinical isolate | FKS1 | S639Y | Single substitution | A0A2H1A4W2 | 1888 | Model |  | Caspofungin (>2) | 2022 | 36421245 |
| Ca_4 | C. auris | Clinical isolate | FKS1 | S639P | Single substitution | A0A2H1A4W2 | 1888 | Model |  | Caspofungin (>2) | 2022 | 36421245 |
| TJ1197 | C. parapsilosis | Clinical isolate | ERG11MRR1FKS1 | R398IY552HS656P | Single substitutionSingle substitutionSingle substitution | G8B9T3G8BAV4G8B820 | 52211281909 | AF-G8B9T3-F1AF-G8BAV4-F1Model |  | Echinocandin (>8), Fluconazole (>8), Voriconazole (>1) | 2023 | 36440795 |
| Ca2 | C. albicans | Clinical isolate | ERG11 | E517Q | Single substitution | P10613 | 528 | 5V5Z |  | Fluconazole (>=32) | 2022 | 36654793 |
| Cg1 | C. glabrata | Clinical isolate | FKS1 | S642L | Single substitution | Q6FTN8 | 1863 | Model | Mismatch residue | Fluconazole (>=32) | 2022 | 36654793 |
| Cg2 | C. glabrata | Clinical isolate | FKS1 | S642L | Single substitution | Q6FTN8 | 1863 | Model | Mismatch residue | Fluconazole (>=32), Itraconazole (>=8) | 2022 | 36654793 |
| Cg3 | C. glabrata | Clinical isolate | FKS1 | S642L | Single substitution | Q6FTN8 | 1863 | Model | Mismatch residue | Fluconazole (>=32), Itraconazole (>=8) | 2022 | 36654793 |
| Cg4 | C. glabrata | Clinical isolate | FKS1 | S642L | Single substitution | Q6FTN8 | 1863 | Model | Mismatch residue | Fluconazole (>=32), Itraconazole (>=8) | 2022 | 36654793 |
| Cg5 | C. glabrata | Clinical isolate | FKS1 | S642L | Single substitution | Q6FTN8 | 1863 | Model | Mismatch residue | Fluconazole (>=32), Caspofungin (4) | 2022 | 36654793 |
| CAS08-0725 (CMD00311) | C. glabrata | Clinical isolate | FKS2 | F659Y | Single substitution | Q6FMZ3 | 1897 | Model |  | Fluconazole (64) Micafungin (0.5) Anidulfungin (2) Amphotericin B (1) | 2023 | 36864040 |
| CAS09-1437 (CGA01045) | C. glabrata | Clinical isolate | FKS1 | R631G | Single substitution | Q6FTN8 | 1863 | Model |  | Fluconazole (64) Micafungin (2) Anidulfungin (1) Amphotericin B (1) | 2023 | 36864040 |
| DPL155 (M234) | C. glabrata | Clinical isolate | FKS2 | F659V | Single substitution | Q6FMZ3 | 1897 | Model |  | Micafungin (0.25) Anidulfungin (1) | 2023 | 36864040 |
| DPL217 | C. glabrata | Clinical isolate | FKS2 | S663F | Single substitution | Q6FMZ3 | 1897 | Model |  | Micafungin (0.5) Anidulfungin (1) | 2023 | 36864040 |
| DPL245 (1611) | C. glabrata | Clinical isolate | FKS1 | S629P | Single substitution | Q6FTN8 | 1863 | Model |  | Micafungin (4) Anidulfungin (4) | 2023 | 36864040 |
| DPL274 (3-CPHW20800) | C. glabrata | Clinical isolate | FKS2 | F659S | Single substitution | Q6FMZ3 | 1897 | Model |  | Micafungin (1) Anidulfungin (4) | 2023 | 36864040 |
| Beijing Chaoyang Hospital | C. tropicalis | Clinical isolate | ERG11ERG11ERG11ERG11 | S154FV125AY132FY257H | Single substitutionSingle substitutionSingle substitutionSingle substitution | C5MGS9C5MGS9C5MGS9C5MGS9 | 528528528528 | AF-C5MGS9-F1AF-C5MGS9-F1AF-C5MGS9-F1AF-C5MGS9-F1 |  | Fluconazole | 2023 | 36937265 |
| 19-45 | C. auris | Clinical isolate | FKS1 | F635Y | Single substitution | A0A2H1A4W2 | 1888 | Model |  | Anidulafungin (4) Caspofungin (16) | 2023 | 36975998 |
| 20-16 | C. auris | Clinical isolate | FKS1 | F635C | Single substitution | A0A2H1A4W2 | 1888 | Model |  | Anidulafungin (4) Caspofungin (2) Micafungin (4) | 2023 | 36975998 |
| 21-3 | C. auris | Clinical isolate | FKS1 | S639F | Single substitution | A0A2H1A4W2 | 1888 | Model |  | Anidulafungin (4) Micafungin (4) | 2023 | 36975998 |
| CAAL-F | C. albicans | Clinical isolate | ERG11 | T220L | Single substitution | Q5I4C6 | 528 | AF-Q5I4C6-F1 | Mismatch residue | Voriconazole (32) Fluconazole (128) | 2023 | 37026059 |
| CAAU-A | C. auris | Clinical isolate | ERG11 | Y132F | Single substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 |  | Fluconazole (64) | 2023 | 37026059 |
| CAAU-B | C. auris | Clinical isolate | ERG11 | Y132F | Single substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 |  | Voriconazole (2) Fluconazole (64) | 2023 | 37026059 |
| CAAU-C | C. auris | Clinical isolate | ERG11 | Y132F | Single substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 |  | Fluconazole (>128) | 2023 | 37026059 |
| CAAU-F | C. auris | Clinical isolate | ERG11 | Y132F | Single substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 |  | Voriconazole (1) Fluconazole (>128) | 2023 | 37026059 |
| CAAU-G | C. auris | Clinical isolate | ERG11 | Y132F | Single substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 |  | Voriconazole (8) Fluconazole (>128) | 2023 | 37026059 |
| CAPA-B | C. parapsilosis | Clinical isolate | ERG11 | Y132F | Single substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Voriconazole (1) Fluconazole (32) | 2023 | 37026059 |
| CAPA-C | C. parapsilosis | Clinical isolate | ERG11 | Y132F | Single substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (32) | 2023 | 37026059 |
| CAPA-D | C. parapsilosis | Clinical isolate | ERG11 | Y132F | Single substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (32) | 2023 | 37026059 |
| CAPA-E | C. parapsilosis | Clinical isolate | ERG11 | K143R | Single substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (64) | 2023 | 37026059 |
| CAPA-F | C. parapsilosis | Clinical isolate | ERG11 | Y132F | Single substitution | C7EXA5 | 522 | AF-C7EXA5-F1 |  | Fluconazole (64) | 2023 | 37026059 |
| CAS105 | C. auris | Clinical isolate | CIS2ERG4ERG5SNQ2STE6 | K74EM192IT290TK52NK719N | Single substitutionSingle substitutionSingle substitutionSingle substitutionSingle substitution | A0A2H0ZLW4A0A2H0ZRG0A0A2H0ZI96A0A2H1A137A0A2H0ZW99 | 6254625171486725 | AF-A0A2H0ZLW4-F1AF-A0A2H0ZRG0-F1AF-A0A2H0ZI96-F1ModelAF-A0A2H0ZW99-F1 |  | Amphotericin B (2) Fluconazole (128) | 2023 | 37116861 |
| CAS107 | C. auris | Clinical isolate | CIS2ERG4ERG5SNQ2STE6 | K74EM192IT290TK52NK719N | Single substitutionSingle substitutionSingle substitutionSingle substitutionSingle substitution | A0A2H0ZLW4A0A2H0ZRG0A0A2H0ZI96A0A2H1A137A0A2H0ZW99 | 6254625171486725 | AF-A0A2H0ZLW4-F1AF-A0A2H0ZRG0-F1AF-A0A2H0ZI96-F1ModelAF-A0A2H0ZW99-F1 |  | Amphotericin B (1) Fluconazole (128) | 2023 | 37116861 |
| CAS109 | C. auris | Clinical isolate | CDR1CIS2ERG3ERG4ERG5FKS1SNQ2STE6 | L1124PK74EE68stopM192IT290TS639FK52NK719N | Single substitutionSingle substitutionStopSingle substitutionSingle substitutionSingle substitutionSingle substitutionSingle substitution | A0A2H0ZWG2A0A2H0ZLW4A0A2H0ZNC5A0A2H0ZRG0A0A2H0ZI96A0A2H1A4W2A0A2H1A137A0A2H0ZW99 | 146962536346251718881486725 | ModelAF-A0A2H0ZLW4-F1AF-A0A2H0ZNC5-F1AF-A0A2H0ZRG0-F1AF-A0A2H0ZI96-F1A0A2H1A4W2ModelAF-A0A2H0ZW99-F1 |  | Amphotericin B (2) Fluconazole (128) Caspofungin (8) Anidulafungin (8) Micafungin (8) | 2023 | 37116861 |
| CAS111 | C. auris | Clinical isolate | CIS2ERG4ERG5SNQ2STE6 | K74EM192IT290TK52NK719N | Single substitutionSingle substitutionSingle substitutionSingle substitutionSingle substitution | A0A2H0ZLW4A0A2H0ZRG0A0A2H0ZI96A0A2H1A137A0A2H0ZW99 | 6254625171486725 | AF-A0A2H0ZLW4-F1AF-A0A2H0ZRG0-F1AF-A0A2H0ZI96-F1ModelAF-A0A2H0ZW99-F1 |  | Amphotericin B (4) Fluconazole (64) | 2023 | 37116861 |
| CAS112 | C. auris | Clinical isolate | CIS2ERG4ERG5FKS1SNQ2STE6 | K74EM192IT290TS639FK52NK719N | Single substitutionSingle substitutionSingle substitutionSingle substitutionSingle substitutionSingle substitution | A0A2H0ZLW4A0A2H0ZRG0A0A2H0ZI96A0A2H1A4W2A0A2H1A137A0A2H0ZW99 | 62546251718881486725 | AF-A0A2H0ZLW4-F1AF-A0A2H0ZRG0-F1AF-A0A2H0ZI96-F1A0A2H1A4W2ModelAF-A0A2H0ZW99-F1 |  | Amphotericin B (2) Fluconazole (64) | 2023 | 37116861 |
| CAS113 | C. auris | Clinical isolate | CIS2ERG4ERG5SNQ2STE6 | K74EM192IT290TK52NK719N | Single substitutionSingle substitutionSingle substitutionSingle substitutionSingle substitution | A0A2H0ZLW4A0A2H0ZRG0A0A2H0ZI96A0A2H1A137A0A2H0ZW99 | 6254625171486725 | AF-A0A2H0ZLW4-F1AF-A0A2H0ZRG0-F1AF-A0A2H0ZI96-F1ModelAF-A0A2H0ZW99-F1 |  | Amphotericin B (4) Fluconazole (64) | 2023 | 37116861 |
| CAS115 | C. auris | Clinical isolate | CIS2ERG4ERG5SNQ2STE6 | K74EM192IT290TK52NK719N | Single substitutionSingle substitutionSingle substitutionSingle substitutionSingle substitution | A0A2H0ZLW4A0A2H0ZRG0A0A2H0ZI96A0A2H1A137A0A2H0ZW99 | 6254625171486725 | AF-A0A2H0ZLW4-F1AF-A0A2H0ZRG0-F1AF-A0A2H0ZI96-F1ModelAF-A0A2H0ZW99-F1 |  | Amphotericin B (1) Fluconazole (64) | 2023 | 37116861 |
| CAS116 | C. auris | Clinical isolate | CIS2ERG4ERG5SNQ2STE6 | K74EM192IT290TK52NK719N | Single substitutionSingle substitutionSingle substitutionSingle substitutionSingle substitution | A0A2H0ZLW4A0A2H0ZRG0A0A2H0ZI96A0A2H1A137A0A2H0ZW99 | 6254625171486725 | AF-A0A2H0ZLW4-F1AF-A0A2H0ZRG0-F1AF-A0A2H0ZI96-F1ModelAF-A0A2H0ZW99-F1 |  | Amphotericin B (4) Fluconazole (128) Caspofungin (8) | 2023 | 37116861 |
| CAS119 | C. auris | Clinical isolate | CIS2ERG4ERG5SNQ2STE6 | K74EM192IT290TK52NK719N | Single substitutionSingle substitutionSingle substitutionSingle substitutionSingle substitution | A0A2H0ZLW4A0A2H0ZRG0A0A2H0ZI96A0A2H1A137A0A2H0ZW99 | 6254625171486725 | AF-A0A2H0ZLW4-F1AF-A0A2H0ZRG0-F1AF-A0A2H0ZI96-F1ModelAF-A0A2H0ZW99-F1 |  | Amphotericin B (2) Fluconazole (64) | 2023 | 37116861 |
| CAS120 | C. auris | Clinical isolate | CIS2ERG4ERG5SNQ2STE6 | K74EM192IT290TK52NK719N | Single substitutionSingle substitutionSingle substitutionSingle substitutionSingle substitution | A0A2H0ZLW4A0A2H0ZRG0A0A2H0ZI96A0A2H1A137A0A2H0ZW99 | 6254625171486725 | AF-A0A2H0ZLW4-F1AF-A0A2H0ZRG0-F1AF-A0A2H0ZI96-F1ModelAF-A0A2H0ZW99-F1 |  | Amphotericin B (>16) Fluconazole (16) | 2023 | 37116861 |
| CAS121 | C. auris | Clinical isolate | CIS2ERG4ERG5SNQ2STE6 | K74EM192IT290TK52NK719N | Single substitutionSingle substitutionSingle substitutionSingle substitutionSingle substitution | A0A2H0ZLW4A0A2H0ZRG0A0A2H0ZI96A0A2H1A137A0A2H0ZW99 | 6254625171486725 | AF-A0A2H0ZLW4-F1AF-A0A2H0ZRG0-F1AF-A0A2H0ZI96-F1ModelAF-A0A2H0ZW99-F1 |  | Fluconazole (32) | 2023 | 37116861 |
| CAS123 | C. auris | Clinical isolate | CIS2ERG4ERG5SNQ2STE6 | K74EM192IT290TK52NK719N | Single substitutionSingle substitutionSingle substitutionSingle substitutionSingle substitution | A0A2H0ZLW4A0A2H0ZRG0A0A2H0ZI96A0A2H1A137A0A2H0ZW99 | 6254625171486725 | AF-A0A2H0ZLW4-F1AF-A0A2H0ZRG0-F1AF-A0A2H0ZI96-F1ModelAF-A0A2H0ZW99-F1 |  | Amphotericin B (1) Fluconazole (64) | 2023 | 37116861 |
| CAS124 | C. auris | Clinical isolate | CIS2ERG4ERG5SNQ2STE6 | K74EM192IT290TK52NK719N | Single substitutionSingle substitutionSingle substitutionSingle substitutionSingle substitution | A0A2H0ZLW4A0A2H0ZRG0A0A2H0ZI96A0A2H1A137A0A2H0ZW99 | 6254625171486725 | AF-A0A2H0ZLW4-F1AF-A0A2H0ZRG0-F1AF-A0A2H0ZI96-F1ModelAF-A0A2H0ZW99-F1 |  | Amphotericin B (1) Fluconazole (128) | 2023 | 37116861 |
| CAS126 | C. auris | Clinical isolate | CIS2ERG4ERG5SNQ2STE6 | K74EM192IT290TK52NK719N | Single substitutionSingle substitutionSingle substitutionSingle substitutionSingle substitution | A0A2H0ZLW4A0A2H0ZRG0A0A2H0ZI96A0A2H1A137A0A2H0ZW99 | 6254625171486725 | AF-A0A2H0ZLW4-F1AF-A0A2H0ZRG0-F1AF-A0A2H0ZI96-F1ModelAF-A0A2H0ZW99-F1 |  | Amphotericin B (1) Fluconazole (128) | 2023 | 37116861 |
| CAS127 | C. auris | Clinical isolate | CIS2ERG4ERG5SNQ2STE6 | K74EM192IT290TK52NK719N | Single substitutionSingle substitutionSingle substitutionSingle substitutionSingle substitution | A0A2H0ZLW4A0A2H0ZRG0A0A2H0ZI96A0A2H1A137A0A2H0ZW99 | 6254625171486725 | AF-A0A2H0ZLW4-F1AF-A0A2H0ZRG0-F1AF-A0A2H0ZI96-F1ModelAF-A0A2H0ZW99-F1 |  | Amphotericin B (4) Fluconazole (32) | 2023 | 37116861 |
| CAS129 | C. auris | Clinical isolate | CIS2ERG4ERG5FKS1SNQ2STE6 | K74EM192IT290TS639FK52NK719N | Single substitutionSingle substitutionSingle substitutionSingle substitutionSingle substitutionSingle substitution | A0A2H0ZLW4A0A2H0ZRG0A0A2H0ZI96A0A2H1A4W2A0A2H1A137A0A2H0ZW99 | 62546251718881486725 | AF-A0A2H0ZLW4-F1AF-A0A2H0ZRG0-F1AF-A0A2H0ZI96-F1A0A2H1A4W2ModelAF-A0A2H0ZW99-F1 |  | Amphotericin B (2) Fluconazole (32) Caspofungin (2) Anidulafungin (8) Micafungin (8) | 2023 | 37116861 |
| CAS130 | C. auris | Clinical isolate | CIS2ERG4ERG5SNQ2STE6 | K74EM192IT290TK52NK719N | Single substitutionSingle substitutionSingle substitutionSingle substitutionSingle substitution | A0A2H0ZLW4A0A2H0ZRG0A0A2H0ZI96A0A2H1A137A0A2H0ZW99 | 6254625171486725 | AF-A0A2H0ZLW4-F1AF-A0A2H0ZRG0-F1AF-A0A2H0ZI96-F1ModelAF-A0A2H0ZW99-F1 |  | Amphotericin B (2) Fluconazole (128) | 2023 | 37116861 |
| CAS131 | C. auris | Clinical isolate | CIS2ERG4ERG5SNQ2STE6 | K74EM192IT290TK52NK719N | Single substitutionSingle substitutionSingle substitutionSingle substitutionSingle substitution | A0A2H0ZLW4A0A2H0ZRG0A0A2H0ZI96A0A2H1A137A0A2H0ZW99 | 6254625171486725 | AF-A0A2H0ZLW4-F1AF-A0A2H0ZRG0-F1AF-A0A2H0ZI96-F1ModelAF-A0A2H0ZW99-F1 |  | Amphotericin B (2) Fluconazole (128) | 2023 | 37116861 |
| CAS55 | C. auris | Clinical isolate | CIS2ERG4ERG5SNQ2STE6 | K74EM192IT290TK52NK719N | Single substitutionSingle substitutionSingle substitutionSingle substitutionSingle substitution | A0A2H0ZLW4A0A2H0ZRG0A0A2H0ZI96A0A2H1A137A0A2H0ZW99 | 6254625171486725 | AF-A0A2H0ZLW4-F1AF-A0A2H0ZRG0-F1AF-A0A2H0ZI96-F1ModelAF-A0A2H0ZW99-F1 |  | Amphotericin B (2) Fluconazole (128) Caspofungin (8) | 2023 | 37116861 |
| CAS57 | C. auris | Clinical isolate | CIS2ERG4ERG5SNQ2STE6 | K74EM192IT290TK52NK719N | Single substitutionSingle substitutionSingle substitutionSingle substitutionSingle substitution | A0A2H0ZLW4A0A2H0ZRG0A0A2H0ZI96A0A2H1A137A0A2H0ZW99 | 6254625171486725 | AF-A0A2H0ZLW4-F1AF-A0A2H0ZRG0-F1AF-A0A2H0ZI96-F1ModelAF-A0A2H0ZW99-F1 |  | Amphotericin B (2) Fluconazole (64) | 2023 | 37116861 |
| CAS58 | C. auris | Clinical isolate | CIS2ERG4ERG5SNQ2STE6 | K74EM192IT290TK52NK719N | Single substitutionSingle substitutionSingle substitutionSingle substitutionSingle substitution | A0A2H0ZLW4A0A2H0ZRG0A0A2H0ZI96A0A2H1A137A0A2H0ZW99 | 6254625171486725 | AF-A0A2H0ZLW4-F1AF-A0A2H0ZRG0-F1AF-A0A2H0ZI96-F1ModelAF-A0A2H0ZW99-F1 |  | Amphotericin B (2) Fluconazole (64) | 2023 | 37116861 |
| CAS59 | C. auris | Clinical isolate | CIS2ERG4ERG5SNQ2STE6 | K74EM192IT290TK52NK719N | Single substitutionSingle substitutionSingle substitutionSingle substitutionSingle substitution | A0A2H0ZLW4A0A2H0ZRG0A0A2H0ZI96A0A2H1A137A0A2H0ZW99 | 6254625171486725 | AF-A0A2H0ZLW4-F1AF-A0A2H0ZRG0-F1AF-A0A2H0ZI96-F1ModelAF-A0A2H0ZW99-F1 |  | Amphotericin B (2) Fluconazole (64) | 2023 | 37116861 |
| CAS67 | C. auris | Clinical isolate | CIS2ERG4ERG5SNQ2STE6 | K74EM192IT290TK52NK719N | Single substitutionSingle substitutionSingle substitutionSingle substitutionSingle substitution | A0A2H0ZLW4A0A2H0ZRG0A0A2H0ZI96A0A2H1A137A0A2H0ZW99 | 6254625171486725 | AF-A0A2H0ZLW4-F1AF-A0A2H0ZRG0-F1AF-A0A2H0ZI96-F1ModelAF-A0A2H0ZW99-F1 |  | Amphotericin B (2) Fluconazole (64) | 2023 | 37116861 |
| CAS69 | C. auris | Clinical isolate | CIS2ERG4ERG5SNQ2STE6 | K74EM192IT290TK52NK719N | Single substitutionSingle substitutionSingle substitutionSingle substitutionSingle substitution | A0A2H0ZLW4A0A2H0ZRG0A0A2H0ZI96A0A2H1A137A0A2H0ZW99 | 6254625171486725 | AF-A0A2H0ZLW4-F1AF-A0A2H0ZRG0-F1AF-A0A2H0ZI96-F1ModelAF-A0A2H0ZW99-F1 |  | Amphotericin B (1) Fluconazole (64) | 2023 | 37116861 |
| CAS73 | C. auris | Clinical isolate | CDR1CIS2ERG4ERG5SNQ2STE6 | L1124PK74EM192IT290TK52NK719N | Single substitutionSingle substitutionSingle substitutionSingle substitutionSingle substitutionSingle substitution | A0A2H0ZWG2A0A2H0ZLW4A0A2H0ZRG0A0A2H0ZI96A0A2H1A137A0A2H0ZW99 | 14696254625171486725 | ModelAF-A0A2H0ZLW4-F1AF-A0A2H0ZRG0-F1AF-A0A2H0ZI96-F1ModelAF-A0A2H0ZW99-F1 |  | Amphotericin B (8) Fluconazole (32) | 2023 | 37116861 |
| CAS77 | C. auris | Clinical isolate | CIS2ERG4ERG5SNQ2STE6 | K74EM192IT290TK52NK719N | Single substitutionSingle substitutionSingle substitutionSingle substitutionSingle substitution | A0A2H0ZLW4A0A2H0ZRG0A0A2H0ZI96A0A2H1A137A0A2H0ZW99 | 6254625171486725 | AF-A0A2H0ZLW4-F1AF-A0A2H0ZRG0-F1AF-A0A2H0ZI96-F1ModelAF-A0A2H0ZW99-F1 |  | Amphotericin B (2) Fluconazole (128) | 2023 | 37116861 |
| CAS86 | C. auris | Clinical isolate | CDR1CIS2ERG4ERG5SNQ2STE6 | L1124PK74EM192IT290TK52NK719N | Single substitutionSingle substitutionSingle substitutionSingle substitutionSingle substitutionSingle substitution | A0A2H0ZWG2A0A2H0ZLW4A0A2H0ZRG0A0A2H0ZI96A0A2H1A137A0A2H0ZW99 | 14696254625171486725 | ModelAF-A0A2H0ZLW4-F1AF-A0A2H0ZRG0-F1AF-A0A2H0ZI96-F1ModelAF-A0A2H0ZW99-F1 |  | Amphotericin B (8) Fluconazole (16) | 2023 | 37116861 |
| CAS87 | C. auris | Clinical isolate | CIS2ERG4ERG5SNQ2STE6 | K74EM192IT290TK52NK719N | Single substitutionSingle substitutionSingle substitutionSingle substitutionSingle substitution | A0A2H0ZLW4A0A2H0ZRG0A0A2H0ZI96A0A2H1A137A0A2H0ZW99 | 6254625171486725 | AF-A0A2H0ZLW4-F1AF-A0A2H0ZRG0-F1AF-A0A2H0ZI96-F1ModelAF-A0A2H0ZW99-F1 |  | Amphotericin B (2) Fluconazole (128) | 2023 | 37116861 |
| ct | C. tropicalis | Clinical isolate | ERG11 | Y132F, S154F | Double substitution | P14263 | 528 | Model |  | Fluconazole | 2023 | 37159900 |
| 1923/2021 | C. auris | Clinical isolate | FKS1 | W691L | Single substitution | A0A2H1A4W2 | 1888 | Model |  | Caspofungin (>16) Micafungin (>16) Anidulafungin (2) | 2023 | 37222585 |
| 1980/2021 | C. auris | Clinical isolate | FKS1 | W691L | Single substitution | A0A2H1A4W2 | 1888 | Model |  | Caspofungin (>16) Micafungin (>16) Anidulafungin (2) | 2023 | 37222585 |
| 1985/2021 | C. auris | Clinical isolate | FKS1 | W691L | Single substitution | A0A2H1A4W2 | 1888 | Model |  | Caspofungin (>16) Micafungin (>16) Anidulafungin (16) | 2023 | 37222585 |
| BJCA003 | C. auris | Clinical isolate | ERG11 | Y132F | Single substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 |  | Fluconazole (>=128) Amphotericin B (2) | 2023 | 37222986 |
| 1 | C. glabrata | Clinical isolate | MSH2PDR1 | V239LL825P | Single substitutionSingle substitution | Q6FQA9Q6FXU7 | 9571107 | AF-Q6FQA9-F1AF-Q6FXU7-F1 |  | Fluconazole (256) Voriconazole (4) Posaconazole (>8) Itraconazole (>16) Micafungin (0.25) | 2023 | 37233226 |
| 10 | C. glabrata | Clinical isolate | ERG3MSH2PDR1 | F226fsV239LL825P | FrameshiftSingle substitutionSingle substitution | P50860Q6FQA9Q6FXU7 | 3649571107 | AF-P50860-F1AF-Q6FQA9-F1AF-Q6FXU7-F1 |  | Amphotericin B (2) Fluconazole (256) Voriconazole (8) Posaconazole (>8) Caspofungin (0.5) Micafungin (0.5) | 2023 | 37233226 |
| 2 | C. glabrata | Clinical isolate | FKS1FKS2MSH2PDR1 | C499fsI661_L662insFV239LL825P | FrameshiftInsertionSingle substitutionSingle substitution | Q6FTN8Q6FMZ3Q6FQA9Q6FXU7 | 186318979571107 | ModelModelAF-Q6FQA9-F1AF-Q6FXU7-F1 |  | Fluconazole (256) Voriconazole (8) Posaconazole (>8) Itraconazole (>16) Anidulafungin (>8) Caspofungin (>8) Micafungin (0.25P) | 2023 | 37233226 |
| 3 | C. glabrata | Clinical isolate | ERG6MSH2PDR1 | A158fsV239LL825P | FrameshiftSingle substitutionSingle substitution | Q6FRZ7Q6FQA9Q6FXU7 | 3729571107 | AF-Q6FRZ7-F1AF-Q6FQA9-F1AF-Q6FXU7-F1 |  | Amphotericin B (16) Voriconazole (0.5) Micafungin (0.25) | 2023 | 37233226 |
| 4 | C. glabrata | Clinical isolate | MSH2PDR1 | V239LL825P | Single substitutionSingle substitution | Q6FQA9Q6FXU7 | 9571107 | AF-Q6FQA9-F1AF-Q6FXU7-F1 |  | Fluconazole (256) Voriconazole (4) Posaconazole (>8) Itraconazole (>16) Caspofungin (0.25) | 2023 | 37233226 |
| 5 | C. glabrata | Clinical isolate | FKS1FKS2MSH2PDR1 | C499fsI661_L662insFV239LL825P | FrameshiftInsertionSingle substitutionSingle substitution | Q6FTN8Q6FMZ3Q6FQA9Q6FXU7 | 186318979571107 | ModelModelAF-Q6FQA9-F1AF-Q6FXU7-F1 |  | Amphotericin B (2) Anidulafungin (>8) Caspofungin (>8) Micafungin (>8) | 2023 | 37233226 |
| 6 | C. glabrata | Clinical isolate | ERG6MSH2PDR1 | A158fsV239LL825P | FrameshiftSingle substitutionSingle substitution | Q6FRZ7Q6FQA9Q6FXU7 | 3729571107 | AF-Q6FRZ7-F1AF-Q6FQA9-F1AF-Q6FXU7-F1 |  | Amphotericin B (8) Voriconazole (0.5) Micafungin (0.25) | 2023 | 37233226 |
| 7 | C. glabrata | Clinical isolate | ERG6MSH2PDR1 | A158fsV239LL825P | FrameshiftSingle substitutionSingle substitution | Q6FRZ7Q6FQA9Q6FXU7 | 3729571107 | AF-Q6FRZ7-F1AF-Q6FQA9-F1AF-Q6FXU7-F1 |  | Amphotericin B (12) Voriconazole (0.5) Micafungin (0.25) | 2023 | 37233226 |
| 8 | C. glabrata | Clinical isolate | ERG3ERG4MSH2PDR1 | G236DP227fsV239LL825P | Single substitutionFrameshiftSingle substitutionSingle substitution | P50860Q6FXU8Q6FQA9Q6FXU7 | 3644649571107 | AF-P50860-F1AF-Q6FXU8-F1AF-Q6FQA9-F1AF-Q6FXU7-F1 |  | Amphotericin B (3) Fluconazole (>256) Voriconazole (>8) Posaconazole (>8) Itraconazole (>16) Anidulafungin (0.5) Caspofungin (0.5) Micafungin (2) | 2023 | 37233226 |
| 9 | C. glabrata | Clinical isolate | FKS2MSH2PDR1 | F659delV239LL825P | DeletionSingle substitutionSingle substitution | Q6FMZ3Q6FQA9Q6FXU7 | 18979571107 | ModelAF-Q6FQA9-F1AF-Q6FXU7-F1 |  | Fluconazole (>256) Voriconazole (>8) Posaconazole (>8) Itraconazole (>16) Anidulafungin (2) Caspofungin (>8) Micafungin (1) | 2023 | 37233226 |
| NCPF8985 | C. auris | Clinical isolate | FKS1 | R1354H | Single substitution | A0A2H1A4W2 | 1888 | A0A2H1A4W2 |  | Caspofungin (8) | 2023 | 37233240 |
| ca | C. albicans | Clinical isolate | CDR2 | R683T, L1337F | Double substitution | P78595 | 1499 | AF-P78595-F1 |  | Nystatin (>2) | 2023 | 37233291 |
| Kw 2153/18 | C. kefyr | Clinical isolate | ERG3ERG6 | S218PF363L | Single substitutionSingle substitution | W0T7I0W0TAZ1 | 352375 | AF-W0T7I0-F1AF-W0TAZ1-F1 |  | Etest[Amphotericin B (4) Fluconazole (256) Voriconazole (32) Micafungin (1)], SYO[Amphotericin B (2)] | 2024 | 37358415 |
| Kw 3267/17 | C. kefyr | Clinical isolate | ERG2ERG6 | A113SK163Q | Single substitutionSingle substitution | W0TF99W0TAZ1 | 223375 | AF-W0TF99-F1AF-W0TAZ1-F1 |  | SYO[Amphotericin B (2)] | 2024 | 37358415 |
| Kw 3352/11 | C. kefyr | Clinical isolate | ERG2ERG3 | G121CN313S | Single substitutionSingle substitution | W0TF99W0T7I0 | 223352 | AF-W0TF99-F1AF-W0T7I0-F1 |  | Etest[Amphotericin B (32)], SYO[Amphotericin B (8)] | 2024 | 37358415 |
| Kw135/15 | C. kefyr | Clinical isolate | ERG11ERG2 | K151R, Y227DE105K | Double substitutionSingle substitution | W0TA79W0TF99 | 526223 | AF-W0TA79-F1AF-W0TF99-F1 |  | Etest[Amphotericin B (32) Fluconazole (3)], SYO[Amphotericin B (8) Fluconazole (4)] | 2024 | 37358415 |
| Kw196-11/20 | C. kefyr | Clinical isolate | ERG2 | L107S | Single substitution | W0TF99 | 223 | AF-W0TF99-F1 |  | Etest[Amphotericin B (32)], SYO[Amphotericin B (2)] | 2024 | 37358415 |
| Kw20-12/20 | C. kefyr | Clinical isolate | ERG2ERG6 | G90CF363L | Single substitutionSingle substitution | W0TF99W0TAZ1 | 223375 | AF-W0TF99-F1AF-W0TAZ1-F1 |  | Etest[Amphotericin B (32)], SYO[Amphotericin B (8)] | 2024 | 37358415 |
| R10 | C. albicans | Clinical isolate | TAC1 | A736V | Single substitution | Q1WCU6 | 981 | AF-Q1WCU6-F1 |  | Fluconazole (8) | 2023 | 37387494 |
| R11 | C. albicans | Clinical isolate | ERG11TAC1 | K143RA736T | Single substitutionSingle substitution | P10613Q1WCU6 | 528981 | 5V5ZAF-Q1WCU6-F1 |  | Fluconazole (8) | 2023 | 37387494 |
| R2 | C. albicans | Clinical isolate | ERG11 | K143R | Single substitution | P10613 | 528 | 5V5Z |  | Fluconazole (>256) | 2023 | 37387494 |
| R3 | C. albicans | Clinical isolate | ERG11TAC1 | K143RA736T | Single substitutionSingle substitution | P10613Q1WCU6 | 528981 | 5V5ZAF-Q1WCU6-F1 |  | Fluconazole (16) | 2023 | 37387494 |
| R4 | C. albicans | Clinical isolate | ERG11TAC1 | K143RA736T | Single substitutionSingle substitution | P10613Q1WCU6 | 528981 | 5V5ZAF-Q1WCU6-F1 |  | Fluconazole (16) | 2023 | 37387494 |
| R5 | C. albicans | Clinical isolate | ERG11TAC1 | K143RA736T | Single substitutionSingle substitution | P10613Q1WCU6 | 528981 | 5V5ZAF-Q1WCU6-F1 |  | Fluconazole (16) | 2023 | 37387494 |
| R6 | C. albicans | Clinical isolate | ERG11 | G464S | Single substitution | P10613 | 528 | 5V5Z |  | Fluconazole (16) | 2023 | 37387494 |
| R7 | C. albicans | Clinical isolate | TAC1 | R673L | Single substitution | Q1WCU6 | 981 | AF-Q1WCU6-F1 |  | Fluconazole (8) | 2023 | 37387494 |
| R9 | C. albicans | Clinical isolate | ERG11 | F145L | Single substitution | P10613 | 528 | 5V5Z |  | Fluconazole (8) | 2023 | 37387494 |
| D11.1 | C. lusitaniae | Clinical isolate | FKS1RLM1RPL8BSIP3 | L685FN181KA161VD333K | Single substitutionSingle substitutionSingle substitutionSingle substitution | UPI00202CA3ADUPI00202C4402UPI0012A9C4CEUPI00202BCDCF | 18864203321185 | ModelAF-A0A5Q0IQS7-F1ModelModel |  | Micafungin (1) | 2023 | 37428075 |
| D6.1 | C. lusitaniae | Clinical isolate | FKS1 | R1352C | Single substitution | UPI00202CA3AD | 1886 | Model |  | Micafungin (0.25) | 2023 | 37428075 |
| D7.1 | C. lusitaniae | Clinical isolate | FKS1SEC24SYG1 | L1355ST831TE386K | Single substitutionSingle substitutionSingle substitution | UPI00202CA3ADC4Y0Z0UPI0012A91E08 | 1886932912 | ModelAF-C4Y0Z0-F1Model |  | Micafungin (0.25) | 2023 | 37428075 |
| D7.2 | C. lusitaniae | Clinical isolate | FKS1 | L1355S | Single substitution | UPI00202CA3AD | 1886 | Model |  | Micafungin (0.25) | 2023 | 37428075 |
| D8.1 | C. lusitaniae | Clinical isolate | FKS1 | L1355S | Single substitution | UPI00202CA3AD | 1886 | Model |  | Micafungin (0.25) | 2023 | 37428075 |
| D8.2 | C. lusitaniae | Clinical isolate | FKS1 | L1355S | Single substitution | UPI00202CA3AD | 1886 | Model |  | Micafungin (0.25) | 2023 | 37428075 |
| D9.1 | C. lusitaniae | Clinical isolate | ERG3 | Q308K | Single substitution | C4YAI2 | 367 | AF-C4YAI2-F1 |  | Micafungin (0.25) Fluconazole (2) | 2023 | 37428075 |
| Ch4′r | C. haemulonii | Clinical isolate | FKS1 | R1354H | Single substitution | A0A2V1ALV5 | 1888 | Model |  | Micafungin (>=4) Caspofungin (>=2) Anidulafungin (>=4) | 2023 | 37623630 |
| clade III | C. auris | Clinical isolate | ERG11 | V125A, F126L | Double substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 |  | Fluconazole (>=32) | 2023 | 37735719 |
| clade IV | C. auris | Clinical isolate | ERG11 | K177R, N335S, E343D | Multiple substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 |  | Fluconazole (>=32) | 2023 | 37735719 |
| 1 (Blood, 2018, E) | C. auris | Clinical isolate | ERG11 | K143R | Single substitution | A0A2H1A309 | 524 | AF-A0A2H4QC40-F1 |  | Fluconazole | 2023 | 37888235 |
| 11 (AR0383) | C. auris | Clinical isolate | ERG11 | F126L | Single substitution | A0A2H1A309 | 524 | AF-A0A2H4QC40-F1 |  | Fluconazole | 2023 | 37888235 |
| 12 (AR0384) | C. auris | Clinical isolate | ERG11 | F126L | Single substitution | A0A2H1A309 | 524 | AF-A0A2H4QC40-F1 |  | Fluconazole | 2023 | 37888235 |
| 13 (AR0385) | C. auris | Clinical isolate | ERG11 | Y132F | Single substitution | A0A2H1A309 | 524 | AF-A0A2H4QC40-F1 |  | Fluconazole | 2023 | 37888235 |
| 14 (AR0386) | C. auris | Clinical isolate | ERG11 | Y132F | Single substitution | A0A2H1A309 | 524 | AF-A0A2H4QC40-F1 |  | Fluconazole | 2023 | 37888235 |
| 16 (AR0388) | C. auris | Clinical isolate | ERG11 | K143R | Single substitution | A0A2H1A309 | 524 | AF-A0A2H4QC40-F1 |  | Fluconazole | 2023 | 37888235 |
| 17 (AR0389) | C. auris | Clinical isolate | ERG11 | Y132F | Single substitution | A0A2H1A309 | 524 | AF-A0A2H4QC40-F1 |  | Fluconazole, Amphotericin B | 2023 | 37888235 |
| 18 (AR0390) | C. auris | Clinical isolate | ERG11 | K143R | Single substitution | A0A2H1A309 | 524 | AF-A0A2H4QC40-F1 |  | Fluconazole | 2023 | 37888235 |
| cgl_107 | C. glabrata | Clinical isolate | FKS1FKS2 | Y3D, W929stopS663F | ComplexSingle substitution | Q6FTN8Q6FMZ3 | 18631897 | ModelModel |  | Caspofungin (1) Micafungin (0.25) Anidulafungin (1) | 2023 | 37974063 |
| cgl_118 | C. glabrata | Clinical isolate | FKS1FKS2 | F625delE1117stop | DeletionStop | Q6FTN8Q6FMZ3 | 18631897 | ModelModel |  | Caspofungin (>8) Micafungin (>8) Anidulafungin (4) | 2023 | 37974063 |
| cgl_123 | C. glabrata | Clinical isolate | FKS2 | S663F | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (0.5) | 2023 | 37974063 |
| cgl_14 | C. glabrata | Clinical isolate | FKS2 | R1378H, Q927R | Double substitution | Q6FMZ3 | 1897 | Model |  | Caspofungin (0.5) | 2023 | 37974063 |
| cgl_178 | C. glabrata | Clinical isolate | FKS1FKS2ZCF15 | G14SF659del, T926PG154N, N189T, A213T, P319H | Single substitutionComplexMultiple substitution | Q6FTN8Q6FMZ3Q6FTY2 | 186318971049 | ModelModelAF-Q6FTY2-F1 |  | Caspofungin (>8) Micafungin (4) Anidulafungin (4) | 2023 | 37974063 |
| cgl_179 | C. glabrata | Clinical isolate | FKS1FKS2 | K1323EY1825fs | Single substitutionFrameshift | Q6FTN8Q6FMZ3 | 18631897 | ModelModel |  | Micafungin (0.5) | 2023 | 37974063 |
| cgl_181 | C. glabrata | Clinical isolate | FKS2 | F659del | Deletion | Q6FMZ3 | 1897 | Model |  | Caspofungin (2) Micafungin (2) Anidulafungin (1) | 2023 | 37974063 |
| cgl_182 | C. glabrata | Clinical isolate | FKS2ZCF15 | S663PM19I | Single substitutionSingle substitution | Q6FMZ3Q6FTY2 | 18971049 | ModelAF-Q6FTY2-F1 |  | Caspofungin (1) Micafungin (1) Anidulafungin (2) | 2023 | 37974063 |
| cgl_183 | C. glabrata | Clinical isolate | FKS2 | F659C | Single substitution | Q6FMZ3 | 1897 | Model |  | Caspofungin (1) | 2023 | 37974063 |
| cgl_22 | C. glabrata | Clinical isolate | FKS1FKS2ZCF15 | D632VG1116DQ193fs, S862L | Single substitutionSingle substitutionComplex | Q6FTN8Q6FMZ3Q6FTY2 | 186318971049 | ModelModelAF-Q6FTY2-F1 |  | Caspofungin (1) Micafungin (0.5) Anidulafungin (1) | 2023 | 37974063 |
| cgl_37 | C. glabrata | Clinical isolate | FKS2 | Q12K, S663F | Double substitution | Q6FMZ3 | 1897 | Model |  | Caspofungin (0.25) Anidulafungin (1) | 2023 | 37974063 |
| cgl_40 | C. glabrata | Clinical isolate | FKS2 | Q12K, S663F | Double substitution | Q6FMZ3 | 1897 | Model |  | Caspofungin (1) Micafungin (0.25) Anidulafungin (0.5) | 2023 | 37974063 |
| cgl_88 | C. glabrata | Clinical isolate | FKS2 | F659del | Deletion | Q6FMZ3 | 1897 | Model |  | Anidulafungin (0.5) | 2023 | 37974063 |
| Case 1 | C. auris | Clinical | ERG11 | F126L | Single substitution | A0A411K953 | 524 | AF-A0A411K953-F1 |  | Fluconazole (>=64) | 2024 | 38164742 |
| Case 2 | C. auris | Clinical | ERG11 | F126L | Single substitution | A0A411K953 | 524 | AF-A0A411K953-F1 |  | Fluconazole (>=64) | 2024 | 38164742 |
| Case 3 | C. auris | Clinical | ERG11 | F126L | Single substitution | A0A411K953 | 524 | AF-A0A411K953-F1 |  | Fluconazole (>=64) | 2024 | 38164742 |
| Case 4 | C. auris | Clinical | ERG11 | F126L | Single substitution | A0A411K953 | 524 | AF-A0A411K953-F1 |  | Fluconazole (>=64) | 2024 | 38164742 |
| Case 5 | C. auris | Clinical | ERG11 | F126L | Single substitution | A0A411K953 | 524 | AF-A0A411K953-F1 |  | Fluconazole (>=64) | 2024 | 38164742 |
| Case 6 | C. auris | Clinical | ERG11 | Y132F | Single substitution | A0A411K953 | 524 | AF-A0A411K953-F1 |  | Fluconazole (>=64), Amphotericin B (2) | 2024 | 38164742 |
| Case 7 | C. auris | Clinical | ERG11 | Y132F | Single substitution | A0A411K953 | 524 | AF-A0A411K953-F1 |  | Fluconazole (>=64), Amphotericin B (2) | 2024 | 38164742 |
| clade I | C. auris | Clinical isolate | ERG11 | Y132F | Single substitution | A0A411K953 | 524 | AF-A0A411K953-F1 |  | Fluconazole (>=64) Amphotericin B (2) | 2024 | 38164742 |
| clade III | C. auris | Clinical isolate | ERG11 | V125A, F126L | Double substitution | A0A411K953 | 524 | AF-A0A411K953-F1 |  | Fluconazole (>=64) | 2024 | 38164742 |
| 109 | C. albicans | Clinical isolate | ERG11 | K128T | Single substitution | A0A0A0Y2M9 | 528 | AF-A0A0A0Y2M9-F1 |  | Fluconazole (128) | 2024 | 38179314 |
| 128 | C. albicans | Clinical isolate | ERG11 | K128T | Single substitution | A0A0A0Y2M9 | 528 | AF-A0A0A0Y2M9-F1 |  | Fluconazole (128) | 2024 | 38179314 |
| 15XL | C. albicans | Clinical isolate | ERG11 | K128T | Single substitution | A0A0A0Y2M9 | 528 | AF-A0A0A0Y2M9-F1 |  | Fluconazole (128) | 2024 | 38179314 |
| 26 | C. albicans | Clinical isolate | ERG11 | K128T | Single substitution | A0A0A0Y2M9 | 528 | AF-A0A0A0Y2M9-F1 |  | Fluconazole (128) | 2024 | 38179314 |
| 32 | C. albicans | Clinical isolate | ERG11 | K128T | Single substitution | A0A0A0Y2M9 | 528 | AF-A0A0A0Y2M9-F1 |  | Fluconazole (128) | 2024 | 38179314 |
| 38 | C. albicans | Clinical isolate | ERG11 | K128T | Single substitution | A0A0A0Y2M9 | 528 | AF-A0A0A0Y2M9-F1 |  | Fluconazole (128) | 2024 | 38179314 |
| 53 | C. albicans | Clinical isolate | ERG11 | K128T | Single substitution | A0A0A0Y2M9 | 528 | AF-A0A0A0Y2M9-F1 |  | Fluconazole (128) | 2024 | 38179314 |
| 55 | C. albicans | Clinical isolate | ERG11 | K128T | Single substitution | A0A0A0Y2M9 | 528 | AF-A0A0A0Y2M9-F1 |  | Fluconazole (128) | 2024 | 38179314 |
| 92-2 | C. albicans | Clinical isolate | ERG11 | K128T | Single substitution | A0A0A0Y2M9 | 528 | AF-A0A0A0Y2M9-F1 |  | Fluconazole (128) | 2024 | 38179314 |
| 94 | C. albicans | Clinical isolate | ERG11 | K128T | Single substitution | A0A0A0Y2M9 | 528 | AF-A0A0A0Y2M9-F1 |  | Fluconazole (128) | 2024 | 38179314 |
| 99 | C. albicans | Clinical isolate | ERG11 | K128T | Single substitution | A0A0A0Y2M9 | 528 | AF-A0A0A0Y2M9-F1 |  | Fluconazole (128) | 2024 | 38179314 |
| NRZ-2015-156 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (2) | 2024 | 38206004 |
| NRZ-2015-198 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (2) | 2024 | 38206004 |
| NRZ-2016-160 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (2) | 2024 | 38206004 |
| NRZ-2016-205 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (2) | 2024 | 38206004 |
| NRZ-2016-244 | C. glabrata | Clinical isolate | FKS2 | S663F | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (2) | 2024 | 38206004 |
| NRZ-2017-449i | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (2) | 2024 | 38206004 |
| NRZ-2017-521 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (2) | 2024 | 38206004 |
| NRZ-2017-538 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (2) | 2024 | 38206004 |
| NRZ-2018-016 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (2) | 2024 | 38206004 |
| NRZ-2018-190 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (2) | 2024 | 38206004 |
| NRZ-2018-320 | C. glabrata | Clinical isolate | FKS2 | F659del | Deletion | Q6FMZ3 | 1897 | Model |  | Anidulafungin (4) Ibrexafungerp (>4) | 2024 | 38206004 |
| NRZ-2018-606 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (2) | 2024 | 38206004 |
| NRZ-2019-198 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (2) | 2024 | 38206004 |
| NRZ-2019-400 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (2) | 2024 | 38206004 |
| NRZ-2020-008 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (2) | 2024 | 38206004 |
| NRZ-2020-260 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (2) | 2024 | 38206004 |
| NRZ-2020-444 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (2) | 2024 | 38206004 |
| NRZ-2020-537f* | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (2) | 2024 | 38206004 |
| NRZ-2020-587 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (2) | 2024 | 38206004 |
| NRZ-2020-675 | C. glabrata | Clinical isolate | FKS2 | F659del | Deletion | Q6FMZ3 | 1897 | Model |  | Anidulafungin (4) Ibrexafungerp (>4) | 2024 | 38206004 |
| NRZ-2020-780 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (2) | 2024 | 38206004 |
| NRZ-2021-0026 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (2) | 2024 | 38206004 |
| NRZ-2021-0075 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (2) | 2024 | 38206004 |
| NRZ-2021-0255 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (2) | 2024 | 38206004 |
| NRZ-2021-0299i | C. glabrata | Clinical isolate | FKS2 | F659S | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (4) Ibrexafungerp (>4) | 2024 | 38206004 |
| NRZ-2021-0392f* | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (2) | 2024 | 38206004 |
| NRZ-2021-0451f* | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (2) | 2024 | 38206004 |
| NRZ-2021-0498 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (2) | 2024 | 38206004 |
| NRZ-2021-0577 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (2) | 2024 | 38206004 |
| NRZ-2021-0737 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (2) | 2024 | 38206004 |
| NRZ-2021-0738 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (2) | 2024 | 38206004 |
| NRZ-2022-0202 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (2) | 2024 | 38206004 |
| CAS08-0725_S45 | C. glabrata | Clinical isolate | FKS2 | F659Y | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (1) Caspofungin (0.5) | 2024 | 38265207 |
| CAS09-1513_S89 | C. glabrata | Clinical isolate | PDR1 | R376Q | Single substitution | Q6FXU7 | 1107 | AF-Q6FXU7-F1 |  | Fluconazole (256) | 2024 | 38265207 |
| CAS09_0869_S25 | C. glabrata | Clinical isolate | FKS2 | F659Y | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (1) Caspofungin (2) | 2024 | 38265207 |
| CAS10-2227_S31 | C. glabrata | Clinical isolate | PDR1 | N1091D | Single substitution | Q6FXU7 | 1107 | AF-Q6FXU7-F1 |  | Fluconazole (64) | 2024 | 38265207 |
| CAS10-2596_S8 | C. glabrata | Clinical isolate | PDR1 | G1099S | Single substitution | Q6FXU7 | 1107 | AF-Q6FXU7-F1 |  | Fluconazole (64) | 2024 | 38265207 |
| CAS11-2996_S80 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (4) Caspofungin (>16) | 2024 | 38265207 |
| CAS12-3684_S68 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (1) Caspofungin (2) | 2024 | 38265207 |
| CAS12-3743_S58 | C. glabrata | Clinical isolate | PDR1 | G1079R | Single substitution | Q6FXU7 | 1107 | AF-Q6FXU7-F1 |  | Fluconazole (128) | 2024 | 38265207 |
| CAS12-4416_S11 | C. glabrata | Clinical isolate | FKS1 | S629P | Single substitution | Q6FTN8 | 1863 | Model |  | Anidulafungin (2) Caspofungin (2) | 2024 | 38265207 |
| CAS13-4530_S71 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (4) Caspofungin (>16) | 2024 | 38265207 |
| CAS13-4778_S42 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (0.5) Caspofungin (0.5) | 2024 | 38265207 |
| CAS13-5011_S55 | C. glabrata | Clinical isolate | FKS2PDR1 | S663PE714D | Single substitutionSingle substitution | Q6FMZ3Q6FXU7 | 18971107 | ModelAF-Q6FXU7-F1 |  | Anidulafungin (2) Caspofungin (8) Fluconazole (64) | 2024 | 38265207 |
| CAS13-5257_S26 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (2) Caspofungin (8) | 2024 | 38265207 |
| CAS14-5368_S62 | C. glabrata | Clinical isolate | FKS2 | S663P | Single substitution | Q6FMZ3 | 1897 | Model |  | Anidulafungin (2) Caspofungin (8) | 2024 | 38265207 |
| CAS14-5468_S77 21 | C. glabrata | Clinical isolate | FKS1 | S629P | Single substitution | Q6FTN8 | 1863 | Model |  | Anidulafungin (2) Caspofungin (4) | 2024 | 38265207 |
| CAS156677_S67 | C. glabrata | Clinical isolate | FKS1 | S629P | Single substitution | Q6FTN8 | 1863 | Model |  | Anidulafungin (2) Caspofungin (8) | 2024 | 38265207 |
| clade III | C. auris | Clinical isolate | FKS1 | S639F | Single substitution | A0A2H1A4W2 | 1888 | A0A2H1A4W2 |  | Amphotericin B (2) Fluconazole (>64) | 2024 | 38276031 |
| B18580 | C. auris | Clinical isolate | ERG11TAC1B | F444LS611P | Single substitutionSingle substitution | A0A2H1A309A0A894YV30 | 524868 | AF-A0A2H1A309-F1AF-A0A894YV30-F1 |  | Fluconazole (128) | 2024 | 38299868 |
| B18581 | C. auris | Clinical isolate | ERG11TAC1B | F444LS611P | Single substitutionSingle substitution | A0A2H1A309A0A894YV30 | 524868 | AF-A0A2H1A309-F1AF-A0A894YV30-F1 |  | Fluconazole (64) | 2024 | 38299868 |
| B18582 | C. auris | Clinical isolate | ERG11TAC1B | F444LS611P | Single substitutionSingle substitution | A0A2H1A309A0A894YV30 | 524868 | AF-A0A2H1A309-F1AF-A0A894YV30-F1 |  | Fluconazole (128) | 2024 | 38299868 |
| B18583 | C. auris | Clinical isolate | ERG11TAC1B | F444LS611P | Single substitutionSingle substitution | A0A2H1A309A0A894YV30 | 524868 | AF-A0A2H1A309-F1AF-A0A894YV30-F1 |  | Fluconazole (64) | 2024 | 38299868 |
| B18584 | C. auris | Clinical isolate | ERG11TAC1B | F444LS611P | Single substitutionSingle substitution | A0A2H1A309A0A894YV30 | 524868 | AF-A0A2H1A309-F1AF-A0A894YV30-F1 |  | Fluconazole (64) | 2024 | 38299868 |
| B18585 | C. auris | Clinical isolate | ERG11TAC1B | F444LS611P | Single substitutionSingle substitution | A0A2H1A309A0A894YV30 | 524868 | AF-A0A2H1A309-F1AF-A0A894YV30-F1 |  | Fluconazole (128) | 2024 | 38299868 |
| B18587 | C. auris | Clinical isolate | ERG11TAC1B | F444LS611P | Single substitutionSingle substitution | A0A2H1A309A0A894YV30 | 524868 | AF-A0A2H1A309-F1AF-A0A894YV30-F1 |  | Fluconazole (64) | 2024 | 38299868 |
| B18592 | C. auris | Clinical isolate | ERG11TAC1B | F444LS611P | Single substitutionSingle substitution | A0A2H1A309A0A894YV30 | 524868 | AF-A0A2H1A309-F1AF-A0A894YV30-F1 |  | Fluconazole (64) | 2024 | 38299868 |
| B18593 | C. auris | Clinical isolate | ERG11TAC1B | F444LS611P | Single substitutionSingle substitution | A0A2H1A309A0A894YV30 | 524868 | AF-A0A2H1A309-F1AF-A0A894YV30-F1 |  | Fluconazole (64) | 2024 | 38299868 |
| B18594 | C. auris | Clinical isolate | ERG11TAC1B | F444LS611P | Single substitutionSingle substitution | A0A2H1A309A0A894YV30 | 524868 | AF-A0A2H1A309-F1AF-A0A894YV30-F1 |  | Fluconazole (32) | 2024 | 38299868 |
| B18595 | C. auris | Clinical isolate | ERG11TAC1B | F444LS611P | Single substitutionSingle substitution | A0A2H1A309A0A894YV30 | 524868 | AF-A0A2H1A309-F1AF-A0A894YV30-F1 |  | Fluconazole (32) | 2024 | 38299868 |
| B18596 | C. auris | Clinical isolate | ERG11TAC1B | F444LS611P | Single substitutionSingle substitution | A0A2H1A309A0A894YV30 | 524868 | AF-A0A2H1A309-F1AF-A0A894YV30-F1 |  | Fluconazole (256) | 2024 | 38299868 |
| B18597 | C. auris | Clinical isolate | ERG11TAC1B | F444LS611P | Single substitutionSingle substitution | A0A2H1A309A0A894YV30 | 524868 | AF-A0A2H1A309-F1AF-A0A894YV30-F1 |  | Fluconazole (64) | 2024 | 38299868 |
| B18598 | C. auris | Clinical isolate | ERG11TAC1B | F444LS611P | Single substitutionSingle substitution | A0A2H1A309A0A894YV30 | 524868 | AF-A0A2H1A309-F1AF-A0A894YV30-F1 |  | Fluconazole (64) | 2024 | 38299868 |
| B18599 | C. auris | Clinical isolate | ERG11TAC1B | F444LS611P | Single substitutionSingle substitution | A0A2H1A309A0A894YV30 | 524868 | AF-A0A2H1A309-F1AF-A0A894YV30-F1 |  | Fluconazole (64) | 2024 | 38299868 |
| B18600 | C. auris | Clinical isolate | ERG11TAC1B | F444LS611P | Single substitutionSingle substitution | A0A2H1A309A0A894YV30 | 524868 | AF-A0A2H1A309-F1AF-A0A894YV30-F1 |  | Fluconazole (128) | 2024 | 38299868 |
| B18601 | C. auris | Clinical isolate | ERG11TAC1B | F444LS611P | Single substitutionSingle substitution | A0A2H1A309A0A894YV30 | 524868 | AF-A0A2H1A309-F1AF-A0A894YV30-F1 |  | Fluconazole (256) | 2024 | 38299868 |
| B18602 | C. auris | Clinical isolate | ERG11 | Y132F | Single substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 |  | Fluconazole (256) | 2024 | 38299868 |
| B18603 | C. auris | Clinical isolate | ERG11 | Y132F | Single substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 |  | Fluconazole (256) | 2024 | 38299868 |
| B18604 | C. auris | Clinical isolate | ERG11 | Y132F | Single substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 |  | Fluconazole (256) | 2024 | 38299868 |
| B18605 | C. auris | Clinical isolate | ERG11 | Y132F | Single substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 |  | Fluconazole (256) | 2024 | 38299868 |
| B18606 | C. auris | Clinical isolate | ERG11TAC1B | F444LS611P | Single substitutionSingle substitution | A0A2H1A309A0A894YV30 | 524868 | AF-A0A2H1A309-F1AF-A0A894YV30-F1 |  | Fluconazole (64) | 2024 | 38299868 |
| B18607 | C. auris | Clinical isolate | ERG11TAC1B | F444LS611P | Single substitutionSingle substitution | A0A2H1A309A0A894YV30 | 524868 | AF-A0A2H1A309-F1AF-A0A894YV30-F1 |  | Fluconazole (64) | 2024 | 38299868 |
| B18608 | C. auris | Clinical isolate | ERG11 | Y132F | Single substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 |  | Fluconazole (256) | 2024 | 38299868 |
| B18609 | C. auris | Clinical isolate | ERG11 | Y132F | Single substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 |  | Fluconazole (256) | 2024 | 38299868 |
| B18611 | C. auris | Clinical isolate | ERG11 | Y132F | Single substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 |  | Fluconazole (256) | 2024 | 38299868 |
| B18612 | C. auris | Clinical isolate | ERG11TAC1B | F444LS611P | Single substitutionSingle substitution | A0A2H1A309A0A894YV30 | 524868 | AF-A0A2H1A309-F1AF-A0A894YV30-F1 |  | Fluconazole (64) | 2024 | 38299868 |
| B18614 | C. auris | Clinical isolate | ERG11 | F444L | Single substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 |  | Fluconazole (32) | 2024 | 38299868 |
| B20796 | C. auris | Clinical isolate | ERG11 | K143R | Single substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 |  | Fluconazole (128) | 2024 | 38299868 |
| B20798 | C. auris | Clinical isolate | ERG11 | F444L | Single substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 |  | Fluconazole (32) | 2024 | 38299868 |
| B20799 | C. auris | Clinical isolate | ERG11 | F444L | Single substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 |  | Fluconazole (32) | 2024 | 38299868 |
| B20800 | C. auris | Clinical isolate | ERG11 | Y132F | Single substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 |  | Fluconazole (256) | 2024 | 38299868 |
| B20801 | C. auris | Clinical isolate | ERG11 | Y132F | Single substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 |  | Fluconazole (256) | 2024 | 38299868 |
| B20802 | C. auris | Clinical isolate | ERG11 | Y132F | Single substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 |  | Fluconazole (256) | 2024 | 38299868 |
| B20803 | C. auris | Clinical isolate | ERG11 | Y132F | Single substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 |  | Fluconazole (256) | 2024 | 38299868 |
| B20804 | C. auris | Clinical isolate | ERG11 | Y132F | Single substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 |  | Fluconazole (256) | 2024 | 38299868 |
| B20805 | C. auris | Clinical isolate | ERG11 | Y132F | Single substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 |  | Fluconazole (256) | 2024 | 38299868 |
| B20806 | C. auris | Clinical isolate | ERG11 | Y132F | Single substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 |  | Fluconazole (256) | 2024 | 38299868 |
| B20809 | C. auris | Clinical isolate | ERG11 | Y132F | Single substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 |  | Fluconazole (256) | 2024 | 38299868 |
| B20810 | C. auris | Clinical isolate | ERG11 | Y132F | Single substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 |  | Fluconazole (256) | 2024 | 38299868 |
| B20811 | C. auris | Clinical isolate | ERG11 | Y132F | Single substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 |  | Fluconazole (256) | 2024 | 38299868 |
| B20812 | C. auris | Clinical isolate | ERG11 | Y132F | Single substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 |  | Fluconazole (256) | 2024 | 38299868 |
| B20813 | C. auris | Clinical isolate | ERG11 | Y132F | Single substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 |  | Fluconazole (256) | 2024 | 38299868 |
| B20814 | C. auris | Clinical isolate | ERG11 | Y132F | Single substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 |  | Fluconazole (256) | 2024 | 38299868 |
| B20816 | C. auris | Clinical isolate | ERG11 | Y132F | Single substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 |  | Fluconazole (256) | 2024 | 38299868 |
| B20817 | C. auris | Clinical isolate | ERG11 | Y132F | Single substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 |  | Fluconazole (256) | 2024 | 38299868 |
| B20820 | C. auris | Clinical isolate | ERG11 | Y132F | Single substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 |  | Fluconazole (256) | 2024 | 38299868 |
| B20821 | C. auris | Clinical isolate | ERG11 | Y132F | Single substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 |  | Fluconazole (256) | 2024 | 38299868 |
| B20824 | C. auris | Clinical isolate | ERG11 | Y132F | Single substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 |  | Fluconazole (256) | 2024 | 38299868 |
| B20825 | C. auris | Clinical isolate | ERG11 | Y132F | Single substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 |  | Fluconazole (256) | 2024 | 38299868 |
| B20826 | C. auris | Clinical isolate | ERG11 | Y132F | Single substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 |  | Fluconazole (256) | 2024 | 38299868 |
| B20831 | C. auris | Clinical isolate | ERG11TAC1B | F444LS611P | Single substitutionSingle substitution | A0A2H1A309A0A894YV30 | 524868 | AF-A0A2H1A309-F1AF-A0A894YV30-F1 |  | Fluconazole (256) | 2024 | 38299868 |
| B20835 | C. auris | Clinical isolate | ERG11 | Y132F | Single substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 |  | Fluconazole (256) | 2024 | 38299868 |
| B20838 | C. auris | Clinical isolate | ERG11 | Y132F | Single substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 |  | Fluconazole (256) | 2024 | 38299868 |
| B20850 | C. auris | Clinical isolate | ERG11 | Y132F | Single substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 |  | Fluconazole (256) | 2024 | 38299868 |
| B20851 | C. auris | Clinical isolate | ERG11TAC1B | F444LS611P | Single substitutionSingle substitution | A0A2H1A309A0A894YV30 | 524868 | AF-A0A2H1A309-F1AF-A0A894YV30-F1 |  | Fluconazole (256) | 2024 | 38299868 |
| B20852 | C. auris | Clinical isolate | ERG11 | F444L | Single substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 |  | Fluconazole (32) | 2024 | 38299868 |
| B20855 | C. auris | Clinical isolate | ERG11 | F444L | Single substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 |  | Fluconazole (64) | 2024 | 38299868 |
| B20856 | C. auris | Clinical isolate | ERG11TAC1B | F444LS611P | Single substitutionSingle substitution | A0A2H1A309A0A894YV30 | 524868 | AF-A0A2H1A309-F1AF-A0A894YV30-F1 |  | Fluconazole (256) | 2024 | 38299868 |
| MIL-ITA-2023 | C. auris | Clinical isolate | ERG11ERG11FCY1 | G54WY132FS70R | Single substitutionSingle substitutionSingle substitution | A0A2H1A309A0A2H1A309A0A2H0ZDJ1 | 524524150 | AF-A0A2H1A309-F1AF-A0A2H1A309-F1AF-A0A2H0ZDJ1-F1 |  | Posaconazole (>=8) Fluconazole (>=32) 5-Flucytosine (32) | 2024 | 38557967 |
| 101008 | C. auris | Clinical isolate | ERG11FCY1 | Y132FS70R | Single substitutionSingle substitution | A0A2H1A309A0A2H0ZDJ1 | 524150 | AF-A0A2H1A309-F1AF-A0A2H0ZDJ1-F1 |  | Fluconazole (256) Voriconazole (32) | 2024 | 38842332 |
| 101009 | C. auris | Clinical isolate | ERG11FCY1 | Y132FS70R | Single substitutionSingle substitution | A0A2H1A309A0A2H0ZDJ1 | 524150 | AF-A0A2H1A309-F1AF-A0A2H0ZDJ1-F1 |  | Fluconazole (256) Voriconazole (32) | 2024 | 38842332 |
| 101019 | C. auris | Clinical isolate | ERG11FCY1 | Y132FS70R | Single substitutionSingle substitution | A0A2H1A309A0A2H0ZDJ1 | 524150 | AF-A0A2H1A309-F1AF-A0A2H0ZDJ1-F1 |  | CDC[Fluconazole (256) Voriconazole (32)] CLSI-M60[5-Flucytosine (>=64)] | 2024 | 38842332 |
| 101022 | C. auris | Clinical isolate | ERG11FCY1 | Y132FS70R | Single substitutionSingle substitution | A0A2H1A309A0A2H0ZDJ1 | 524150 | AF-A0A2H1A309-F1AF-A0A2H0ZDJ1-F1 |  | Fluconazole (256) Voriconazole (32) | 2024 | 38842332 |
| 101077 | C. auris | Clinical isolate | ERG11FCY1 | Y132FS70R | Single substitutionSingle substitution | A0A2H1A309A0A2H0ZDJ1 | 524150 | AF-A0A2H1A309-F1AF-A0A2H0ZDJ1-F1 |  | Fluconazole (256) Voriconazole (32) | 2024 | 38842332 |
| 101082 | C. auris | Clinical isolate | ERG11FCY1 | Y132FS70R | Single substitutionSingle substitution | A0A2H1A309A0A2H0ZDJ1 | 524150 | AF-A0A2H1A309-F1AF-A0A2H0ZDJ1-F1 |  | Fluconazole (256) Voriconazole (32) | 2024 | 38842332 |
| 101087 | C. auris | Clinical isolate | ERG11FCY1 | Y132FS70R | Single substitutionSingle substitution | A0A2H1A309A0A2H0ZDJ1 | 524150 | AF-A0A2H1A309-F1AF-A0A2H0ZDJ1-F1 |  | Fluconazole (256) Voriconazole (32) | 2024 | 38842332 |
| 101101 | C. auris | Clinical isolate | ERG11FCY1 | Y132FS70R | Single substitutionSingle substitution | A0A2H1A309A0A2H0ZDJ1 | 524150 | AF-A0A2H1A309-F1AF-A0A2H0ZDJ1-F1 |  | Fluconazole (256) Voriconazole (32) | 2024 | 38842332 |
| CTR12 | C. tropicalis | Clinical isolate | FKS1 | S654P | Single substitution | B6S6L8 | 1904 | Model |  | Anidulafungin (4) Rezafungin (4) Caspofungin (4) Fluconazole (128) | 2024 | 38921383 |
| CTR16 | C. tropicalis | Clinical isolate | FKS1 | S654P, R1220T | Double substitution | B6S6L8 | 1904 | Model |  | Anidulafungin (2) Rezafungin (2) Caspofungin (4) Fluconazole (128) | 2024 | 38921383 |
| CTR17 | C. tropicalis | Clinical isolate | FKS1 | S654P | Single substitution | B6S6L8 | 1904 | Model |  | Anidulafungin (1) Rezafungin (2) Caspofungin (4) Fluconazole (128) | 2024 | 38921383 |
| CTR18 | C. tropicalis | Clinical isolate | FKS1 | S654P, G324R | Double substitution | B6S6L8 | 1904 | Model |  | Anidulafungin (1) Rezafungin (2) Caspofungin (2) Fluconazole (128) | 2024 | 38921383 |
| CTR20 | C. tropicalis | Clinical isolate | FKS1 | S654P | Single substitution | B6S6L8 | 1904 | Model |  | Anidulafungin (1) Rezafungin (2) Caspofungin (4) Fluconazole (64) | 2024 | 38921383 |
| CTR21 | C. tropicalis | Clinical isolate | FKS1 | S654P | Single substitution | B6S6L8 | 1904 | Model |  | Anidulafungin (1) Rezafungin (2) Caspofungin (4) Fluconazole (128) | 2024 | 38921383 |
| CTR22 | C. tropicalis | Clinical isolate | FKS1 | S654P | Single substitution | B6S6L8 | 1904 | Model |  | Anidulafungin (1) Rezafungin (2) Caspofungin (4) Fluconazole (128) | 2024 | 38921383 |
| CTR24 | C. tropicalis | Clinical isolate | FKS1 | S654P | Single substitution | B6S6L8 | 1904 | Model |  | Anidulafungin (1) Rezafungin (0.5) Caspofungin (2) Fluconazole (64) | 2024 | 38921383 |
| CTR25 | C. tropicalis | Clinical isolate | FKS1 | S654P | Single substitution | B6S6L8 | 1904 | Model |  | Anidulafungin (1) Rezafungin (1) Caspofungin (2) Fluconazole (128) | 2024 | 38921383 |
| CTR3 | C. tropicalis | Clinical isolate | FKS1 | S654P | Single substitution | B6S6L8 | 1904 | Model |  | Anidulafungin (1) Rezafungin (2) Caspofungin (4) Fluconazole (64) | 2024 | 38921383 |
| CTR30 | C. tropicalis | Clinical isolate | FKS1 | S654P | Single substitution | B6S6L8 | 1904 | Model |  | Anidulafungin (1) Rezafungin (2) Caspofungin (4) Fluconazole (128) | 2024 | 38921383 |
| CTR36 | C. tropicalis | Clinical isolate | FKS1 | S654P | Single substitution | B6S6L8 | 1904 | Model |  | Anidulafungin (1) Rezafungin (2) Caspofungin (4) Fluconazole (64) | 2024 | 38921383 |
| CTR8 | C. tropicalis | Clinical isolate | FKS1 | S654P | Single substitution | B6S6L8 | 1904 | Model |  | Anidulafungin (2) Rezafungin (2) Caspofungin (4) Fluconazole (128) | 2024 | 38921383 |
| RICU38 A382 | C. auris | Clinical | FKS1 | S639P | Single substitution | A0A2H1A4W2 | 1888 | Model |  | Micafungin (8), Caspofungin (8), Anidulafungin (4) | 2024 | 38989545 |
| RICU40 A430 | C. auris | Clinical | FKS1 | S639Y | Single substitution | A0A2H1A4W2 | 1888 | Model |  | Micafungin (8), Caspofungin (2), Anidulafungin (8) | 2024 | 38989545 |
| RICU40 A441 | C. auris | Clinical | FKS1 | S639F | Single substitution | A0A2H1A4W2 | 1888 | Model |  | Micafungin (8), Caspofungin (2), Anidulafungin (8) | 2024 | 38989545 |
| RICU40 A447 | C. auris | Clinical | FKS1 | S639F | Single substitution | A0A2H1A4W2 | 1888 | Model |  | Micafungin (8), Caspofungin (2), Anidulafungin (8) | 2024 | 38989545 |
| RICU40 A451 | C. auris | Clinical | FKS1 | S639F | Single substitution | A0A2H1A4W2 | 1888 | Model |  | Micafungin (8), Caspofungin (2), Anidulafungin (8) | 2024 | 38989545 |
| RICU7 A33 | C. auris | Clinical | FKS1 | S639F | Single substitution | A0A2H1A4W2 | 1888 | Model |  | Micafungin (8), Caspofungin (4), Anidulafungin (8) | 2024 | 38989545 |
| RICU7 A34 | C. auris | Clinical | FKS1 | S639F | Single substitution | A0A2H1A4W2 | 1888 | Model |  | Micafungin (8), Caspofungin (4), Anidulafungin (8) | 2024 | 38989545 |
| SICU8 A466 | C. auris | Clinical | FKS1 | S639P | Single substitution | A0A2H1A4W2 | 1888 | Model |  | Micafungin (>8), Caspofungin (>8), Anidulafungin (8) | 2024 | 38989545 |
| Y0021 | C. auris | Clinical | FKS1 | S639F | Single substitution | A0A2H1A4W2 | 1888 | Model |  | Micafungin (8), Caspofungin (8), Anidulafungin (4) | 2024 | 38989545 |
| R1 | C. albicans | Clinical | UPC2 | S249K, P259W, Q703L | Multiple substitution | Q59QC7 | 712 | AF-Q59QC7-F1 |  | Fluconazole, Posaconazole | 2024 | 39059553 |
| R2 | C. albicans | Clinical | UPC2 | S401R, A446Y | Double substitution | Q59QC7 | 712 | AF-Q59QC7-F1 |  | Fluconazole, Posaconazole | 2024 | 39059553 |
| CJ_3469 | C. auris | Clinical | CDR1CIS2ERG11ERG4FKS1TAC1 | E709DK74EY132FM192IF635IA583S | Single substitutionSingle substitutionSingle substitutionSingle substitutionSingle substitutionSingle substitution | A0A2H1A768A0A2H0ZLW4A0A2H1A309A0A2H0ZRG0A0A2H1A4W2A0A2H0ZHW2 | 15086255244621888868 | ModelAF-A0A2H0ZLW4-F1AF-A0A2H1A309-F1AF-A0A2H0ZRG0-F1ModelAF-A0A2H0ZHW2-F1 |  | Fluconazole (>=128), Amphotericin B (>=2), Caspofungin (>=2) | 2024 | 39186218 |
| CJ_4775 | C. auris | Clinical | CDR1CIS2ERG11ERG4FKS1TAC1 | E709DK74EY132FM192IR1354HA583S | Single substitutionSingle substitutionSingle substitutionSingle substitutionSingle substitutionSingle substitution | A0A2H1A768A0A2H0ZLW4A0A2H1A309A0A2H0ZRG0A0A2H1A4W2A0A2H0ZHW2 | 15086255244621888868 | ModelAF-A0A2H0ZLW4-F1AF-A0A2H1A309-F1AF-A0A2H0ZRG0-F1ModelAF-A0A2H0ZHW2-F1 |  | Fluconazole (>=128), Amphotericin B (>=2), Caspofungin (>=2) | 2024 | 39186218 |
| CJ_4810 | C. auris | Clinical | CDR1CIS2ERG11ERG4FKS1TAC1 | E709DK74EY132FM192IW1471LA583S | Single substitutionSingle substitutionSingle substitutionSingle substitutionSingle substitutionSingle substitution | A0A2H1A768A0A2H0ZLW4A0A2H1A309A0A2H0ZRG0A0A2H1A4W2A0A2H0ZHW2 | 15086255244621888868 | ModelAF-A0A2H0ZLW4-F1AF-A0A2H1A309-F1AF-A0A2H0ZRG0-F1ModelAF-A0A2H0ZHW2-F1 |  | Fluconazole (>=128), Amphotericin B (>=2), Caspofungin (>=2) | 2024 | 39186218 |
| CA01 | C. auris | Clinical | ERG11 | Y132F | Single substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 |  | Fluconazole (256) | 2024 | 39284275 |
| Clade I | C. auris | Clinical | ERG11 | Y132F, K143R | Double substitution | A0A2H1A309 | 524 | AF-A0A2H1A309-F1 |  | Fluconazole (>=32), Amphotericin B (>=2) | 2024 | 39335013 |
| CT1 | C. tropicalis | Clinical | ERG11 | G464S | Single substitution | C5MGS9 | 528 | AF-C5MGS9-F1 |  | Fluconazole (128) | 2024 | 39354378 |
| CT2 | C. tropicalis | Clinical | ERG11 | G464S | Single substitution | C5MGS9 | 528 | AF-C5MGS9-F1 |  | Fluconazole (128) | 2024 | 39354378 |
| CT3 | C. tropicalis | Clinical | ERG11 | G464S | Single substitution | C5MGS9 | 528 | AF-C5MGS9-F1 |  | Fluconazole (128) | 2024 | 39354378 |
| CT8 | C. tropicalis | Clinical | ERG11 | G464S | Single substitution | C5MGS9 | 528 | AF-C5MGS9-F1 |  | Fluconazole (256) | 2024 | 39354378 |
| RJ070 | C. glabrata | Clinical | FKS2 | S663P | Single substitution | E2GKZ6 | 1897 | Model |  | Caspofungin (2) | 2024 | 39435186 |
| RJ097 | C. glabrata | Clinical | FKS1FKS2 | S629PW1497stop | Single substitutionStop | E2GKZ4E2GKZ6 | 18631897 | AF-P40989-F1Model |  | Caspofungin (>8) | 2024 | 39435186 |
| RJ111 | C. glabrata | Clinical | FKS2 | S663P | Single substitution | E2GKZ6 | 1897 | Model |  | Caspofungin (0.5), Fluconazole (64), Voriconazole (2) | 2024 | 39435186 |
| RJ162 | C. glabrata | Clinical | FKS2 | P667T | Single substitution | E2GKZ6 | 1897 | Model |  | Caspofungin (1), Fluconazole (64), Voriconazole (2), Itraconazole (>16) | 2024 | 39435186 |
| RJ270 | C. glabrata | Clinical | FKS1 | S629P | Single substitution | E2GKZ4 | 1863 | AF-P40989-F1 |  | Caspofungin (8) | 2024 | 39435186 |
| YM140066 | C. tropicalis | Clinical | ERG11 | Y132F, S154F | Double substitution | C5MGS9 | 528 | AF-C5MGS9-F1 |  | Fluconazole (64) | 2024 | 39447155 |
| YM140132 | C. tropicalis | Clinical | ERG11 | Y132F, S154F | Double substitution | C5MGS9 | 528 | AF-C5MGS9-F1 |  | Fluconazole (32) | 2024 | 39447155 |
| YM140298 | C. tropicalis | Clinical | ERG11 | Y132F, S154F | Double substitution | C5MGS9 | 528 | AF-C5MGS9-F1 |  | Fluconazole (8) | 2024 | 39447155 |
| YM140372 | C. tropicalis | Clinical | ERG11 | Y132F, S154F | Double substitution | C5MGS9 | 528 | AF-C5MGS9-F1 |  | Fluconazole (32) | 2024 | 39447155 |
| YM140441 | C. tropicalis | Clinical | ERG11 | Y132F, S154F | Double substitution | C5MGS9 | 528 | AF-C5MGS9-F1 |  | Fluconazole (32) | 2024 | 39447155 |
| YM140586 | C. tropicalis | Clinical | ERG11 | Y132F, S154F | Double substitution | C5MGS9 | 528 | AF-C5MGS9-F1 |  | Fluconazole (64) | 2024 | 39447155 |
| YM141055 | C. tropicalis | Clinical | ERG11 | Y132F, S154F | Double substitution | C5MGS9 | 528 | AF-C5MGS9-F1 |  | Fluconazole (>64) | 2024 | 39447155 |
| Cg20 | C. glabrata | Clinical | MSH2 | V239L, L359S, S431P | Multiple substitution | Q6FQA9 | 957 | AF-Q6FQA9-F1 |  | Fluconazole, Itraconazole, Voriconazole | 2024 | 39516859 |
| Cg34 | C. glabrata | Clinical | MSH2 | V239L, L359S, S431P | Multiple substitution | Q6FQA9 | 957 | AF-Q6FQA9-F1 |  | Fluconazole, Itraconazole, Voriconazole | 2024 | 39516859 |
| Cg43 | C. glabrata | Clinical | MSH2 | V239L, L359S, S431P | Multiple substitution | Q6FQA9 | 957 | AF-Q6FQA9-F1 |  | Fluconazole, Itraconazole, Voriconazole | 2024 | 39516859 |
| Cg48 | C. glabrata | Clinical | MSH2 | V239L, L359S, S431P | Multiple substitution | Q6FQA9 | 957 | AF-Q6FQA9-F1 |  | Fluconazole, Itraconazole, Voriconazole | 2024 | 39516859 |
| Cg49 | C. glabrata | Clinical | MSH2 | V239L, L359S, S431P | Multiple substitution | Q6FQA9 | 957 | AF-Q6FQA9-F1 |  | Fluconazole, Itraconazole, Voriconazole | 2024 | 39516859 |
| Cg56 | C. glabrata | Clinical | MSH2 | V239L, L359S, S431P | Multiple substitution | Q6FQA9 | 957 | AF-Q6FQA9-F1 |  | Fluconazole, Itraconazole, Voriconazole | 2024 | 39516859 |
| Cg57 | C. glabrata | Clinical | MSH2 | L359S | Single substitution | Q6FQA9 | 957 | AF-Q6FQA9-F1 |  | Fluconazole, Itraconazole, Voriconazole | 2024 | 39516859 |
| Cg59 | C. glabrata | Clinical | MSH2 | V239L, L359S, S431P | Multiple substitution | Q6FQA9 | 957 | AF-Q6FQA9-F1 |  | Fluconazole, Itraconazole, Voriconazole | 2024 | 39516859 |
| Cg60 | C. glabrata | Clinical | MSH2 | V239L, L359S | Double substitution | Q6FQA9 | 957 | AF-Q6FQA9-F1 |  | Fluconazole, Itraconazole, Voriconazole | 2024 | 39516859 |
| Cg64 | C. glabrata | Clinical | MSH2 | V239L | Single substitution | Q6FQA9 | 957 | AF-Q6FQA9-F1 |  | Fluconazole, Itraconazole, Voriconazole | 2024 | 39516859 |
| Cg68 | C. glabrata | Clinical | MSH2 | P202S | Single substitution | Q6FQA9 | 957 | AF-Q6FQA9-F1 | Mismatch residue | Fluconazole, Itraconazole, Voriconazole | 2024 | 39516859 |
| Cg83 | C. glabrata | Clinical | MSH2 | P208S | Single substitution | Q6FQA9 | 957 | AF-Q6FQA9-F1 |  | Fluconazole, Itraconazole, Voriconazole | 2024 | 39516859 |
| Cg86 | C. glabrata | Clinical | MSH2 | V239L, L359S, S431P | Multiple substitution | Q6FQA9 | 957 | AF-Q6FQA9-F1 |  | Fluconazole, Itraconazole, Voriconazole | 2024 | 39516859 |
| Cg98 | C. glabrata | Clinical | MSH2 | V239L, L359S, S431P | Multiple substitution | Q6FQA9 | 957 | AF-Q6FQA9-F1 |  | Fluconazole, Itraconazole, Voriconazole | 2024 | 39516859 |
| Cg99 | C. glabrata | Clinical | MSH2 | V239L, S431P | Double substitution | Q6FQA9 | 957 | AF-Q6FQA9-F1 |  | Fluconazole, Itraconazole, Voriconazole | 2024 | 39516859 |
| CP-AR-542 | C. parapsilosis | Clinical | ERG11 | Y132F | Single substitution | A0A0K1LGA0 | 522 | AF-A0A1A9C770-F1 | Structure not available | Fluconazole (256) | 2024 | 39590671 |
| CP-AR-544 | C. parapsilosis | Clinical | ERG11 | Y132F | Single substitution | A0A0K1LGA0 | 522 | AF-A0A1A9C770-F1 | Structure not available | Fluconazole (256) | 2024 | 39590671 |
| ECIFIG1112 | C. tropicalis | Clinical | ERG11TAC1UPC2 | Y132F, S154FN164IA251T, Q289L | Double substitutionSingle substitutionDouble substitution | P14263C5MGV3C5MAR7 | 528943782 | AF-P14263-F1AF-C5MGV3-F1AF-C5MAR7-F1 |  | Fluconazole (256), Voriconazole (8) | 2024 | 39641536 |
| ECIFIG1831 | C. tropicalis | Clinical | ERG11TAC1UPC2 | Y132F, S154FN164IA251T, Q289L | Double substitutionSingle substitutionDouble substitution | P14263C5MGV3C5MAR7 | 528943782 | AF-P14263-F1AF-C5MGV3-F1AF-C5MAR7-F1 |  | Fluconazole (256), Voriconazole (8) | 2024 | 39641536 |
| ECIFIG21032 | C. tropicalis | Clinical | UPC2 | A251T, Q289L, T393I | Multiple substitution | C5MAR7 | 782 | AF-C5MAR7-F1 |  | Anidulafungin (1), Micafungin (1), Fluconazole (8) | 2024 | 39641536 |
| ECIFIG685 | C. tropicalis | Clinical | ERG11TAC1UPC2 | Y132F, S154FN164IA251T, Q289L | Double substitutionSingle substitutionDouble substitution | P14263C5MGV3C5MAR7 | 528943782 | AF-P14263-F1AF-C5MGV3-F1AF-C5MAR7-F1 |  | Fluconazole (128), Voriconazole (8) | 2024 | 39641536 |
| ECIFIG687 | C. tropicalis | Clinical | ERG11TAC1UPC2 | Y132F, S154FN164IA251T, Q289L | Double substitutionSingle substitutionDouble substitution | P14263C5MGV3C5MAR7 | 528943782 | AF-P14263-F1AF-C5MGV3-F1AF-C5MAR7-F1 |  | Fluconazole (256), Voriconazole (8) | 2024 | 39641536 |
| I12 | C. albicans | Laboratory strain | ERG11 | F105L | Single substitution | P10613 | 528 | 5V5Z |  | Fluconazole (8) | 1997 | 9228762 |
| I4 | C. albicans | Laboratory strain | ERG11 | F105L | Single substitution | P10613 | 528 | 5V5Z |  | Fluconazole (128) | 1997 | 9228762 |
| I8 | C. albicans | Laboratory strain | ERG11 | G464S | Single substitution | P10613 | 528 | 5V5Z |  | Fluconazole (>256), Itraconazole (>32), Ketoconazole (16) | 1997 | 9228762 |
| P2 | C. albicans | Laboratory strain | ERG11 | F105L, G464S | Double substitution | P10613 | 528 | 5V5Z |  | Fluconazole (>256), Itraconazole (>32) | 1997 | 9228762 |
| P3 | C. albicans | Laboratory strain | ERG11 | F105L | Single substitution | P10613 | 528 | 5V5Z |  | Fluconazole (>256) | 1997 | 9228762 |
| P5 | C. albicans | Laboratory strain | ERG11 | F105L | Single substitution | P10613 | 528 | 5V5Z |  | Fluconazole (>256), Itraconazole (>32), Ketoconazole (3) | 1997 | 9228762 |
| TU3 | C. albicans | Laboratory strain | ERG11 | G448E | Single substitution | P10613 | 528 | 5V5Z | Structure not available | Fluconazole (>256), Itraconazole (4), Ketoconazole (0.5) | 1997 | 9228762 |
| TU6 | C. albicans | Laboratory strain | ERG11 | F105L | Single substitution | P10613 | 528 | 5V5Z |  | Fluconazole (>256), Itraconazole (6) | 1997 | 9228762 |
| TU9 | C. albicans | Laboratory strain | ERG11 | K287R, G464S | Double substitution | P10613 | 528 | 5V5Z |  | Fluconazole (>256), Itraconazole (>32) | 1997 | 9228762 |
| C26 | C. albicans | Clinical isolate | ERG11 | Y132H, S405F | Double substitution | P10613 | 528 | 5V5Z |  | Fluconazole (>128) | 1998 | 9527767 |
| C39 | C. albicans | Clinical isolate | ERG11 | S405F | Single substitution | P10613 | 528 | 5V5Z |  | Fluconazole (32) | 1998 | 9527767 |
| C40 | C. albicans | Clinical isolate | ERG11 | Y132H, R467K | Double substitution | P10613 | 528 | 5V5Z |  | Fluconazole (128) | 1998 | 9527767 |
| C56 | C. albicans | Clinical isolate | ERG11 | G129A, G464S | Double substitution | P10613 | 528 | 5V5Z |  | Fluconazole (128) | 1998 | 9527767 |
| C82 | C. albicans | Clinical isolate | ERG11 | S405F | Single substitution | P10613 | 528 | 5V5Z |  | Fluconazole (32) | 1998 | 9527767 |